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Abstract 
Background: Pressure ulcers (PUs) have been identified as a worldwide 
problem that contribute significantly to increasing health care costs, compromise an 
individual’s health, and in some cases contribute to mortality. Generally, PUs are 
considered predictable and preventable, thus making them a priority patient safety and 
risk management issue. Despite a number of published guidelines for PU prevention 
in general healthcare contexts, PU prevention guidelines for the intensive care patient 
is not a well-defined area. The intensive care context poses special challenges to PU 
prevention due to the high acuity of patients and the highly invasive nature of 
interventions and therapies critically ill patients receive. Accordingly, PU prevalence 
and incidence rates reported in the adult critical care population are as high as 56%. 
However, no data is available for the Kingdom of Saudi Arabia (KSA) intensive care 
context. These high rates could reflect a gap between dissemination and 
implementation of evidence-based PU prevention approaches in intensive care. 
Importantly, this is an under-researched area of need in the KSA context. 
In response to these challenges, this research proposed a comprehensive process, 
integrating a care bundle approach of best available evidence and a model of research 
implementation, the Ottawa Model of Research Use (OMRU). The care bundle 
approach provides a protocol of high quality evidence of PU prevention strategies, 
while the OMRU, a knowledge translation framework, can be used to guide the 
translation of the care bundle into action. 
Aim: The overarching research aim guiding this study is to examine the 
effectiveness of an interventional patient skin integrity care bundle in the intensive 
care unit to best manage skin integrity in critically ill patients. 
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Design: In Phase One Part A, a prospective observation study was conducted to 
generate benchmark profiles of the problem (PU incidence). Phase One Part B used 
survey methods, (the Attitude towards Pressure ulcer Prevention instrument [APuP], 
and the modified PU prevention in the Paediatric Intensive Care Unit (PICU) "Barriers 
and Facilitators") to identify the barriers and facilitators to research use in the intensive 
care unit (ICU) context. Tailored research transfer strategies were enacted based on 
the findings. In Phase Two, a two-arm cluster randomised experimental control trial 
and observation design was used to monitor and evaluate the implementation of the 
PU prevention bundle.  
Participants: Participants were recruited from the ICUs of two major tertiary 
care hospitals in KSA. In Phase One Part A, a total of 84 ICU patients were screened 
on a second daily basis until discharge or death, over a consecutive 30-day period. In 
Phase One Part B, 56 of the available 60 intensive care Registered Nurses (RNs) 
participated in the study. In Phase Two, a total of 140 ICU patients were recruited; 70 
control participants (with a total of 728 days of observation) and 70 intervention 
participants (with a total of 784 days of observation).  
Result: Phase One Part A identified a cumulative hospital-acquired PU incidence 
rate of 39⋅3% (33/84 participants). The incidence of medical device-related PUs was 
8⋅3% (7/84). According to binary logistic regression analyses, age, longer stay in the 
ICU, and infrequent repositioning were significant predictors of all stages of PUs, 
while the length of stay in the ICU and infrequent repositioning were associated with 
the development of PUs staged II–IV. 
Phase One Part B found no significant differences between the demographic 
characteristics of the participants with the RNs attitude subscale, and perceived 
barriers and facilitators towards PU prevention in the ICU. Several barriers influenced 
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RNs ability in PU prevention; including time demands (β=0.388, p=0.011), limitation 
of RNs knowledge (β=-0.632, p=0.022), and the current documentation format 
(β=0.344, p=0.046). Impact of workload and lack of education were also reported as 
barriers that impeded the implementation of high quality in PU prevention evidence in 
the ICU. However, there were some statistically significant facilitating factors that 
increased the RN’s ability to implement PU prevention strategies in the ICU, such as 
ease of obtaining pressure relieving support surfaces (β=-0.388, p=0.007), 
collaboration with interdisciplinary teams (nursing/medicine/pharmacy/dietary) 
(β=0.37,p=0.02), and availability of appropriate skin care products (β=0.44, p=0.015). 
Moreover, RNs showed a moderately positive attitude towards PU prevention 
(μ=38.19/52, 73.44%). However, two factors showed lower attitude scores; the impact 
of a PU on the patient and society (μ=8.19/12, 68%), and the priority of PU prevention 
(μ=8.28/12, 69%) in their daily routine work.  
Phase Two revealed no significant differences between both groups 
(intervention and control) in all demographic characteristics and all clinical 
characteristics, except time in the operating room prior to ICU admission. Braden 
Scale data showed that a majority of the participants in both groups were at high risk 
of PU development. PU cumulative incidence was significantly lower in the 
intervention group (7.14%) compared to the control group (32.86%). Poisson 
regression modelling inferred that the rate of any new PUs in the intervention group 
was 70% lower in the intervention group than the control. The intervention, the PU 
prevention care bundle, contributed positively in lowering the severity of PU 
development between the intervention and control group, with significant differences 
in stage I and stage II PUs between the groups (p= .001 and p=0.029 respectively).  
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Conclusion: This the first study to examine the phenomena of PUs and PU 
prevention strategies in the KSA context. Further, this study was the first to determine 
the incidence of PU events in KSA ICUs and to test the effectiveness of a PU 
prevention bundle that comprises the best available evidence to improve skin integrity. 
The initial incidence rate of 39% was higher than that reported in other international 
studies. This indicates the importance of putting PU prevention strategies into practice 
in this setting. The PU prevention bundle, based on a tailored assessment of the health 
care setting (ICUs) and clinicians (RNs), and implemented effectively in practice had 
a significant effect in reducing PU development in critically ill patients in the ICU. 
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A Note Regarding Format  
This dissertation is a thesis by publication. It contains six articles that have either 
been published or are under blind-peer review by refereed journals, therefore, the 
wording and spelling of the journals are as published and some contain American 
spelling. The logical flow of the thesis is maintained by introducing these articles 
where they fit most appropriately into the thesis structure. All articles have been 
reformatted using the APA referencing style and reconfigured to Word to provide 
consistent formatting throughout the thesis. Moreover, tables and figures have been 
numbered continuously throughout the thesis, for consistency. 
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Chapter 1: Introduction 
Pressure ulcers (PUs) represent a common but potentially preventable 
condition seen most often in high-risk populations such as elderly persons, those with 
physical impairments, and the critically ill. Evidence suggests that PUs can be 
prevented with the implementation of PU prevention guidelines or a care bundle 
(Elliott, McKinley, & Fox, 2008; Gray-Siracusa & Schrier, 2011; Schindler, 2009). 
Care bundle approaches have been frequently used in clinical practice, and have been 
shown to provide improvement in the process of care and patient outcomes (Fulbrook 
& Mooney, 2003; Gray-Siracusa & Schrier, 2011; Kiernan & Downie, 2011; 
Pronovost et al., 2006; Schindler et al., 2013). While there is considerable evidence 
for PU prevention globally (Coyer et al., 2015; Dibsie, 2008; Elliott et al., 2008), a PU 
prevention bundle suited to the Kingdom of Saudi Arabia (KSA) intensive care unit 
(ICU) context has not been clearly defined, nor previously implemented and tested. 
Therefore, a new PU prevention bundle for the KSA ICU context is crucial to improve 
patients’ outcomes, decrease costs, and reduce the morbidity and mortality rates of 
ICU patients. This study evaluates the effectiveness of the PU prevention bundle in a 
KSA ICU context.  
The term “pressure ulcer” is used throughout this document in lieu of “pressure 
injury”. There is a view that the term pressure injury is more realistic, as it denotes 
damage from pressure as an injury, possibly a preventable occurrence, whereas the 
term ulcer connotes a wound occurring as a complication of an event (Australian 
Wound Management Association (AWMA), 2012). This study was conducted in KSA, 
where the healthcare system is linked to Europe and the United States of America 
(USA). In Europe and the USA the term PU is used, accepted, and reported (European 
Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel [EPUAP 
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& NPUAP], 2009). Therefore, in keeping with the convention where this study was 
conducted, the term “pressure ulcer” is used throughout this study. 
This chapter outlines the background and significance of the research 
programme and presents the aims, research questions, and hypotheses. The provision 
of background information and significance of PUs and issues surrounding this 
phenomenon will highlight the importance of this study. This chapter concludes with 
the outline of the thesis document. 
 
1.1 BACKGROUND 
Critically ill patients managed in an ICU may experience multiple physiological 
changes directly related to their illness and possibly their care (Bouten, Oomens, 
Baaijens, & Bader, 2003; Brower, 2009; Clavet, Hébert, Fergusson, Doucette, & 
Trudel, 2008; Convertino, 1997; Fan, Zanni, Dennison, Lepre, & Needham, 2009; 
Hamburg et al., 2007; Morris, 2007; Truong, Fan, Brower, & Needham, 2009; 
Vollman, 2010; Winkelman, 2009; Youngman, 2008). The majority of ICU patients 
are ventilated and sedated and, therefore, unable to care for themselves, move or 
change position. Further, the patient’s critical illness may involve haemodynamic 
instability which potentially may complicate and accelerate the effects of prolonged 
immobility. Paradoxically, mobility is a natural defence to alleviate prolonged pressure 
on the skin (Shahin, Dassen, & Halfens, 2008). Extensive exposure to pressure, from 
lying or sitting, on a specific part of the body renders patients at greater risk of skin 
breakdown. Therefore, the vulnerability of these patients places them at high risk of 
impaired skin integrity, particularly PU development. 
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Pressure ulcers are one of the most common problems in health care settings. 
Hospital patients are often particularly vulnerable because of their illness. Literature 
suggests that PUs have devastating effects on patients’ care outcomes, either on an 
individual patient level (such as quality of life [Gorecki et al., 2009], pain [Günes, 
2008], infection [Baranoski, 2006; Yoshikawa, Livesley, & Chow, 2002], length of 
stay [Graves, Birrell, & Whitby, 2005], and morbidity and mortality [Spear, 2013] or 
the healthcare system levels (such as quality of care [Vollman, 2010] , and economic 
cost [Bennett, Dealey, & Posnett, 2004; Padula, Mishra, Makic, & Sullivan, 2011]).  
Pressure ulcer rates are most frequently measured as either prevalence or 
incidence. Reports of prevalence and incidence fluctuate widely across different 
healthcare settings globally (Berlowitz, 2014). However, difficulties are apparent 
when reviewing or comparing PU studies due to different methodologies, differing 
patient populations in different health care settings, variance in the reporting of PU 
stages, underreporting of PU prevalence or incidence, different sample sizes, and 
insufficient control of data acquisition (Ikechukwu, 2012; Prentice, Stacey, & Lewin, 
2003; Stotts, Brown, Donaldson, Aydin, & Fridman, 2013; Woodbury & Houghton, 
2004). Moreover, the use of different PU classification systems (Bethell, 2002), and 
organisational considerations such as varied nurse/patient ratios and differing use of 
preventive devices all contribute to inherent difficulties in comparing PU incidence or 
prevalence studies (Benbow, 2004; Kaltenthaler, Whitfield, Walters, Akehurst, & 
Paisley, 2001; Meehan, 1990; Prentice, Stacey, & Lewin, 2003; Whittington, Patrick, 
& Roberts, 2000). Overall, all these studies highlight that the ICU context is the most 
common acute care setting for PU development. In KSA where this research was 
conducted there is no data reflecting the magnitude of the PU problems in the ICU 
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context. Therefore, increased awareness of the scope of the problem and the 
importance of prevention is essential. 
 
1.1.1 Brief Historical Prospective 
The earliest examples of PUs have been found in Egyptian mummies, dated more 
than 5000 years old (Agrawal & Chauhan, 2012). In 1593, the clinical characteristics 
and causes of PUs were identified for the first time by Fabricius Hildanus, a “father of 
German surgery”, who hypothesised that the development of a PU was influenced by 
external and internal supernatural factors, and interruption of the blood and nutrient 
supply in the tissue (Defloor, 1999). During the sixteenth century, the first 
recommendations for PU prevention and treatment were developed, including good 
nutrition, debridement, and relief of pain and pressure (Agrawal & Chauhan, 2012). 
Interestingly, these recommendations are still relevant to recently published guidelines 
for PU prevention strategies (NPUAP, EPUAP, & Pan Pacific Pressure Injury Alliance 
(PPPIA), 2014). In 1722, PU development was positively associated with mechanical 
pressure and incontinence (Defloor, 1999). In the nineteenth-century, Charcot 
suggested “neurotropic theory” as the causation of ulcers, rather than pressure or local 
irritation (Levine, 2005). However, this theory was rejected and direct pressure was 
then understood to be the main contributing factor for PU development (Agrawal & 
Chauhan, 2012). In the twentieth century, shear and pressure forces were considered 
the fundamental factors for PU development; the same factors underlying the present 
understanding of PU aetiology (Agrawal & Chauhan, 2012; Defloor, 1999). In recent 
years, many clinicians and researchers have paid closer attention to the PU phenomena 
in order to identify pathophysiological sequale, associated risk factors, and different 
prevention and treatment strategies (AWMA, 2012; Kottner, Balzer, Dassen, & 
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Heinze, 2009; EPUAP & NPUAP, 2009; The Wound Ostomy and Continence Nurses 
Society, 2010). 
 
1.1.2 Pressure Ulcers Defined  
A PU, also known as pressure injury, pressure sore, decubitus ulcer, trophic 
ulcer, ischaemic ulcer, decubiti, or bed sore, results from a prolonged exposure to 
pressure from lying or sitting on a specific part of the body. This renders patients at 
greater risk of skin breakdown and delayed wound healing (Lyder, 2003;Vollman, 
2010; Youngman, 2008). The NPUAP and EPUAP (2009) defined a PU as a lesion or 
trauma to the skin and underlying tissue resulting from unrelieved pressure, shear, 
friction, moisture, or a combination of these, usually over a bony prominence (EPUAP 
& NPUAP, 2009). Constant pressure to specific areas of the skin will impair blood 
circulation and disturb nerve impulses in the localised area, which in turn decreases 
supply of oxygen and essential nutrients to the part. Therefore, underlying tissue 
ischaemia occurs, leading to ulceration and necrosis (Black et al., 2007; Ousey, 2009). 
Moreover, there is emerging laboratory and animal evidence to show that high shear 
forces also contribute to cellular deformation which results in PU development 
(Bouten, Oomens, Baaijens, & Bader, 2003; Gefen, van Nierop, Bader, & Oomens, 
2008; Stekelenburg et al., 2007). Bouten et al. (2003) suggests there are two types of 
PU based on the mechanism of PU development: superficial (which is a result of shear 
forces in the skin layers) and deep PUs (which occur due to sustained compression of 
the tissue). It could be assumed that a superficial PU could be a stage I or II ulcer, 
however Bouten et al. (2003) did not link this argument to PU staging.   
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Pressure ulcer development is a complex phenomenon. Understanding and 
increased awareness by all healthcare practitioners is required for all aspects of the PU 
phenomenon, including staging, common sites, risk factors, and prevention strategies. 
There are two categories of PU: hospital-acquired PU (HAPU), which is defined as a 
PU developed after 24 hours of hospital admission, and community-acquired PU 
(CAPU), defined as PU developed before hospital admission or with 24 hours of 
admission (Asimus & Li, 2011; Gibbons, Shanks, Kleinhelter, & Jones, 2006). 
 
1.1.3 PU Staging  
PU staging (grading/classification) refers to a recognised and established 
system to classify the level of tissue damage or depth of the ulcer observed. Such 
staging and determination of the magnitude of the problem is central to developing PU 
prevention programmes and treatment. Moreover, the use of a standardised staging 
system permits health care workers to be objective in their assessment of the depth of 
tissue ulcer. The NPUAP and EPUAP (2005) updated the definition of the staging 
system of PUs by adding two stages to the traditional classification, namely I to IV 
(see Appendix A).  
The updated classification system has solved some of the limitations of the old 
staging system. For example, in the previous system, when an eschar (a slough of dead 
tissue cast off from the skin) was present, accurate determination of the stage of the 
PU was not possible until the eschar had sloughed or the wound had been debrided, as 
necrotic tissues could mask the true extent of the wound (Doughty et al., 2006). 
However, classification systems still have limitations, such as identifying stage one 
PUs and deep-tissue injury in dark-skinned people (Doughty et al., 2006). Defloor, 
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Schoonhoven, Katrien, Westrate and Myny (2006) suggested classifying stage I PUs 
(non-blanchable erythema) not as PUs, but as alarm signals. Despite the recent work 
on the staging system of PUs, which reflects the existing level of tissue damage as 
observed, the pathology or history of PUs in the patient needs to be considered in the 
management of PUs (Black et al., 2007).  
Hart, Berquist, Gajewski and Dunton (2006) conducted a survey study that 
explored the inter-rater reliability to standard reliability of PU identification, staging, 
and source of PUs among 256 participants from 48 hospitals. The inter-rater reliability 
of the updated classification was substantially reliable, as shown by the Cohen's kappa 
coefficient (PU identification κ = 0.56; PU binary identification κ = 0.84; PU stage κ 
= 0.65; PU source κ = 0.80). However, the majority of participants (67%) were staff 
nurses and had received a higher level of education, and 17% of participants were 
certified in wound, incontinence, and ostomy care. This could have positively affected 
the accuracy of the results (Hart et al., 2006). A systematic review of the inter-rater 
reliability of the PU classification found that the classification reliability should be 
taken with caution because of identified limitations such as sample size and sample 
characteristics (Kottner, Raeder, Halfens, & Dassen, 2009). Accurate and standardised 
identification of PU staging is required to measure PUs as the primary outcome of 
prevention strategies and to reliably enhance comparison between studies (Kottner et 
al., 2009).  
 
1.1.4 Common PU Sites  
PUs commonly occur over bony prominence areas, as the soft tissue is 
compressed between two firm surfaces; the bone and the surface that the body part is 
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lying on or against. Approximately 95% of PUs occur in the lower part of the body 
(Thomas, 2007). Literature suggests that in the general clinical context, the sacral and 
coccygeal, ischial tuberosities, and greater trochanteric areas account for the majority 
of PU site occurrences (Amlung, Miller, & Bosley, 2001; Dealey, 1991; Peterson, 
2009; Thomas, 2007). The most frequent site for PU development is the sacrum (36%), 
followed by the heel (30%), and other areas (6%), such as upper extremities and the 
head (Amlung et al., 2001; Meehan, 1990; Thomas, 2007). Similarly, the most 
common anatomical locations for PU development in ICU patients have been 
identified as the sacrum (24.3 - 45.2%), and heel area (22.6 - 29.2%) (Ahtiala, Soppi, 
Wiksten, Koskela, & Grönlund, 2014; Tayyib, Coyer, & Lewis, 2015a). However, 
evidence suggests that 20% - 34.5% of total PU incidence in the intensive care 
environment relates to medical devices (Black et al., 2010; Tayyib et al., 2015a). 
 
1.1.5 International Guideline for PU Assessment and Prevention  
Given the heightened risk ICU patients face in developing a PU, prevention 
strategies are paramount. For this to occur, the primary aim of PU prevention is to 
reduce, manage, and monitor risk factors. To achieve this aim, regular skin 
examination, relief of intensive and prolonged pressure, and assessment and 
management of factors such as malnutrition, faecal incontinence, and shear and 
friction forces should be considered. Several strategies can be used to prevent PU 
formation, such as the use of special skin care products, frequent patient repositioning, 
and pressure-relieving devices and support surfaces (Reilly, Karakousis, Schrag, & 
Stawicki, 2007). These strategies can be grouped together in a guideline to improve 
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patient outcomes in terms of reducing the incidence of PU development for critically 
ill patients in the ICU.  
Many guidelines have been published by world organisations such as the 
Australian Wound Management Association (AWMA) (2012), the NPAUP and the 
EPAUP (2009), and the Wound, Ostomy and Continence Nurses Society (2010). 
However, these are not specific to the ICU. The NPAUP and EPAUP collaborated to 
produce the international prevention of PUs guideline (EPUAP & NPUAP, 2009). This 
guideline is based on updated evidence-based recommendations for all patients in 
different health care settings. These include current definitions and the new 
classification of PUs, risk assessment scales, including the role of nutrition, skin 
assessment, and skin care, positioning and repositioning patients, evidence for the use 
of pressure relieving devices and protective devices used for PU prevention, and 
education and training for health care providers. The Wound, Ostomy and Continence 
Nurses Society (2010) suggested that the principles of PU prevention and treatment 
should contain risk assessment, systemic skin assessment, reduction of risk factors, 
patient, family, and staff education, and evaluation (Wound Ostomy and Continence 
Nurses Society, 2010).The Australian Wound Management Association (AWMA) 
(2012), as part of a collaboration between the AWMA, the New Zealand Wound Care 
Society, Hong Kong Enterostomal Therapists Association, and the Wound Healing 
Society of Singapore presented the Pan Pacific Clinical Practice Guideline for the 
Prevention and Management of Pressure Injuries. This guideline includes the 
following components: identifying individuals ‘at risk’ and associated risk factors, 
implementing strategies aimed at eliminating risk factors and protecting the individual 
from potential further risk, and continually evaluating the effectiveness of the 
delivered care (AWMA, 2012). Despite some apparent variations noted in the 
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comparison of the above guidelines, the differences are not significant. The core 
components are identical, namely comprehensive skin assessment, assessment of risk 
factors, nutritional management, pressure relieving devices, strategies to reduce 
pressure, friction, shear and moisture, and education. Thus, the development of any 
comprehensive and effective PU prevention guideline or care bundle should be based 
on contemporaneous high quality evidence related to the core components of the 
aforementioned guidelines, as well as the use of advanced technological, contextually 
compatible techniques for decreasing the incidences of PU. For the purpose of this 
study, the NPAUP & the EPAUP (2009) guideline was followed, as this was the most 
current, widely accepted guideline published at the time the study was conducted. 
 
1.2 RESEARCH AIM AND QUESTIONS 
This research aims to address the gap in PU prevention practice for critically ill 
patients in KSA ICU. The overarching research aim guiding this study is to examine 
the effectiveness of an interventional patient skin integrity care bundle in the intensive 
care unit to best manage skin integrity in critically ill patients. A number of research 
questions addressing this aim underpin this study. These are:  
1- What are the factors that accelerate PU development in adult ICUs? 
2- What are the common risk assessments that are used and the most effective 
scales for identifying at risk patients to PU development in the ICU? 
3- What are the effects of prevention strategies on the incidence/prevalence of 
pressure ulcers in adult ICUs? 
4- What are the characteristics of ICU patients in the KSA? 
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5- What is the incidence of PU development in critically ill patients in the 
intensive care units of two tertiary referral hospitals in the KSA? 
6- What are the factors associated with PU development in the ICU in the KSA? 
7- What is the RNs attitude towards PUs prevention in a Saudi Arabian tertiary 
referral hospital ICU? 
8- What are the facilitators and barriers for RNs in the adoption of PU 
prevention strategies in a Saudi Arabian tertiary referral hospital ICU? 
9- Is there any association between participants’ characteristics and RNs’ 
attitude, or perceived barriers and facilitators to implement the PU prevention 
strategies?  
10- Does a PU prevention bundle reduce the cumulative incidence of PU 
development in critically ill patients in the intensive care unit of a Saudi 
Arabian tertiary referral hospital? 
H0: There is no difference in PU incidence between ICU who 
implements the PU prevention bundle with ICU continuing to implement 
standard care. 
11- Does a PU prevention bundle decrease the cumulative PU incidence by 25% 
or greater when compared to standard hospital care?  
H0: The difference in PU incidence between ICU who implements the 
PU prevention bundle with ICU continuing to implement standard care was 
less than 25%. 
12- Will patients who receive a PU prevention bundle develop PU later in their 
intensive care unit stay? 
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H0:  There is no significant difference in a delayed time to PU 
development with implement the PU prevention bundle. 
13- Will patients who receive the PU prevention bundle have fewer numbers of 
PUs per patient during their ICU stay? 
H0: There is no significant difference in number of PU per patients 
with implement the PU prevention bundle during the ICU stay 
14- Will patients who receive the PU prevention bundle have fewer full thickness 
PUs (Stage III and IV)? 
H0: There are no significant differences in full thicknesses PUs (Stage 
III and IV) with implement the PU prevention bundle. 
15- Does the PU prevention bundle increase the adherence to the process of care 
in comparison to standard hospital skin care?  
16-  Does the OMRU model, as a framework, facilitate the implementation of the 
PU prevention bundle in the ICU context?  
 
1.3 RESEARCH OUTLINE 
In order to address the research questions this research was conducted in two 
phases, which were underpinned by a literature review of PU risk factors and common 
risk assessment scales in ICU contexts, and a systematic review of PU prevention 
strategies (Publications 1 and 2). This study was guided by an evidence translation 
model, the Ottawa Model of Research Use (OMRU). According to the OMRU model, 
Phase One consisted of two parts. Part A used a prospective observational design to 
measure the incidence of PU development in the ICUs of two KSA tertiary teaching 
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hospitals, the King Abdul-Aziz Hospital (KAAH) and the King Fasil Hospital (KFH) 
(Publication 3). Part B used a cross-sectional survey design to explore barriers and 
facilitators related to PU prevention strategies among KSA registered nurses (RNs) 
working in the intervention arm of the Phase Two (Publication 4). In this phase, RNs’ 
perceptions and the environment (ICU) were assessed to determine the barriers and 
facilitators for implementation of the PU prevention bundle. Consequently, 
comprehensive and supported strategies were designed for effective implementation 
and adoption of the PU prevention bundle. Phase Two used a two-arm cluster 
randomised control trail (cRCT) to monitor the implementation of a PU prevention 
bundle and evaluate the effectiveness of the bundle in reducing PU incidence of ICU 
patients (Publication 5). Finally, the validity of a study conceptual framework was 
assessed and presented in the last publication with the title “Translating pressure ulcer 
prevention bundle into intensive care practice; overlying a care bundle approach with 
a model of research implementation” (Publication 6). 
 
1.4 SIGNIFICANCE OF THE STUDY  
PUs are recognised as potentially preventable conditions; however, their 
epidemiological rate of occurrence is still alarming. Literature suggests that this 
problem is underreported, particularly in the KSA, and that there is a lack of awareness 
concerning PU prevention and management through the health care systems (Anthony, 
Parboteeah, Saleh, & Papanikolaou, 2008). 
Several studies have measured the effectiveness of PU prevention using different 
methodological approaches and in different clinical settings (Turpin & Pemberton, 
2006; Uzun, Aylaz, & Karadag, 2009; van Nieuwenhoven et al., 2006; Verbelen, 
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2007). The purpose of these studies was to improve the knowledge and awareness of 
healthcare providers and clinical decision makers regarding the effectiveness of 
different PU prevention strategies in reducing incidence/prevalence. However, 
reduction of HAPUs in health care systems has shown little improvement, as the 
prevalence of PUs worldwide, especially in the ICU, remains high, with up to 50% of 
ICU patients experiencing skin breakdown (Ballard et al., 2008; Berlowitz, 2014; 
Frankel, Sperry, & Kaplan, 2007; Shahin, Dassen, & Halfens, 2008). Possible 
explanations for this might be found in inconsistencies of methodology; different PU 
definitions, different PU staging systems (Keller, Wille, van Ramshorst, & van der 
Werken, 2002), as well as the factors that influence the adoption and the process of 
translation of research evidence to real clinical practice not being reported (Russell et 
al., 2003; Theaker, Kuper, & Soni, 2005; Verbelen, 2007).  
The present study was conducted in the ICU, which is a complex environment 
involving many factors that negatively affect fundamental care in improving skin 
integrity for critically ill patients. These include nursing workload, dependence on 
technological support, availability of effective devices, and critical illness. These 
alarming figures indicate that imperative change is required in the current practices for 
skin management for this patient population and complex practice environment. This 
research provided a novel approach to enhancing PU prevention in intensive care. This 
research aimed to develop, implement, and measure the effectiveness of a PU 
prevention bundle to reduce the incidence of PU development or delay the occurrence 
of PUs in the context of Saudi Arabian critically ill patients. This was firstly achieved 
by describing the PU problem in Saudi ICUs by calculating PU incidence and 
developing a PU prevention bundle that comprised the best available evidence to 
inform individual patient care and team approaches to patient skincare, within the 
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particular environment of the ICU. The PU prevention bundle was also focused upon 
organisational issues in order to develop a problem-solving approach that will lead to 
an improvement in the quality of skincare for patients. Secondly, the implementation 
of the PU prevention bundle was monitored. Finally, the effectiveness of the PU 
prevention bundle was evaluated for its efficacy in reducing the PU incidence. 
This research is significant because it is the first study of its kind to test the 
effectiveness of a PU prevention bundle, combining the best available evidence to 
improve critically ill patients’ skin integrity in the KSA. This research identified the 
barriers and facilitators that affected the implementation of PU prevention bundle in 
the ICU. Further, this research increases knowledge and awareness of nurses regarding 
PU prevention and management to enable nurses to provide high quality nursing care. 
Moreover, this research can be considered a reliable benchmark that will enable 
comparison with other PU studies in ICU contexts.  
Patient outcomes may potentially improve by reducing PU incidence rates 
through implementation of the PU prevention bundle. Further, patient’s morbidity and 
mortality, along with their pain level, and length of stay in ICU are all associated with 
PU incidence reduction (Bennett, Dealey, & Posnett, 2004; Brown, 2003; EPUAP, & 
NPUAP, 2009; Graves, Birrell, & Whitby, 2005). This reduction will contribute to 
lower costs and increased quality of care for healthcare organisations.  
 
1.5 DEFINITION OF TERMS  
Intensive care unit (ICU) defined as: 
In the Australian context, an intensive/ critical care unit is:  
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A distinct unit within a hospital that has easy access to the emergency 
department, operating theatre, and medical imaging. It provides care to patients 
with a life-threatening illness or injury and concentrates the clinical expertise 
and technological and therapeutic resources required (Elliott, Aitken, Chaboyer, 
& Australian College of Critical Care Nurses, 2015). 
In the American and also KSA context: 
Intensive care units (ICUs) are specially equipped hospital units that provide 
highly specialised care to patients who suffer from a serious injury or illness. 
The ICU staff includes doctors, nurses, respiratory therapists, clinical nurse 
specialists, pharmacists, physical therapists, nurse practitioners, physician 
assistants, dietitians, social workers and chaplains. Three factors differentiate 
intensive care units from other units in the hospital: 1) a very high nurse-to-
patient ratio, 2) the availability of invasive monitoring, 3) the use of mechanical 
and pharmacological life sustaining therapies (mechanical ventilation, 
vasopressors, continuous dialysis) (American Association of Critical-Care 
Nurses, n.d.). 
Critically ill patients: Patients who are managed in the ICU for their illness 
or disease state are defined as critically ill (Estenssoro et al., 2006). Critical illness 
means the presence of actual and/or potentially life threatening health problems. 
However, all critically ill patients require continuous observation and intervention to 
restore and prevent complications (Moreno & Rhodes, 2011). 
Pressure ulcer: Defined according to the NPUAP/EPUAP guideline (see 
Section 1.1.2 pressure ulcer definition). 
Hospital-acquired pressure ulcer: See Section 1.1.2 pressure ulcer definition 
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Community-acquired pressure ulcer: See Section 1.1.2 pressure ulcer 
definition.  
Strategy: High level plan of evidence-based methods or actions designed to 
achieve one or more goals (for this study to prevent PU development), which is not 
systematically implemented. This term is usually used with quasi-experiential trial 
(Meinert, 2012; Mosby, 2013).  
Intervention: A program, set of actions, or structured strategies specifically 
designed to address an identified deficiency (PU prevention), systematically 
implemented, monitored, and evaluated to ensure the effectiveness of this intervention 
in outcome (PU incidence). The term intervention is more commonly used with 
randomised control trails (Meinert, 2012; Porta et al., 2014).  
 
1.6 THESIS OUTLINE 
This thesis demonstrates the work undertaken in fulfilment of the Doctor of 
Philosophy degree and is presented as a series of publications. The document consists 
of 10 chapters. The publications framing this thesis are depicted in Figure 1.1. (See 
publication list, page xv) 
Chapter 2 presents the first of two literature reviews that inform this thesis, and 
was published in the Journal of Nursing Education and Practice (Tayyib, Coyer, & 
Lewis, 2013). It provides a detailed explanation and critique of the literature that 
focuses on risk factors for PU development in critically ill patients and the utility of 
risk assessment scales in the intensive care setting.  
Chapter 3 presents the second literature review. This chapter compromises a 
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systematic review that was submitted to the Worldview Evidence Based Nursing and 
is in press now (Tayyib & Coyer, in-press). This systematic review explored effective 
PU prevention strategies in the adult ICU context.  
Chapter 4 presents the conceptual framework underpinning this research. The 
framework chosen guided and facilitated the implementation of the intervention (the 
PU prevention bundle) in an effective, efficient, and consistent manner, using a care 
bundle approach overlayed with a research implementation model (OMRU). 
Chapter 5 presents the methodology of the two phases of this research and 
outlines the research design and justification, methodology, sampling strategies, 
recruitment process, instrument development, data collection methods, and analysis 
plan for the research. An overview of the ethical considerations pertinent to this 
research is also addressed. 
Chapter 6 is one of three publications to address the findings of this thesis (see 
also Chapters 7 and 8). This chapter was published in the International Wound Journal 
(Tayyib, Coyer, & Lewis, 2015a). The publication identifies PU incidence in two 
Saudi ICUs.  
Chapter 7 has been accepted for publication in the Journal of Wound Ostomy 
Continence Nursing (Tayyib, Coyer & Lewis, 2016). It provides an overview of 
assessment regarding the RNs who provide the intervention, and the ICU environment. 
Chapter 8 addresses the effectiveness of the implementation of the PU 
prevention bundle in reducing PU incidences in the ICU. This article was published in 
the Journal of Nursing Scholarship (Tayyib, Coyer & Lewis, 2015b). 
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Chapter 9, the final publication of this research, addresses the importance of 
using a framework, such as the OMRU model, in the translation of evidence (the PU 
prevention bundle) to clinical practice (the ICU). This chapter comprises a manuscript 
that has been submitted to the Journal of Nursing Care Quality (Tayyib & Coyer, 
2016b). 
Chapter 10 concludes this thesis and summarises the research process 
undertaken to address the research aims and the conclusions drawn from this research 
study. Further, the strengths and limitations of the study, along with implications for 
clinical practice and further research are addressed.
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Chapter 2: (Article 1) Pressure Ulcers in the 
Adult Intensive Care Unit: A 
Literature Review of Patient’s 
Risk Factors and Risk 
Assessment Scales 
This chapter comprises the following published article:  
Tayyib, N., Coyer, F. & Lewis, P. (2013) Pressure ulcer in the adult 
intensive care unit: a literature review of patient risk factors and risk 
assessment scales. Journal of Nursing Education and Practice, 3(11), p28-
42. 
 
Pressure ulcers (PUs) are a matter of significant concern for worldwide health 
organisations. Ischaemia or necrosis is considered the main reason for the development 
of ulceration in the skin. Different risk factors have been identified that accelerate the 
development of PU in ICU contexts and have an influence on the level and extent of 
tissue necrosis. This chapter presents the published article that summarised potential 
risk factors for PU development in adult critically ill patients. Identification of the 
main factors that enhance PU development in the ICU aids the design and development 
of PU prevention practice. 
Moreover, this article reviewed the utility of risk assessment scales (RASs) in 
ICU settings and their possible limitations. Pressure ulcer RASs were evaluated 
through reliability, predictive validity, and choice of appropriate cut off points. While 
this review highlighted the fluctuation of reported predictive validity values of the 
RASs, all of the existing scales tended to over predict due to low identified scale 
specificity. The findings of this review were consistent with those of another 
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systematic review (García-Fernández, 2013), in that many RASs have been developed 
for ICU patients, but not validated. However, the Braden Scale score as RAS for ICU 
patients was recommended (García-Fernández, 2013; Tayyib, Coyer, & Lewis, 2013)  
Recently, Richardson and Barrow (2015) developed a new risk assessment scale 
for critically ill patients (CALCULATE), which was not included in this review. This 
scale consists of seven items, including too unstable to turn, impaired circulation, 
dialysis, mechanical ventilation, long period of surgery > 4 hours, low protein and 
albumin serum (albumin below 35 g/l), and faecal incontinence. Each item is scored 
with a single point. Patients are classified based on the total score: four or more factors 
are classed as ‘very high’ risk and patients with three or less risk factors classed as 
‘high’ risk. However, this scale has some noted limitations. There is a noted lack of 
refinement to the scale, as validity and reliability have not been measured. Some of the 
factors, such as age and longer length of stay in the ICU, identified in this review 
(Tayyib, Coyer, & Lewis, 2013) were not considered. Moreover, appropriate 
intervention plans for each at risk group were not included.  
Achieving a valid PU RAS for ICUs requires identification of the underlying 
factors that accelerate PU development in critically ill patients, determination of 
appropriate scale cut off points, and preventive measures for each risk category. 
However, international best practice guidelines advocate the use of RASs as a 
fundamental component of a PU prevention and management strategy (Chou et al., 
2013). 
This article answers research questions one and two for this study  
Research Question 1: What are the factors that accelerate PU development in adult 
ICUs? 
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Research Question 2: What are the common risk assessments used and the most 
effective scales for identifying at risk patients for PU development in the ICU? 
This article adds to existing literature by reviewing recent research published in 
the area of the PU risk factors and RASs. The last review conducted on PU risk factors 
and risk assessment scales in adult ICU was undertaken prior to 2000 (Keller et al, 
2002). This review represents an update on current research. The article informed this 
study by identifying the main potential risk factors that needed to be considered during 
the planning of the PU prevention intervention. Moreover, it facilitated the selection 
of a reliable and valid RAS instrument for use in this research in the ICU, the Braden 
Scale score.  
This article has been cited nine times in Google scholar.  
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Pressure ulcer in the adult intensive care unit: a 
literature review of patient risk factors and risk 
assessmnet scales  
 
Nahla Tayyib, Fiona Coyer, & Peter Lewis. (2013). Journal of Nursing 
Education and Practice, 3(11), p28-42.  
 
2.1 ABSTRACT  
Background: Critically ill patients are at high risk for pressure ulcer (PU) 
development due to their high acuity and the invasive nature of the multiple 
interventions and therapies they receive. With reported incidence rates of PU 
development in the adult critical care population as high as 56%, the identification of 
patients at high risk of PU development is essential. This paper will explore the 
association between PU development and risk factors. It will also explore PU 
development and the use of risk assessment scales for critically ill patients in adult 
intensive care units. 
Method: A literature search from 2000 to 2012 using the CINHAL, Cochrane 
Library, EBSCOHost, Medline (via EBSCOHost), PubMed, ProQuest, and Google 
Scholar databases was conducted. Key words used were: pressure ulcer/s, pressure 
sore/s, decubitus ulcer/s, bed sore/s, critical care, intensive care, critical illness, 
prevalence, incidence, prevention, management, risk factor, risk assessment scale. 
Results: Nineteen articles were included in this review: eight studies addressing 
PU risk factors, eight studies addressing risk assessment scales, and three studies 
overlapping both. Results from the studies reviewed identified 28 intrinsic and 
extrinsic risk factors, which may lead to PU development. Development of a risk factor 
 Chapter 2: (Article 1) Pressure Ulcers in the Adult Intensive Care Unit: A Literature Review of Patient’s Risk Factors and Risk 
Assessment Scales 25 
prediction model in this patient population, although beneficial, appears problematic 
due to many issues such as diverse diagnoses and subsequent patient needs. 
Additionally, several risk assessment instruments have been developed for early 
screening of patients at higher risk of developing PU in the ICU. No existing risk 
assessment scales are valid for identification high-risk critically ill patient, with the 
majority of scales potentially over-predicting patients at risk for PU development. 
Conclusion: Research studies to inform the risk factors for potential pressure 
ulcer development are inconsistent. Additionally, there is no consistent or clear 
evidence which demonstrates any scale to better or more effective than another when 
used to identify the patients at risk for PU development. Furthermore, robust research 
is needed to identify the risk factors and develop valid scales for measuring the risk 
of PU development in ICU. 
Keywords: Pressure ulcer, pressure ulcer risk, risk factors, risk assessment, 
adult intensive care, literature review. 
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2.2 INTRODUCTION  
A pressure ulcer (PU) can occur anywhere on the body where there is 
prolonged exposure to pressure. Prolonged pressure (from lying or sitting on a specific 
part of the body) will impede capillary blood supply to an area and thus limit the 
delivery of oxygen and nutrients to tissue, placing patients at risk for skin breakdown 
(Niezgoda & Mendez-Eastman, 2006). Expected capillary pressure ranges are between 
10 and 30 mmHg (Guyton & Hall, 2006). Tissue hypo-perfusion occurs when the 
interface pressure exceeds capillary pressure (Bader, Oomens, Bouten, & Baaijens, 
2003; Youngman, 2008), thus increasing the likelihood of PU development.  
The epidemiology of PU varies appreciably by clinical setting. In acute care 
settings PU incidence ranges from 0.4% to 38%, in long term care setting from 2.2% 
to 39.4%, in the home care environment from 0% to 17%. According to the National 
Healing Corporation (2005), the worldwide incidence of PU in intensive care units 
(ICU) ranged widely from 1- 56% (Kaitani, Tokunaga, Matsui, & Sanada, 2010; 
Keller, Wille, van Ramshorst, & van der Werken, 2002). Further, there is wide 
variation reported in PU prevalence in ICUs between countries and continents: 49% 
across Western Europe (Shahin, Dassen, & Halfens, 2008), 22% in North America 
(Frankel, Sperry, & Kaplan, 2007; Shahin et al., 2008), 50% in Australia (Ballard et 
al., 2008; Elliott, McKinley, & Fox, 2008), and 29% in Jordan (Tubaishat, Anthony, 
& Saleh, 2011).  
Prevalence is the most commonly reported measure of PU, largely because this 
is a simple and cost effective method of data collection. However, it has recognized 
that prevalence data is a snapshot and not a true reflection of the scope of a given 
problem (Baharestani et al., 2009). Incidence data provides a more accurate picture of 
the magnitude of a problem. However, incidence data presents problems with lengthy 
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and time-consuming data collection (Baharestani et al., 2009). Critically ill patients in 
ICU are considered to be at greatest risk for PU development, as this patient group is 
likely to present with high acuity, may require mechanical ventilation and subsequent 
administration of sedation and pharmacological drugs potentially reducing peripheral 
circulation and be immobile (Johnson & Meyenburg, 2009; Vollman, 2010).  
According to Vollman (2010), the negative impact of patient immobility is 
directly related to the adverse event of PU development and subsequent undesirable 
long-term implications, such as reduction in quality of life, pain, increased medical 
costs, and increased mortality and morbidity rates and increase in ICU length of stay. 
In addition to these consequences of PU, the financial impact of treatment should be 
considered, including cost to healthcare system and also personal costs to patients. 
Worldwide PU treatment costs to healthcare systems are a significant burden. The 
annual cost is approximately £1.4–£2.1 billion in the UK (Bennett, Dealey, & Posnett, 
2004) and $1.6 billion in the US for the treatment of pressure ulcers (Whittington, 
Patrick, & Roberts, 2000). In Australia, pressure ulcer costs have been identified as 
$18,964 per each critically ill patient (Graves, Birrell, & Whitby, 2005). In the UK, 
the cost of PU was four per cent of total healthcare expenditure (Bennett et al., 2004). 
These adverse outcomes emphasize the importance of preventing PU. While PU has 
been extensively examined in the literature, only one review addresses this issue in the 
context of ICU. Given this paper was published in 2002 and the literature included in 
the review was published between 1980 and 1999; a further review of PU in the ICU 
environment is timely.  
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2.3 AIMS 
The aim of this paper is to review existing literature to explore the association 
between PU development and risk factors. The paper also aims to examine PU risk 
assessment scales for critically ill patients managed in adult intensive care units.  
 
2.4 METHOD  
A comprehensive search of databases and Internet research engines holding 
information related to PU in intensive care units conducted. PU defined and classified 
according to NPUAP/EPUAP guidelines (National Pressure Ulcer Advisory Panel & 
European Pressure Ulcer Advisory Panel, 2009). The CINHAL; Cochrane Library; 
EBSCOHost; Medline (via EBSCOHost); PubMed; ProQuest databases were 
searched, along with Google Scholar search engine from 2000 to 2012. The key search 
terms entered into database searches were: pressure ulcer, pressure sore, decubitus 
ulcer, bed sore, critical care, intensive care, critical illness, prevalence and incidence, 
prevention, management, risk factor, risk assessment scale. Databases were searched 
for relevant information contained within journals, books, handbooks, and abstracts. 
Literature searches were limited by language (English). The criteria used for article 
selection were 1) quantitative studies, 2) studies related to risk factors of pressure ulcer 
development, 3) studies of adult patients. 4) studies specific to the intensive care 
environment, and 5) studies that contained a sub-analysis of results specific to the adult 
intensive care setting. The reference list of each selected article was also checked 
manually as a source of additional information. A total of 28 original studies were 
reviewed. Following this initial review, eight papers were excluded as they failed to 
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meet the above inclusion criteria. A total of 19 articles are included in this review 
(Figure 2.1). 
Figure 2.1 Flow Diagram: Selection Process for Literature Review (Moher, D., et al., 2009)   
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2.5 RESULTS 
2.5.1 Risk Factors for PU Development  
Among the 19 articles that met the inclusion criteria, 11 studies identified risk 
factors that may accelerate the development of PU in the critically ill patient 
population (Table 2.1). Table 2.1 provides an overview of the year of publication, 
setting, population, study method, measures, and results of each study. The studies 
presented in Table 2.1 will be discussed under relevant risk factors below
 Chapter 2: (Article 1) Pressure Ulcers in the Adult Intensive Care Unit: A Literature Review of Patient’s Risk Factors and Risk Assessment Scales 31 
. Table 2.1 Studies Addressing Factors Associated with PU in ICU 
 
Author, year of 
publication Sample Setting Study method 
Potential predictor 
variable  
Result 
(Risk factors associated with PU 
development) 
Limitations 
Theaker et al 
(2000)  
286 
Medical & 
Surgical ICU,  
UK  
Prospective  
22 Factors including 
demographic and clinical 
variables  
norepinephrine infusions,  
APACHE II scores of 13 or above,  
fecal incontinence,  
anemia and  
length of stay in ICU of > 3 days  
Unmeasured factors such as 
BMI could be significant.  
Boyle and 
Green (2001)  
534 
ICU, 
Australia  
Prospective 
observational  
Waterlow scale  
Jackson/Cubbin scale  
coma/unresponsiveness and paralysis  
sedation 
cardiovascular instability  
Inter-rater reliability of the two 
scales is not measured.  
Eachempati et al 
(2001)  
3027 
Surgical ICU, 
USA 
Prospective  
Cornell ulcer risk score  
APACH II 
Systemic inflammatory 
Multiple organ 
dysfunction  
Demographic data  
Emergency ICU admission  
ICU LOS > 7 days  
Older age  
Prolonged time without nutrition  
Non-ambulatory status  
Stage 1 PU excluded 
Fife et al (2001)  186 
Neurological 
ICU, USA 
Prospective 
cohort 
Demographic and clinical 
data  
Braden scale ≤ 13  
Low BMI on admission  
Stage I PU excluded. 
 
Frankel et al 
(2007)  
820  
Surgical ICU, 
USA 
 
Retrospective 
analysis  
Demographic and 
laboratory data  
LOS 
APACHE II  
History of diabetes, spinal cord injury, 
renal insufficiency, and older age >60 
years 
The incidence of PU was low 
(3%). 
Excluded Stage I. 
Difficulties acknowledged in 
measurement of incidence and 
prevalence rate.  
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Author, year 
of publication Sample Setting Study method Potential predictor variable  
Result 
(Risk factors associated with PU 
development) 
Limitations 
Suriadi et al. 
(2007)  
105  
ICUs, 
Indonesia  
Prospective 
cohort study  
Interface pressure  
Skin moisture  
Body temperature 
Smoking 
Diastolic blood pressure  
Fecal incontinence, Nutrition  
Increase interface pressure  
Skin moisture  
Increase body temperature 
Smoking 
 
Authors disregard the 
underlying patient's 
condition and treatment.  
Many instruments to 
measure interface 
pressure, moisture and 
temperature.  
Cigarette composition 
may different from other 
countries.  
Nijis et al. 
(2008)  
520  
Surgical 
ICU,  
Belgium 
Prospective 
descriptive 
research 
Demographic, clinical data. Other 
preventive measures such as (frequent 
turning, floating heels, alternating 
mattresses and sitting in chair) 
Vascular disease 
Uses of Dopamine or Dobutamine 
medication 
Intermittent hemodialysis or continuous 
veno-venous hemofiltration (renal 
insufficiency) 
Mechanical ventilation 
Infrequent turning  
Adequate prevention measures 
Alternating mattresses 
Floating heels  
No association between the uses of 
sedatives, patient's body temperature 
above 38.5c, and sitting in chair and PU 
formation grade 2- 4 in ICU.  
Stage 1 PU excluded.  
 
 Chapter 2: (Article 1) Pressure Ulcers in the Adult Intensive Care Unit: A Literature Review of Patient’s Risk Factors and Risk Assessment Scales 33 
Author, year 
of 
publication 
Sample Setting Study method Potential predictor variable  
Result 
(Risk factors associated with PU 
development) 
Limitations 
Shahin et al 
(2009)  
121 
Nephrology, 
surgical and 
cardiology 
ICUs, 
 Germany  
Longitudinal 
study  
Assess demographic and clinical data 
such  
as (length of stay, unconsciousness, 
urinary catheter at admission and 
existing of pressure ulcer in admission) 
with Braden scale and APACHE II 
APACHE II score above 14. 
 
Small sample size 
Kaitani et al. 
(2010)  606 ICU, Japan  Prospective  
Severity of illness and pressure ulcer 
development 
Emergency ICU/HCU admission. 
Infrequent turning 
APACHE II score not associated with PU 
development 
The lower APACH II 
score is 19.9  
Slowikowski 
& Funk 
(2010)  
230 
Surgical 
ICU,  
USA 
Prospective  Demographic and clinical data  
History of diabetes. 
Age > 70 years 
Low Braden scale  
 
Missing data for some 
variables.  
Data for some variables 
such as (BMI and 
sedation) not provided. 
Cox (2011)  347 
Medical & 
Surgical 
ICU, USA 
retrospective 
analysis 
Braden score, mobilization, activity, 
sensory perception, moisture, nutrition, 
friction/shear, length of stay, age, 
arteriolar pressure, vasopressor 
administration, APACHE II score and 
comorbid conditions 
Older age; length of stay more than 3.3 
days; mobility; and cardiovascular 
disease 
Additionally, this study identified the 
predictive factors which were 
significantly associated with PU stage II 
and greater. They were friction/shear; 
norepinephrine infusion; length of stay 
and cardiovascular disease. 
Retrospective analysis 
affects accuracy of 
identification of stage 
development and 
assessment.  
Measure risk factors 
with Braden scale in the 
first 24 hours of 
patient's admission.  
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A total of 28 factors were identified as risk factors for PU development in ICU 
patients. These are conceptualized and labeled as intrinsic (inherent factors of critical 
illness) and extrinsic (related to external forces) factors (Table 2.2). The main risk 
factors identified or evidenced as enhancing PU development in ICU setting by two or 
more studies will discussed below. Intrinsic factors identified in two or more studies 
were older age, increased length of stay in ICU and history of cardiovascular disease. 
Extrinsic factors identified in two or more studies were the administration of 
norepinephrine and patient repositioning (turning).  
Older age usually involves skin alterations, including a thinning of the 
epidermis, a 20% loss of dermal thickness, and the loss of elastin fibers (Baranoski, 
2001). Eachempati, Hydo, and Barie (2001) examined age factors by multivariate 
analysis, and found that age was significantly associated with PU development (OR 
1.08, 95% CI 0.0026–0.0131, p= 0.003). Frankel, Sperry, and Kaplan, (2007) reported 
that older age was significantly associated with PU development for surgical ICU 
(SICU) patients (OR 2.9, 95% CI 1.2-7.1, p= 0.022). Slowikowski and Funk (2010) 
using logistic regression analysis, also found that patients aged over 70 who were 
admitted to ICU had a significantly higher incidence of PU development (OR 2.14, 
95% CI 1.27-3.62, p= 0.004). Recently, this result was confirmed by Cox (2010) who 
identified that age was a predictive factor for PU development in ICU (OR 1.033, 95% 
CI 1.003-1.064, p= 0.03). It appears clear that the older critically ill adult patient is 
vulnerable for PU development. 
Length of stay (LOS) in ICU is another commonly identified risk factor for PU 
development. In three studies (Cox, 2010; Eachempati et al., 2001; Theaker, Mannan, 
Ives, & Soni, 2000), it was found that patients with an ICU LOS of greater than three 
days were at increased risk for PU development. Eachempati and team (2001), using 
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univariate analysis, found that ICU patients with LOS of seven days or more were at 
high risk for PU development (p = 0.0288). Theaker and associates (2000) showed that 
a longer stay in ICU for three days or more was significantly associated with PU 
development (OR 2.76, 95% CI 1.08-7.05, p= 0.034). Cox (2010) found a significant 
association between LOS and PU development (OR 1.008, 95% CI 1.004-1.012, p< 
0.001). Significantly, Fife and colleagues (2001) argued, by correlation or logistic 
regression analysis, that LOS did not predict PU development in a neurological ICU 
(p= 0.31). However, the authors conducted this study in a special population which 
included adults with spinal cord or closed head injuries who were more susceptible to 
PU development because of prolonged immobility, also the authors did not 
acknowledge a reason for this association. Further research will be essential to clarify 
this association. While these papers clearly indicate a longer LOS increases the 
likelihood of an increased incidence of PU development, it should also be considered 
that a longer LOS would logically correlate with an increased patient acuity.  
Comorbidities including cardiovascular disease and diabetes can be one of the 
prognostic indicators for PU development in ICU. Cardiovascular disease was found 
in several studies to be significantly associated with PU development (Boyle & Green, 
2001; Cox, 2010; Nijs et al., 2009). Boyle and Green (2001) reported that patients with 
cardiovascular instability were at higher risk of PU occurrence (χ2 =6.850, p= 0.009). 
Using logistic regression Cox (2010) found that a history of cardiovascular disease 
was a significant predictor of PU (OR 2.952, 95% CI 1.3-6.4, p= 0.007). Similarly, 
Nijis et al. (2009), found a positive association between vascular disease and 24 hours 
before PU occurrence (OR 4.51, 95% CI 1.99-10.24, p= 0.001) or 48 hours before PU 
occurrence (OR 2.85, 95% CI 1.29-6.30, p= 0.001). A possible explanation for this 
association is that cardiovascular disease predisposes patients to ischemia or reduced 
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peripheral blood flow (Nijs et al., 2009). Patients with a compromised cardiac pump 
and vasculature disease are likely to exhibit lower capillary perfusion pressures which 
can be overcome with lower interface pressures. Thus, cardiovascular disease should 
be considered as a predictive factor for PU development. 
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Table 2.2 Identified Risk Factors Contributing to PU Development in ICU Patients  
Cluster  Factor Reference  Statistical test, p value 
Intrinsic factors - 
inherent factors 
of critical illness 
Age  
Eachempati et al 
(2001)  
Slowikowski & 
Funk (2010)  
Frankel et al (2007)  
Cox (2011)  
χ2*, p= 0.0030 
LRA†, p= 0.004 
Stepwise LRA†, 
p=0.022 
LRA†, p= 0.03 
Low BMI Fife et al (2001)  
MLRA‡, p= 
0.0133 
Smoking  Suriadi et al(2007)  MLRA‡, p= 0.001 
Body temperature  Suriadi et al(2007)  MLRA‡, p= 0.001 
Emergency ICU/HCU 
admission  
Eachempati et al 
(2001)  
Kaitani et al (2010)  
χ2*, p= 0.0001 
LRA†, p < 0.01 
Length of stay in ICU  
Eachempati et al 
(2001)  
Cox (2011)  
Theaker et al (2000)  
LRA†, p= 0.0288 
LRA†, p < 0.001 
MA§, p= 0.034 
Days without nutrition  
Eachempati et al 
(2001)  
χ2*, p= 0.0014 
Immobilitystatus  
Eachempati et al 
(2001)  
Cox (2011)  
χ2*, p= 0.0064 
LRA†, p= 0.04 
Coma/unresponsiveness/paraly
sis & sedation 
Boyle and Green 
(2001)  
χ2*, p= 0.001 
Anemia Theaker et al (2000)  MA§ , p= 0.013 
Diabetes  
Slowikowski & 
Funk (2010)  
Frankel et al (2007)  
LRA†, p= 0.019 
Stepwise LRA†, 
p=0.023 
Spinal cord injury  Frankel et al (2007)  
Stepwise LRA†, 
p=0.021 
Renal insufficiency  Frankel et al (2007)  
Stepwise LRA†, 
p=0.019 
Cardiovascular disease  
Nijis et al (2008)  
Boyle and Green 
(2001) 
Cox (2011)  
MLRA‡, p= 0.001 
χ2*, p= 0.009 
LRA†, p= 0.007 
APACHE II 
 Shahin et al (2009)  
Theaker et al (2000) 
 
 
 
Mean= 16  
MA§, p= 0.004 
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Cluster  Factor Reference  Statistical test, p 
value 
Extrinsic factors- 
external forces 
Norepinephrine medication Cox (2011)  
Theaker et al (2000)  
LRA†, p= 0.04 
MA§ , p <0.001 
Dopamine or Dobutamine 
medication 
Nijis et al (2008)  MLRA‡, p= 0.003 
Sedation  Nijis et al (2008)  MLRA‡, p= 0.004 
Fecal incontinence Theaker et al (2000)  MA§ , p=0.010 
Interface pressure Suriadi et al(2007)  MLRA‡, p= 0.001 
Skin moisture   Suriadi et al(2007)  MLRA‡, p= 0.002 
Friction/shear Cox (2011)  LRA†, p= 0.01 
Mechanical ventilation Nijis et al (2008)  MLRA‡, p= 0.003 
Intermittent 
hemodialysis/Continuous 
veno-venous hemofiltration 
Nijis et al (2008)  MLRA‡, p= 0.001 
Infrequent turning  Kaitani et al (2010) 
Nijis et al (2008)  
LRA†, p < 0.05 
MLRA‡, p < 
0.001 
Floating heels Nijis et al (2008)  MLRA‡, p= 0.002 
Alternating mattresses Nijis et al (2008)  MLRA‡, p < 
0.001 
Adequate prevention  Nijis et al (2008)  MLRA‡, p < 
0.001 
* Chi-square; † Logistic regression analysis; ‡ Multivariate Logistic regression analysis; § Multivariate analysis 
 
Diabetes is a common disorder which effects vascular perfusion and may 
predispose patients to PU development (Frankel et al., 2007; Slowikowski & Funk, 
2010). Frankel and team (2007) also reported that diabetes has positive association 
with PU occurrence in SICU (OR 2.7, 95% CI 1.1-6.4, p= 0.023). More recently, 
Slowikowski and Funk (2010) using logistic regression analysis found that diabetes 
significantly predicted PU development in critically ill patients (OR 1.93, 95% CI 
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1.11-3.35, p= 0.019). Therefore, a history of diabetes has been found to be an indicator 
for developing pressure ulcers in ICU. 
Hemodynamic instability in critically ill patients leads to tissue hypoxia (Keller 
et al., 2002). These patients also require vasoactive drugs, such as norepinephrine, to 
treat hypotension and maintain organ perfusion. Theaker and co-workers (2009) used 
a multivariate analysis to reveal that norepinephrine perfusion was positively 
associated with PU occurrence (OR 8.11, 95% CI 3.64-18.0, p= 0.001). Cox (2010) 
also found that norepinephrine perfusion was a significant predictor of stage II, or 
greater, PU development (OR 1.017, 95% CI 1.001-1.033, p= 0.04). It might also be 
considered that the use of norepinephrine while stabilizing hemodynamic function in 
optimal circumstances will also simultaneously reduce tissue perfusion. This too may 
potentially increase the risk of PU.  
While having many contributing factors, PU occurrence is also dependent on 
the length of time an area is exposed to pressure. Patient's immobility is considered a 
preeminent factor for PU development. In the ICU this could be a direct result of uses 
of sedation or patient's status—not simply patient acuity. Nijis and team (2009) 
showed a significant association between frequent of repositioning and time, with a 
period of 24 hours before PU development (OR 6.66, 95% CI 2.70-16.44, p= 0.001) 
being particularly relevant. Recently, Kaitani and colleagues (2010) demonstrated that 
PU development in an ICU could be predicted by analyzing the frequent of 
repositioning patient (OR 0.452, 95% CI 0.004-0.470, p< 0.01). Therefore, critically 
ill patients are at a greater risk of experiencing PU due to their poor mobility. 
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2.5.2 Pressure Ulcer Risk Assessment Scales  
Eleven articles were identified that examined PU risk assessment scales in 
ICUs. Several risk assessment instruments have been developed for early screening of 
patients at higher risk of developing PU in the ICU. Table 2.3 provides a summary of 
the year of publication, setting, population, study method, scale, cut-off point, 
sensitivity, and results of each study. Table 2.4 provides background information and 
overviews of each risk assessment scale used in ICU including items of assessment, 
score and total score, and determination of ‘at risk’ category.  
The Braden scale, utilized in nine studies was the most commonly applied risk 
assessment scale in research studies included in this review. Recently, Gomes, Bastos, 
Matozinhos, Temponi, and Velásquez-Meléndez (2011) in across-sectional analytic 
study of 22 ICUs, found the moderate and high risk categories of the Braden Scale to 
be highly predictive for PU development (OR 5.54, 95% CI 1.36-22.49, p= 0.017), 
(OR 11.60, 95% CI 3.56-37.74, p= 0.000) respectively. Lewicki, Mion, and Secic 
(2000) in a descriptive study in 337 cardiothoracic ICU patients examined the 
sensitivity and specificity of the Braden Scale using different cut-off points at various 
days of hospitalization to determine the optimal cut-off point in a cardiac surgical 
population. The author recommended that several cut-off scores corresponding with 
day of hospitalization exist in populations whose conditions change greatly over the 
course of their hospital stay. Ongoing assessment is always required as the clinical 
status of patients is liable to change (Lewicki, et al., 2000).  
Other scales used in the ICU setting include the Jackson/Cubbin (Hunt, 1993; 
Seongsook, Ihnsook, & Younghee, 2004; Kim, S. M. Lee, E. Lee, & Eom, 2009), 
Waterlow (Boyle & Green, 2001;  de Araujo, M F. de Araujo, & Caetano, 2011; 
Kottner & Dassen, 2010), Modified Norton (Feuchtinger, Halfens, & Dassen, 2007), 
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Suriadi and Sanda (Sanada, Sugama, Thigpen, & Subuh, 2008), and Douglas 
(Seongsook et al., 2004). T. M. De Araujo and collaborates found the Waterlow scale 
to be significantly predictive for patients at risk for PU development (p=0.005) in 
comparison with the Braden or Norton scales ( de Araujo et al., 2011). Boyle and 
Green (2001) meanwhile argue that the Waterlow scale and Jackson/Cubbin scale are 
not predictive for patients at risk for PU development in ICU (p= 0.92, p=0.47 
respectively). Using Chi square analysis Boyle and Green (2001), found that the "high 
risk" category only in Jackson/Cubbin scale was positively associated with PU 
development (p=0.0005).  
The Jackson/Cubbin scale was a modification of the Norton scale which was 
developed and revised specifically for ICU patients. Seongsook and coworkers (2004) 
tested the sensitivity and specificity of three risk assessment scales in ICU, the Braden, 
Jackson/Cubbin, and Douglas scale, and found that Jackson/Cubbin scale was more 
valid as its sensitivity was 89% and specificity 61% in comparison with the two other 
scales. Also Kim et al. (2009) prospectively examined different risk assessment scales, 
namely Braden, Song and Choi, and Jackson/Cubbin scale and found that 
Jackson/Cubbin was higher predictor for PU than the two scales, with a sensitivity of 
95% and specificity of 81.5%. However, the reliability of these scales were not 
reported. 
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Table 2.3 Studies Examined the Effectiveness of Risk Assessment Scales for PU Development 
 
Author, year of 
publication Sample Setting Study method 
Scale/ 
Assessment  
Cut-off 
point*  
Sensitivity 
(%) 
Specificity 
(%) Result 
Lewicki et al. 
(2000)  
337 
Cardiac surgical 
ICU 
Prospective 
cohort 
Braden scale  
Cutoff 
Braden 
scale score 
varied by 
hospital 
day 
1st day 
(13)=50% 
3rd days 
(14)=57.1 
5th days (20)= 
50  
1st day 
(13)=45.7 
3rd days 
(14)=92 
5th days (20)= 
70.9 
On 1st day 
postoperative, 67% 
of patients were 
identified as PU 
positive with cut-off 
13 
On 3rd day, 57% 
with cut-off 14 
On 5th day, 50% 
with cut-off 20 
Boyle & Green 
(2001)  
314 
188 
ICU 
Prospective 
observational  
Waterlow scale  
Jackson/cubbin scale  
≥ 10 
≤ 29  
Not reported Not reported 
Waterlow scale (all 
categories) is not 
significantly 
predictive for PU 
occurrence. 
High risk category 
of Jackson/Cubbin 
scale is significantly 
predictive forPU 
development  
Fife et al. 
(2001)  
186 ICU (Neurological) 
Prospective 
cohort 
Braden scale  ≤ 13 91.4 Not reported 
Braden scale ≤ 13 
score predicting to 
PU development. 
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*Cut-off point divides the sample into two groups. One group has significantly risk for developing pressure ulcer, while the other group no significantly risk
Author, year 
of 
publication 
Sample Setting Study method Scale/ Assessment  Cut-off point*  Sensitivity (%) Specificity (%) Result 
Seongsook et 
al. (2004)  
112 
 
ICU  
Longitudinal 
study  
Braden  
Jackson/Cubbin  
Douglas  
≤ 16 
≤ 24 
≤ 18 
79 
89 
100 
26 
61 
18 
Jackson/Cubbin scale has 
higher validity 
Feuchtinger et 
al. (2007)  
53 
ICU (cardiac 
surgery) 
Explorative 
prospective 
study 
Braden  
Modified 
Norton  
4-factor model  
≤ 20 
≤ 25 
≥ 2 
97 
58 
85 
5 
47 
31 
Braden scale has higher 
validity for cardiac 
surgery ICU 
Suriadi et al. 
(2007)  
253 
ICU in 
Indonesia 
Prospective 
cohort  
Suriadi and 
Sanada scale 
 
S.S > 4  
81  
 
83 
PU incidence in first ICU: 
27%  
Second ICU: 31% 
Kottner & 
Dassen (2009)  
45 ICU Observational  
Braden scale  
Waterlow scale  
Subjective scale  
Not reported Not reported Not reported 
The three scales are not 
recommended in ICU. 
Braden scale was more 
reliable in comparison.  
Kim (2009)  219 
ICU (Surgical)  
In Korea 
Non-
experimental 
prospective 
study 
Braden scale  
Song and Choi 
scale 
Jackson/cubbin 
Braden ≤ 24 
Song and Choi ≤ 
21 
Jackson/Cubbin ≤ 
28 
Braden (92.5) 
Song and Choi 
(95) 
Jackson/Cubbin 
(95) 
Braden 69.8 
Song and Choi 
69.2 
Jackson/Cubbin 
81.5 
Jackson/Cubbin was the 
most effective scale in 
prediction PU  
Slowikowski 
& Funk 
(2010)  
230 
Surgical ICU  
in USA 
Prospective  Braden scale  Not reported Not reported Not reported  
Braden scale was 
effective scale in 
prediction PrU patients 
de Araujo et 
al. (2011)  
42 
 ICU  
In Brazil 
Exploratory and 
Longitudinal 
study  
Norton scale 
Braden scale  
Waterlow scale 
Norton ≤ 14 
Braden ≤ 16 
Waterlow ≥ 10 
Not reported  Not reported 
The Waterlow scale has 
higher score in PrU risk 
assessment in comparison 
to Norton and Braden 
scales 
Gomes et al. 
(2011)  
140 ICU 
A crosssectional 
and analytic 
study  
Braden scale Not reported Not reported Not reported 
Braden scale was high 
predictive for PU  
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The Suriadi and Sanda scale was developed for ICU patients in Indonesia. This 
scale produced a balance between sensitivity (81%) and specificity (83%) (Sanada et 
al., 2008). However, the author noted several limitations with this scale including; 
specific factors that may be unique on Indonesian populations and the influence of 
cigarette composition of nicotine and tar which may differ from other countries. To 
confirm this result, a longitudinal study in different populations is essential. 
Table 2.4 Comparison of the Concepts of the Risk Assessment Instruments 
Scale  Item  Score  
Total 
(min, 
max) 
At risk  
Norton  
Physical condition 
Level of consciousness 
Activity  
Mobility  
Incontinence 
Each 
subscale 
rated from 1 
to 4 
5 to 20  
Lower score, higher risk of 
pressure ulcer formation 
the score ≤ 14 for patients 
at risk. 
Modified 
Norton  
Skin condition 
Cooperation/motivation 
Physical condition 
Additional diseases 
Mental state 
Incontinence 
Activity 
Mobility  
Age  
Each 
subscale 
rated from 1 
to 4 
≤ 25 
Lower score, higher risk of 
pressure ulcer formation 
4-factor 
model 
Sensory perception 
Moisture 
Friction and shear 
Age  
1 
> 2 
 
Higher score, higher risk 
of pressure ulcer formation 
Braden  
Sensory perception, 
activity and mobility; 
moisture, 
nutritional status  
friction/shear 
Each 
subscale 
rated from 1 
to 3 or 4  
6 to 23 
The score for mild-risk 
patients is 15–16, for 
moderate risk is 12–14 and 
for high risk is 11 or 
below. 
Thus, lower score, a higher 
risk of PrU development  
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Scale  Item  Score  Total (min,max) At risk  
Waterlow  
Build/weight, continence, skin type, 
mobility, gender, age, appetite, 
tissue malnutrition, neurological 
deficit, surgery/trauma and specific 
medications 
Each 
subscale rate 
from 0 to 3 
or 5 or 8  
< 10 to 
>20 
Scores between 10 
and 14 is n the ‘at-
risk group’, 
between 15 and 19 
in the ‘high-risk 
group’, and 20 or 
above in the ‘very 
high-risk group’ 
Higher score, 
higher risk of 
 pressure ulcer 
formation 
Suriadi and 
Sanada (S.S) 
Interface pressure 
Body temperature  
Cigarette smoking 
Interface 
pressure, in 
mmHg, (3 
and 0) 
Body 
temperature 
(4 and 0) 
Cigarette 
smoking (2 
and 0) 
0-9 
Higher score, 
higher risk of 
pressure ulcer 
formation 
Douglas scale  
(adapter of 
Norton)  
Pain 
Activity  
Physical condition 
Incontinence  
Steroid therapy  
Diabetes 
Cytotoxic therapy  
Dyspnea 
 8 to 24 
Lower score, a 
higher risk of PU 
development 
Jackson/Cubbi
n 
(adaption of 
the Norton 
scale) 
Age 
Weight 
General skin  
Mental condition 
Mobility  
Hemodynamic status 
Respiration 
Nutrition 
Incontinence  
Hygiene 
Each scale is 
rated from 1- 
4 
10 to 40 
Lower score, a 
higher risk of PU 
development  
Song and Choi 
(adapter of 
Braden) 
Body temperature  
Amount of medication (analgesics, 
sedation and anticoagulants) 
Sensory perception, activity and 
mobility 
moisture, nutritional status and  
friction/shear 
Each 
subscale is 
rated from 1-
3 or 4 
8 to 31 
Lower score, a 
higher risk of PU 
development  
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Considering the review of these PU risk assessment tools, there appears a 
lack of consistency regarding the appropriate risk assessment scale in ICU settings. It 
would appear further research to clarify a valid and reliable PU risk assessment tool 
for the ICU setting is needed.  
 
2.6 DISCUSSION  
2.6.1 Risk Factors for PU Development  
The first aim of this review was to identify factors or risks that contribute to PU 
development in ICU. Schoonhoven, Bousema and Buskens (2007) argues that the 
cornerstone of PU prevention is to identify, assess, and manage potential risk before 
an injury occurs. Identification of potential risk is important; however, results from 
this review suggest that PU formation is enhanced by presence of multiple, rather than 
single, risk factors in the one critically ill individual (Theaker et al., 2000). Sound 
evidence demonstrates that older age (Cox, 2010; Eachempati et al., 2001; Frankel et 
al., 2007a; Slowikowski & Funk, 2010), length of stay (Cox, 2010; Eachempati et al., 
2001; Theaker et al., 2000), norepinephrine infusion (Cox, 2010; Theaker et al., 2000) 
and prolonged immobility (Kaitani et al., 2010; Nijs et al., 2009) were significantly 
associated with PU development in ICU patients. These risk factors will each be 
discussed. 
Age  
Patient age was evidenced by literature to be a predictive variable for PU 
development in ICU patients. While critical illness has a significant impact on the older 
adult, older people are at high risk for skin breakdown also because of limitations in 
their mobility. Additionally, their skin becomes fragile and thin and they have a 
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predisposition to degenerative and other diseases (Finch, 2003). These considerations 
suggest the effects of ageing on skin integrity cannot be preventable, but rather need 
to be managed more carefully. Aggressive implementation of preventative measures 
in this patient group such as use of appropriate pressure relieving mattresses and other 
support surfaces, frequent turning, regular bathing and the prevention of skin tears will 
greatly reduce the risk of PU. 
 
Length of stay 
As evidenced by numerous studies in this review (Cox, 2010; Eachempati et al., 
2001; Theaker et al., 2000), the longer the patient remains in ICU, the greater the risk 
of PU development. This would be viewed as a logical conclusion as higher acuity 
patients may have a longer length of stay and are consequently at a greater potential 
for risk of complications, such as PU development. 
 
Norepinephrine 
The nature of critical illness often results in the majority of ICU patients 
presenting with impaired ventilation and circulation, which affects body tissue 
oxygenation. This issue may be ameliorated by special medications such as 
norepinephrine. Norepinephrine acts via the binding to adrenergic receptors, which 
causes peripheral vasoconstriction, and may further impair peripheral tissue perfusion 
leading to peripheral cellular hypoxia (Offermanns & Rosenthal, 2008), which causes 
ischemia. Thus, profound peripheral vasoconstriction with norepinephrine 
administration leads to reduced local circulation and increased risk of PU 
development. Bedside nurses need to be cognizant of the patient’s medication regime 
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and its potential effects when implementing PU reduction measures, i.e., such patients 
may require higher level pressure relieving mattresses and more frequent turning.  
 
Prolonged immobility 
Infrequent turning for ICU patients has a significant impact on PU development. 
Infrequent turning will result in increased pressure on one point for prolonged periods 
of time. However, there is no evidence for the optimum frequency for repositioning 
the critically ill ICU patients. Two-hourly repositioning of patients is accepted as 
standard practice on the basis of anecdotal data (Hagisawa & Ferguson-Pell, 2008). 
Goldhill, Badacsonyi, Goldhill and Waldmann (2008) undertook a prospective 
observational study to examine ICU patient position and frequency of turning. They 
identified the mean time between turning for patients in over 50 ICUs in the United 
Kingdom was 4.88 hours (Goldhill, Badacsonyi, Goldhill, & Waldmann, 2008). 
Tayyib, Lewis and Coyer (2011) found the mean time between patient repositioning 
in a Saudi Arabian ICU to be two hours. The reviewed studies described the mean time 
to reposition an ICU patient were between two (Kaitani et al., 2010) and four hours 
(Nijs et al., 2009). Therefore, while the mean time for repositioning critically ill 
patients will vary across countries and even individual ICUs within a country, it should 
still be recognised that, for the most part, turning regimes in ICU aim to reposition 
patients within time frames of two to four hours. As such repositioning practices 
should be sensitive to individual patient needs. 
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Summary  
It should be noted that a risk factor prediction model for critically ill patients has 
yet to be developed. Development of a model is, however, problematic as there are a 
multiple risk factors to be considered. Further contributing to this, the studies reviewed 
have utilized different methodologies, different measures of analyses, varying PU 
definitions and PU classifications, and examined PU across a diverse ICU population. 
Consequently, development of a risk factor prediction model would be difficult. 
Further, these complexities have limited the translation and implementation of this 
research into clinical practice (Keller et al., 2002). Ideally, to examine the association 
between risk factors and PU development a multicentre longitudinal prospective 
observational study is needed.  
 
2.6.2 Pressure Ulcer Risk Assessment Scales  
The second aim of this review was to examine published studies exploring risk 
assessment scales that predict PU development in critically ill patients in ICU settings. 
In this section, discussion of the reviewed studies will focus on reported reliability, 
validity measures, and sensitivity and specificity of the instruments (Pancorbo-
Hidalgo et al., 2006). 
 
Reliability  
Reliability concerns a measure’s accuracy, and for the purpose of this review 
relates to the frequency with which the risk assessment tool produces similar results in 
the absence of change in the patient's status (inter- rater reliability), and stability of the 
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instrument over period of time (test-retest reliability). Only three studies included this 
review assessed inter-rater reliability of the following scales; Braden scale (Lewicki et 
al., 2000), Braden and Waterlow scale (Kottner & Dassen, 2010), and Suriadi and 
Sanada scale (Sanada et al., 2008). The Braden scale demonstrated high reliability 
(Pearson's r: 0.83 – 0.99) (Lewicki et al., 2000). Kottner & Dassen (2009) confirmed 
that the Braden scale has high inter-rater reliability value compared to Waterlow scale 
(Kottner & Dassen, 2010). However, Pancorbo-Hidalgo et al. (2006) demonstrated 
that the Braden scale is reliable in terms of inter-rater reliability compared to other risk 
assessment scales for prediction patient who at risk for PU development such as 
Norton, Waterlow and Cubbin/Jacksoon scale (Pancorbo-Hidalgo et al., 2006). The 
Suriadi and Sanada scale showed high inter-rater reliability (r = 1), but this scale was 
examined in a single study for a specific population (Sanada et al., 2008). No studies 
included in this review reported test-retest reliability. Further, reliability of the scales 
may influenced by many factors, such as training on the use of the risk assessment 
scale, and competence of individual nurses who assessing patients at risk (Kottner & 
Dassen, 2010). 
 
Validity 
Validity refers to the accuracy of the scale. In terms of predictive validity three 
types of validity exist; content, construct, and criterion validity (Tappen, 2011). 
Predictive validity refers to the ability of an instrument to consistently identify those 
patients who are at risk for developing PU (Keller et al., 2002). The National Pressure 
Ulcer Advisory Panel examined predictive validity of numerous risk assessment 
scales, for example; Braden scale (Tappen, 2011). The majority of the studies included 
in this review examined predictive validity through sensitivity and specificity, and the 
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receiver operating curve (ROC) (Seongsook et al., 2004; Kim et al., 2009; Kottner & 
Dassen, 2010; Lewicki et al., 2000; Sanada et al., 2008). 
 
Sensitivity, specificity and ROC 
Sensitivity is defined as the proportion of true positives for patients at risk of 
PU development who are correctly identified by the scale as at risk. Specificity is 
defined as the proportion of patients who did not develop PU and were correctly 
identified by the scale as not at risk (Burns & Grove, 2005; Polit & Beck, 2004). 
Further to this, the appropriate cut-off point for determination of ‘at risk’ status for the 
PU risk scale is an important consideration. Investigators often use appropriate 
statistical analysis to detect cut-off points such as receiver operating curve (ROC) 
(Burns & Grove, 2005). The ROC also measures the association between predictive 
validity and the scale (Burns & Grove, 2005). 
This review has highlighted that existing risk assessment scales may 
potentially over-predict patients at risk for PU development (as the sensitivity of the 
existing scales was reported as acceptable but the specificity reported was low, i.e., the 
scales failed to identify patients who are not risk for PU development (Seongsook et 
al., 2004; Kim et al., 2009; Kottner & Dassen, 2010; Lewicki et al., 2000). The risk 
associated with an overly sensitive risk assessment scale is that patients may receive 
prevention measures that they do not need resulting in increased costs for the health 
care facility. Although, the Suriadi and Sanda scale achieved a sound sensitivity and 
specificity for an Indonesian population (Sanada et al., 2008), a quasi-experimental 
trial is needed to clarify this result in different countries. 
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The review also highlighted fluctuations of reported specificity and sensitivity 
values between different studies (Seongsook et al., 2004; Kim et al., 2009; Kottner & 
Dassen, 2010; Lewicki et al., 2000; Sanada et al., 2008). These varying results may 
arise from differences among study settings, populations, PU definition, outcome 
measures, patient's demographic data, sample sizes and preventive measures which 
have been implemented. Additionally, performance of risk assessment scales depends 
on the competence of individual nurses who assess risk in different ways (Flanagan, 
1995). 
However, Defloor and Grypdonck (2004) suggest that the comparison between 
risk assessment scales using specificity and sensitivity is meaningless, and the 
differences between the scales is doubtful. Defloor and Grypdonck (2004) argue that 
scale items do not consider preventative measures which can impact the PU outcome 
and thus their value cannot be generalized (Scott, 2000). This poses the question as to 
whether or not the validity of the scales can be measured through sensitivity, 
specificity and predictive values (Defloor & Grypdonck, 2005). Since the ideal scale 
has yet to be developed, these measures should be calculated to test risk assessment 
scales. 
Further, debate continues regarding the use of risk assessment scales for 
critically ill patients in the ICU. Seongsook et al. (2004)  stated that the identification 
of patients who are at risk for PU would increase nursing care efficiency and be more 
cost effective, while Pender and Frazier (2005) state that almost all ICU patients are 
almost at risk for PU development. Similarly, Webster, Gavin, Nicholas, Coleman and 
Gardner (2010) stated that patients who are unable to reposition themselves 
independently should be automatically considered as at high risk for PU development. 
It is timely to consider this argument for ICU patients who are largely immobile, and 
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by the nature of their critical illness, at high risk for PU development. The current 
international NPUAP/EPUAP guidelines recommend that risk assessment scales 
should be used in conjunction with the implementation of preventative PU measures 
and a clear evaluative framework, which examines all factors influencing the PU risk 
scale (European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory 
Panel (EPUAP & NPUAP), 2009). 
 
2.6.3 Limitations  
This review is limited by a number of factors: Firstly, the review was based on 
specific exclusion and inclusion criteria. Consequently, this yielded a smaller number 
of studies. However, as the last previous work in this field was published in 2002 
(Keller et al., 2002), the intent of this study was to review studies published after this 
date contributing to the body of knowledge in this area. Secondly, the inclusion of 
studies only published in the English language may have introduced a risk of language 
bias. However, it was beyond the financial scope of this review to include studies 
requiring translation into English. Consequently, it is acknowledged that this review 
does not include a potential body of work in this field. Finally, the 19 studies reviewed 
demonstrated inconsistency in methodological approaches and quality making in-
depth synthesis and generalization of results across ICU population difficult.  
 
2.6.4 Conclusion 
 This review identified 28 intrinsic (inherent factors of critical illness related) 
and extrinsic (external forces related) risk factors for PU development in the adult ICU 
 54   Chapter 2: (Article 1) Pressure Ulcers in the Adult Intensive Care Unit: A Literature Review of Patient’s Risk Factors and 
Risk Assessment Scales 
patient population. While ICU patients are confronted with multiple factors for 
potential PU development, there is inconsistency specific to how these factors are 
measured. Furthermore, several risk assessment scales have been examined in many 
studies in terms of predictive performance. There is no consistent or clear evidence 
which demonstrates any scale to better or more effective than another when used to 
identify the patients at risk for PU development. Many scales were found to have 
problems with validity or to be over predictive. There is therefore, a strong need to 
undertake well designed prospective studies to identify the risk factors and develop 
valid scales for measuring the risk of PU development in ICU.   
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Chapter 3:  (Article 2) Effectiveness of 
Pressure Ulcer Prevention 
Strategies for Adult Patients in 
Intensive Care Units: A 
Systematic Review  
As identified in Chapter Two, PU development is a complex phenomenon, 
dependent on a wide variety of extrinsic and intrinsic risk factors. Thus, preventing the 
development of PUs requires multiple strategies aimed at ameliorating known risk 
factors associated with PU development in intensive care units (ICU). Initial searching 
identified that the National Pressure Ulcer Advisory Panel (NPUAP) and the European 
Pressure Ulcer Advisory Panel (EPUAP), which are professional associations in the 
field of PU prevention and treatment, collaborated to produce a free comprehensive 
guideline that provides brief summaries of evidence-based recommendations for the 
PU prevention (NPUAP, EPUAP, & PPPIA, 2014). However, at the time of the study 
(2012- 2013) the critically ill patient population was not acknowledged in this or other 
published guidelines. This omission is of note, as critically ill patients in the ICU 
present the highest risk for PU development (EPUAP, & NPUAP, 2009).  
Recently, the NPUAP & EPUAP collaborated with the Pan Pacific Pressure 
Injury Prevention Alliance (2014) to produce comprehensive global prevention 
guidelines. The main recommendations of the NPUAP, EPUAP and PPPIA prevention 
guidelines include risk factors and risk assessment (RAS), skin and tissue assessment 
and preventative skin care, nutrition, repositioning and early mobilisation, 
repositioning to prevent heel PUs, use of support surfaces, medical device 
management, and recommendations for special populations, such as bariatric patients, 
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the critically ill, older adults, adults with spinal cord injury, paediatric patients, and the 
operating room. Both guidelines addressed the main area that should be considered 
during the prevention plan in general, and neither guideline focused on education and 
training as the main recommendation. However, the updated guideline includes 
specialist groups, such as critically ill patients in the ICU. In addition, the recent 
guideline presents an increased focus on skin care, medical device-related PUs, and 
new intervention strategies, such as dressings. Therefore, the updated guideline could 
be considered more current, more applicable, and containing readily available 
information on the practice guidelines, which could assist and guide the health care 
clinician in preventing PU development. 
This chapter contains the following article:  
Tayyib, N., & Coyer, F. (in-press) Effectiveness of pressure ulcer prevention 
strategies for adult patients in intensive care units: A systematic review. 
Worldview Evidence Based Nursing. doi:10.1111/wvn.12177  
 
This publication presents the review and appraisal of the quality of existing up-
to date literature relevant to PU prevention and the management of risk factors 
identified in the previous chapter, that relate specifically to critically ill patients. The 
protocol for this systematic review is published on the JBI Database of Systematic 
Reviews and Implementation Reports (Tayyib & Coyer, 2016a). 
This chapter answers research question three in this study.  
Research Question 3: What are the effects of prevention strategies on the incidence/ 
prevalence of pressure ulcers in adult ICUs? 
This review provides an update on current research on PU prevention in adult 
ICUs. This will inform healthcare practitioners about the best available current 
evidence in preventing PU development in ICUs.  
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The Journal of Worldviews of Evidence Based Nursing was the journal chosen 
for submission, as the journal attracts a wide international readership and the results 
of the review highlighted the available current evidence base related to PU prevention 
in the ICU which would be of interest to an international audience. 
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Effectiveness of pressure ulcer prevention strategies 
for adult patients in intensive care units: A systematic 
review  
Tayyib, N., & Coyer, F. (in-press) Effectiveness of pressure ulcer prevention 
strategies for adult patients in intensive care units: A systematic review. 
Journal of Worldview Evidence-Based Nursing. doi: 10.1111/wvn.12177 
 
3.1 ABSTRACT  
Background: Pressure ulcers are associated with substantial health burden, but 
could be preventable. Prevention of hospital acquired pressure ulcers (HAPUs) has 
become a priority for all healthcare settings, as it considered a sign of the provision of 
quality of care. Critically ill patients in the intensive care unit (ICU) are at higher risk 
for HAPU development. Incidence of HAPUs in the ICU ranges from 22-49%. Despite 
the availability of published prevention strategies, there is a little evidence to support 
which strategies have impact on HAPUs prevention and can be safely integrated into 
routine standard care. 
Aims: The aim of this systematic review was to synthesize the best available 
evidence regarding the effectiveness of single strategies designed to reduce the 
incidence and prevalence of HAPU development in critically ill patients in the ICU.  
Methods: The search strategy was designed to retrieve studies published 
between 2000 and 2015 in English language. All adult ICU participants were aged 18 
years or over. This review included randomized controlled trials, quasi-experimental 
and comparative studies. The studies that were selected for retrieval were assessed by 
two independent reviewers for methodological validity prior to inclusion in the review 
using standardized critical-appraisal instruments.  
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Results: The review included 25 studies and meta-analysis revealed a 
statistically significant effect of a silicon foam dressing strategy in reducing sacral and 
heel HAPU incidence (effect size = 4.62; 95% CI: 0.05-0.29; p < 0.00001, effect size 
= 4.50; 95% CI: 0.05-0.31; p= 0.00001 respectively) in critically ill patients. Evidence 
of the effectiveness of nutritional interventions, skin care regimens, positioning and 
repositioning schedules, support surfaces, and the role education in prevention HAPUs 
development in ICU were limited, which precludes significant conclusions.  
Conclusions and Implication: The review provides an evidence-based guide to 
future priorities for clinical practice. A silicone foam dressing has a demonstrated 
positive impact in reducing the incidence of sacral and heel HAPUs in the ICU. 
Keywords: pressure ulcer, intensive care, prevention, intervention, strategy, 
adult, and systematic review. 
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3.2 INTRODUCTION  
Skin injury or ulceration as a result of pressure and shear forces is increasingly 
being viewed as an indicator of the quality of care given to patients. Therefore, the 
testing of strategies to prevent the development of hospital acquired pressure ulcers 
(HAPUs) has been of growing interest in all health-care settings. Nevertheless, PUs 
are still a common problem in healthcare settings (Berlowitz, 2014), especially in 
intensive care (ICU), with approximately 22-49% of critically ill patients affected 
(Berlowitz, 2014).  
The development of PUs is a complex process, dependent on a wide variety of 
extrinsic and intrinsic risk factors (Tayyib, Coyer, & Lewis, 2013). Various strategies 
have been examined in the prevention of PUs with different methodological 
approaches and in different clinical settings (Behrendt, Ghaznavi, Mahan, Craft, & 
Siddiqui, 2014; Girard et al., 2014; Park & Kim, 2014; Theaker, 2003; van 
Nieuwenhoven et al., 2006; Verbelen, 2007). These studies aimed to inform the 
clinical decision making of healthcare workers of the best predictors and prevention 
strategies for HAPUs. However, these studies have limitations, such as lack uniformity 
in defining and staging of HAPUs and study power. It is argued that providing concise 
summaries of the supporting evidence, in terms of a systematic review, increases 
healthcare practitioners’ satisfaction with, acceptance of, and level of implementation 
of specific strategies (Dobbins, Rosenbaum, Plews, Law, & Fysh, 2007) 
The National Pressure Ulcer Advisory Panel (NPUAP), the European Pressure 
Ulcer Advisory Panel (EPUAP), and the Pan Pacific Pressure Injury Prevention 
Alliance (PPPIA) collaborated to produce a comprehensive guideline that provides 
brief summaries of evidence-based recommendations for the prevention and treatment 
of HAPUs (NPUAP, EPUAP, & PPPIA, 2014). The NPUAP, EPUAP, and PPPIA 
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guideline is framed in two sections; prevention of PUs and interventions for prevention 
and treatment. Prevention is summarized through the topics of risk factors and the use 
of a risk assessment scale (RAS), skin and tissue assessment, and preventative skin 
care. Interventions for prevention and treatment of PUs are addressed in sections 
covering nutrition, repositioning and early mobilization, repositioning to prevent heel 
PUs, support surfaces, medical device management, and recommendations for special 
populations such as bariatric, critically ill, older adult, with spinal cord injury, 
paediatric, and in the operating room. While the intensive care critically ill patient 
population was acknowledged in this international guideline, this document failed to 
address PU prevention in ICU from strong evidence based perspective (NPUAP, 
EPUAP, & PPPIA, 2014). This is significant as ICU patients present the highest risk 
of HAPU development. 
To date, most systematic reviews have investigated the effectiveness of 
prevention strategies in general ward or healthcare settings. Because there are 
significant differences in patient acuity and diagnoses, care provided, and 
environmental factors between ICU and general wards or units, it is inappropriate to 
extrapolate general care-related results to the intensive care setting. Further, no 
systematic review of PU prevention strategies in ICU has been conducted since 2000 
(Keller, Wille, van Ramshorst, & van der Werken, 2002).  
There is evidence that PU prevention is more effective with multiple prevention 
strategies. However, many studies employ single intervention measured against 
standard care. Therefore, this systematic review examined the effectiveness of single 
prevention strategies on HAPUs in ICU patients with the goal of gathering scientific 
evidence to support or refute the benefit of using such strategies for critically ill 
patients. The NPUAP, EPUAP, & PPPIA prevention guideline (2014) was utilised as 
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the framework for this systematic review. The results of this study may serve as a 
reference for professional caregivers and the information provided could be put into 
practice during the clinical skin care of ICU patients. The methods of this review were 
specified in advance in a previously published protocol (Tayyib, & Coyer, 2016). 
 
3.3 OBJECTIVE  
The objective of this review was to identify the effectiveness of single strategies 
designed to reduce the incidence and prevalence of HAPUs development in ICUs in 
comparison to no strategy, other strategies, or usual practice. The review question was: 
what is the effectiveness of implementing single PU prevention strategies to reduce 
the incidence/prevalence of HAPUs compared to different PU prevention strategies, 
standard/usual care, or no strategies in the adult intensive/critical care environment? 
 
3.4 METHOD  
3.4.1 Search Strategy  
The search strategy used a three-step search strategy to identify both published 
and unpublished studies. An initial limited search of MEDLINE (PubMed) and 
CINAHL was undertaken, followed by analysis of the keywords and index terms 
contained in the title and abstract. A second search using all identified keywords and 
index terms was then undertaken across all included databases. Thirdly, the reference 
list of all identified reports and articles was searched for additional studies. Studies 
published in non- English language were not considered for inclusion in this review 
due to lack of available resources for translation. Studies published from 2000 to 2015 
were considered for inclusion in this review.  
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All databases were searched from 2000 to week 30 (26 July) 2015 included: 
CINAHL, Medline, Cochrane Central Register of Controlled Trials, Web of Science, 
Embase, ERIC, Scopus, and Mednar. The search for unpublished studies included New 
York Academy of Medicine Library Gray Literature Report, Google, National Institute 
for Health and Care Excellence (NICE), Agency for Healthcare Research and Quality 
(AHRQ) National Guideline Clearing House, Centers for Disease Control and 
Prevention (CDC), and Dissertation/Thesis Abstracts International. 
Initial keywords used were: "pressure ulcer*", "pressure injury", "pressure sore", 
"bed sore", "critical care", "intensive care", "prevent*", "reduc*", "incid*", and 
"preval*".  
 
3.4.2 Selection Criteria  
This review considered quantitative experimental studies (randomized 
controlled trials [RCT]), non-randomized controlled trials, quasi-experimental, before 
and after, and comparative studies, published in English, with adult participants who 
were aged 18 years or over and managed in intensive or critical care units. Studies 
where the results for adult intensive care were unclearly separated from general data 
were excluded.  
This review considered studies that included the following primary outcome 
measures: HAPU incidence, HAPU prevalence, PU severity, time to occurrence, and 
number of PUs per patients. The Secondary outcome measure was any adverse effect 
caused by, or associated with, the use of the prevention strategy. 
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3.4.3 Quality Assessment  
Papers selected for retrieval were assessed by two independent reviewers for 
methodological validity prior to inclusion in the review using standardized critical 
appraisal instruments from the Joanna Briggs Institute Meta-Analysis of Statistics 
Assessment and Review Instrument (JBI-MAStARI) (Joanna Briggs Institute, 2014). 
The JBI-MAStARI tool is standardised appraisal tool encompassing an assessment 
checklist of the risk of bias in study selection, performance, detection, attrition and 
reporting. Studies that met 50% of the JBI-MAStARI checklist tool were included in 
this review. Any disagreements that arose between the reviewers were resolved 
through referring the study for the adjudication of a third reviewer.  
 
3.4.4 Data Abstraction  
Data were abstracted from papers included in the review using the standard data 
extraction tool from JBI-MAStARI. The data abstracted included specific details about 
the strategies, populations, study methods, and outcomes of significance to the review 
question and specific objectives. 
 
3.4.5 Data Synthesis 
 Quantitative data was intended to be pooled in statistical meta-analysis as 
planned in the published protocol (Tayyib & Coyer, 2016). The heterogeneity of the 
studies was assessed by considering their population, intervention, and outcome. 
Where possible, odds ratios with 95% confidence interval (CI) were calculated for 
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binary outcomes. As statistical pooling was not possible the findings are presented in 
narrative form. 
 
3.5 CHARACTERISTICS OF INCLUDED STUDIES  
Searching identified 675 potentially relevant papers, and after sifting of titles and 
abstracts according to the above inclusion criteria, 78 papers were selected for 
retrieval. When the full text versions of the papers were examined, 35 of the 78 
retrieved papers were found to fully meet the inclusion criteria. These 35 studies were 
critically appraised by two independent reviewers using the Joanna Briggs Institute 
Meta-Analysis of Statistics and Review Instrument (JBI-MAStARI) critical appraisal 
tools. Only 24 were found to be of sufficient quality to include. The flowchart (see 
Figure 3.1) presents further details of the search results and study selection process.  
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Figure 3.1 Flow Diagram: Selection Process for Systematic Review  
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The level of evidence overall was moderate to strength or levels II to III-2 according 
to the National Health and Medical Research Council (NHMRC) evidence hierarchy 
(NHMRC, 2009). The majority of included studies were RCT designs (n=14). One 
was a post-test only design with three-group comparisons, three were pre-post 
experimental studies, and six were two-group quasi-experimental studies. Included 
studies were conducted worldwide and participants were all intensive care patients 
(n=6642). Studies details are described further in Tables 3.1. 
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Table 3.1 Strategies for Pressure Ulcer Prevention in Intensive Care Units 
Guideline 
Elements*  
Author (year of 
publication) 
Design/ level of 
evidence 
Sample Setting Intervention measure Outcome/ recommendation 
Sk
in
 C
ar
e Pittman; et al 
(2012) 
RCT/ II 59 ICU (USA) To compare (1) bowel management system 
(BMS) catheter; (2) Rectal trumpet RT 
utilized as a rectal fecal incontinence device, 
and (3) usual care (UC) consisting of barrier 
creams and/or a fecal pouch collector. 
No significant difference in HAPU 
prevalence (P =0.63) 
Em
er
gi
ng
 T
he
ra
pi
es
 
Brindle & 
Wegelin (2012) 
Two group quasi-
experimental/III-1 
100 CSICU (USA) To evaluate the silicone border foam dressing 
in the sacrum area 
No significant differences in the 
incidence between both groups (P = 
0.3) 
Park (2014) Quasi-
experimental/III-1 
102 ICU (South 
Korea) 
To evaluate the silicone foam dressing in the 
sacrum area 
Significant decrease in HAPUs 
incidence (P < 0.001) 
Santamaria N, 
et al. (2015) 
RCT/ II 313 ICU 
(Australia) 
To evaluate silicone foam dressings when 
applied to the sacrum and heel in the 
emergency department and maintained 
throughout their ICU stay 
Significant decrease: 
- Overall incidence of HAPUs (P 
=0.001). 
- sacral event (P =0.05) 
- Heel event (P =0.002) 
Santamaria N, 
et al. (2015) 
Pre-post quasi-
experimental/III-1 
341 
 
ICU 
(Australia) 
To evaluate silicone foam dressings when 
applied on heel in the emergency department 
and maintained in ICU 
Significant decrease heel HAPUs 
incidence 
 (P <0.001) 
Verbelen J 
(2007) 
RCT/II 23 ICU 
(Belgium)  
To examine the polarised light (once a day) 
on the sacrum and heel in preventing HAPUs 
grade II or above 
Significant decrease in HAPUs 
incidence (P = 0.019) 
 
N
ut
rit
io
n Theilla, et al (2007) 
RCT/II 100 ICU (Israel) To compare a diet enriched in lipids and 
vitamins A, C and E with a diet similar in 
macronutrient composition 
The intervention diet significantly 
decreased the incidence of HAPUs 
(P<0.05). 
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Guideline 
Elements*  
Author (year of 
publication) 
Design/ level of 
evidence 
Sample Setting Intervention measure Outcome/ recommendation 
R
ep
os
iti
on
in
g 
an
d 
ea
rly
 m
ob
ili
ty
 
Still, et al. 
(2013) 
Pre-post 
experimental trial/ 
III-1  
1112 SICU (USA) To evaluate a turn team with a 2 hours 
repositioning schedule 
A turn team strategy significantly 
decreased HAPUs incidence (P < 
0.0001) 
Behrendt, et al. 
(2014) 
RCT/II 422 MICU (USA) To evaluate a continuous bedside pressure 
mapping (CBPM) device with 2-hour 
repositioning 
HAPUs incidence was significantly 
lower in the CBPM group (P =0.02). 
Manzano, et al. 
(2014) 
RCT/II 329 ICU (Spain) To compare 2 and 4 hours  
repositioning with alternating pressure air 
mattresses 
No significant difference between both 
repositioning regimen (P =0 .73) 
van 
Nieuwenhoven, 
et al (2006) 
RCT/II 255 ICU 
(Netherlands) 
To compare 45° with 10° head of bed (HOB) 
elevation 
The authors compared between the 
achieved angles of HOB (28° vs. 10°), 
and no significant differences were 
found between groups (28% vs 30% 
respectively) 
Girard, et al. 
(2014) 
RCT/II 466 ICU (France) To compare prone with supine positioning. Supine positioning significantly 
decreased HAPUs incidence of (P =0 
.005) after seven days of ICU stay 
Schallom et al. 
(2015) 
RCT/II 15 ICU (USA) To compare between 30o and 45o HOB 
elevation 
No HAPUs developed in either group. 
Su
pp
or
t s
ur
fa
ce
s 
Theaker, Kuper, 
& Soni (2005) 
RCT/II 62 ICU (UK) To compare an alternating pressure 
mattresses with a low air loss mattress 
No significant difference between both 
groups (P =0.35) 
Malbrain M, et 
al. (2010) 
RCT/II 16 MICU 
(Belgium) 
To compare an active alternating pressure 
mattress with a reactive mattress overlay 
No difference in incidence (1 vs. 2, 
respectively) 
Jackson, et al. 
(2011) 
Pre-post 
experimental trial/ 
III-1 
53 CTV ICU 
(USA) 
To evaluate the effect of air fluidized therapy 
beds 
Incidence decreased after strategy 
(40% pre. vs 15% post) 
Black, Berke, 
Urzendowski 
(2012) 
Two group 
comparative study/ 
III-2 
52 SICU (USA) To compare a low air loss with microclimate 
management bed to the integrated powered 
air pressure redistribution bed 
Incidence was significantly lower with 
the low air loss bed (P = 0.046) 
Manzano F, et 
al. (2013) 
Two group quasi-
experimental/III-1 
221 ICU (Spain) To compare an alternating pressure mattress 
with a foam overlay mattress 
Incidence was significantly lower with  
an alternating pressure mattress  
(P = 0.038) 
Ozyurek & 
Yavuz (2015) 
RCT/ II 105 ICU (Turkey) To compare two types of viscoelastic 
mattresses 
No significant difference between both 
groups  
(P =0.44) 
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Guideline 
Elements* 
Author (year 
of 
publication) 
Design/ level of 
evidence 
Sample Setting Intervention measure Outcome/ recommendation 
M
ed
ica
l d
ev
ice
s r
ela
ted
 P
Us
 
Gregoretti, C., 
et al. (2002) 
RCT/II 194 ICU (Italy) To compare prototype face masks (PMs) with 
conventional face masks (CMs) 
The PMs significantly decrease the 
incidence of MDRPU (P < 0.001). 
Weng  (2008) 
 
Three group 
quasiexperimental/ 
III-1 
60 ICU (Taiwan) To compare HAPUs incidence related to face-
mask when using a protective dressing 
(hydrocolloid, or transparent film) with 
nothing applied with face-mask  
The protective dressings significantly 
decrease the HAPUs incidence (P < 
0.001). However, no significant 
different was reported between both 
dressings. 
Rassin et al. 
(2013) 
Three group 
RCT/II 
Phase I: 
57 
PhaseII: 
112 
ICU (Israel) Phase I: to compare urinary catheter skin care 
regimen of once every 24 hours to standard 
care on the incidence of HAPUs related to 
urethral catheterization 
Phase II: to compareurinary catheter three 
times daily skin regimen to standard care 
Phase I: No significant differences 
between both groups in the incidence 
(intervention= 24.1% vs control= 
28.6%)  
Phase II; the intervention Significantly 
decrease the incidence (P = 0.002). 
Alali, et al. 
(2013) 
Two group 
comparative 
study/III-2 
1811 ICU (Canada) To evaluate early tracheostomy ( ≤ 8 days) in 
trauma brain injury 
Early tracheostomy was significantly 
decreased the incidence of HAPUs (P 
= 0.001) 
Ed
uc
ati
on
 Uzun, Aylaz,  Karadag 
(2009) 
Two group 
comparative 
study/III-2 
 
186 ICU (Turkey) To evaluate the impact of an 
educationalstrategy (2 seminars for 2 hours) 
on the incidence of stage II or greater PUs 
Significantly lower the incidence with 
educational strategy (P < 0.01) 
*National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel, & Pan Pacific Pressure Injury Alliance, 2014 
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3.6 FINDINGS  
The results will be reported according to the NPUAP, EPUAP, and PPPIA 
guideline (2014) and framed in two sections; prevention of PUs and interventions for 
prevention and treatment.  
 
3.6.1 Effectiveness of Risk Assessment/Skin and Tissue Assessment 
No studies were found that examined the contribution of RASs as a strategy to 
reducing HAPUs in ICU.  
 
3.6.2 Preventive Skin Care  
One study evaluated the impact of a strategy for faecal incontinence on the rate 
of PU development (Pittman, Beeson, Terry, Kessler, & Kirk, 2012). The study 
compared three strategies of bowel management to control fecal incontinence on the 
prevalence of HAPUs with no significant difference found in the prevalence rate of 
HAPUs (p=0.63) in either group 
 
3.6.3 Emerging Therapies for Hapus Prevention  
Polarised light.  
One study investigated the efficacy of polarised light once/day for 10 minutes in 
preventing the incidence of HAPUs on the sacral and heel area  (Verbelen, 2007). The 
study showed no significant difference in the development of all stages of PUs with 
the use of polarised light on the sacrum and heels (p = 0.196), despite there a significant 
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decrease in the incidence of HAPUs when stage I PUs were excluded (p= 0.019). 
However, the control group had more assessed areas of skin at risk for PUs (39 areas/ 
13 participants) compared to the intervention group (28 areas/ 10 participants). 
Additionally, a small sample size of 23 participants limited the study’s findings. 
 
Dressings.  
Three studies reported the effectiveness of the application of prophylactic 
silicone foam dressings in decreasing the incidence of sacral HAPUs (Brindle & 
Wegelin, 2012; Park, 2014; Santamaria et al., 2015b). The overall effect size across 
studies was 0.12 (95% confidence interval [CI]: 0.05-0.29; p < 0.00001), the result 
indicating that HAPU incidence of sacral area decreased after the application the 
dressing (see Figure 3.2). 
Two studies examined the effectiveness of similar dressings in reducing the 
incidence of heel HAPUs (Santamaria et al., 2015a; Santamaria et al., 2015b). These 
two studies demonstrated that heel HAPU incidence significantly decreased after 
implementation of the dressing. The first trial’s result demonstrated a significant 
reduction of heel HAPU incidence in the intervention group (5 vs. 19, p = 0.002) 
compared to the control group (Santamaria et al., 2015b). The result was confirmed 
with a subsequent study that evaluated the dressing on heel HAPU incidence. No PU 
was reported on heels following the implementation of the dressing strategy (0 vs. 19, 
p < 0.001) (Santamaria et al., 2015a). Both studies used the same control group where 
the second study (Santamaria et al., 2015a) recruited a new intervention group and 
measured against a historical control group (Santamaria et al., 2015b). 
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Sacrum HAPU Events  
 
 
Figure 3.2 Forest Plot for HAPUs Events after Application of the Silicone Foam Dressing on the 
Sacrum Area  
 
3.6.4 Nutrition 
Only one study examined specific nutritional strategies to prevent HAPUs in 
critically ill patients with acute lung injuries (Theilla, Singer, Cohen, & Dekeyser, 
2007), reporting that the intervention diet was significantly associated with reduction 
of HAPU incidence (p=0.05). However, more participants were recruited with existing 
PUs in the control group, and so were more likely to develop subsequent PUs, therefore 
biasing the results. 
 
3.6.5 Repositioning and Early Mobilization  
Repositioning frequency  
Two studies supported two-hour repositioning intervals in reducing the 
incidence of HAPUs through different interventions (Behrendt et al., 2014; Still et al., 
2013). The first study investigated the efficacy of using continuous bed pressure 
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mapping (CBPM) with a 2-hourly repositioning regimen (Behrendt et al., 2014). 
Results showed a significant difference in the incidence of HAPUs, stage II or greater, 
between groups (p=0.02). The second study showed improvements with two-hour 
repositioning using a turn team strategy (Still et al., 2013). A turn team composed of 
two trained patient care assistants showed significant improvement in the incidence of 
HAPUs between pre and post implementation (p < 0.0001) (Still et al., 2013). 
However, these two studies pose a number of limitations, such as the compliance to 
turn team to the strategy (Still et al., 2013), other prevention strategies employed at the 
time of the study (Behrendt et al., 2014; Still et al., 2013), and the duration of time to 
reach peak interface pressure were not reported (Behrendt et al., 2014) .  
Only one cluster RCT study investigated the efficacy of different patients 
repositioning regimens (2 versus 4 h) in mechanically ventilated patients who were 
managed on an alternating pressure air mattress (Manzano et al., 2014). No significant 
differences in reduction of HAPUs of stage II or greater were found between groups 
(p = 0.73). However, the compliance to both repositioning regimens was not reported. 
 
Positioning the patient in bed  
Three studies examined the effectiveness of a variety of patient positioning 
strategies and the impact on PU development (Girard et al., 2014; Schallom, Dykeman, 
Metheny, Kirby, & Pierce, 2015; van Nieuwenhoven et al., 2006). Strategies trialled 
were diverse: one study compared the effectiveness of the backrest elevation of 28° vs 
10° for semi recumbent positioning with findings revealing no differences between 
each position (28° vs. 10°) groups in developing HAPUs (28% vs. 30% respectively) 
(van Nieuwenhoven et al., 2006). The second study compared the effectiveness of a 
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backrest elevation of 45° vs. 30°. No HAPUs developed for both groups (Schallom et 
al., 2015). The third study compared prone vs. supine position in HAPU development 
with severe acute respiratory distress syndrome (ARDS) (Girard et al., 2014). Results 
suggested that the prone position was associated with significantly greater HAPU 
development compared to a supine position in the first seven days of patient admission 
(p=0.05). However, these three studies did not address the frequency of repositioning 
patients, other supportive PU prevention strategies, and the angle of lower part of the 
body. 
 
Repositioning the patient out of bed  
No studies were identified that investigated the strategy of positioning the patient 
out of bed in a chair, the types of surfaces to seat ICU patients out of bed, or the 
frequency and or duration of sitting out of bed to reduce the incidence of HAPUs.  
 
3.6.6 Support Surfaces  
Six studies investigated the efficacy of a variety of pressure-relieving support 
surfaces (Black, Berke, & Urzendowski, 2012; Jackson et al., 2011; Malbrain et al., 
2010; Manzano et al., 2013; Ozyurek & Yavuz, 2015; Theaker, Kuper, & Soni, 2005). 
Two of these studies investigated the efficacy of using an active alternating pressure 
mattress in preventing PU development in the ICU setting in comparison to a mattress 
overlay. A small pilot trial demonstrated similar impact of two support surfaces on 
prevention of HAPUs (1/8 in active alternating pressure mattress vs. 2/8 in reactive 
mattress overlay (Malbrain et al., 2010). In contrast, Manzano and colleagues 
suggested that the alternating pressure mattress can significantly lower the incidence 
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of HAPUs, stage II or greater, in comparison with the foam overlay mattress (p=0.038) 
(Manzano et al., 2013). However, these studies have limitations, notably, small sample 
sizes (n=16), the compliance to other prevention strategies were not declared, and the 
heterogeneity of the outcome measures. 
The efficacy of using an alternating pressure mattresses compared to a low air 
loss mattress on reducing the HAPU in ICU was investigated in a single study with no 
significant difference found between the groups (p=0.35). This study was limited by 
retrospective data collection, small sample size, lack of reporting of other PU 
preventive care strategies in place and compliance to the intervention (Theaker et al., 
2005). A low air loss with microclimate management bed (LAL-MCM) was compared 
to integrated powered air pressure redistribution bed (IP-AR) (Black et al., 2012). The 
LAL-MCM significantly decreased the incidence of HAPUs compared to IP-AR (p = 
0.046) (Black et al., 2012).  
A single study trialled the effectiveness of air fluidized therapy support surface 
beds on preventing PU development (Jackson et al., 2011) reporting that the air 
fluidized therapy bed was more effective in reducing the incidence of HAPUs 
development in a cardiothoracic vascular ICU (40% pre-implementation vs 15% post-
implementation) (Jackson et al., 2011). The characteristics of standards beds were not 
reported.  
Recently, one trial compared the efficacy of two viscoelastic mattresses 
(Ozyurek & Yavuz, 2015), one composed of two layers, while the second was 
composed of three layers. No significant differences were found in the incidence of 
HAPUS between groups (p=0.44) (Ozyurek & Yavuz, 2015). 
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3.6.7 Medical Devices-Related PUs  
One study with a 2-phase design addressed the effectiveness of a strategy to 
prevent HAPUs in the critically ill male’s urinary meatus (Rassin, Markovski, Fishlov, 
& Naveh, 2013). Each phase evaluated different intervention strategies compared to 
usual standard care. The standard care was washing the area around the catheter entry 
point once/day. The findings for Phase I (daily washing the area around the catheter 
entry point) showed no significant difference in the incidence of urinary catheter 
related PUs between groups (7/29 intervention vs. 8/28 control). In Phase II (three 
times daily washing the area around the catheter entry point) showed a significant 
difference between groups (p=0.002).  
Two studies evaluated different strategies to reduce device-related PUs with 
non-invasive ventilation (Gregoretti et al., 2002; Weng, 2008). One study investigated 
the effectiveness of prototype face masks (PMs) compared to conventional face masks 
(CMs) and found significant improvement in device-related PUs using PMs (p<0.001). 
Another study investigated the effectiveness of using different protective dressings 
(hydrocolloid, and transparent film) with CM to prevent device-related PU (Weng, 
2008). The findings showed a significant difference in the incidence of device-related 
PUs between groups (p=0.001) (Weng, 2008). However, no significant difference was 
found with using different types of protective dressings (Weng, 2008). 
Only one trial examined the timing of a tracheostomy procedure for traumatic 
brain injury patients in reducing the incidence of HAPUs in ICU (Alali et al., 2014). 
The findings showed that early tracheostomy, ≤ 8 days of the patient’s admission, 
significantly lowered the incidence of HAPUs (p=0.001) (Alali et al., 2014). However, 
the study was limited as it was retrospective study, unclear that the outcomes were 
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measured based on objective criteria and in reliable way, and no other PU preventive 
strategies for both groups were mentioned (Alali et al., 2014).  
 
3.6.8 Educational Strategies  
A single study examined the effectiveness of educational strategies on the 
reduction of HAPU incidence in ICU settings (Uzun, Aylaz, & Karadağ, 2009). This 
study aimed to increase understanding and knowledge of PU prevention strategies 
through two 2-hour seminars for ICU nursing staff. A significant reduction of the 
HAPUs incidence was reported after implementation of the educational strategy (p 
<0.01) (Uzun et al., 2009).  
 
3.7 DISCUSSION  
Using the NHMRC (2009) evidence hierarchy for study design, this review 
found 24 studies in level II to III-2 evidence categories that evaluated different PU 
prevention strategies in the ICU. However, uncertainty in interpretation of these 
studies results exists due to small underpowered sample sizes with wide confidence 
intervals, and intention to treat was calculated (Gregoretti et al., 2002; Jackson et al., 
2011; Malbrain et al., 2010; Schallom et al., 2015; Theaker et al., 2005; Verbelen, 
2007). 
There was no evidence that use of a RAS, with or without a protocol 
intervention strategy, could reduce the incidence of HAPUs in ICU. Tayyib and 
colleagues (2013) recommended developing a RAS specifically for ICU, as most 
common RASs appear to be unreliable in prioritizing the higher risk patients in ICU, 
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possibly affecting deployment of available resources. Risk and skin assessment are not 
stand-alone events, nor are interventions. Thus no studies have, or can, examine the 
association between risk or skin assessment by itself and PU development. However, 
risk and skin assessments are recommended to always be incorporated into study 
protocols (NPUAP, EPUAP & PPPIA, 2014) to identify the patient at risk and guide 
the implementation of appropriate strategies. A gap remains as what intensive care 
clinicians could provide for specific patient’s condition (e.g sepsis, hypotension, and 
multi-organ failure) 
Evidence was inadequate to determine the effectiveness strategies for 
controlling faecal incontinence, and keeping patients’ skin dry and clean but not 
excessively dry in impeding overall HAPU development specifically in the sacral area 
of ICU patients. To develop a full picture of effective skin care strategies additional 
studies will be needed that aim to manage skin moisture, skin hygiene, skin 
dehydration, and the maintenance of natural skin pH.  
A few studies demonstrated the effectiveness of supine positioning with 
different elevation angles of backrest on preventing HAPUs development. Defloor 
(2000) reported that the supine position has the lowest interface pressure (Defloor, 
2000). Frequent repositioning, “two-hour repositioning”, is considered to be standard 
care to prevent PUs development (Behrendt et al., 2014) and is reported in this review 
to be effective in reducing the incidence of HAPUs, which is often not achieved. 
Goldhill and colleagues found that the average time for repositioning the ICU patients 
was 4.85 hours (Goldhill, Badacsonyi, Goldhill, & Waldmann, 2008). However, four-
hour repositioning using alternating pressure air mattress showed similar impact on 
HAPUs. This finding reveals a possible interaction between positioning, turning and 
using a support-surfaces strategy. In this review, different types of support surfaces 
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were evaluated and compared. However, the most effective support surfaces are 
difficult to ascertain in the absence of effective sample sizes, huge variety of support 
surface products availability/ choice, and inconsistency in the use of PU staging 
systems as an outcome measure (Black et al., 2012; Jackson et al., 2011; Malbrain et 
al., 2010; Manzano et al., 2013; Ozyurek & Yavuz, 2015; Theaker et al., 2005). Further 
evaluations are therefore required between different support-surfaces with sufficient 
power to identify the most effective surfaces on the reduction of HAPU incidence in 
ICU.   
Moreover, different prevention strategies were implemented, such as high 
protein diet with multivitamins, polarised light, timing of a tracheostomy, and different 
education and training strategies. These studies overall, have yielded improved results 
in preventing PU development, however, more research is required to validate these 
finding.   
Medical devices could increase risk for developing HAPUs in areas such as the 
face, neck and inner thigh. Few trials with small sample sizes compared and evaluated 
the efficacy of different devices and different types of dressing for securement for non-
invasive ventilation devices, as well as the efficacy of frequently cleaning the area 
underneath devices and changing positioning. The resulting of sample size trial could 
affect the reliability of the outcome.  
All studies which examined the application of prophylactic silicon border foam 
dressings suggested statistically significant decrease in the incidence of sacral and heel 
HAPUs in ICU. Using a prophylactic silicon border foam dressing on the sacrum was 
confirmed by a meta-analysis which demonstrated a statistically significant decrease 
in the incidence of sacral HAPUs. In regards heel HAPUs and prophylactic silicon 
border foam dressings, statistical pooling was not conducted as both studies had same 
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control group.  Further, standard care is to offload pressure on heels. A comparison 
study is required to determine if the outcomes with the use of dressings are better than 
the outcomes of heel offloading devices.    
In this review it was found that authors of most PUs prevention strategy trials 
did not acknowledge or monitor the degree of compliance to either the strategy itself 
or other PU prevention strategies, which may have affected the trials’ results. 
Moreover, the measurement tools in the study (the assessment and staging of PUs) 
were based on different definitions. Therefore, standardized PU definition and tools of 
measurement, monitoring the intervention compliance, and the reporting other 
prevention strategies are required to increase the understanding of these strategies. 
Consequently, a more systematic meta-analysis could be developed and more effective 
PUs prevention guideline could be generated.  
 
3.8 CONCLUSION  
The present review demonstrated different prevention strategies with positive 
impact that reduces the incidence of HAPUs in ICUs. A meta-analysis of this review 
reveals the effectiveness of using silicon foam dressing for preventing sacral HAPUs 
in ICU settings. However, pooled data from studies with different research designs and 
settings could be potential sources of heterogeneity and could affect this review’s 
findings. Moreover, the included studies pose many limitations such as different PU 
staging systems, small sample size, lack of randomisation, heterogeneity of these 
studies and compliance to intervention or other prevention strategies. Thus, no 
conclusions can be reached regarding the effectiveness of these strategies over another 
to prevent HAPUs in the intensive care context.  
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Further rigorous-designed RCTs that follow standardised criteria for reporting 
intervention are required. The criteria should consider multiple factors including a 
standard PU definition, staging systems, the degree of compliance to the intervention 
and other PUs prevention care, and characteristics of both groups either related to 
participants, and other PUs prevention care. This will promote the understanding and 
generalizability of these interventions’ effectiveness to different patient populations 
and settings. 
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Chapter 4: Conceptual Framework 
4.1 INTRODUCTION  
The previous chapters demonstrated that while several studies have addressed 
pressure ulcer (PU) prevention strategies in the ICU, PU incidence and prevalence in 
this setting remains high globally (Ballard et al., 2008; Coyer et al., 2015; Frankel et 
al., 2007). This suggests a lack of translation of best available evidence in real clinical 
settings. A possible explanation for this phenomenon could be related to the factors 
influencing the implementation of strategies, and possibly the validity of the studies’ 
findings themselves. It could be argued that a lack of comprehensive processes exist 
to guide the application of PU prevention strategies in the clinical setting, particularly 
the ICU. As the objective of this study was to develop, implement, and evaluate a PU 
prevention strategy in the intensive care setting, a comprehensive framework was 
required to effectively guide the implementation of PU prevention evidence in the 
ICU. This chapter provides an outline and justification for the conceptual framework 
used to inform this study, a care bundle approach combined with a research 
implementation framework. 
 
4.2 CARE BUNDLE APPROACH  
All critically ill patients in intensive care units are at risk for PU development 
due to their high acuity, physiological responses to critical illness, and subsequent 
length of stay in the ICU. Therefore, it is important to implement strategies that prevent 
PU development in critically ill patients. Evidence reveals that PU incidence can be 
reduced through the implementation of a PU prevention care bundle (or practice 
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guideline) (Coyer et al., 2015; Griffin, Cooper, Horack, Klyber, & Schimmelpfenning, 
2007). 
The term “care bundle approach” refers to a set of three to six treatment 
interventions targeted towards a specific procedure, symptom, or treatment (Cinel & 
Dellinger, 2006; Frantz, 2004; Fulbrook & Mooney, 2003; Marwick & Davey, 2009; 
Robb et al., 2010). Robb et al. (2010) argued that the care bundle approach is more 
effective than simply following clinical guidelines. This may be due to the mandatory 
and audited nature of care bundles, whilst clinical guidelines are regarded as advisory. 
The main concept of the care bundle approach is to group best evidence together, 
implemented at the same time, and then audited regularly. Such interventions can 
increase compliance and produce greater positive outcomes for patients than when 
carried out individually (Crunden, Boyce, Woodman, & Bray, 2005; Fulbrook & 
Mooney, 2003; Gillespie, 2007; Griffin et al., 2007; Lawrence & Fulbrook, 2011; 
Marwick & Davey, 2009; Pronovost, Nolan, Zeger, Miller, & Rubin, 2011; Robb et 
al., 2010; Thomson, Angus, & Scott, 2000). There is an emphasis on the importance 
of all elements of the “all or nothing” care within the care bundle approach, rather than 
the traditional audit approach, whereby each element is considered individually (Robb 
et al., 2010). The philosophy behind the practice is the combined use of evidence that 
has been accumulated.  
This approach has been shown to be effective in many clinical areas such as PU 
prevention (Cherry & Midyette, 2011), reduction in ventilator‐associated pneumonia 
(Crunden et al., 2005), antibiotic management (Toth, Chambers, & Davis, 2010), and 
increased compliance for hand hygiene (Pincock, Bernstein, Warthman, & Holst, 
2012). Therefore, mounting evidence supports that bundling or grouping of high 
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quality evidence into one intervention is more effective in achieving the desired 
outcome, reduced PU incidence, in critically ill patients.  
However, some healthcare practitioners have voiced opposition to care bundle 
approaches for a variety of reasons, namely: deprivation of the autonomy to make other 
clinical decisions, perceived inefficiencies (similar outcomes may be achieved with 
fewer elements), or ineffectiveness (the bundle may not be up to date with the most 
recent effective interventions) (Amerling, Winchester, & Ronco, 2008). Further, the 
risk of over or under-treatment could be increased, as not all patients may need all 
elements of the bundle. Finally, the care bundle approach does not address the process 
of translation of knowledge and evidence into the real clinical setting (Camporota & 
Brett, 2011).  
Despite these acknowledged limitations, the care bundle approach has proven to 
be effective through its all-inclusive nature. Namely, it promotes standardised care 
grounded in current evidence, which is more effective than single symptom 
management in complex areas (Fulbrook & Mooney, 2003). This standardisation helps 
to increase clinician compliance to adopt effective, evidence-based strategies to 
prevent, manage, and treat health problems. Thus, this research used a care bundle 
approach to guide the development of PU prevention strategies.  
 
4.3 RESEARCH IMPLEMENTATION FRAMEWORKS  
A care bundle itself is insufficient to implement evidence based practice; a 
systematic and dynamic model is required to guide the implementation and consequent 
adoption of a PU prevention bundle. There are a range of valid, effective, context-
focused models/or frameworks that have been used across numerous clinical settings 
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to promote research uptake by health care practitioners. These frameworks include: 
the Promoting Action on Research Implementation in Health Services Framework 
(PARIHS) (Kitson, Harvey, & McCormack, 1998; Kitson et al., 2008; Rycroft-
Malone, 2004), the Johns Hopkins Nursing EBP model (JHNEBP) (Newhouse, 
Dearholt, Poe, Pugh, & White, 2005; Newhouse, Dearholt, Poe, Pugh, & White, 2007), 
the Iowa model (Cullen & Titler, 2004; Titler et al., 1994), and the Ottawa Model for 
Research Use (OMRU) (Graham & Logan, 2004). A brief overview of these 
models/frameworks is discussed in the next section. 
 
4.3.1 Promoting Action on Research Implementation in Health Services 
Framework (PARIHS) 
The PARIHS is a conceptual model for translating research evidence into clinical 
practice and assessing components that could facilitate the implementation of an 
intervention. It was originally developed in 1998 (Kitson et al., 1998), and refined over 
time based on concept analyses and exploratory research (Kitson et al., 2008). 
According to this model, successful implementation of evidence is based on three core 
elements: evidence, context, and the facilitator. These three elements are ranked on a 
low-to high continuum, and the framework predicts successful intervention 
implementation when each element falls within the high continuum (see Figure 4.1). 
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The first element, evidence, includes propositional and non-propositional 
knowledge (research, clinical experience, patient and carers’ experience, and local 
information). Each piece of evidence is considered and ranked as low or high on the 
continuum according to the criteria to be met. Research evidence within PARIHS is 
one of the sources of knowledge that facilitates decision making for specific topics, 
especially when the research is well-conceived and conducted, and judged to be 
reliable. Clinical experiences are another source of evidence, therefore, these 
experiences should be verified and critiqued with other community practices to be 
considered effective sources for making a decision. Patient experience could also 
High 
Figure 4.1 PARIHS Elements "Evidence, Context, and Facilitation" 
(Adapted from Rycroft-Malone & Bucknall, 2011) 
 
Evidence  
Low Context  High  
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influence decision making through individual interaction, and perception and 
appropriateness of patient care. Moreover, local information such as audit and quality 
measurement and evaluation could contribute positively to making a decision 
regarding evidence, which could be translated to a clinical setting (Kitson et al., 2008; 
Rycroft-Malone, 2004).  
The second element of context refers to the setting or environment in which the 
practice change will be applied. This includes three sub-elements, which are culture, 
leaders, and evaluation. Culture is defined as a “learning organisation”, which includes 
leaders’ management styles and the relationship between the workers in a specific 
organisation. Leaders play an important role in transforming culture to create a context 
more conducive to translating evidence to practice. Evaluation reflects on whether the 
change of practice was appropriate, effective, and efficient (Kitson et al., 2008; 
McCormack et al., 2002; Rycroft-Malone, 2004). 
The final element is facilitation, which reflects the strategies or techniques that 
allow the implementation of research evidence into clinical practice. The role of the 
facilitator is to help the individual, team, and organisation to understand how, when, 
and what strategies they need to translate the evidence to practice. Therefore, 
facilitators need to have appropriate information and skills (Harvey et al., 2002; Kitson 
et al., 2008).  
While the PARHIS framework (see Figure 4.1) provides a comprehensive 
process to explore the factors and barriers that contribute to the successful 
implementation of research, there remains a lack of knowledge regarding how this 
framework could be applied in real clinical practice (Sudsawad, 2007). In addition, 
this framework neglects to outline or explain how the core elements interrelate and 
interact with each other (Rycroft-Malone & Bucknall, 2011). 
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4.3.2 The Johns Hopkins Nursing EBP Model (JHNEBP) 
The Johns Hopkins Nursing EBP model and guidelines were the result of 
collaboration between the Johns Hopkins Hospital Department of Nursing and the 
Johns Hopkins University School of Nursing in 2002 (Newhouse et al., 2005; 
Newhouse et al., 2007). The healthcare setting is a dynamic environment where nurses 
cannot achieve expertise without maintaining continual awareness of the entire realm 
of recent knowledge and how this can be utilised in practice (Pape, 2003). The 
expertise of both hospital nursing staff and school of nursing staff was derived to 
develop and test the EBP process. The Johns Hopkins Hospital identified the 
development of an EBP model as a strategic initiative (Newhouse et al., 2007).  
The JHNEBP model assists nursing clinicians to translate research evidence into 
practice whilst considering the impact of internal and external factors. External factors 
in this model include quality measures, standards, and professional regulatory and 
accreditation bodies. Internal factors include the organisational culture, which 
comprises values and beliefs; and the environment; leadership support; resource 
allocation; patient services; organisational mission or value statement; organisational 
priorities; availability of technology; library support; and finance (Newhouse et al., 
2007) (see Figure 4.2). 
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Practice Question Evidence Translation
•Step 1: Identify an EBP question
•Step 2: Define the scope of the practice question
•Step 3: Assign responsibility for leadership
•Step 4: Recruit an interdisciplinary team
•Step 5: Schedule a team conference
Practice 
Question 
•Step 6: Conduct an internal and external search for 
evidence
•Step 7: Appraise all types of evidence
•Step 8: Summarise the evidence
•Step 9: Rate the strength of the evidence
•Step 10: Develop recommendations for change in systems 
or processes of care based on the strength of the evidence
Evidence
•Step 11: Determine the appropriateness and feasibility of 
translating recommendations into the specific practice 
setting
•Step 12: Create an action plan
•Step 13: Implement the change
•Step 14: Evaluate outcomes
•Step 15: Report the results of the preliminary evaluation 
to decision makers
•Step 16: Secure support from decision makers to 
implement the recommended change internally
•Step 17: Identify the next steps
•Step 18: Communicate the findings
Translation
Figure 4.2 The John Hopkins Nursing Process for Evidence-Based Practice 
(Adapted from Newhouse et al., 2007) 
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The processes of this model are depicted by the essential cornerstone of the 
profession of nursing practice education and research, practice questions; evidence; 
and translation (PET) (see Figure 4.2). The practice question is the first phase; the 
process of generating a research question. The question is designed and refined, the 
scope of the question is determined, and an interdisciplinary team is formed. Evidence 
is the second phase of the PET process, and deals with the search for, and appraisal of, 
the best available evidence. Based on the results of this appraisal, recommendations 
are made by the team regarding identified practice changes. Translation is the third 
phase of the process, the EBP team determines if the changes to practice are feasible 
given the target setting. If so, an action plan is created. The change is then implemented 
and evaluated and the results are communicated to appropriate individuals both 
internal and external to the organisation. Each element of the process has many aspects 
that should be considered in assessing the success of the implementation, as shown in 
Figure 4.2. 
However, the nature of the process should be not presented as unidirectional, as 
elements could be influenced by each other. As with any research translation model, 
emphasis should be on the implementation component within the translation process; 
however, a major criticism of the JHNEBP model is that the degree of adoption of 
evidence is not monitored (Newhouse et al., 2007). Therefore, a true translation of 
research findings would be lost. 
 
4.3.3 The Iowa Model  
This model was established from 1994 to 2001 by staff nurses of the University 
of Iowa Hospital and Clinics. It aimed to demonstrate the process of utilising research 
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to improve healthcare outcome in clinical practice (Rycroft-Malone & Bucknall, 2011; 
Titler et al., 2002). This model focuses on knowledge and problem-focused triggers, 
leading staff to question existing health care practices and whether care can be 
improved through the implementation of up-to-date research results (Titler, 2007; 
Titler et al., 2002). This model was developed and tested, firstly in acute care setting 
(Titler et al., 2002), then adopted widely in academic and acute care settings (Aitken 
et al., 2011; Bowman et al., 2005; M. Gordon, Bartruff, S. Gordon, Lofgren, & 
Widness, 2008; Haxton, Doering, Gingras, & Kelly, 2012; Ong, Miller, Appleby, 
Allegretto, & Gawlinski, 2009; Van Waning, Kleiber, & Freyenberger, 2005; Witzke 
et al., 2008). Moreover, it is applicable for all health care disciplines (see Figure 4.3). 
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Monitor and Analyze 
Structure, Process, and 
Outcome Data 
x Environment  
x Staff 
x Cost  
x Patient and family  
Yes  No  
Yes  No  
Figure 4.3 The Iowa Model of Evidence-Based Practice to Promote Quality of Care  
(Adapted from Titler et al., 2002) 
No  
Knowledge- focused triggers 
1- New research or other literature  
2- National agencies or organizational 
standards and guidelines 
3- Philosophies of care 
4- Questions from institutional standards 
committee 
Problem-focused triggers  
1- Risk management data 
2- Process improvement data 
3- Internal/external benchmarking data  
4- Financial data 
5- Identification of clinical problem 
Is this topic a priority 
for the organization?  
Is there a sufficient 
research base? 
Is change 
appropriate for 
adoption in practice? 
Form a team 
Assemble relevant research and related literature  
Critique and synthesize research for use in practice  
Consider other 
triggers  
Base Practice on Other 
Types of Evidence 
1. Case reports  
2. Expert opinion  
3. Scientific principles 
4. Theory  
Pilot the Change in Practice  
1. Select outcomes to be achieved 
2. Collect baseline data 
3. Design evidence-based practice 
(EBP) guideline(s) 
4. Implement EBP on pilot units 
5. Evaluate the process and 
outcomes  
6. Modify the practice guidelines 
Conduct 
research  
Institute the change 
in practice  Continue to evaluate 
quality of care and new 
knowledge  
Disseminate 
results  
Yes  
 106   Chapter 4: Conceptual Framework 
Many studies, guided by the Iowa model, suggest that this model facilitated the 
implementation of evidence based practice in real settings (Bowman et al., 2005; 
Brown, 2014; M. Gordon et al., 2008). The Iowa model uses a seven step process: 
selecting a topic, forming a team, evidence retrieval, grading the evidence, developing 
an EBP standard, implementing the EBP, and evaluation (see Figure 4.3). 
 Although it is evident that the Iowa model is an effective model for translating 
knowledge into practice, there are some notable limitations. For example, the Iowa 
model was criticised as the process of informing the individual practitioner about the 
outcome of change practices is not addressed (Rycroft-Malone & Bucknall, 2011; 
Schaffer, Sandau, & Diedrick, 2013), thus, there is no continuous feedback from the 
practitioners during the implementation period. Furthermore, there are questions 
regarding the fidelity of the implementation of this model in relation to adoption of 
critical and relevant evidence (Aitken et al., 2011). 
4.3.4 The Ottawa Model of Research Use (OMRU) 
The OMRU, designed by Logan and Graham (1998), is a dynamic, interactive 
model used to apply knowledge in clinical practice (Logan, Harrison, Graham, Dunn, 
& Bissonnette, 1999). As OMRU processes interconnected decisions and actions by 
different individuals related to each of the model’s elements (Buxton & Hanney, 
1996), this means that the process can be repeated at any stage of the implementation. 
Many studies have applied the OMRU model to facilitate transfer of knowledge in real 
practice contexts (Hogan & Logan, 2004; Logan et al., 1999; Stacey, Pomey, 
O'Connor, & Graham, 2006).  
The OMRU consists of six phases framed by assessment, monitoring, and 
evaluation: 1) research-based innovation, 2) the practice environment, 3) potential 
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adopters, 4) implementation of the intervention, 5) adoption, and 6) outcomes (see 
Figure 4.4) (Logan et al., 1999). 
The model is classified as a planned action model, as it provides direction for 
the issues that should be addressed and the activities that change agents should 
undertake (Logan & Graham, 1998). When knowledge transfer is being planned, the 
model relies on a process of assessing, monitoring, and evaluating each element 
before, during, and after the decision is made to promote the innovation (Rycroft-
Malone & Bucknall, 2011). The OMRU directs change agents through assessment of 
the barriers and facilitators to research use related to the practice environment (in this 
instance the ICU), adopter characteristics (in this instance intensive care specialist 
registered nurses), and the clinical innovation (PU prevention bundle). These three 
phases result in the identification of factors that could hinder or assist the 
implementation of evidence-based innovation. An implementation plan is then tailored 
to overcome the identified facilitators and barriers. The strategies to deliver the 
intervention are based on the situational assessment and the transfer of the strategies 
with the ongoing evaluation. How the evidence-based research is transferred to clinical 
practice is then monitored. Finally, the intervention is evaluated by assessing the effect 
on patients, practitioners, and the system to conclude the effectiveness of the 
intervention. 
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barriers and support     intervention and degree of use     outcomes 
Practice environment  
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Research-based innovation  
 
Development process 
Innovation attributes 
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Awareness 
Attitudes  
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Implementation 
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Transfer 
Follow up 
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Intention 
Use 
Outcomes  
Patient 
Practitioner 
System 
Figure 4.4 The Ottawa Model of Research Use  
(Adapted from Graham & Logan, 2004) 
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4.3.5 Summary of Research Implementation Frameworks  
In comparing previous models/frameworks, it could be suggested that the 
OMRU model translated the evidence to the real clinical setting most effectively, and 
consequently, increased the validity of the research findings. In addition, it has 
previously been adopted in the translation of evidence to improve skin integrity 
(Graham & Logan, 2004). In response to the research questions, this study required a 
comprehensive framework to develop, effectively implement, and evaluate the PU 
prevention intervention in the critical care context. Thus, combining a care bundle 
approach of best available evidence with a complementary model of research 
implementation, the OMRU has provided a novel comprehensive framework for this 
study. The care bundle approach provides a protocol of high quality evidence toward 
PU prevention, while the OMRU, a knowledge translation framework, is used to guide 
the transformation of the care bundle into action.  
 
4.4 APPLYING THE OMRU MODEL TO THIS STUDY 
 This section illustrates how the OMRU was used to theoretically direct the 
implementation of a PU prevention bundle within the intensive care environment to 
reduce PU incidence. Further, this section provides insight into this novel and 
comprehensive vehicle for using high quality evidence to improve skin integrity within 
an ICU practice setting. Each phase of the OMRU process as applied to this study is 
represented in Figure 4.5 and discussed below:
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Research-based innovation  
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Patient 
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Figure 4.5 The Ottawa Model of Research Use for Implementing a PU Prevention bundle in ICU  
(Adapted from Graham & Logan, 2004) 
Note: Italic, and underline = Study specific information 
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4.4.1 Assessment 
Phase 1: Research-based innovation (PU prevention bundle) 
 Innovations within a hospital setting are defined as representing new things 
based on current knowledge and current research data, which may be in the form of 
procedures, policy practice guidelines, or a care bundle. These innovations should be 
of low complexity, compatible with the context (including current practice and value), 
clear, noncontroversial, and cost effective (Khosrowpour, 2009). 
Whenever an innovative care bundle is planned, the following steps should be 
considered: a review of the relevant literature and a synthesis of the best evidence 
along with the contextual demands and formation of an integrated bundle of care. 
However, the bundle approach is based upon holistic principles, whereby the whole is 
greater than the sum of its parts, and is an approach with which most nurses are 
familiar. The advantage of the care bundle approach is the provision of quality 
measurement indicators, which allows targeted interventions and the performance of 
care providers to be evaluated. Cinel and Dellinger (2006) commented that using 
indicators such as a care bundle approach would facilitate hospitals to use a quality of 
care assessment instrument that is objective. Such objective information would assist 
care providers and clinicians to be more effective in their work (Cinel & Dellinger, 
2006). A panel of international experts, constituting the National Pressure Ulcer 
Advisory Panel (NPUAP) and European Pressure Ulcer Advisory Panel (EPUAP), as 
an international consensus committee (2009) reviewed evidence on PU prevention 
strategies and found consensus in the following guidelines for the general context. 
These guidelines were contextualised to the ICU context and presented as a care 
bundle (presented in Table 4.1)(EPUAP & NPUAP, 2009). 
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Table 4.1 The PU Prevention Bundle for Critically Ill Patients  
Intervention The PU prevention bundle 
Risk 
assessment 
Completion and documentation of Braden risk assessment scale 
within 24 hours of ICU admission and daily thereafter.  
Skin 
assessment 
Physical assessment of the patient’s skin is undertaken and 
documented within 4 hours of admission and every 8 hours 
thereafter. 
Loss of skin integrity assessed (and documented) using the PU 
staging tool, noting site, size, depth, and whether any exudates are 
present.  
Skin care: Patients bed-bathed once per day using a pH balanced cleansing 
agent (pre-package washcloth). Skin treated with a topical 
moisturiser. 
Nutrition Nutritional status assessment is undertaken by the clinical 
nutritionist upon admission. 
Repositioning Patients repositioned using a three hourly turning schedule using a 
‘turn clock’.  
Foot of the bed elevated by 20 degrees if clinically permitted. 
Patient's heels are elevated and supported.  
Drawsheets used to transfer and lift patients.  
Where clinically possible, patients are mobilised daily to sit out of 
bed on a chair.  
Position documented, including the time of repositioning and 
position adopted  
Support 
surface 
All ICU patients managed on air mattresses.  
Education 
and training 
RNs educated in the conduct of accurate and reliable Braden Scale 
score risk assessment.  
All ICU health practitioners, especially RNs, educated on targeted 
bundle elements of PU prevention (e.g., risk assessment, the role of 
repositioning in PU prevention, correct methods for patient 
repositioning and use of equipment in reducing pressure, friction 
and shear forces). 
MDRPU Assessment of skin around/underneath medical devices every 12 
hours. Securement and repositioning of nasogastric tubes (NGT) 
and endotracheal tubes (ETT) as per techniques outlined in the 
study bundle. 
 
The PU prevention bundle to improve the skin integrity of critically ill patients 
was based on the international guidelines for general settings, with up to date evidence 
of PU prevention injected to make the bundle compatible with the ICU context. 
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However, the bundle should also be tailored to each individual practice environment 
(ICU) and the potential adopters or users (RNs). 
 
Phase 2: Practice environment (ICU) 
The importance of organisational characteristics, such as leadership, culture, 
mechanisms for evaluation and feedback, and management support, together with the 
presence of champions to implement change in healthcare settings has been identified 
in a considerable volume of research (Bradley et al., 2005; Stetler, 2003; West, 2001). 
Many essential features of healthcare systems, which include the diversity and range 
of stakeholders, governance, and resource arrangements, together with autonomy and 
specialisation of professional staff, may result in varying cultures and norms, as well 
as high levels of interdependency amongst professionals in the system (Urquhart, 
Porter, Grunfeld, & Sargeant, 2012). These factors can promote or inhibit adoption of 
the PU prevention bundle (Logan & Graham, 1998). Interventions at an individual-
level are important when changing clinical practice, yet the complex nature of 
healthcare organisations means that interventions delivered only at an individual level 
cannot result in a change in clinical practice in a sustained manner (Urquhart et al., 
2012). 
The ICU is a complex setting for the translation of knowledge into practice due 
to many aspects, such as nursing workload, dependence on technological support, 
critical illness trajectory, and information overload (Asadoorian, Hearson, 
Satyanarayana, & Ursel, 2010; Hogan & Logan, 2004; Hutchinson & Johnston, 2004; 
Pogorzelska & Larson, 2008; Sinuff et al., 2007; Stacey et al., 2006). Furthermore, the 
severity of illness of patients or patients’ resistance and their family may reduce 
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adherence to a PU prevention bundle (Abrahamson, Fox, & Doebbeling, 2012; Koh, 
Manias, Hutchinson, Donath, & Johnston, 2008; Sinuff et al., 2007). A lack of 
resources has been given as the reason for hindering clinician’s ability to carry out a 
PU prevention bundle (Abrahamson et al., 2012). The acceptance and use of a PU 
prevention bundle may be negatively affected by a lack of endorsement by a champion 
(Marchionni & Ritchie, 2008; Sinuff et al., 2007) or inadequate support from peers or 
administrators (Goossens, Bossuyt, & de Haan, 2008). However, peer practitioner 
support is also one of the major influencing factors within practice settings, as many 
practitioners report relying on colleagues to support their decisions (Gaddis, 
Greenwald, & Huckson, 2007). This practice may reduce with the increased use of a 
PU prevention bundle, thereby reducing the reliance upon experience-based decision 
making (Gaddis et al., 2007).  
Poor skin care is not an individual problem, but a reflection of a failure of the 
health care setting, which may be the result of inadequately organised care processes, 
together with a practice culture that is not based upon evidence based practice, 
collaboration, and the improvement of care. A discussion regarding how the care 
bundle and the OMRU model informed the study is provided in Chapter 5, Section 
5.3.3. Furthermore, an overall summary of the study’s conceptual framework (the care 
bundle and OMRU model) is presented in Chapter 9.  
 
Phase 3: Potential adopters (specialist RNs)  
Potential adopter refers to practitioners, such as registered nurses (RNs), who 
implement the PU prevention bundle (Graham & Logan, 2004). Assessment of RNs 
for their willingness to implement a PU prevention bundle is comprised of three 
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concepts: awareness of the problem and the PU prevention bundle innovation, the 
intention of RNs to change current practice, and concern regarding the PU problem 
(Rycroft-Malone & Bucknall, 2011). Understanding adopters’ perceptions of these 
three concepts is essential to understanding both potential barriers and facilitators in 
implementation of the bundle. Grol & Grimshaw (2003) stressed the importance of 
requesting support from health care providers in order to encourage the use of evidence 
by practitioners (Grol & Grimshaw, 2003). There are many factors affecting changes 
in the practice of ICU RNs, such as workload, no time in the workplace to update their 
knowledge in respect to PU prevention, lack of staffing, fear of the time needed to 
implement the new PU prevention bundle, and fear of overlooking the patient’s 
conditions (Baker et al., 2010; Brown, Wickline, Ecoff, & Glaser, 2009; Strand et al., 
2010). Considering, assessing, and managing all of these factors, both individually or 
organisationally, before planning and implementing PU prevention bundle is crucial. 
 
4.4.2 Monitoring  
Phase 4: Intervention Implementation (education and training of the PU 
prevention bundle) 
It is necessary for the intervention to be tailored to the specific health care setting 
based upon the assessment of the previous three fundamental elements of OMRU: 
barrier management strategies, passive and active implementation strategies, and 
follow-up activities. Therefore, the PU prevention bundle was designed along with the 
latest international guideline and up to date evidence, then tailored to the KSA ICU 
context. Close monitoring of all intervention strategies is required, including the 
implementation and utilisation of research findings, assisted by strategies designed to 
 116   Chapter 4: Conceptual Framework 
meet the specific needs of target adopters, which should involve education, training, 
individual audit, and feedback (Logan et al., 1999). 
Generally, the three fundamental research transfer categories are: passive 
diffusion, targeted dissemination, and active implementation (Rycroft-Malone & 
Bucknall, 2011). These implementation strategies require both voluntary and non-
voluntary approaches (Rycroft-Malone & Bucknall, 2011). Non-voluntary approaches 
include developing a PU prevention bundle for the ICU, whereas a voluntary approach 
includes education and physical changes to the ICU. Multiple intervention approaches 
are related to the innovation adoption process. 
Knowledge about the prevention of PU prevention should be assessed and, when 
insufficient, enriched before barriers may be dealt with effectively. Education is a key 
requirement, but a strategy that is in itself insufficient will fail to effect lasting changes 
in practice. The introduction of practice innovation for ICU RNs is suggested, using 
the resources of the ICU in order to identify the problem, create awareness, and 
persuade clinicians of the need to change practice and examine how this change may 
be achieved. This would be enhanced by the provision of brochures explaining the 
elements of the PU prevention bundle, as well as presenting evidence to support the 
PU prevention bundle. The education and training will empower ICU RNs and 
enhance their confidence in accurately identifying and staging PUs, thus affecting a 
positive change in practice. 
It is important to create an environment that will make it easy for clinicians to 
provide the best care. This is achieved by ensuring that embedding the PU prevention 
bundle into daily practice provides the most appropriate conditions for effective 
change. Regular ICU audits should be performed to ensure compliance with the PU 
prevention bundle. When noncompliance of staff was noted, identification of the 
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barriers and mechanisms to overcome these are required. Support and encouragement 
of ICU RNs can be achieved by informing them of the progress in performance 
improvements. Finally, on-going assessment strategies should be implemented, which 
would explore the effectiveness of the PU prevention bundle, as well as identifying 
barriers and facilitators for its use. 
 
Phase 5: Adoption  
Adoption means action sequences of research evidence innovation (PU 
prevention bundle) represented as behaviour changes in potential adopters, which 
includes starting to implement and continuing to use the PU prevention bundle 
(Rycroft-Malone & Bucknall, 2011). A care bundle monitoring cycle is necessary to 
determine the extent to which the PU prevention bundle has diffused throughout ICU 
RNs and affected the process of care. It can also be used to determine whether the PU 
prevention bundle has been sufficient in bringing about the desired change, which is 
the reduce incidence of PUs, or whether more of the same, or a modification of the 
protocol is required. If the degree of adoption is less than expected, it may be useful at 
this stage to assess the ICU RNs’ perceptions, to determine whether the absence of 
change is related to a lack of interest on their part to reduce PU incidence for ICU 
patients, or whether it is related to other barriers that may be beyond their control. 
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4.4.3 Evaluation  
Phase 6: Outcomes  
Outcome refers to the effect and impact of the implementation of the PU 
prevention bundle on patients, practitioners, and the healthcare system (Rycroft-
Malone & Bucknall, 2011). The purpose of this phase is to determine whether 
promotion of adoption is of value or not; fidelity of ICU RNs to comply with the PU 
prevention bundle, which is monitoring during implementation; and whether the PU 
prevention bundle has achieved the desired patient outcomes in term of reduction of 
incidence or prevalence of PU in critically ill patients in the ICU. 
 
4.5 CONCLUSION  
Despite a significant amount of evidence for PU prevention (Girard et al., 2014; 
Park & Kim, 2014; Theaker, 2003; van Nieuwenhoven et al., 2006; Verbelen, 2007), 
the delivery of quality patient care to prevent PU occurrences remains a challenge in 
the ICU. It is argued that bundling the best available evidence appropriate for critically 
ill patients will be more effective in reducing PU development in patients in the ICU. 
However, the ICU is a complex environment, and to implement high quality evidence 
for PU prevention requires a systematic, methodical approach. For effective 
implementation of the PU prevention bundle, a practical systemic and dynamic model 
is needed to guide the implementation process. The OMRU framework, as a 
knowledge translation model, has proven to be effective and efficient in sustaining 
changes of care in the ICU. Thus, the novel connection between a care bundle approach 
and the use of the best evidence facilitated by this dynamic model provided a logical 
framework to guide this research.
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Chapter 5:  Research Design 
5.1 INTRODUCTION 
Building on the conceptual framework presented in the previous chapter, a care 
bundle in combination with the OMRU approach, this chapter details the methodology 
used to address the research questions for this study. This chapter outlines the research 
design, sample, population and setting, data collection method, instrument, data 
analysis, and ethical considerations for each phase of the study. The rationale for the 
research design and methods are provided in order to justify relevant decisions made.  
 
5.2 RESEARCH DESIGN  
The research aims and questions of this study dictated the quantitative 
methodological approach taken. As previously discussed (see Section 4.4) this 
research design was underpinned by the conceptual framework, which is the care 
bundle approach and OMRU model. The first step of the OMRU model was the 
assessment, including evidence, practice environment (Phase One, Part A), and 
potential adoptors (Phase One, Part B). Implementation and evaluation steps were then 
undertaken in Phase Two. Thus, the study consisted of two phases (see Figure 5.1). 
Phase One was comprised of two parts. Part A used a prospective observational study 
to determine the incidence of PUs at selected tertiary hospitals in the Kingdom of Saudi 
Arabia (KSA). The incidence data informed the sample size calculation for Phase Two 
(a two–arm cluster RCT). Part B used a cross-sectional survey design to explore 
barriers and facilitators related to PU prevention strategies among intensive care 
registered nurses (RNs) working in the intervention arm of the Phase Two study. This 
data assisted with tailoring of the training protocol for the Phase Two intervention. 
 120   Chapter 5: Research Design 
Phase One of this study addressed the key assessment components of the OMRU 
model, and specifically the three elements of assessment of barriers and supports, 
assessment of the RNs as potential adoptors, and assessment of the intensive care 
practice clinical environment (see Figure 5.2). Following this, Phase Two, a two-arm 
cluster randomised control trial (cRCT), evaluated the effectiveness of a care bundle 
guided by a research implementation model in reducing the incidence of PU 
development in the ICU. Each phase of this study is presented according to the specific 
research design, sample, population and setting, data collection method, instrument, 
data analysis, and ethical considerations. 
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Phase Two: A Two-Arm Cluster RCT 
Aim: to evaluate the effectiveness of a care bundle in reducing the incidence of PU in the ICU 
Design: A two-arm cluster RCT
Sample: all ICU patients who met the inclusion and exclusion criteria. The sample size will be 
calculated based on incidence study.
Instrument: specifically designed data collection form including PU incidence form, Braden 
risk assessment scale, and checklist for care bundle performance.
Phase One, Part A: Incidence Study
Aim: to calculate the incidence of PU in the ICUs of two 
KSA hospitals. The incidence data will inform the sample 
size calculation for Phase Two.
Design: prospective cohort study 
Sample: all ICU patients of two KSA hospitals admitted 
during consecutive 4 weeks 
Instrument: data records designed to calculate PrU 
incidence, additionally SOFA, and PU grading tool.
Phase One, Part B: OMRU assessment 
Aim: to identify barriers and facilitators as percieved by RNs 
to the adoption of evidence to reduce PU development. This 
data will assist with tailoring of the training protocol for the 
Phase Two intervention.
Design: descriptive cross-sectional study 
Sample: all convenience RNs in intervention group
Instrument:RNs survey "Barriers and Facilitators"
Figure 5.1 Research Phases and Methodology 
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Figure 5.1 Research Phases and Methodology 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Ottawa Model of Research Use Adapted and Applied to this Study 
Assess   +   Monitor    +  Evaluation 
barriers and support   intervention and degree of use     outcomes 
1- Research-based innovation  
(PU prevention bundle) 
 
 
2- Potential adopters  
(Intensive care RNs) 
“Phase One, Part B” 
 
3- Practice environment  
(KSA ICU) 
“Phase One, Part B” 
 
4- Implementation 
intervention strategies  
(Education and training, 
and process of care) 
“Phase Two” 
 
5- Adoption 
(Implementation of the 
PU prevention bundle) 
“Phase Two” 
6- Outcomes 
(ICU PU incidence & 
RN compliance to the 
bundle) 
“Phase Two” 
Source: Graham & Logan (2004) 
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5.3 PHASE ONE, PART A 
5.3.1 Research Design  
This study used a multicentre prospective cohort observational design to 
calculate the new cases of an event (PUs) occurring in a group of people who share 
similar experiences and characteristics (critically ill patients in the ICU) over a specific 
period of time (four weeks) (Healy & Devane, 2011; Hood, 2009; Levin, 2006b; 
Melnyk & Fineout-Overholt, 2011; Simpson & Hannaford, 2002; Soh & Saw, 2010; 
Tay & Tinmouth, 2007; Wood & Kerr, 2011). An observational cohort study is a 
common quantitative study design used for intensive care patient research because it 
examines the correlation between variables and describes a specific group who share 
the same experience within a defined period (Boyle & Green, 2001; Eachempati et al., 
2001; Sanada et al., 2007; Slowikowski & Funk, 2010). Furthermore, many studies 
examining incidence utilise a prospective design, as a new occurrence of an outcome 
of interest can be monitored and calculated within a specified time interval (Fife et al., 
2001; Kaitani et al., 2010; Nijs et al., 2009; Sayar et al., 2009). A prospective 
observational design enabled the researcher to answer the research questions in this 
study, as it provided descriptions and exploration of PU incidence (Aschengrau & 
Seage, 2008; Bhopal, 2008; Friis & Sellers, 2009; Soh & Saw, 2010) in the ICU 
setting. Additionally, this design allowed the determination of PU incidence required 
to calculate the sample size required for Phase Two (RCT). 
 
5.3.2 Research Questions 
4- What are the characteristics of the ICU patients in KSA? 
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5- What is the incidence of PU development in critically ill patients in the 
intensive care units of two tertiary referral hospitals in the KSA? 
6- What are the factors associated with PU development in the ICU in the 
KSA? 
 
5.3.3 Study Setting and Population 
The study was conducted in the intensive care units at King Abdulaziz Hospital 
(KAAH) and King Fasil Hospital (KFH), Makkah, KSA. Both hospitals are operated 
by the Ministry of Health, KSA and are major and large tertiary care hospitals, each 
with over 400 beds and ambulatory services. Further, both KSA facilities are 
accredited as meeting the national standards of excellence in quality and patient safety 
care and health services by the KSA National Accreditation program, as determined 
by the Central Board of Accreditation for Healthcare Institution (CBAHI). 
At the time of the study, the ICU at KAAH had 24 beds, while the ICU at KFH 
has 20 beds, each in a single room. These two facilities provide services to patients of 
the western region of Saudi Arabia and from neighbouring regions. According to both 
hospitals’ annual reports, the ICUs admit between 2000 (KFH) and 2500 (KAAH) 
patients annually and approximately 70 to 80% of the ICU patients admitted each year 
require mechanical ventilation. A diverse number of complex treatments and advanced 
technological equipment are provided for ICU patients to support their body system 
functions during critical illness. The ICUs also provide continuous intensive 
monitoring for patients who have life-threatening illness or after major surgery. Both 
ICUs are specialist areas that deliver complex multi-system support for adults 
requiring comprehensive intensive care and monitoring by specialists. 
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Patients admitted to KAAH and KFH ICUs have similar high acuity and medical 
diagnoses. Patient’s diagnoses in both ICUs include cardiovascular illness, respiratory 
disease, cancer, renal dysfunction, sepsis, and multi-trauma injury such as head injury. 
According to the 2012 KAAH ICU portfolio, the average length of patient stay was 10 
days. Similarly, for the KFH, the average length of stay was approximately 9 days. 
Both ICUs have approximately 60 RNs working in the department. RNs 
providing care for ICU patients have tertiary qualifications, such as a Bachelor of 
Nursing or Diploma in Nursing, and relevant clinical experience. For both hospitals, 
the ICU staffing ratio is one nurse to two patients and one charge nurse per shift for 
each of the three shifts per day. In both hospitals, the RN in-charge of the ICU is not 
always supernumerary, and is sometimes rostered to provide care for two patients. At 
the time of the study there were no assistant practitioners or care assistants working in 
the unit. Furthermore, there are no dedicated clinical instructors or nurse educators in 
the units. 
Additionally, both facilities have policies related to the prevention of PU 
development, such as a positioning policy where the patients’ position is rotated every 
two hours through right side, back, and then left side or vice versa. Additionally, 
routine historical skin hygiene practice for ICU patients in both units is a bed-bath at 
6:00am using a ‘scrub-stat’ containing hydrogen peroxide. Physical examination and 
assessment of the patient’s skin is recommended three times per day; once per nurses’ 
shift. Moreover, all ICU patients are managed on air mattresses, as a pressure reducing 
mattress and respositioned using draw sheets with the latter being historical practice 
in KSA. Thus, prevention of PU for patients is part of fundamental nursing care in 
intensive care units at KAAH and KFH. 
 
 126   Chapter 5: Research Design 
5.3.4 Sampling Strategy and Size 
The sample for Phase One, Part A was all patients admitted to the KAAH and 
KFH ICUs who met the inclusion criteria over a consecutive four-week period. 
Patients were included if they were to be managed in the ICUs during the period of 
collection data and were aged 18 years or more.  
The sampling framework consisted of a time period of four consecutive weeks 
and the inclusion criteria. Four weeks was selected as a representative timeframe to 
calculate the incidence of both community-acquired PUs (CAPU) and hospital-
acquired PUs (HAPU) in relation to PU stage, type, or site of injury (e.g., medical 
device-related PU), and ICU length of stay. A consecutive sample was recruited to the 
study to minimise the risk of selection bias (Hulley, 2001). As this included all 
accessible participants over specific time period, this could provide a reasonable 
representation for the entire population (Lunsford & Lunsford, 1995). 
 
5.3.5 Data Collection 
Data was collected on three levels: baseline ICU survey, baseline patient survey, 
and second daily patient data collection. The data collection processes were piloted 
with validated instruments where available including SOFA score (Vincent et al., 
1998), and PU grading scales (EPUAP & NPUAP), 2009b).  
A data extraction form, specifically designed for this study, was used to calculate 
PU incidence in ICUs and describe the sample. This form recorded each participant’s 
demographic characteristics (age, sex, weight, height, body mass index (BMI), 
primary diagnosis, co-morbidities, ventilation status, the Sequential Organ Failure 
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Assessment (SOFA) score, reason for or type of admission, date of admission to the 
hospital and ICU, and length of stay in ICU before the occurrence of a PU).  
Second daily data of the patient's skin assessment, any changes of skin integrity, 
PU site and stage, relationship to medical devices, and whether community acquired 
or hospital was also recorded. Pressure ulcers were staged according to the EPUAP 
and NPUAP criteria current at the time of the study. All instruments are discussed 
below:  
 
Baseline ICU data  
The system level data current at the time of commencement of data collection 
for each ICU was collected, including total bed capacity, ratio of ventilator/non-
ventilator beds, annual number of patient admissions, average length of patient stay, 
number of patient mechanical ventilation days, nurse:patient ratios, years of RN 
nursing and critical care experience, and the number of RNs with a critical care 
qualification. Baseline ICU data also included the existence of specific policies 
regarding skin care, the existence of potential adopters such as ‘PU Prevention 
Champions’, and the existence or implementation of unit based preventative strategies 
for PU. 
Baseline patient data 
Patient level data was collected upon admission for all patients including 
demographics such as age; sex; nationality; BMI; and clinical data including diagnosis 
on admission, comorbidities, emergency or elective admission, length of time in 
operating theatre or emergency department or to ICU admission in hours if applicable, 
SOFA score, presence or absence of PU on admission (yes/no), mechanical ventilation 
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(yes/no), duration of mechanical ventilation in days if applicable, ICU length of stay 
in days, and ICU outcome (discharge to ward or death). 
 
Second daily patient data collection 
Data was collected over a consecutive 48-day period (four weeks) on all patients 
admitted to the ICUs on a second daily basis until patient discharge. This data included 
the presence or absence of PU, PU staging and site, and SOFA score. 
 
Sequential Organ Failure Assessment (SOFA) 
The SOFA was designed by the European Society of Intensive Care Medicine in 
1994 and revised in 1996. The SOFA score is a scoring system used to determine the 
extent of a person's organ function or rate of failure in the ICU (Ferreira, Bota, Bross, 
Mélot, & Vincent, 2001). The score is based on a six-organ dysfunction/failure score: 
the respiratory, cardiovascular, hepatic, coagulation, renal, and neurological systems. 
Each organ is graded from 0 (normal) to 4 (the most abnormal), providing a daily score 
of 0 to 24 points. The purpose of the development the SOFA score was to create a 
reliable, simple, and continuous score that could be easily applied in all institutions. 
The SOFA score is an indicator of prognosis when applied during the first few 
days of admission to the ICU. The SOFA mean and highest scores are very useful 
outcome predictors, whereby an increase in score during the first 24 to 48 hours in the 
ICU predicts where a mortality rate of at least 50% and up to 95% is predicted. When 
the SOFA scores are less than nine a predictive mortality is 33%, whilst 11 and above 
can be close to or above 95% predictive mortality rate (Ferreira et al., 2001). SOFA 
score demonstrates organ function progress during a period spend in ICU stay (KM, 
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2007). Although APACHE II offers greater discriminative power than the SOFA score 
during the first 24 hours of a patient's admission, a more sensitive approach to daily 
changes in the condition of patients is provided by the SOFA score, which provides an 
instrument to determine when organ dysfunction could develop after admission to ICU 
(Qiao, Lu, Li, Shen, & Xu, 2012) (see appendix A). 
 
PU staging tool  
PU staging refers to the level of tissue damage or depth of the injury observed, 
and is central to developing PU prevention programs and treatment. Moreover, staging 
permits health care workers to be objective in their assessment of the depth of tissue 
injury. The NPUAP and EPUAP (2005) updated the definition of the staging system 
of PUs by adding two stages to the traditional classification, which included stages I 
to IV.NPUAP & EPUAP (2009) provide a clear definition of each PU stage (see 
Appendix A). 
For this study, a record form was designed for each patient to identify the PU 
staging according to EPUAP and NPUAP criteria (2009). Additionally, the PU site 
was identified on the data collection form by drawing a circle over the relevant area in 
the body figure (see Appendix A). 
 
Braden Scale score  
The Braden Scale score for predicting PU risk (see Appendix A), was designed 
in 1987 (Smith et al., 1995). The Braden Scale reflects the conceptualisation of the 
physiological sequale of PU development and formation. Accordingly, it consists of 
six elements: sensory perception (which measures an individual's ability to feel, 
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identify, and respond to pain or discomfort that is related to pressure on any part of 
their body); moisture (which measures the degree of moisture the skin is exposed to); 
activity (which measures the individual level of physical activity); mobility (which 
measures the physical competency of the individual for moving and change position); 
nutrition (which reflects the normal pattern of food and fluid intake); and friction and 
shear (which assesses the individual's ability to keep the skin safe from any force that 
could be generated through movement and positioning). While the first five elements 
are rated from 1 (most impaired) to 4 (least impaired), the last item "friction and shear" 
is rated from 1 (problem) to 3 (no problem). The total score then ranges from 6 to 23, 
with a higher score meaning a lower risk of developing a PU and vice-versa. When 
using this scale, all patients are divided into four subcategories: at mild risk (those with 
sum sores ranging from 15 to 18), moderate risk (those with sum scores ranging from 
13 to 14), high risk (those with sum scores ranging from 10 to 12), and very high risk 
(those with sum scores of 9 or below).The Braden Scale has been validated for the 
identification of patients who are at risk of PU development in the ICU (Pancorbo-
Hidalgo et al., 2006). 
 
5.3.6 Procedure  
Following ethical approval from the university and both KAAH and KFH 
hospitals, the researcher liaised with the medical staff and nursing unit manager 
(NUM) to negotiate the commencement of the study, and specifically, a convenient 
time to collect the local unit data. Following this, the researcher visited each ICU every 
other day for four weeks (alternating days in each ICU) to liaise with the NUM to 
identify those patients who met the study inclusion criteria and to recruit patients to 
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the study. Patient demographic data and the complete second daily patient data 
collection was collected as per the data collection tool for all included patients. 
All patients were assigned a study number. A study enrolment log was 
maintained to correlate basic patient information (patient initials, bed number, hospital 
number) and the patient study number data collection form (see Appendix A). Re-
identified participant information (the enrolment log) was only kept during the period 
of data collection. At the conclusion of the study, after the data collection period, the 
enrolment log sheet was shredded to ensure all data was de-identified. 
 
5.3.7 Data Management  
The data collected was entered into the Statistical Package for Social Sciences 
(SPSS) program, version 21.0. The researcher entered all data to decrease any potential 
data entry error. The data was checked before any statistical analysis was undertaken 
to ensure the reliability and accuracy of data entry (Kirkwood & Sterne, 2003; 
Tabachnick & Fidell, 2007) by randomly re-entering 10% of the collected data and 
comparing the two files. To check any invalid response codes, missing data and 
duplicates were run for a frequency distribution statistical analysis. All hard copy data 
was kept in a locked filing cabinet accessible only to the research team. Electronic data 
was stored on password protected files. All data will be maintained for seven years 
after the completion of the study. Following this time, data will be destroyed in 
accordance with the ethics research policies at KAAH and KFH. 
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5.3.8 Data Analysis  
Descriptive and correlation statistical methods were used to answer the research 
questions. Statistical analysis was performed using SPSS version 21.0. The level of 
statistical significance was set at a p-value less than or equal to 0.05 (p≤ 0.05), to 
reduce the risk of type 1 errors (Kirkwood & Sterne, 2003). This level of significance 
was applied to all analyses.  
For Phase One Part A, incidence was calculated as cumulative incidence. 
Cumulative incidence is defined as the proportion of participants that develop a new 
PU within a specific time (Baharestani et al., 2009). Demographic and other data was 
also analysed using descriptive statistics (frequencies and means where appropriate) 
to describe the sample. Moreover, the normality of distribution for the data was 
measured. Bivariate analyses using chi-square, in-dependent t-test, and Mann-Whitney 
U were performed to identify variables associated with PU development. A binary 
logistic regression model was used to develop the best model for predicting PU 
occurrence in the ICU. It also explored the direction of the relationship between the 
predictive variables and PU occurrence. Further details of data analysis are presented 
in the publication in Chapter 6.  
  
5.3.9 Ethical Consideration 
Ethical approval to conduct this study was obtained from the Unit of Ethics of 
King Abdul-Aziz Hospital and King Fasil Hospital, Ministry of Health, Makkah, Saudi 
Arabia and the Queensland University of Technology (QUT) Human Research Ethics 
Committees (1300000341), Australia (see appendix C, D). This part of the study 
received approval with waiver of consent. 
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5.4 PHASE ONE, PART B  
The purpose of Phase One, Part B was to assess the barriers and facilitators 
related to the practice context and the adoptors of the intervention. Findings from this 
phase assisted in customising the intervention and the intervention training protocol to 
the RNs and the practice context. 
 
5.4.1 Research Design  
For Phase One Part B, a cross sectional descriptive survey was used to describe 
RNs perceptions regarding factors that hinder and/or assist them in the implementation 
of best available evidence to reduce PU occurrence in critically ill patients. Cross-
sectional studies are observational in nature and known as descriptive research, not 
causal or relational research (Levin, 2006a). Researchers record the information that 
is present in a population, but they do not manipulate variables. This type of research 
can be used to describe characteristics that exist in a population, but not to determine 
cause-and-effect relationships between different variables. These methods are often 
used to make inferences about possible relationships, or to gather preliminary data to 
support further research and experimentation. (Oleckno, 2008).  
A disadvantage of a cross-sectional survey is selection bias, i.e., non-response. 
Non-response is a particular problem affecting cross-sectional survey studies and bias 
can result when the characteristics or perceptions of non-responders differ from 
responding participants (Barriball & While, 1999; Rupp et al., 2002). In order to 
minimise this potential problem, all RNs who were working in the ICU of the 
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intervention site (KAAH) were invited to participate in the survey. Effort was made to 
approach each potential RN participant individually to explain the study. 
Counterbalancing these weaknesses are the strengths of cross section descriptive 
survey designs. This is the most widely used data gathering technique in research. It is 
also less costly compared with other methods, as it is easy to obtain rapid data 
acquisition from a sample (Neuman & Kreuger, 2003). Other strengths of this design 
include a single point of data collection (i.e., a survey) and the ability to describe 
characteristics of the participants and their perceptions (Burns & Grove, 2005). The 
latter is particularly important, as results from this study were used to inform the 
intervention implementation strategies used for the Phase Two, a two-arm cluster RCT 
study. 
 
5.4.2 Research Question 
7- What is the RNs’ attitude towards PUs prevention in a KSA tertiary 
referral hospital ICU? 
8- What are the facilitators and barriers for RNs in the adoption of PU 
prevention strategies in a KSA tertiary referral hospital ICU?  
9- Is there any association between participants characteristic and RNs’ 
attitude, or perceived barriers and facilitators to implement the PU 
prevention strategies? 
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5.4.3 Sampling Strategy and Size  
This phase used a convenience sample of all RNs working in the intervention 
arm of the Phase Two study. There were approximately 60 RNs working in the ICU. 
 
5.4.4 Data Collection  
Data was collected using a survey method. The survey included a total of 42 
items (38 items from the original instruments and four items added based on the 
literature) that were incorporated into four parts: demographic information, potential 
barriers to optimal skin care, potential facilitators to skin care, and RNs’ attitude 
towards PU care and prevention in ICU (see Appendix A).  
Items for the first three parts of the survey were modified from the PUPrevention 
in the PICU "Barriers and Facilitators" questionnaire (see Appendix B) (Schindler, 
2009). The purpose of the original survey was to determine the barriers and facilitators 
that RNs could encounter in a paediatric intensive care unit (PICU), that affected the 
implementation of the S.K.I.N. bundle. Therefore, this survey was adopted, with 
modification to be compatible for RNs in an adult ICU. The original survey consisted 
of three dimensions: demographic information about the RNs, and barriers and 
facilitators for the bundle implementation in the PICU. The survey comprised a total 
of 25 items; 19 questions where participants rated their response using a 10 point Likert 
scale (0 being to no extent to 10 being to a great extent), two open ended questions, 
and four items for participant demographic information. The advantage of using open-
ended questions is that they provide an opportunity for participants to raise issues with 
no restriction, thus providing the participant with the opportunity to elaborate their 
response (Polit & Beck, 2004). This assists the researcher to acquire in-depth 
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information (Kumar, 2005). The survey is an established tool used in the PICU in the 
Children's Hospital of Wisconsin in Milwaukee (Schindler, 2009), but has no reported 
validity or reliability testing.  
The fourth part of the survey was adopted from the Attitude towards Pressure 
ulcer Prevention instrument (APuP) (Beeckman, Defloor, Demarré, Van Hecke, & 
Vanderwee, 2010). This instrument was designed to measure the attitudes of nurses 
towards PU prevention. This instrument includes 13 items and covers five dimensions 
of RNs’ attitude towards personal competency to prevent PU, the priority of PU 
prevention, the impact of PUs, personal responsibility in PU prevention, and 
confidence in the effectiveness of prevention. The original instrument validation 
reported a Cronbach’s alpha of 0.79 (Beeckman et al., 2010).  
Permission was sought and obtained from the original authors of the instruments, 
Dr. Christine A. Schindler and Dr. Dimitri Beeckman, via email (see Appendix B). 
5.4.5 Survey Validity and Reliability  
The survey for this study required content validity testing in order to assure the 
instrument’s structure and consistency were valid to the study context. To measure 
content validity, the survey was reviewed by a panel of five local expert nursing 
members (Netemeyer, Bearden, & Sharma, 2003), as the OMRU model assesses the 
local context. The panel included two nursing educators (one from each hospital) and 
two critical care nursing supervisors (one from each hospital), and one adult care RN.  
The process of inferring content validity for this research survey included 
providing the participants with an overview of the research and a copy of a survey. The 
panel were asked to evaluate the relevancy of the items to intensive care nursing 
practice and management of critically ill patients. The relevancy of the survey items 
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was measured using a five point Likert scale for each item (1=irrelevant to 4=highly 
relevant). The result of the content validity was defined by the proportion of experts’ 
responses for these items (Polit & Beck, 2010). The internal reliability for the study 
survey items were measured by finding the Cronbach’s alpha of the completed survey. 
Additional detail of validity assessment is presented in the publication in Chapter 7.  
 
5.4.6 Procedure  
The researcher liaised with the nursing unit manager (NUM) of the ICU, 
randomised to receive the intervention, to determine a strategy to inform RNs about 
the study. All RNs working in the intervention arm of the Phase Two study were 
provided with a copy of the information sheet detailing the overview and purpose of 
the study. The survey was distributed to RNs in person by the researcher. Participation 
was voluntary. Completion and return of the survey were signified consent to 
participate. Participants were asked to deposit the completed survey in a marked, 
sealed mailbox placed at the nurses’ station in the ICU. A reminder message was 
posted to all RNs to complete the survey through staff communication books. 
Encouragement to complete and return the survey was given at relevant unit meetings. 
The survey was confidential and did not include personal information. Consequently, 
having completed and deposited the survey, the participant was unable to withdraw 
from the study, as their survey was not able to be identified. The survey data was 
collected over a one-week period. 
 
5.4.7 Data Management  
Data was managed in the same manner as for Phase One, Part A 
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5.4.8 Data Analysis  
Descriptive statistics (i.e., frequencies and means) were used to analyse the 
results of the survey data, which included demographic data about participants and 
data from barrier-facilitator scales. Data was analysed using SPSS version (21.0). 
Correlation statistical methods were used to determine differences between both 
groups by comparing a mean with an independent t-test, Mann-Whitney tests, or 
ANOVA for continuous variables, and Chi-square test of independence between 
categorical variables. The level of statistical significance was set at a p-value less than 
or equal to 0.05 (p≤0.05). Multiple regression analysis was used to predict any barriers 
or facilitators that influenced RNs’ ability in PU preventive care. Negative statements 
in the APuP instrument were scored in reverse to obtain the total sum score. A total 
sum score is recommended to measure the total RNs attitude toward PU prevention. 
In addition, multinominal regression and correlation analyses were used to detect any 
association between the demographic variable and RNs attitude subscale. The 
participants' narrative responses in the two open-ended questions were analysed and 
reviewed using thematic analysis and linked with the quantitative data. This approach 
comprised of six steps: familiarisation with data, generating initial codes, searching 
for themes among codes, reviewing themes, defining and naming themes, and 
producing the final report (Braun, & Clarke, 2006). 
 
5.4.9 Ethical Consideration 
Ethical approval to conduct this study was obtained from the Unit of Ethics of 
the King Abdulaziz Hospital, Makkah, Saudi Arabia, as well as the Queensland 
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University of Technology Human Research Ethics Committees (1300000341), 
Australia (see appendix C, E).  
 
5.5 PHASE TWO  
5.5.1 Research Design  
The second phase of the study used a two-arm cluster randomised control trial 
(cRCT) design that followed the Consolidated Standards of Reporting Trials 
(CONSORT) guidelines. A two-arm cRCT study design was selected in order to assess 
the effect of the interventions and to identify the causal relationships between the 
variables (Oleckno, 2008). The study examined the influence of the demographic 
characteristics of the participants (age, sex, weight, height, primary diagnosis, 
ventilation status, SOFA score, Braden Scale score, reason for or type of admission, 
co-morbidities, and length of stay in intensive care) and organisational considerations 
(type of bed and mattress, and nurse/patient ratio) on PU incidence. 
The two-arm cRCT provided the researcher with the ability to control the 
exposure of the intervention, thus permitting evaluation of the effectiveness of the 
prevention strategies in a group of people who share the same characteristics or 
experience in a specific period (Akobeng, 2005; Duffy, 2006; Oleckno, 2008; 
Salmond, 2008; Stolberg, Norman, & Trop, 2004). Moreover, a cRCT was the design 
of choice, as a controlled trial avoids overestimation of the effectiveness of an 
intervention (Grimshaw, Campbell, Eccles, & Steen, 2000). The efficacy of 
implementing the PU prevention bundle in the critically ill population in the intensive 
care unit of a KSA tertiary referral hospital in this research was measured in relation 
to the primary outcome; incidence of PUs. While the two-arm cRCT design offers 
 140   Chapter 5: Research Design 
numerous merits, some disadvantages exist. A cRCT may be time consuming to 
conduct, costly, and may require a large participant number for an effective sample 
size (Polit & Beck, 2004). Further details of the methodology are presented in the 
publication in Chapter 9. 
 
5.5.2 Research Questions  
10- Does a PU prevention bundle reduce the cumulative incidence of PU 
development in critically ill patients in the intensive care unit of a KSA 
tertiary referral hospital? 
H0: There is no difference in PU incidence between ICU who 
implements the PU prevention bundle with ICU continuing to 
implement standard care. 
11- Dose a PU prevention bundle decrease the cumulative PU incidence by 
25% or greater when compared to standard hospital care?  
H0: The difference in PU incidence between ICU who 
implements the PU prevention bundle with ICU continuing to 
implement standard care was less than 25%. 
12- Will patients who receive a PU prevention bundle develop PU later in 
their intensive care unit stay? 
H0:  There is no significant difference in a delayed time to PU 
development with implement the PU prevention bundle. 
13- Will patients who receive the PU prevention bundle have fewer 
numbers of PUs/patients during their ICU stay? 
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H0: There is no significant difference in number of PU per 
patients with implement the PU prevention bundle during the ICU stay. 
14- Will patients who receive the PU prevention bundle have fewer full 
thicknesses PUs (Stage III and IV)? 
H0: There are no significant differences in full thicknesses PUs 
(Stage III and IV) with implement the PU prevention bundle.  
15- Does the PU prevention bundle increase the adherence to the process 
of care in comparison to standard hospital skin care?  
 
5.5.3 Study Setting 
The study setting was the same for Phase One Part A, the ICUs at KAAH and 
KFH. The characteristics of the two hospitals and ICUs were previously presented 
under Phase One, Part A.  
 
5.5.4 Population and Sample 
The population was all critically ill patients admitted to the ICUs at the KAAH 
and KFH. The general characteristics of these patients were presented in Phase One, 
Part A. 
All ICU patients at KAAH and KFH during data collection who met the 
inclusion criteria were recruited to participate in this study. The inclusion criteria were:  
x patients admitted to the ICU during the study period,  
x expected to stay more than 24 hours, and  
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x 18 years of age or over.  
x For the intervention arm, potential participants were excluded if they:  
o were admitted to the ICU with a community-acquired PU, 
o had any medical contraindications for the implementation of the 
care bundle intervention (e.g., patients with a fractured pelvis or 
burns whose care could not follow the repositioning schedule), 
and 
o were diagnosed with any stage of PU in the first 24 hours of 
admission to ICU. 
 
5.5.5 Sample Size  
The sample size to determine a clinically significant difference was calculated 
using the PU incidence in the KAAH and KFH ICUs (determined from Phase One Part 
A), which was 39.3%. Eighty percent statistical power was required to detect the 25-
50% difference between the comparative groups. Therefore, the required sample size 
under individual randomisation was 48 participants per group. As a two-arm cluster 
randomised control design was taken for this study with the intra-cluster correlation 
(ICC = 0.05), to adjust the sample calculation (Hemming, Girling, Sitch, Marsh, & 
Lilford, 2011; van Breukelen, & Candel, 2012), giving an effective sample size of 70 
per group, inclusive of a 20% allowance for patient attrition.  
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5.5.6 Randomisation  
The research sites (the ICUs of the KAAH and KFH), not individual patients, 
were randomised to either the intervention or control arm of the study by a computer 
generated randomisation, where one hospital ICU was the intervention arm (KAAH) 
and the other the control arm (KFH). This is a commonly used and intuitive procedure, 
similar to "repeated fair coin-tossing”, also known as “unrestricted" or "complete" 
randomisation, it is essential to avoid both selection and accidental biases.  
The KAAH ICU was randomly selected to receive the intervention, the PU 
prevention bundle. Recruitment and enrolment of participants is illustrated in a 
CONSORT flow diagram in the publication in Chapter 9. 
 
5.5.7 Intervention  
As the intervention was a bundle of best available evidence it required a ‘whole 
of intensive care unit’ adoption. Therefore, the intervention was delivered at the unit 
level. The PU prevention bundle was specifically designed so that it was able to target 
the area of interest (i.e., the impact of the PU prevention bundle in incidences of PU), 
be suitable for RNs to deliver, and to fit within the structure of the ICUs in KSA. The 
intensive care RNs working in the intervention arm ICU were trained in the PU 
prevention bundle and delivered the intervention. The PU prevention bundle was based 
on the latest international guideline at the time of the study (2009), which comprised 
evidence-based recommendations incorporated from the results of RCTs and 
systematic reviews for the general hospital context, but was not specific to the ICU 
context (EPUAP & NPUAP), 2009b). This guideline was therefore modified and 
interpreted for the ICU setting and presented as a care bundle. The key aspects of the 
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PU prevention bundle were: risk assessment, skin assessment, skin care, nutrition, 
repositioning, support surface, education and training, and medical devices related PU 
as presented in Table 8.1 (See page 219). The contents of a PU prevention bundle were 
then reviewed by a panel of five local (KSA) expert nursing members with more than 
seven years of clinical experience, and accepted for implementation 
 
5.5.8 Data Collection  
Data was collected on specific measures implemented to reduce PU 
development.  
Data was gathered on three levels: baseline patient survey, second daily patient 
data collection, and RNs adherence to the PU prevention bundle. Baseline patient 
survey and second daily patient data collection were collected for both intervention 
and control ICUs; however, RNs intervention fidelity to the PU prevention bundle was 
collected for the intervention unit only. As per Phase One, Part A, the data collection 
processes were piloted with validated instruments where available, including SOFA 
(Vincent et al., 1998), PU staging scales (European Pressure Ulcer Advisory Panel and 
National Pressure Ulcer Advisory Panel (EPUAP & NPUAP), 2009b), and Braden 
scale (Smith et al., 1995). 
 
Instruments  
The baseline patient data, second daily patient data collection, SOFA, PU staging 
tools, and Braden Scale score instrument were previously outlined in Phase One, Part 
A.  
RNs adherence to the PU prevention bundle (intervention unit only).  
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The intervention fidelity (process of care) of RNs to the PU prevention bundle 
was measured through two levels: researcher audit and RN self-reporting. The 
researcher audit included a series of ordinal questions (see Appendix A). The ordinal 
questions covered key aspects of the PU prevention bundle: risk assessment, skin 
assessment, skin care, nutrition, repositioning, support surface, and education and 
training. This audit was collected every two weeks. The RN self-report included RNs' 
demographic details, RNs’ reflection toward adherence to the bundle, and one open-
ended question (see Appendix A). The purpose of the open-ended question was to 
provide an opportunity for RNs to note any facilitators and barriers that may have 
affected their ability to adhere to the PU prevention bundle and that could be addressed 
in ‘real time’.  
 
5.5.9 Procedure  
Initial procedures for this phase were as per Phase One Part A. The researcher 
attended each ICU second daily (alternating ICUs) to liaise with the NUMs and recruit 
patients, and obtain informed consent from the patient or the patient's next of kin. 
Furthermore, for all patients recruited, the researcher collected the patient's 
demographic data and completed second daily patient data collection, as per the data 
collection tool.  
For the control group, the researcher collected data using the Phase One Part A 
data collection forms. The control group proceeded with standard care as per Table 
5.1. For the intervention group, the ICU RNs who delivered the intervention were 
trained in implementation of the PU prevention bundle. Results from Phase One Part 
B were used to develop appropriate and targeted educational resources for the ICU 
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RNs in the intervention group, such as positive attitude towards PU prevention, and 
awareness of workload. All ICU RNs were informed about the PU prevention bundle 
through in-service, meetings, and one-to-one bedside education, all provided by the 
researcher. The training and education program consisted of: 1) brochures that 
explained the elements of the PU prevention bundle and presented the evidence that 
supported the bundle; 2) a PowerPoint presentation with a handout used during in-
service; 3) consultation and clarification on an individual basis with the researcher 
throughout the study; and 4) feedback to staff in the intervention unit of the weekly 
PU incidence rates. 
Measuring the RNs’ fidelity (processes of care) to compliance with the PU 
prevention bundle is important to assist in understanding the strengths and weakness 
of the intervention, determine the association between intervention and research 
outcomes, and to enhance both internal and external validity of the research (Horner, 
Rew, & Torres, 2006). The RNs' compliance to the intervention was measured on two 
levels: audit and RN self-report (see Appendix A). The audit was conducted every two 
weeks by the researcher and was a de-identified audit. The finding of this audit were 
presented as a percentage and compared with new PU events per patient that occurred 
that week. This feedback was provided to all RNs working in the intervention unit. 
The RN self-report was collected from a convenience sample of RNs working in the 
intervention hospital. The researcher distributed the survey manually every four weeks 
during the implementation of the PU prevention bundle. Participation in this survey 
was voluntary. Completion of the survey indicated consent. Completed surveys were 
deposited in a marked and sealed mailbox located in the ICU nurses’ station for a week. 
The survey was anonymous. The findings were compared with PU incidence. A 
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detailed description of the implementation and adoption of the bundle is presented in 
the publication in Chapter 8. 
 
5.5.10 Data Management  
As previously outlined for Phase One, Part A.  
5.5.11 Data Analysis  
Data was first checked for normality of distribution. Descriptive statistics were 
used to describe each group: experimental and control. PU cumulative incidence rates 
were measured for both groups. Log-rank and Cox proportional-hazards analyses were 
used to compare time to new PU events between the two groups, and to determine a 
hazard ratio. A generalised liner model (Poisson regression) was used to measure 
incidence rates over a certain period of time to test the effectiveness of the intervention 
over time (i.e., by checking the slope of the incidence rate between the two groups 
over time) (Dobson & Barnett, 2008; Hardin & Hilbe, 2007). The assumption of this 
analysis is that the outcome (incidence rate) has a positive distribution (i.e., is 
positively skewed). This test is appropriate when the mean is equal to the variance 
(Dobson & Barnett, 2008; Hardin & Hilbe, 2007). PU stage differences between 
groups were analysed using Chi-square test of independence. 
To determine the proportion of RNs who adhered to the key aspects of the PU 
prevention bundle, cross-tabulation was utilised. Following this, the Spearman rank 
correlation coefficient test was used to explore the association between two variables 
that were either both continuous variables or did not met the assumption of linearity, 
normality, and homogeneity (Cronk, 2006; Kirkwood & Sterne, 2003; Tabachnick & 
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Fidell, 2007). Further details regarding the data analysis of this section are presented 
in the publication in Chapter 8.  
 
5.5.12 Ethical Considerations  
Ethical approval to conduct this study was obtained from the Unit of Ethics of 
King Abdul-Aziz Hospital and King Fasil Hospital, Ministry of Health, Makkah, Saudi 
Arabia and the Queensland University of Technology (QUT) Human Research Ethics 
Committees (1300000341), Australia (see appendix C, F). In this phase, informed 
written consent was sought from all eligible participants. The study was explained 
verbally to all participants and their family members. Moreover, information letters 
were posted on each patient’s bed. These notices informed participants and their next 
of kin about the nature, purpose, and risk/benefits of this study. 
 
5.6 CHAPTER SUMMARY  
This chapter outlined the methods used to measure the effectiveness of the care 
bundle protocol in reducing the incidence of PU development in the KSA critically ill 
patient population, together with the identification of the facilitators and barriers that 
hindered or assisted with the implementation the PU prevention bundle. The study 
design, setting, and population, and the research questions were presented, along with 
a description of the data collection process and proposed analyses for both phases. 
The findings for this study are presented as articles in the next three chapters. 
This is followed by Chapter 9, which presents an integration of all findings in this 
study, guided by the study’s conceptual framework. 
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Chapter 6: (Article 3) Saudi Arabian Adult 
Intensive Care Unit Pressure 
Ulcer Incidence and Risk 
Factors: a Prospective Cohort 
Study 
This chapter includes the following article:  
Tayyib, N., Coyer, F., & Lewis, P. (2015) Saudi Arabian adult intensive care 
unit pressure ulcer incidence and risk factors: a prospective cohort 
study. International Wound Journal. doi: 10.1111/iwj.12406 
 
This article presents the findings of Phase One Part A of this study, which was 
the assessment of the practice environment as recommended by the research 
implementation model, the Ottawa Model of Research Use (OMRU). The aim was to 
describe the characteristics of ICU patients in the Kingdom of Saudi Arabia (KSA), 
identify the incidence of PUs in the ICU in the KSA, and determine risk factors 
associated with PU development in the KSA population. 
This article answers research questions 4-6: 
Research Question 4: What are the characteristics of the ICU patients in the 
KSA? 
Research Question 5: What is the incidence of PU development in critically ill 
patients in the intensive care unit of two tertiary referral hospitals in the KSA? 
Research Question 6: What are the factors associated with PU development in 
KSA ICUs? 
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This paper adds to the existing literature by providing, for the first time, a report 
of PU incidence in the KSA. The study also reveals different risk factors that may 
accelerate PU development in the KSA critically ill patient population in the ICU. 
These results indicate the importance of implementing a comprehensive PU prevention 
program. 
Findings from this phase were published in the International Wound Journal, as 
the results from this study would be of interest to all healthcare practitioners involved 
in the care of patients with PUs. The International Wound Journal has an impact factor 
of 2.15. This article has been cited twice in Google scholar, and three times on the 
Scopus database.  
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Saudi Arabian adult intensive care unit pressure ulcer 
incidence and risk factors: a prospective cohort study. 
 
Tayyib, N., Coyer, F., & Lewis, P.  (2015). International Wound Journal. 
doi: 10.1111/iwj.12406 
 
6.1 Abstract 
The purpose of this study was to identify pressure ulcer (PU) incidence and risk 
factors that are associated with PU development in patients in two adult intensive care 
units (ICU) in Saudi Arabia. A prospective cohort study design was used. A total of 
84 participants were screened second daily basis until discharge or death, over a 
consecutive 30-day period, out of which 33 participants with new PUs were identified 
giving a cumulative hospital-acquired PU incidence of 39⋅3% (33/84 participants). The 
incidence of medical devices-related PUs was 8⋅3% (7/84). Age, length of stay in the 
ICU, history of cardiovascular disease and kidney disease, infrequent repositioning, 
time of operation, emergency admission, mechanical ventilation and lower Braden 
Scale scores independently predicted the development of a PU. According to binary 
logistic regression analyses, age, longer stay in ICU and infrequent repositioning were 
significant predictors of all stages of PUs, while the length of stay in the ICU and 
infrequent repositioning were associated with the development of stages II–IV PUs. In 
conclusion, PU incidence rate was higher than that reported in other international 
studies. This indicates that urgent attention is required for PU prevention strategies in 
this setting. 
Key words: Incidence; intensive care; medical devices-related pressure ulcer; 
pressure ulcer; risk factors 
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6.2 INTRODUCTION  
Pressure ulcers (PUs) are one of the most common problems faced globally in 
healthcare settings (Feuchtinger, Halfens, & Dassen, 2007; Nijs et al., 2009; Shahin, 
Dassen, & Halfens, 2008). PUs have an impact on rising health care costs and on 
patient’s health through the increase of both morbidity and mortality (Vollman, 2010). 
Studies that examine PU development have become of increasing interest in the drive 
to improve patient outcomes. PUs are a predictable and preventable phenomena; thus, 
making this complication one of the key indicators to measure quality of nursing care 
and patient safety in the healthcare setting (Aydin et al., 2004; Tayyib, Coyer, & Lewis, 
2013).  
The National Pressure Ulcer Advisory Panel (NPUAP) and the European 
Pressure Ulcer Advisory Panel (EPUAP) (National Pressure Ulcer Advisory Panel & 
European Pressure Ulcer Advisory Panel, 2009) defined a PU as a lesion or trauma to 
the skin and underlying tissue resulting from unrelieved pressure, shear, friction, 
moisture, or a combination of all these, usually over a bony prominence. PU staging 
refers to a recognised and established system to classify the level of tissue damage or 
depth of injury observed (National Pressure Ulcer Advisory Panel & European 
Pressure Ulcer Advisory Panel, 2009). Use of the NPUAP/EPUAP PU-staging system 
enables objectivity of assessment of the depth of tissue injury by the health care 
workers.  
PU prevalence data varies widely across both settings and country. Prevalence 
rates have been reported at: 3% - 26% in North America (Berlowitz, 2014; Woodbury 
& Houghton, 2004), 8.1% - 49% across Europe (Shahin et al., 2008; Vanderwee et al., 
2007), 3% - 50% in Australia (Elliott, McKinley, & Fox, 2008; Prentice, Stacey, & 
Lewin, 2003), 7% - 44.4% in Middle East (Saleh, 2007; Tubaishat, Anthony, & Saleh, 
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2011) 2.1% - 31.3% in Asia (Sanada et al., 2007); and 9.7% - 51.6% in Africa 
(Ikechukwu, 2012). Further, PU incidence data also varies by clinical setting: in long-
term care from 2.3% - 23.9%; in acute care from 0.4% - 38.6%; in home care from 0% 
-17%; and in rehabilitative care from 0% -6% (Dorner, Posthauer, Thomas, & National 
Pressure Ulcer Advisory, 2009; Saleh, 2007). However, data highlight that intensive 
care units (ICUs) have the highest PU incidence in health care settings – these 
incidence rates have been reported as high as 50% (Keller, Wille, van Ramshorst, & 
van der Werken, 2002). The high rates in the ICUs can be attributed to the high acuity 
of patients, the nature of their critical illness and the highly invasive nature of the 
interventions and therapies that critically ill patients receive (Johnson & Meyenburg, 
2009; Vollman, 2010).  
Identifying patients at risk for PUs development is essential for effective 
implementation of PU prevention programs and usage of resources. Tayyib and 
colleagues (Tayyib et al., 2013) ascertained 28 factors associated with accelerated PU 
development in critically ill patients; however the most frequently reported risk factors 
were older age, longer ICU stay, history of cardiovascular and diabetes disease and 
infrequent repositioning.  
There is a paucity of research examining the extent of hospital-acquired pressure 
ulcers (HAPUs) in Middle East countries with only two studies identified. One Saudi 
Arabian (SA) study (Saleh, 2007) reported acute care PU prevalence of 44.4% and 
incidence of 38.6%. A second Jordanian study reported overall PU prevalence of 12% 
in the health care setting, and 29% PU prevalence in the intensive care setting 
(Tubaishat et al., 2011). However, prevalence data does not adequately reflect the 
magnitude of the problem; it provides a snapshot of the problem for quality assurance 
purposes. Incidence data, on other hand, provides an accurate figure and a picture of 
 154   Chapter 6: (Article 3) Saudi Arabian Adult Intensive Care Unit Pressure Ulcer Incidence and Risk Factors: a Prospective 
Cohort Study 
the extent of the problem in the health care setting over a period of time (Baharestani 
et al., 2009).  
In SA, no reported baseline data exists on PU incidence in ICU. This is the first 
study conducted in the Middle East, specifically Saudi Arabia, to identify PU incidence 
in the intensive care setting. Therefore, this study aimed to: (i) describe characteristic 
of the ICU patients in Saudi Arabia, (ii) identify the incidence of PUs in the ICU in 
Saudi Arabia, and (iii) determine risk factors associated with PU development in this 
population. This study also provided a benchmark for PU incidence in the ICU and 
risk factors studies in Saudi Arabia and a comparison with other international studies. 
 
6.3 MATERIALS AND METHOD 
6.3.1 Study Design  
This multicentre prospective observational cohort study was completed over a 4 
weeks consecutive period between July and August 2013 in the ICUs of two major 
metropolitan hospitals in Saudi Arabia. 
 
6.3.2 Participants and Setting  
All patients admitted to the ICU during the data collection period, who were 
aged 18 years or more, were included in the study.  
The research setting was two hospitals operated by the Ministry of Health, Saudi 
Arabia. Both facilities are major tertiary care hospitals, each with over 400 beds and 
ambulatory services. These two facilities each provide services to patients of the 
western region of Saudi Arabia and from neighboring regions and each site has 24 
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intensive care beds. Patient admission diagnoses in both ICUs include: cardiovascular 
illness, respiratory disease, cancer, renal dysfunction, sepsis and multi-trauma injury 
such as head injury. A diverse number of complex treatments and advanced 
technological equipment are provided for intensive care patients to support their body 
system functions during critical illness. According to the portfolios of both ICUs the 
average length of patient stay in 2011 was 8 - 9 days (King Abdul-Aziz Hospital, 2011; 
King Fasiel Hospital, 2011). 
 
6.3.3 Data Collection  
A data extraction form was specifically designed for this study. Data were 
collected on three levels: baseline ICU survey; baseline patient survey; and second 
daily patient’s skin inspection and data collection. Data collection processes were 
piloted with validated instruments where available including the Sequential Organ 
Failure Assessment score (SOFA) (Vincent et al., 1998); Braden Scale score (Smith et 
al., 1995); and PU-staging scales (National Pressure Ulcer Advisory Panel & European 
Pressure Ulcer Advisory Panel, 2009). 
 
Baseline ICU data  
Current system-level data present at the time of commencement of data 
collection at each ICU were collected, which included total bed capacity, ratio of 
ventilator/non-ventilator beds, annual number of patient admissions, average length of 
patient stay, number of patient mechanical ventilation days, nurse/patient ratios, 
existence of specific practices regarding skin care, and the types of strategies used to 
prevent PU development.  
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Baseline patient data  
 Patient demographic data was collected on admission for all patients that 
included age, sex, nationality, body mass index (BMI) and clinical demographic data 
including diagnosis on admission, comorbidities, emergency or elective admission, 
length of time in operating theatre or emergency department prior to ICU admission 
in hours if applicable, Braden Scale Score (Smith et al., 1995), presence or absence of 
PU on admission (yes/no), mechanical ventilation (yes/no) duration in days if 
applicable, ICU length of stay in days, and ICU outcome (discharge to ward or death). 
 
Second daily patient data collection 
Every second day patients’ skin was assessed using standard physical 
examination techniques (Talley & O'Connor, 2014). The data collected included the 
presence or absence of a PU. If a PU present, it’s grading and site, patients’ ventilation 
status, frequency of patient repositioning and SOFA score were also recorded. 
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Established data collection tools 
Braden Scale Score.  
The Braden Scale score (Smith et al., 1995) is a well-recognised, widely used 
and validated score for predicting risk of PU development (Pancorbo-Hidalgo, Garcia-
Fernandez, Lopez-Medina, & Alvarez-Nieto, 2006). Accordingly, it consists of six 
elements: sensory perception; moisture; activity; mobility; nutrition; and friction and 
shear. The total score ranges from 6 to 23, with a higher score indicating a lower risk 
of developing a PU and vice-versa. Using this scale all patients are divided into four 
subcategories: at mild risk (score 15 -18), moderate risk (score 13 -14), high risk (score 
10 - 12), and very high risk (score ≤ 9). 
 
PU staging. 
PUs were identified as either community-acquired PUs (CAPU) or hospital-
acquired PUs (HAPU), and if they related to equipment, as medical device-related PUs 
(MDRPU). CAPUs were defined as PU diagnosed on admission, or within the first 24 
hours of the patient’s admission to ICU. Further, PUs were classified according to 
NPUAP and EPUAP (National Pressure Ulcer Advisory Panel & European Pressure 
Ulcer Advisory Panel, 2009) definitions in relation to stage, type or site of injury (e.g. 
skin or mucosal ulcers). Additionally the PU site was identified on the data collection 
form by drawing a circle over the relevant area in the body figure. 
 
 
 
SOFA.  
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SOFA was designed to determine the extent of a person's organ function or rate 
of failure in the ICU (Ferreira, Bota, Bross, Mélot, & Vincent, 2001). The score is 
based on the description of six- organ dysfunction/ failure: the respiratory, 
cardiovascular, hepatic, coagulation, renal and neurological systems. Each organ is 
graded from 0 (normal) to 4 (the most abnormal), providing a daily score of 0 to 24 
points. The purpose of the SOFA score is to create a reliable, simple and continuous 
score that can be easily applied in all institutions. Furthermore, the SOFA score 
provides an indication of patient acuity on a daily basis (i.e. when measured).  
 
6.3.4 Procedure 
Permission to access the ICUs was received from the medical and nursing 
directors. All ICU nurses and doctors were informed in writing and in person about 
the study. All the patients who met the study inclusion criteria were included in the 
study. The researcher, who was trained in data collection tools, collected all data to 
ensure reliability. 
While a comprehensive skin examination and assessment was performed second 
daily on each participant, owing to the variation in admission times, data were 
collected daily over a consecutive 30 day period in the ICU. Data was collected on 
participants on a second daily basis until patient discharge from ICU or death. The 
baseline ICU data was collected at the time of commencement of the study and patient 
baseline data collection was completed on admission. 
6.3.5 Ethical Considerations 
Ethical approval to conduct this study was obtained from the Unit of Ethics of 
the relevant hospitals, Saudi Arabia and the Queensland University of Technology 
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(QUT) Human Research Ethics Committees, Australia. This study received approval 
with waiver of informed consent, in accordance with National Health and Medical 
Research Council (NHMRC) guidelines. Measuring PU incidence in the ICU does not 
involve an intervention or a change to standard care. Furthermore, informed consent 
can be impractical to obtain when patients are critically ill, mechanically ventilated 
and sedated (National Health and Medical Research Council (NHMRC), 2007). As 
this study aimed to identify the incidence of PU development in two ICUs, complete 
patient numbers were crucial to accurately calculate the incidence. 
 
6.3.6 Statistics 
Descriptive statistical methods were performed using SPSS (version 21; SPSS, 
Chicago, IL). Level of statistical significance was set at a p-value less than or equal to 
0.05 (p≤ 0.05) (Sterne & Kirkwood, 2010). All demographic and clinical 
characteristics were analyzed using descriptive statistics (frequencies and means 
where appropriate). Incidence was calculated as cumulative incidence, defined as the 
proportion of the participants that develop new PUs within a specific time (Baharestani 
et al., 2009). Bivariate analyses using chi square, in-dependent t test, and 
MannWhitney U were performed to identify the variables associated with PU 
development. A binary logistic regression model was used to develop the best model 
for predicting PU occurrence in the ICU. It also explored the direction of the 
relationship between the predictive variables and PU occurrence.  
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6.4 RESULTS 
6.4.1 Baseline Intensive Care Unit Characteristics 
Table 6.1 shows the main characteristics of both ICUs. For both ICUs, the 
staffing ratio was one nurse to two, or at times three, mechanically ventilated patients 
and one charge nurse per shift for each of the three eight-hour shifts per day. In both 
hospitals the registered nurse in-charge of the ICU was not always supernumerary and 
was sometimes allocated to provide care for two patients. Registered nurses (RNs) 
delivered complete patient care. Furthermore, there were no dedicated clinical 
instructors or nurse educators in the units and no dedicated respiratory therapists or 
physiotherapists.  
Both study facilities had practices related to the prevention of PU development 
(see Table 6.1). These practices included physical examination of the patient’s skin 
each shift (however, no risk assessment tool was used), use of support surfaces to 
manage patient load and pressure, and a two-hourly repositioning policy. Additionally, 
routine skin hygiene practice for ICU patients in both units was a bed-bath at 6:00 am 
using an antiseptic soap containing 2% of hydrogen peroxide without application of a 
skin moisturiser. 
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Table 6.1 Baseline Intensive Care Unit (ICU) Characteristic  
 
Variable  
 ICU 1 ICU 2 
Total bed capacity  24 beds  24 beds 
Ratio of ventilator/non-
ventilator beds 
6:1  
Annual number of patient 
admissions, 
2000-2500 Patients/ annually 2000-2300 
Patients/annually  
Average length of patient 
stay 
9 days  10 days 
Nurse/patient ratio 1:2 to 1:3 1:2 to 1:3 
ICU patient skin care:   
x Risk assessment No PU risk assessment scale 
used 
Same as per ICU 1 
x Skin assessment Comprehensive physical 
assessment of the patient’s skin 
is undertaken and documented 
within 24 hours of admission 
and every eight hours. 
Same as per ICU 1 
x Skin care: Bed-bath once a day at 
06:00hours using antiseptic 
soap containing 2% hydrogen 
peroxide.  
Same as per ICU 1 
x Nutrition Nutrition plan for each patient 
will be provided by clinical 
nutritionist  
Same as per ICU 1 
x Repositioning Patients’ position alternated 
form right side, back and then 
left side or vice versa.  
Same as per ICU 1 
x Support surface All patients managed on 
reactive support surface (i.e. air 
mattress) 
Same as per ICU 1 
x Education and 
training 
During the orientation for new 
ICU staff 
Same as per ICU 1 
x Documentation of 
pressure ulcers 
Pressure ulcer documentation 
tool especially designed for the 
hospital. 
Same as per ICU 1 
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6.4.2 Characteristics of the Study Population 
Of a total of 90 patients admitted to the ICUs during 30-day study period, 84 
participants were included to this study. Six participants were excluded as they had 
CAPUs on admission. Participant mean age was 52.8 years, with a range of 18 to 99 
years. Almost two-thirds of the participants were men (56, 66.6%). Majority of the 
individual in the study sample were non-Saudi nationals (46, 54.8%). Table 6.2 
provides an overview of participants’ demographic characteristics and clinical 
features. About 85.7% of the participants were at high risk for PU development with a 
mean Braden scale score of 10 (SD 2.12). 
Table 6.2 Demographic and Clinical Characteristics of Study’s Participants  
 
Variable Total 
participants 
(n=84) 
Participants with 
PU (n=33) 
Test P Value  
Male (number, %) 56 (66.7) 18 (54.5) 3.59 * 0.58 
Nationality (number, %) 
Saudi  
 
38 (45.2) 
 
18 (54.5) 
1.9 * .168 
Pakistani  6 (7.1) 3 (9.1)   
Indian 4 (4.8) 1 (3)   
Burmese 5 (6) 2 (6.1)   
Bangladeshi 4 (4.8) 1 (3)   
Yemeni 3 (3.6) 2 (6.1)   
Indonesian 2 (2.4) 0   
Thai 2 (2.4) 0   
Malaysian 1 (1.2) 0   
Chinese 1 (1.2) 0   
Egyptian 3 (3.6) 2 (6.1)   
Algerian 1 (1.2) 1 (3)   
Sudanese 2 (2.4) 1 (3)   
Somali 2 (2.4) 0   
Nigerian 3 (3.6) 1 (3)   
Ethiopian 2 (2.4) 0   
Mauritanian 4 (4.8) 1 (3)   
Burkinabe 1(1.2) 0   
Age (years) (mean, SD, range)  (52, 20.1, 18-
99) 
(65.45, 20.21, 27-
99) 
5.33 † <0.001§ 
BMI (mean, SD) (26.18, 3.86) (26.67, 3.89) 0.926 † 0.357 
Braden scale (mean, SD) (10, 2.1) (9.33, 1.63) 537.5 ‡ 0.004 § 
Admission via emergency department 
(Yes) 
64 (76.2) 29 (87.9) 4.093 * 0.043 § 
 Chapter 6: (Article 3) Saudi Arabian Adult Intensive Care Unit Pressure Ulcer Incidence and Risk Factors: a Prospective Cohort 
Study 163 
Variable Total 
participants 
(n=84) 
Participants with 
PU (n=33) 
Test P Value  
     
Length of time in emergency 
department (min) (mean, SD) 
(81.40, 54.89) (81.55, 50.62) 653.0 ‡ 0.081 
Admission post operation (Yes) 11 (13.1) 0   
Length of time in operating theatre 
(min) (mean, SD) 
(50.9, 24.16) 0   
Comorbitities (number, %)     
Hypertension  46 (54.8) 20 (60.6)   
Insulin dependent diabetes 43 (51.2) 18 (54.5)   
Peripheral vascular disease 11 (13.1) 6 (18.2)   
Kidney disease  
Respiratory disease 
Heart disease 
9 (10.7) 
19 (22.6) 
20 (23.8) 
6 (18.2) 
7 (21.2) 
12 (36.4) 
 
 
4.722 * 
 
 
0.03§ 
Nil  7 (8.3) 3 (9.1)   
Diagnosis (number, %)     
Trauma 17 (20.2) 6 (18.2)   
Medical related illness 50 (59.5) 16 (48.5)   
Post-Surgery 10 (11.9) 6 (18.2)   
Sepsis/Infectious disease 7 (8.3) 5 (15.2)   
ICU Length of stay (days) (mean, SD) (9.1, 6.66) (13.3, 8.36) 397.0 ‡ <0.001§ 
SOFA Score (mean, SD)  (7.8, 3.01) (8.75, 3.16) 1.9 † 0.06 
Mechanical ventilation (yes) 64 (76.2)  31 (93.9) 5.86 * 0.015§ 
Average hours of patient repositioned 
hours (mean, SD) 
(3.8, 1.3) (4.96, 1.28) 7.304 † <0.001§ 
Average days before PU development 
(SD, median, range) 
N/A 10.09 (4.62, 9, 5-
23) 
  
ICU, intensive care unit; PU, pressure ulcer; SOFA, Sequential Organ Failure Assessment. 
* Pearson Chi-Square test 
† t-test 
‡ Mann-Whitney U test 
§ Significance at P < 0.05 
 
6.4.3 Incidence Rate of PUs in ICUs 
Of the 84 patients, 33 patients with new PUs were identified giving a HAPU 
incidence of 39.3% (33/84 patients). Table 6.2 shows the demographic and clinical 
characteristics of participants with PUs. A total of 41 HAPUs were recorded in 33 
patients. The common areas of PU development were sacrum (24.3%) and heel 
(29.2%), with a greater tendency for PUs to develop in the heels. Grade I (23/41) and 
II (15/41) PUs were the most often recorded. Only three PUs were stage III, and no 
grade IV PU was recorded (see Table 6.3). The overall incidence of MDRPU was 8.3% 
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(7/84). Of the 41 HAPUs, 8 (20%) were related to medical devices, and the most 
common site was the ear (37.5%).  
 
Table 6.3 PU Incidence of Surveyed Participants (n=84) 
6.4.4 Risk Factors 
Table 6.2 shows that age (t(82) = 5.33, p< 0.001), length of stay in the ICU (U= 
397.0, z= 1723.0, p <0.001), history of cardiovascular disease (X2 =4.722, p= 0.03), 
infrequent reposition (t(48.7) = 7.308, p< 0.001), emergency admission (X2 =4.093, 
p= 0.043), mechanically ventilation status (X2 =5.86, p= 0.015), and a lower Braden 
Variable HAPU 
Number of participants with Pus 33 
Number of PUs per participants  
x One (number, %) 19 
x Two (number, %) 4 
x Three (number, %) 2 
x Four (number, %) 0  
Description of PUs:  
Patients with skin ulcers  
x Suspected deep injury  0 
x PU Stage I (number, %) 23 
x PU Stage II (number, %) 15 
x PU Stage III & IV (number, %) 3  
x Unstagable (number, %) 0 
MDRPUs * (number, %) 8 (19.5) 
Total number of PUs  41 
Skin ulcer location (number, %)  
x Occiput  1 
x Ear  2 
x Elbow 1 
x Shoulder 2 
x Ischium 1  
x Sacrum 10 (24.3) 
x Buttock 4  
x Heel  12 (29.2) 
MDRPU Location (number, %)  
x Nare 1 
x Lip 1  
x Neck  2 
x Ear 3  
x Leg  1 
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Scale score (U= 537.5, z= 1098.5, p= 0.004) were significantly associated with all 
stages of PU development. Mechanical ventilated patients (X2 =5.707, p= 0.017), 
length of stay in ICU (U= 397.0, z= 1723.0, p <0.001) and infrequent repositioning (t 
(82) = -4.562, p < 0.001) were positively associated with the development of stage II-
IV PUs.  
All of the factors mentioned above were entered into a binary logistic regression 
model as exploratory variables for all stages of PU development (Table 6.4). Age (OR: 
1.254; 95% CI: 1.054–1.492; p = 0·011), longer stay in the ICU (OR: 1.831; 95% CI: 
1.014–3.309; p = 0·045), and infrequent repositioning (OR: 250.04; 95% CI: 5.230-
11954.16; p = 0·005) were significant predictors of all stages of PUs. Length of stay 
in ICU (OR: 1·23; 95% CI: 1.087–1.392; p = 0·001), and infrequent repositioning 
(OR: 2.96; 95% CI: 1.23–7.153; p = 0·015) were associated with the development of 
stage II-IV PUs. 
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Table 6.4 Risk Factors of Pressure Ulcer (PU) Development Using Binary Logestic Regression 
 
A) For all PU stages  
Independent variable B S.E. Wald Sig. Exp(B) 95% C.I. for EXP(B) 
Lower Upper 
AGE .226 .089 6.521 .011 1.254 1.054 1.492 
Infrequent 
repositioning 
5.522 1.973 7.831 .005 250.043 5.230 11954.166 
ICU_LOS .605 .302 4.019 .045 1.831 1.014 3.309 
Constant -32.969 12.746 6.691 .010 .000   
Nagelkerke R Square = 0.914    
Hosmer and Lemeshow Test = 2.395, df = 8, p = .966 
 
 
B) For participants with stages II- IV 
Independent variable B S.E. Wald Sig. Exp(B) 95% C.I. for EXP(B) 
Lower Upper 
Infrequent 
repositioning 
1.087 .449 5.861 .015 2.966 1.230 7.153 
ICU_LOS .207 .063 10.762 .001 1.230 1.087 1.392 
Constant 16.511 7157.897 .000 .998 14810627.253   
Nagelkerke R Square = 0.683    
Hosmer and Lemeshow Test = 1.781, df = 8, p = .987  
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6.5 DISCUSSION  
6.5.1 Characteristics of the Study Population 
Results of this study showed an increased percentage of participants from outside 
Saudi Arabia. This is typical of the patient population in this research setting as Makah 
is a city of significant spiritual significance with many Muslims travelling to Makah 
for religious pilgrimage. Almost 72% (33/46) of non-Saudi participants were older 
than 40 years, which is expected, as many Muslims delay the pilgrimage journey until 
they become older (Centers for Disease Control and Prevention (CDC), 2013). The 
reasons behind this could be financial, social, or spiritual beliefs. 
 
6.5.2 Incidence of PUs  
In this study the cumulative incidence of HAPUs in the adult ICUs was 39.3%. 
This HAPU rate was higher than other international studies’ finding of 1.8% (Stotts, 
Brown, Donaldson, Aydin, & Fridman, 2013), 7.5-14.3% (Gunningberg, Donaldson, 
Aydin, & Idvall, 2012), and 12% (Tschannen, Bates, Talsma, & Guo, 2012). A 
possible explanation of the higher PU incidence rate in ICUs in this study is the length 
of stay in the ICU (mean 9.3 days), which is longer than other times periods reported 
in international studies (Cox, 2010; Kaitani, Tokunaga, Matsui, & Sanada, 2010; Nijs 
et al., 2009; Sanada et al., 2007). In the SA context the longer length of stay may be 
related to patients’ prognosis, patients’ treatment, and the fact that in Saudi Arabia, 
withholding or withdrawal of treatment is not practiced because of religious and 
cultural beliefs. Furthermore, the incidence rate may be high because of low 
nurse/patient ratios (i.e 1:2 or 1:3), and consequent high nursing workload leading to 
infrequent repositioning of these high risk patients, thus accelerating PU development. 
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We found the mean time to reposition patients in this study was 4.96 hours, although 
it is acknowledged that this data was collected retrospectively from the patient’s chart 
and may therefore not present an accurate picture of clinical care. Although low 
nurse/patient ratios exist in other countries, the ICU patient care delivery is organized 
differently. For example, in the United States, patient care in intensive care is provided 
by a dedicated team including RNs (care co-ordinator), nursing assistants (who provide 
hygiene care), respiratory therapists, nutritional consultants, and ICU physicians 
(Amaravadi, Dimick, Pronovost, & Lipsett, 2000; Haupt et al., 2003). Conversely, in 
Australia and the United Kingdom, the nurse/patient ratio for mechanically ventilated 
patients is 1:1 however, RNs provide and coordinate all patient care (Armstrong, 
2009). A number of studies have reported that the high nurse/patient ratio was 
significantly associated with high quality, safety, and positive patient outcome 
(McGahan, Kucharski, Coyer, & Winner, 2012; Stone et al., 2007; Whitman, Kim, 
Davidson, Wolf, & Wang, 2002).  
Interestingly, our findings show a low incidence rate of MDRPUs, but these 
accounted for one fifth of HAPUs in this study. MDRPUs in the ICU remain an under-
reported phenomenon however our findings are similar to other reported MDRPUs 
rates (Apold & Rydrych, 2012; Black et al., 2010; Coyer, Stotts, & Blackman, 2013). 
The majority of MDRPUs were related to poor positioning or fixation of respiratory 
equipment. Occurrence of these ulcers could be prevented with implementation 
preventive strategies such as regular assessment of the area underneath and around 
medical devices and regular repositioning or securement of devices (Fletcher, 2012). 
Using protective dressings to secure and stabilize devices also could reduce risk for 
MDRPU development.  
 Chapter 6: (Article 3) Saudi Arabian Adult Intensive Care Unit Pressure Ulcer Incidence and Risk Factors: a Prospective Cohort 
Study 169 
Of the PUs identified in this study, 56% were found to be stage I while 36.5% 
were stage II. Consistent with findings from previous research (Sanada et al., 2007; 
Sayar et al., 2009) the most common anatomical areas for PU development in this 
study were the sacrum and heels. The majority of the patients in this study were 
positioned in a semi-fowler’s position with no heel elevation or off-loading of 
pressure, leading to increased pressure points on the heels and sacrum. This was 
compounded by reduced frequency of patient repositioning. Santamaria and 
colleagues (2013) found the prophylactic use of a soft silicone multi-layered foam 
dressing effective in the prevention of sacral and heel PUs in trauma and critically ill 
patients.  
 
6.5.3 Risk Factors  
The present study indicates that age, length of stay in ICU, history of 
cardiovascular disease and kidney disease, infrequent repositioning, time of operation, 
emergency admission, mechanically ventilated patients, and lower Braden scale scores 
were significant factors contributing to PU development. This finding corroborates 
that of other reported international findings (Cox, 2010; Eachempati, Hydo, & Barie, 
2001; Tayyib et al., 2013). However, there are conflicting findings in the literature 
regarding age as a PU risk factor. Many studies report ICU patients over 60 show 
significant association with PU development; similar to our findings (Cox, 2010; 
Eachempati et al., 2001; Frankel, Sperry, & Kaplan, 2007). Hoshowsky and Schramm 
(1994) state that patients who are aged over 40 were at high risk for PUs development. 
This is in contrast to studies which demonstrate that age is not predisposing factor for 
PUs development (Nixon, Brown, McElvenny, Mason, & Bond, 2000; Sayar et al., 
2009; Theaker, Kuper, & Soni, 2005). However, comparison between studies is limited 
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by small sample sizes, shorter stays in the ICU (Theaker et al., 2005), differing 
nurse/patient ratios (Sayar et al., 2009), and purposive sample age (Nixon et al., 2000). 
Thus, further research is needed to examine different age groups as predictors of PUs 
development and include them in the risk assessment scale.  
In contrast, the present study did not find an association between PU 
development and other factors previously identified such as: low BMI (Fife et al., 
2001); and time spent in the emergency department (Eachempati et al., 2001). A 
possible explanation for this is related to; those studies had some limitations such as: 
small sample size, retrospective design, and excluding grade I PU. Therefore, further 
prospective longitudinal studies are required to confirm the association between those 
factors and PUs occurrence in ICUs.  
 
6.6 LIMITATIONS 
Our study is limited by the time frame of data collection. A longer data collection 
period may have provided different data. Beside the frequency of repositioning, we 
did not collect data on processes of care measures and, therefore cannot confirm the 
preventative PU measures were carried out according to hospital/unit policy. 
Furthermore, data on patient repositioning time frames was recorded retrospectively 
from patient notes.  
 
6.7 CONCLUSION  
This study has reported the PU incidence in two ICUs in SA hospitals. It is 
argued that measuring PU incidence rates is essential for obtaining an accurate picture 
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of the scope of the problem and for evaluating quality of care and monitoring patient 
outcomes. The data presented in this study provides baseline information of PU 
incidence rates in the ICU in Saudi Arabia, thus significantly adding new information 
in this area. The PU incidence rate in SA ICUs is high (39.5%), which indicates that 
more attention is required for PU prevention. Furthermore, urgent implementation of 
evidence-based PU prevention protocols is needed to alleviate this pressing problem. 
This study also reports that MDRPUs are a continuing problem in the ICU. A set of 
prevention strategies to prevent potential MDRPUs for highly dependent patients is 
recommended to directly address this problem. Furthermore, identification of risk 
factors that accelerate PU development in ICU in Saudi Arabia is essential to 
determine appropriate prevention strategies and appropriate usage of available 
resources.  
Findings from this study indicate strongly that implementation of a 
comprehensive PU prevention program could prevent the majority of PU development 
in the ICU in Saudi Arabia. Randomized control trials are needed to develop and 
determine optimal PU prevention and management strategies. Moreover, continued 
measurement and evaluation of PU incidence, including MDRPUs, and evaluation of 
the risk factors for PU development are recommended in SA hospitals to monitor and 
promote best practice in skin care for highly dependent patients. 
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This chapter presents the following article:  
Tayyib, N., Coyer, F., & Lewis, P. (2016). Pressure ulcer prevention in the 
Saudi Arabian intensive care unit: registered nurse attitudes toward prevention 
strategies and perceived facilitators and barriers to evidence implementation. 
Journal of Wound Ostomy Continence Nursing, 43(4), 369-374 
 
This article provides the findings of Phase One Part B of this study, which was 
the assessment of the potential adoptors according to the Ottawa Model of Research 
Use (OMRU). The aim of this phase was to examine attitudes towards PU prevention 
strategies in a group of critical care nurses practicing in the KSA. Further, this study 
aimed to identify KSA RNs perceptions of any barriers and facilitators that could 
influence the adoption and implementation of high quality evidence to reduce PU 
occurrences in the ICU.  
This article answers research questions 7-9: 
Research Question 7: What is the RNs attitude towards PUs prevention in a 
Saudi Arabian tertiary referral hospital ICU? 
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Research Question 8: What are the facilitators and barriers for RNs in the 
adoption of PU prevention strategies in a Saudi Arabian tertiary referral hospital ICU? 
Research Question 9: Is there any association between participants’ 
characteristics and RNs’ attitude, or perceived barriers and facilitators to implement 
the PU prevention strategies? 
Findings revealed that overall, RNs had positive attitudes towards PU 
prevention, and their perceived barriers for implementation of PU prevention strategies 
were time demands and limitations in their knowledge. However, they also perceived 
some factors that increased their ability to implement the PU prevention strategies, 
such as availability of support surfaces and skin care products. These factors were 
addressed during the planning and design of the strategies of implementation in Phase 
Two of this study for effective translation and adoption of the PU prevention bundle.  
This paper address the gap in the literature by providing, for the first time, the 
perceived barriers and facilitators that influence the implementation of PU prevention 
strategies in the ICU in the KSA. The study also evaluated the ICU RNs attitudes, 
which impact directly in the implementation of effective evidence of PU prevention.  
Findings from this phase were published in the Journal of Wound Ostomy 
Continence Nursing, as the results from this study would be of interest to all healthcare 
practitioners aiming to improve the quality of care provided, related to wound. The 
Journal of Wound Ostomy Continence Nursing has an impact factor of 1.177. Further, 
the findings of this phase of the study were presented with the title “Identifying 
Registered Nurses’ Attitudes and Perceived Facilitators and Barriers Towards Pressure 
Ulcer Prevention Strategies in the Intensive Care Unit” at the following conference: 
European Wound Management Association Conference. London, May 2015. 
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Tayyib, N., Coyer, F., & Lewis, P. (2016). Journal of Wound Ostomy & Continence 
Nursing, 43(4), 369-374. 
 
7.1 ABSTRACT  
Purpose: The purpose of this study was to examine registered nurses' (RNs) 
attitudes toward PU prevention strategies. Barriers and facilitators perceived by RNs 
to potentially impact on the adoption and implementation of PU prevention 
interventions in the intensive care unit (ICU) were examined.  
Design: Descriptive cross-sectional survey. 
Subjects and Setting: The target population was RNs practicing in an ICU of a 
major tertiary hospital, King Abdul-Aziz, Makkah in Saudi Arabia. Fifty-six of the 
available 60 ICU RNs participated in this study.  
Methods: Data were collected via survey using the Attitude towards Pressure 
ulcer Prevention instrument, which included 13 items rated with four point Likert 
scale, and the modified Pressure Ulcer Prevention in the PICU "Barriers and 
Facilitators" instrument included 27 items incorporated into three parts: demographic 
information, potential barriers to optimal skin care, and potential facilitators to skin 
care. The survey took 10 to 15 minutes to complete. Data were analysed with 
descriptive-correlation statistics and multiple regression analysis. Thematic analysis 
was undertaken for qualitative data. 
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Results: Participants demonstrated positive attitudes toward PU prevention 
(μ=38.19/52, 73.44%). No significant differences were found between demographic 
characteristics of the participants with the RNs attitude subscale, and perceived 
barriers and facilitators associated with implementing PU prevention in the critical 
care setting. Several barriers influenced the ability of RNs to implement PU prevention 
strategies including: time demands (β=0.388, p=0.011), limitation of RNs knowledge 
(β=-0.632, p=0.022), and current document format (β=0.344, p=0.046). Statistically 
significant facilitating factors which increased respondent’s ability to undertake PU 
prevention were: ease of obtaining pressure reduction surfaces (β=-0.388, p=0.007), 
collaboration with interdisciplinary teams (β=0.37, p=0.02), and availability of 
appropriate skin care products (β=0.44, p=0.015). Thematic analysis of open ended 
questions highlighted workload as a barrier that impedes implementation of care 
specific to PU prevention. 
Conclusion: Findings from this study highlighted that ICU RNs showed a 
positive attitude towards PU prevention. Further, factors that facilitated PU prevention 
in the ICU were identified as availability of pressure relieving support surfaces, 
appropriate skin products and collaboration between the healthcare professional team. 
However, perceived barriers which significantly impeded PU prevention practices 
were found to be a low level of PU prevention knowledge and workload demand. 
Identifying context specific factors that may facilitate or impede implementation of 
PU prevention interventions will promote the translation evidence in the ICU. 
Keywords: Pressure ulcer, barriers, facilitators, registered nurses’ attitude, 
intensive care.  
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7.2 INTRODUCTION  
Pressure ulcers (PU) adversely affect morbidity, increase levels of pain, length 
of stay, and the potential for secondary infection (Graves, Birrell, & Whitby, 2005; 
Vollman, 2010). Despite multiple articles and guidelines specific to PU prevention 
strategies (Dealey et al., 2013; European Pressure Ulcer Advisory Panel and National 
Pressure Ulcer Advisory Panel (EPUAP & NPUAP), 2009; Lyder, 2003; 
Meesterberends, Halfens, Lohrmann, & De Wit, 2010; Peterson, 2009), PU prevalence 
and incidence remains clinically relevant, particularly in the intensive care unit (ICU) 
(Berlowitz, 2014; Tayyib, Coyer, & Lewis, 2015). We believe this disparity reflects a 
gap between dissemination and implementation of evidence-based PU prevention 
approaches in clinical practice.  
Multiple studies have focused on identification of factors that impact 
implementation of best available evidence in daily clinical practice (Dalheim, Harthug, 
Nilsen, & Nortvedt, 2012; Kunic & Jackson, 2013; Leasure, Stirlen, & Thompson, 
2008; Moore & Price, 2004; Mwebaza, Katende, Groves, & Nankumbi, 2014). Several 
studies have found that poor adherence to evidence implementation may be a 
consequence of healthcare professional practices, such as questionable decision 
making (Flanagan, 2005; McCaughan, Thompson, Cullum, Sheldon, & Thompson, 
2002); a lack of knowledge or education (Dalheim et al., 2012; Leasure et al., 2008; 
Weng et al., 2013), the complexity of the intervention (Leasure et al., 2008), and the 
time required to deliver the intervention (Dalheim et al., 2012). In addition, certain 
organizational and environmental factors are likely to influence implementation of 
evidence based prevention strategies such as patient/family cooperation (Grol & 
Wensing, 2004), documentation requirements (Grol & Grimshaw, 2003), 
consideration of the ratio of risk versus benefit in current practice (Boström, Kajermo, 
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Nordström, & Wallin, 2009; Griffiths et al., 2001), characteristics of the healthcare 
setting (Boström, Kajermo, Nordström, & Wallin, 2009; Griffiths et al., 2001), and 
lack of organizational support (Fink, Thompson, & Bonnes, 2005; Grol & Grimshaw, 
2003). 
Some authors have observed that RNs may demonstrate poor adherence to PU 
prevention strategies, possibly owing to perceptions that these interventions are less 
important than management of the patient’s critical illness (Buss, Halfens, Abu‐Saad, 
& Kok, 2004; Meesterberends et al., 2010; Panagiotopoulou & Kerr, 2002; Qaddumi 
& Khawaldeh, 2014). Strand and Lindgren (2010) identified that lack of time, severity 
of patient illness, limited access to pressure redistribution devices, and inadequate 
knowledge act as barriers to implementation of PU prevention in the ICU. 
Uncooperative patients (Grol & Wensing, 2004), shortage of staff (Al Kharabsheh, & 
Saleh, 2014; Mwebaza et al., 2014), lack of training (Jankowski & Nadzam, 2011), 
busy wards (Thompson et al., 2008), nurses’ attitudes (Beeckman, Defloor, Demarré, 
Van Hecke, & Vanderwee, 2010), lack of access to literature (Jankowski & Nadzam, 
2011; Panagiotopoulou & Kerr, 2002), resources (Mwebaza et al., 2014), equipment 
and guidelines (Al Kharabsheh, & Saleh, 2014; Jankowski & Nadzam, 2011) have also 
been identified as barriers to PU prevention.  
In Saudi Arabia (SA), PUs in the ICU are a significant problem; a recent study 
found a 39.3% incidence (Tayyib et al., 2015) which is comparatively higher than other 
international studies (1.8%-14.3%) (Gunningberg, Donaldson, Aydin, & Idvall, 2012; 
Stotts, Brown, Donaldson, Aydin, & Fridman, 2013). We believe that implementation 
of new PU prevention strategies are essential in order to reduce PU occurrences in 
ICUs in SA. The implementation of PU prevention evidence requires staff education 
and positive attitudes concerning the urgent need to reduce PU occurrences (Strand & 
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Lindgren, 2010). Therefore, understanding and recognition of barriers to adoption of 
PU prevention strategies is crucial. The purpose of this study was to examine attitudes 
to PU prevention strategies in a group of critical care nurses practicing in SA. Further, 
this study aimed to identify SA RNs’ perceptions of any barriers and facilitators which 
may impact on the adoption and implementation of high quality evidence to reduce 
PU occurrence in the intensive care setting.  
7.3 METHODS  
We used a descriptive, cross-sectional design to guide data collection and 
analysis. Data were collected from July 10th to August 16th, 2013 in the ICU of a major 
metropolitan government-funded public hospital, the King Abdul-Aziz, located in 
Makkah, SA. Common diagnoses of patients admitted to the ICU are cardiovascular 
illness; respiratory diseases; cancer; renal dysfunction; burns; sepsis; and multi-trauma 
injuries. The ICU has 24 beds staffed by approximately 60 RNs; the ICU staffing ratio 
is 1 nurse to every 2 to 3 mechanically ventilated patients. Registered nurses deliver 
all direct patient care. Additionally, there is one charge nurse per shift for each of the 
three 8 hour shifts per day; this person typically cares for 2 patients.  
Ethical approval to conduct this study was obtained from the Human Ethics 
Committees of the King Abdul-Aziz hospital and Queensland University of 
Technology, Australia. The survey was anonymous with no identifying information 
collected, therefore consent to participate was deemed by completion of the survey and 
posting the survey in the mail box at the nurse’s station. 
7.3.1 Instruments 
Data was collected using a survey comprising 42 items. The survey was 
divided into 4 sections: demographic information; potential barriers to optimal skin 
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care; potential facilitators to skin care; and RNs’ attitudes towards PU care and 
prevention in ICU. Thirty eight items were borrowed (with permission) from the 
Attitude towards Pressure ulcer Prevention instrument (APuP) (Beeckman et al., 2010) 
instrument and the Barriers and the Barriers and Facilitators tool used in the pediatric 
ICU at the Children's Hospital of Wisconsin in Milwaukee (Schindler, 2009). An 
additional 4 items were constructed based on current literature and local context.  
The Barriers and Facilitators instrument has not been formally evaluated for 
validity and reliability (Schindler, 2009). However, the instrument was modified in 
this study for use in critical care setting for adults. The original instrument consisted 
of 3 dimensions: RN demographic information; and barriers and facilitators for 
implementing the PU prevention bundle in a pediatric ICU. The survey comprised 25 
items; 19 were answered via a 10 point Likert scale where 0 indicated the barrier or 
facilitator influence PU prevention practices to no extent to 10 indicated the facilitator 
or barrier influenced practice to a great extent. The instrument also contained 2 open-
ended questions and 4 demographic items.  
The fourth section of the survey was the Attitude towards Pressure ulcer 
Prevention (APuP) instrument to measure RNs’ attitudes towards PU prevention 
(Beeckman et al., 2010). The APuP includes 13 items that query 5 dimensions: 
personal competency to prevent PU, priority of PU prevention, PU impact on the 
patient and society, personal responsibility for PU prevention, and confidence in the 
effectiveness of prevention strategies. All items were rated on a 4 point Likert scale 
where 1 indicates strongly disagree and 4 indicates strongly agree. The cumulative 
score for this section of the survey was 52; higher scores indicate a more positive 
attitude to PU prevention. The mean cut point of the attitude score was >70% 
(>36.4/50), indicating a positive attitude toward PU prevention. The original 
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instrument validation reported internal consistency with a Cronbach’s alpha of 0.79, 
(Kaiser-Meyer-Oklin [KMO]=0.72), and construct validity was statistically significant 
with Bartlett’s test of sphericity (χ2 (78) = 1062.6, P<=0.001) (Beeckman et al., 2010).  
 
Evaluation of validity and reliability 
We evaluated validity and reliability of items in sections 1 to 3 of the survey. 
We evaluated content validity using a panel of 5 expert nurses with >7 years of clinical 
experience. The panel included 2 nurse educators (one from King Abdul-Aziz and one 
from King Faisal hospital) and 2 critical care nursing leaders (one from King Abdul-
Aziz and one from King Faisal hospital), and one adult care RN.  
The process of inferring content validity included providing the participants an 
overview of the research and providing them with a copy of the survey. Panel members 
were asked to evaluate the relevance of the items to intensive care nursing practice and 
management of adult critically ill patients. The relevance of the survey items was 
measured by five point Likert scale for each item (1=irrelevant to 4=highly relevant). 
A content validity index of 0.97 and Cronbach’s alpha coefficient of 0.85 were 
achieved.  
Construct validity was assessed for the 13 items that queried potential barriers 
to optimal skin care, and the 7 items that queried facilitators to optimal skin care using 
KMO and Bartlett’s test of Sphericity. For barriers to optimal skin care KMO = 0.874 
and Bartlett’s Test of Sphericity was significant (χ2 (78) = 573.18, p=<0.001). Also, 
for potential facilitators to optimal skin care KMO =0.78, and Bartlett’s Test of 
Sphericity was significant (χ2 (21) = 316.48, p=<0.001). All of the above results show 
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the structure of the questionnaire measures the intended outcome and measures this 
consistently, thus indicating sufficient validity and reliability of the survey.  
 
7.3.2 Study Procedures  
The researcher collaborated with the ICU nurse unit manager (NUM) of the 
study site who provided a list of all RNs who worked in the ICU. The researcher then 
made personal contact with each RN, providing a copy of the study information sheet 
detailing the overview and purpose of the study. Participation in this survey was 
voluntary. 
 
7.3.3 Data Analysis 
Descriptive statistical and correlation statistical methods were performed using 
SPSS (version 21; SPSS, Chicago, IL). Differences between both groups were 
analyzed using an independent t-test, Analysis of Variance (ANOVA), Mann-Whitney 
U test or χ2 test depending on the measurement level of the appropriate outcome 
variable; p-values ≤0.05 were deemed statistically significant. Multiple regression 
analysis was used to predict any barriers or facilitators that influence RNs’ ability in 
PU preventive care.  
The survey included 2 open-ended questions to provide opportunities for 
additional comment. Narrative responses were analyzed and reviewed using thematic 
analysis. This approach comprised of 6 steps: familiarization with the data, generating 
initial codes, searching for themes among codes, reviewing themes, defining and 
naming themes, and producing the final report (Braun & Clarke, 2006). 
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Scores from negative statements in the APuP were inverted to obtain a 
cumulative score recommended for measurement of registered nurse’s attitude toward 
PU prevention (Beeckman et al., 2010). In addition, multinominal regression and 
correlation analyses were used to detect any association between the demographic 
variable and RNs attitude subscale.  
 
7.4 RESULTS 
Of the 60 ICU nurses, 56 nurses participated in this study. The majority were 
female (80.4%) and 50% held a bachelor’s degree in nursing. Table 7.1 summarizes 
their demographic characteristics.  
Table 7.1 Demographic Characteristics of Study’s Participants (N = 56) 
 n (%) Mean ± SD* 
Gender   
 Male (11)19.6%  
 Female (45)80.4%  
   
Education   
 Diploma (26)46.4%  
 Bachelor’s degree (28)50.0%  
 Master’s degree (2)3.6%  
   
Years practicing as an RN  5.94 ± 3.24 
Years practicing in a Critical Care Unit  4.25 ± 1.96  
Years employed in hospital  4.61 ±2.95 
*=Standard Deviation 
 
The majority of participants had a positive attitude toward PU prevention 
strategies as shown by the mean score of 38.19 out of 52 possible points (73.44%, 
Table 7.2). The impact subscale of the APuP, which reflects how RNs’ perceive the 
consequences of PUs on patients and society and the expectation of the quality of PU 
prevention care provided, had the lowest score in comparison to other subscales 
(μ=8.19/12, 68%). Similarly, mean priority subscale were also low (μ=8.28/12, 
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69%), meaning RNs considered PU prevention care as a secondary priority in their 
daily routine work. No significant differences were found between demographic 
characteristics of the participants and the APuP attitude subscale.
 192   Chapter 7: (Article 4) Pressure Ulcer Prevention in the Saudi Arabian Intensive Care Unit: Registered Nurse Attitudes 
Toward Prevention Strategies and Perceived Facilitators and Barriers to Evidence Implementation 
Table 7.2 RNs Attitudes toward PU Prevention in the ICU 
Variable  SDa n 
(%) 
Db n 
(%)  
Ac n 
(%) 
SAd 
n 
(%) 
Mean 
(SD) 
F1: Personal competency to prevent pressure ulcers (3 items) (maximum 
score=12) 
9.30 
(1.69) 
F1.1 (+)f I feel confident in my ability to 
prevent PU 
2 
(3.6) 
6 
(10.7) 
26 
(46.4) 
22 
(39.3) 
3.21 
F1.2. (+)f I am well trained to prevent PU 1 
(1.8) 
14 
(25) 
16 
(28.6) 
25 
(44.6) 
3.16 
F1.3. (-)f PU is too difficult. Other are 
better than I am  
12 
(21.4) 
31 
(55.4) 
10 
(17.9) 
3 
(5.4) 
2.93 
F2: Priority of PU prevention (three items) (maximum score=12) 8.28 
(1.55) 
F2.1. (-)b Too much attention goes to the 
prevention of PU  
1 
(1.8) 
8 
(14.3) 
35 
(62.5) 
12 
(21.4) 
1.96 
F2.2. (-)f PU prevention is not that 
important  
29 
(51.8) 
16 
(28.6) 
6 (10.7) 5 
(8.9) 
3.23 
F2.3. (+)f PU prevention should be a 
priority  
6 
(10.7) 
9 
(16.1) 
15 
(26.8) 
26 
(46.4) 
3.09 
F3: Impact of PU (three items) (maximum score=12) 8.19 
(1.49) 
F3.1. (-)f A PU almost never cause 
discomfort for a patient. 
26 
(46.4) 
15 
(26.8) 
11 
(19.6) 
4 
(7.1) 
3.12 
F3.2. (-)f The impact of PU on a patient 
should not be exaggerated 
16 
(28.6) 
12 
(21.4) 
24 
(42.9) 
4 
(7.1) 
2.71 
F3.3. (+)e The financial impact of PU on 
society should not be exaggerated  
13 
(23.2) 
16 
(28.6) 
21(37.5) 6 
(10.7) 
2.36 
F4: Responsibility in PU prevention (two items) (maximum score=8) 6.34 
(1.47) 
F4.1. (-)f I personally feel not responsible if 
a PU develops in my patient 
23 
(41.1) 
18 
(32.1) 
10 
(17.9) 
5 
(8.9) 
3.05 
F4.2. (+)e I personally have an important 
task in PUprevention 
3 
(5.4) 
3 
(5.4) 
25  
(44.5) 
25 
(44.5) 
3.28 
F5: confidence in the effectiveness of prevention (two items) (maximum score=8) 6.07 
(1.50) 
F5.1. (+)e PUs are preventable in high risk 
patients 
7 
(12.5) 
13 
(23.2) 
17 
(30.4) 
19 
(33.9) 
2.86 
F5.2. (-)f PUs are never preventable 28 
(50) 
16 
(28.6) 
8 (14.3) 4 
(7.1) 
3.21 
Total attitude score (maximum score=52) 38.19 
(5.67) 
Abbreviation: PU = pressure ulcer. 
a = Strongly Disagree, b = Disagree, c= Agree, d=Strongly Agree, e =Positive statement,  
f=Negative statement  
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Results also indicated that RNs reported a moderate level of ability to 
overcome barriers related to the implementation of evidence for optimal skin care (μ 
= 5.02 ± 2.60). Table 7.3 presents an overview of the barriers perceived by the 
participants for optimal skin care delivery. Participants rated time demands as the 
highest barrier (μ=6.16 ± 2.078). Further, insufficient resources and expertise, 
patient’s severity of illness, insufficient equipment, lack of authority to implement 
change, low priority by medical staff, and lack of patient/family cooperation were 
moderate barriers to optimal skin care. These items all had mean scores of between 4 
out of 10 and 4.86 out of 10.  
 
Table 7.3 Overview of the Barriers for PU Prevention Implementation (N = 56) 
Variable  M (SD) 
Ability to overcome barriers 5.02 (2.60) 
Insufficient resources/expertise 4.86 (2.57) 
Demand of time 6.16 (2.08) 
Patient's severity of illness 4.59 (2.65) 
Insufficient equipment 4.55 (2.90) 
Lack of authority to change 4.46 (2.35) 
Low priority by medical staff 4.25 (3.05) 
Patient/Family lack of cooperation 4.11(2.46) 
Low priority by nursing staff 4 (2.43) 
Limitation of RN ability 3.89 (2.73) 
Limitation of RN knowledge 4.84 (3.26) 
Current documentation format 3.79 (2.36) 
Low priority by RN 3.48 (2.49) 
 
Multiple regression analysis was conducted to examine if these barriers 
predicted RNs ability to overcome barriers in the ICU (Table 7.4). The model was 
statistically significant (F(12, 43) = 3.57, p=0.001, R2=0.51). Analysis revealed that 
items related to time demands (β =0.388, p=0.011), limitation of RNs knowledge (β 
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=-0.632, p=0.022), and current documentation format (β =0.344, p=0.046) were 
statistically significantly associated with RNs ability to provide optimal skin care, as 
measured by self-report. 
 
Table 7.4 Multiple Regression Analysis for Variables Predicting the Ability of RNs to Overcome 
Barriers 
Variable  B SE β p 
 Demand on time 0.486 0.183 0.388 0.011 
Limitation of RN ability 0.200 0.260 0.210 0.445 
Limitation of RN knowledge -0.505 0.212 -0.632 0.022 
Low priority by medical staff -0.188 0.201 -0.219 0.357 
Low priority by nursing staff 0.218 0.292 0.204 0.458 
Low priority by RN 0.176 0.239 0.168 0.466 
Current documentation format 0.379 0.184 0.344 0.046 
Insufficient resources/expertise 0.269 0.243 0.266 0.273 
Insufficient equipment -0.078 0.158 -0.087 0.623 
Patient's severity of illness -0.277 0.168 -0.282 0.107 
Patient/Family lack of cooperation 0.001 0.197 0.001 0.994 
Lack of authority to change 0.182 0.190 0.164 0.343 
 
7.4.1 Thematic Analysis 
Thematic analysis of open-ended questions related to the barriers towards PU 
prevention in ICU revealed a broad and over-arching theme we have labelled, impact 
of workload. Participants in this study identified increased workload as directly 
influencing their ability to implement PU prevention care. One participant stated, “We 
are so busy, and don’t have enough staff to provide optimal care.”  
Participants further noted that education played an important part in providing 
optimal care, particularly in informing staff about current PU prevention approaches. 
Responses indicated that increased awareness and training could help RNs provide 
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high quality care for PU prevention in ICU. As one respondent noted, “As we are busy, 
I don’t have time to know and learn new things about PU.” 
 
7.4.2 Facilitators Assisting in Evidence Implementation 
Participants indicated that education about pressure ulcer grading and ease of 
obtaining pressure redistribution surfaces were the 2 most helpful facilitators to 
delivering PU preventive care. The mean scores of 6.45 and 6.29 out of 10 indicate 
these factors act as moderately helpful facilitators (See Table 7.5). 
 
Table 7.5 Overview of the Facilitators for PU Prevention Implementation (N = 56) 
Variable  M (SD) 
Education about PU grading 6.45 (2.49) 
Ease of obtaining pressure reduction surfaces 6.29 (2.34) 
Current documentation format 5.80 (2.47) 
Education about Braden risk assessment scale  5.68 (2.81) 
Interdisciplinary team collaboration 5.54 (3.34) 
Availability of appropriate skin care products 5.16 (3.58) 
Efforts are being made to facilitate your ability to prevent PU 5.46 (2.79) 
 
Multiple regression analysis was also calculated to evaluate whether these 
facilitators could predict RNs’ perceived ability to prevent PU development in 
ICU.The model was statistically significant (F(6,49)=32.552, p=<0.001, R2 = 0.799). 
Statistically significant facilitators that increased RNs ability to undertake PU 
preventive interventions in the ICU were ease of obtaining pressure reduction surfaces 
(β=-0.388, p=0.007), collaboration with interdisciplinary teams 
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(nursing/medicine/pharmacy/dietary) (β=0.37, p=0.02), and availability of appropriate 
skin care products (β=0.44, p=0.015, Table 7.6). 
 
Table 7.6 Multiple Regression Analysis for Variables Facilitating the Ability of RNs toward PU 
Prevention 
Variable  B SE β p 
 Education about PU grading -0.03 0.13 -0.03 0.80 
Current documentation format 0.07 0.09 0.06 0.45 
Ease of obtaining pressure reduction surfaces -0.40 0.14 -0.34 0.007 
Team Collaboration 0.31 0.13 0.37 0.02 
Availability of appropriate skin care products 0.34 0.13 0.44 0.015 
7.5 DISCUSSION  
Participants had a positive attitude toward PU prevention. Multiple studies 
have been conducted that found that a positive attitude toward a particular area was 
positively associated with provision of high quality nursing care (Fishbein & Ajzen, 
2005; Moore & Price, 2004; Strand & Lindgren, 2010). Grol and Wensing (2004) 
argued that RNs’ negative attitudes toward an issue (i.e., PU prevention) may 
contribute to increased non-compliance, which may lead to a higher ICU acquired PU 
prevalence rate. 
Nevertheless, we also found that participants identified PU prevention care as 
a lower priority in their daily routine care, thus creating a potential where evidence 
based PU prevention strategies may be neglected in favor of other interventions 
deemed more important to immediate care needs. This finding is supported by other 
studies where registered nurses ranked PU prevention lower in importance than other 
nursing care tasks (Buss et al., 2004; Moore & Price, 2004; Strand et al., 2010). While 
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the care in intensive care predominantly focuses on the disorders that necessitated 
admission to a critical care unit, skin assessment must be incorporated in the initial 
overall patient assessment and in their ongoing care (Australian Wound Management 
Association, 2012; European Pressure Ulcer Advisory Panel and National Pressure 
Ulcer Advisory Panel (EPUAP & NPUAP), 2009) .  
In addition to a lower prioritization for PU preventive interventions, we found 
that RNs’ attitude was that PUs have a low impact on patients and society.  Beeckman 
et al. (2010) suggest a positive association between the APuP subscales of patient and 
societal impact and quality of care provided towards PU prevention.  
Respondents’ indicated that time was the most significant barrier to 
implementation of evidence based PU preventive interventions. This finding is 
consistent with others who reported that lack of staff time impedes the implementation 
of PU preventive interventions (Jankowski & Nadzam, 2011; Mwebaza et al., 2014; 
Strand et al., 2010). Nevertheless, quantifying the time needed for PU prevention 
within the context of a clinical workload is difficult. Time in the clinical practice 
setting is typically quantified as minutes or hours. Thompson et al. (2008) suggested 
being “time poor” also incorporates mental time; the energy required for RNs to 
implement evidence and the culture of busyness. As a result, environmental factors 
more profoundly influence our concept of time as much as a quantifiable unit of time 
such as minutes or hours (McCaughan et al., 2002; Thompson et al., 2008). Nurses 
who indicate a lack of time as a barrier to implementing PU prevention interventions 
actually may be basing their perceptions on factors that are not directly related to a 
unit of time such as lack of experience, low confidence, or difficulty problem solving 
(Thompson et al., 2008). Our study findings suggest that environmental and personal 
factors should be addressed to enhance adherence to PU preventive interventions.  
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We found that participants’ self-identified lack of knowledge about PU 
preventive interventions also influenced implementation of these actions in daily 
practice. Lack of knowledge among critical care nurses has been barrier to effective 
PU prevention in previous studies (Buss et al., 2004; Chang, Russell, & Jones, 2010; 
Mwebaza et al., 2014; Qaddumi & Khawaldeh, 2014). Numerous factors have been 
identified that may contribute to lower levels of RNs’ knowledge such as staffing 
shortages, limited availability of clinical instructor/or nurse educators in the clinical 
area, and high staff turn-over rates (Grol & Grimshaw, 2003; Hulsenboom, Bours, & 
Halfens, 2007; Moore & Price, 2004; Qaddumi & Khawaldeh, 2014). Several studies 
suggest that increased awareness, and regular training, and availability of current 
clinical practice guidelines may positively influence adoption of PU preventive 
interventions in the critical care setting (Hulsenboom et al., 2007; Qaddumi & 
Khawaldeh, 2014). Therefore, the availability of clinical instructors and the addressing 
of all the factors above may enhance the implementation of up-to-date evidence in PU 
prevention in the SA ICU. 
Analysis found that the ICU documentation format was not perceived as a 
barrier to implementation of PU prevention care. This contrasts to previous work 
suggesting documentation is a barriers for implementation of PU preventive 
interventions (Al Kharabsheh, & Saleh, 2014). However, these data must be 
interpreted with caution because the research site hospital PU documentation tool was 
limited to site and grade (stage) of PU, wound size, and weekly follow-up assessment 
for PU. International PU prevention guidelines recommended documentation should 
be more comprehensive and include comprehensive skin assessment on admission, 
daily skin assessment, risk assessment scores, and positioning regimes to promote RNs 
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communication and continuity of patient care (European Pressure Ulcer Advisory 
Panel and National Pressure Ulcer Advisory Panel (EPUAP & NPUAP), 2009).  
Collaboration with an interdisciplinary team was seen as a facilitator to 
implementation of evidence based PU preventive interventions. This result is 
consistent with previous studies(Dalheim et al., 2012; Jankowski & Nadzam, 2011). 
Ease of obtaining pressure relieving devices and availability of appropriate skin care 
products are facilitating factors were also identified as facilitating PU preventive care 
(Mwebaza et al., 2014; Qaddumi & Khawaldeh, 2014). However, availability of 
resources without an informed knowledge base is not adequate for maintaining 
effective PU prevention and management (Jankowski & Nadzam, 2011).  
 
7.6 LIMITATIONS 
We acknowledge limitations in the external validity of results owing to design 
elements. The sample size was drawn from a single location. Additional limitations 
include reliance on self-report for some study findings as compared to direct 
observation of RN practice. 
 
7.7 CONCLUSIONS  
Recognizing and identifying factors which impact on evidence implementation 
in pressure ulcer prevention strategies is the first step in moving toward translation, 
adoption, and dissemination of PU prevention evidence. Key findings from this study 
highlight that RNs in our ICU have a positive attitude towards PU prevention. 
Moreover, PU prevention was facilitated by the availability of pressure relieving 
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support surfaces and appropriate skin care products, and collaboration between the 
healthcare professional team. However, barriers impeding the implementation of PU 
prevention strategies were identified as RNs lack of knowledge on this topic and 
demands of a high workload. 
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7.9 KEY POINTS  
x Understanding and addressing factors that could impede or facilitate pressure 
ulcer (PU) prevention strategies is important for successful translation of research 
findings. 
x Positive attitude of registered nurses towards PU prevention is a motivational 
factor for facilitating implementation PU prevention strategies. 
x The most frequently cited perceived barriers to PU prevention evidence 
implementation were related to workload, insufficient knowledge, and time 
demands.  
x The most important facilitators assisting implementation of PU prevention 
evidence were ease of obtaining pressure reduction surfaces, collaboration with 
interdisciplinary teams, and availability of appropriate skin care products. 
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Chapter 8:  (Article 5) A Two-Arm Cluster 
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Pressure Ulcer Prevention 
Bundle for Critically Ill Patients 
This chapter includes the following article:  
Tayyib, N., Coyer, F., & Lewis, P. A. (2015). A Two‐Arm Cluster 
Randomized Control Trial to Determine the Effectiveness of a Pressure Ulcer 
Prevention Bundle for Critically Ill Patients. Journal of Nursing Scholarship, 
47(3), 237-247.  
 
This article presents the findings of Phase Two of this study. This chapter 
represents Phases 4-6 of the OMRU model, which belong to the monitoring and 
evalution category. In the previous chapters, incidence and barriers and facilitator 
studies, workload, and equipment were identified as barriers to PU prevention. It was 
beyond the scope of this study to address nursing workload or the departments 
equipment. Therefore, the intervention, the PU prevention bundle, targeted skin and 
risk assessment, skin care, repositioning, and medical devices related ulcers, and 
education and training.  
The aim of this paper was to test the effectiveness of a PU prevention bundle in 
reducing incidence of PUs in critically ill patients in a KSA ICU. The research 
hypotheses were: (a) KSA ICU patients who received the PU prevention bundle would 
have a decreased PU incidence of 25% or greater when compared to patients who 
received standard care; and (b) KSA ICU patients who received the PU prevention 
bundle would have fewer numbers of PUs/patient, and full thickness PUs (Stage II to 
 Chapter 8: (Article 5) A Two-Arm Cluster Randomised Control Trial to Determine the Effectiveness of a Pressure Ulcer 
Prevention Bundle for Critically Ill Patients 207 
IV) compared to those patients who received standard care. Moreover, the study aimed 
to evaluate the process of care with implementation of the PU prevention bundle.  
This article answers research questions 10-15: 
Research Question 10: Does a PU prevention bundle reduce the cumulative 
incidence of PU development in critically ill patients in the intensive care unit of a 
KSA tertiary referral hospital? 
H0: There is no difference in PU incidence between ICU who implements the 
PU prevention bundle with ICU continuing to implement standard care. 
 Research Question 11: Does a PU prevention bundle decrease the cumulative 
PU incidence by 25% or greater when compared to standard hospital care? 
H0: The difference in PU incidence between ICU who implements the PU 
prevention bundle with ICU continuing to implement standard care was less than 25%. 
Research Question 12: Will patients who receive a PU prevention bundle 
develop PU later in their intensive care unit stay? 
H0:  There is no significant difference in a delayed time to PU development with 
implement the PU prevention bundle. 
Research Question 13: Will patients who receive the PU prevention bundle 
have fewer numbers of PUs per patient during their ICU stay? 
H0: There is no significant difference in number of PU per patients with 
implement the PU prevention bundle during the ICU stay. 
Research Question 14: Will patients who receive the PU prevention bundle 
have fewer full thicknesses PUs (Stage III and IV)? 
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H0: There are no significant differences in full thicknesses PUs (Stage 
III and IV) with implement the PU prevention bundle. 
Research Question 15: Does the PU prevention bundle increase the adherence 
to the process of care compared to the hospital standard skin care? 
The publication adds to the existing body of literature by providing evidence that 
a bundle of best available evidence to prevent PU development in the ICU context is 
effective. Moreover, findings showed that standardisation, through the bundle 
approach, improved implementation and adoption of new practices in the clinical 
setting. 
Findings from this phase were published in the Journal of Nursing Scholarship, 
as the results from this study were able to contribute to the quality of nursing practice 
and patient safety. The Journal of Nursing Scholarship has an impact factor of 1.636. 
The chapter is presented according to the style guidelines of the journal; using the 
American Psychological Association (APA), (6th ed) referencing style and American 
English spelling. Tables and figures are presented at the end of the publication 
according to the respective journal submission guidelines. The article has been cited 
three times in Google scholar. 
The findings of this phase of the study were also presented at the following 
conferences:  
Symposium of Advance Wound Care. Las Vegas, Nevada, USA, October 
2014. 
“A pressure ulcer prevention care bundle and its impact on pressure ulcer 
incidence in critical care: randomized control trial” 
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The 11th Emirates Critical Care Conference in conjunction with the 7th 
Asia Africa Conference of the World Federation of Societies of Intensive and 
Critical Care Medicine, the 11 International Pan Arab Critical Care Medicine 
Society Conference, and the 2nd Middle East Surviving Sepsis Campaign 
Meeting. Dubai, UAE, April 2015. 
 “Testing the efficacy of a pressure ulcer prevention bundle to improve the skin 
integrity of ICU patients”  
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A Two‐Arm Cluster Randomized Control Trial to 
Determine the Effectiveness of a Pressure Ulcer 
Prevention Bundle for Critically Ill Patients 
 
Nahla Tayyib, Fiona Coyer, & Peter Lewis. (2015). Journal of Nursing 
Scholarship, 47(3), 237-247. 
 
8.1 ABSTRACT 
Purpose: This study tested the effectiveness of a pressure ulcer (PU) prevention 
bundle in reducing the incidence of PUs in critically ill patients in two Saudi intensive 
care units (ICUs). 
Design: A two-arm cluster randomized experimental control trial. 
Methods: Participants in the intervention group received the PU prevention 
bundle, while the control group received standard skin care as per the local ICU 
policies. Data collected included demographic variables (age, diagnosis, 
comorbidities, admission trajectory, length of stay) and clinical variables (Braden 
Scale score, severity of organ function score, mechanical ventilation, PU presence, and 
staging). All patients were followed every two days from admission through to 
discharge, death, or up to a maximum of 28 days. Data were analysed with descriptive 
correlation statistics, Kaplan-Meier survival analysis, and Poisson regression. 
Findings: The total number of participants recruited was 140: 70 control 
participants (with a total of 728 days of observation) and 70 intervention participants 
(784 days of observation). PU cumulative incidence was significantly lower in the 
intervention group (7.14%) compared to the control group (32.86%). Poisson 
regression revealed the likelihood of PU development was 70% lower in the 
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intervention group. The intervention group had significantly less Stage I (p = .002) and 
Stage II PU development (p = .026). 
Conclusions: Significant improvements were observed in PU-related 
outcomes with the implementation of the PU prevention bundle in the ICU; PU 
incidence, severity, and total number of PUs per patient were reduced. 
Clinical Relevance: Utilizing a bundle approach and standardized nursing 
language through skin assessment and translation of the knowledge to practice has the 
potential to impact positively on the quality of care and patient outcome. 
Keywords: Bundle care, incidence, intensive care, pressure ulcer. 
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8.2 INTRODUCTION 
 
Critically ill patients who are managed in an intensive care unit (ICU) may 
experience multiple physiological changes that relate directly to their illness and 
possibly even care (Vollman, 2010). Many ICU patients are mechanically ventilated 
and sedated and therefore unable to move or change position themselves. Further, the 
patients’ critical illness may involve hemodynamic instability, which potentially may 
complicate and accelerate the effects of prolonged immobility. As mobility is a natural 
defense to alleviate prolonged pressure on the skin (Shahin, Dassen, & Halfens, 2008), 
extensive exposure to pressure, from lying or sitting, on a specific part of the body 
renders patients at greater risk for skin breakdown. Therefore, ICU patients are at high 
risk for impaired skin integrity, particularly pressure ulcer (PU) development. 
PUs have been identified as a worldwide problem that contribute significantly 
to increasing healthcare costs, the compromising of an individual’s health, morbidity, 
and, in some cases, mortality (Vollman, 2010). The prevalence worldwide of PUs in 
the ICU remains high and is documented between 3% and 50% (Berlowitz, 2014; 
Elliott, McKinley, & Fox, 2008). A recent Saudi Arabian study indicates PU incidence 
rate to be 39.3% (Tayyib, Coyer, & Lewis, 2015), which when compared with other 
international incidences is high (Gunningberg, Donaldson, Aydin, & Idvall, 2012; 
Stotts, Brown, Donaldson, Aydin, & Fridman, 2013). It is clear there is a need for 
examination of current ICU skin care practices in this complex practice environment. 
For the most part, PUs are predictable and preventable and are thus a priority 
patient safety and risk management issue. Evidence suggests that PUs could be 
prevented with the implementation of PU guidelines or a care bundle (Gray-Siracusa 
& Schrier, 2011). Robb et al. (2010) suggest that the care bundle approach is more 
effective than clinical guidelines. This may be because of the mandatory and audited 
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nature of care bundles, whilst clinical guidelines are regarded as advisory. The term 
care bundle refers to the implementation of a set of three to six mandatory interventions 
that are targeted toward a specific procedure, symptom, or treatment (Horner & 
Bellamy, 2012). A care bundle approach has been frequently used in clinical practice, 
as it provides improvement in the delivery of evidence-based care and results in patient 
outcomes (Horner & Bellamy, 2012). 
 While a number of studies reveal a positive link between the care bundle and 
patient outcomes in the ICU (Baldelli & Paciella, 2008; Gillespie, 2007), PU 
prevention guidelines/bundles for intensive care patients are not well defined. The 
intensive care context poses special challenges to preventing PU development due to 
the high acuity of patients and the highly invasive nature of interventions and therapies 
that critically ill patients receive. The development of any comprehensive and effective 
PU prevention guideline or bundle should be based on up-to- date, high-quality 
evidence related to the core components of those guidelines as well as the usage of 
advanced technological, contextually compatible measures for reducing the incidence 
of PUs. 
Some individual PU prevention strategies have a positive impact in the 
reduction of PU development. Successful individual strategies include: a 
comprehensive examination and assessment of the patient’s skin (Revello & Fields, 
2012); assessment of risk using a validated risk assessment scale and implementation 
of intervention strategies based on risk (Guy, 2012); implementation of strategies such 
as pressure-relieving devices (Manzano et al., 2013); regular repositioning as per 
patient need (Vanderwee, Grypdonck, De Bacquer, & Defloor, 2007); assessment of 
and regular repositioning and resecurement of medical devices (Coyer, Stotts, & 
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Blackman, 2014); and particular strategies to address high-risk sites for PU 
development (i.e., sacrum and heels) (Reilly, Karakousis, Schrag, & Stawicki, 2007). 
These strategies can be grouped together in a bundle to reduce the incidence of PU 
development for critically ill patients in the ICU. 
Given the high PU incidence in Saudi Arabia, and the evidence that suggests 
the benefits of a PU prevention bundle, use of a PU prevention bundle in the Saudi 
ICU context is likely to improve patient outcomes and reduce the morbidity and 
mortality rates of ICU patients. This study will evaluate the effectiveness of a PU 
prevention bundle in a Saudi ICU. 
 
8.3 AIM 
The aim of this study was to test the effectiveness of a PU prevention bundle 
in reducing incidence of PUs in critically ill patients in a Saudi ICU. The research 
hypotheses are: (a) Saudi ICU patients who receive the PU prevention bundle will have 
a decreased PU incidence of 25% or greater when compared to patients who receive 
standard care, and (b) Saudi ICU patients who receive the PU prevention bundle will 
have fewer full thickness PUs (Stage II to IV) compared to those patients who receive 
standard care. 
 
8.4 METHODS 
8.4.1 Study Design 
The design for this study is a two-arm cluster randomized experimental control 
trial. A two-arm trial can be used to evaluate a single intervention against control; 
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however, this design only provides limited information about the effectiveness of the 
intervention within a single setting (Grimshaw, Campbell, Eccles, & Steen, 2000). 
 
8.4.2 Setting and Participants  
Data were collected during October 2013 to February 2014 across two Saudi 
Arabian tertiary referral hospital ICUs. ICUs are specialist areas that deliver complex 
multisystem support for adults needing comprehensive intensive care and monitoring 
by specialist care staff. Patients admitted to both hospital ICUs have similar high acuity 
and medical diagnoses, including cardiovascular illness, respiratory diseases, cancer, 
renal dysfunction, burns, sepsis, and multi-trauma injuries such as head injury. Each 
ICU was staffed with approximately 60 registered nurses (RNs). All RNs who provide 
care for ICU patients have tertiary qualifications, the minimum being a bachelor of 
nursing degree with many also having a diploma in nursing. For both hospitals the ICU 
staffing ratio is one nurse to two or three mechanically ventilated patients and one 
charge nurse per shift for each of the three 8-hr shifts per day. In both hospitals the RN 
in charge of the ICU was not always supernumerary and sometimes provided care for 
two patients. 
All participants who were admitted during the study collection period were 
included in the study if they were 18 years of age or older and were expected to stay 
in the ICU for more than 24 hr. Those excluded were patients admitted to the ICU with 
an existing PU, those with a medical condition that contraindicated the bundle 
intervention, and those diagnosed with any stage PU in the first 24 hr of admission to 
the ICU. 
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8.4.3 Sample Size 
Sample size was calculated based on the PU incidence of 39.3% in both centers 
from a previous prospective study (Tayyib et al., 2015). Therefore, the effective 
sample size to detect a difference in PU incidence by 25% or greater with 80% power, 
significance criterion of p =<.05, and assuming two-tailed statistical analyses was 48 
persons per group (Eng, 2003). 
 
8.4.4 Intervention: PU Prevention Bundle 
The PU prevention bundle was designed to reduce PU incidence or severity, to 
be suitable for RNs to deliver, and to fit within the care delivery structure of the ICUs. 
The intervention (a PU prevention bundle) was a bundle of best available evidence 
based on the latest international guidelines for PU prevention (European Pressure 
Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel [EPUAP & 
NPUAP], 2009) allied with PU prevention strategies related to medical devices. These 
guidelines were modified and interpreted for the ICU context. The key aspects of the 
PU prevention bundle were risk assessment, skin assessment, skin care, nutrition, 
repositioning, support surface, education and training, and care of medical devices 
(Table 8.1). 
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Table 8.1 The Pressure Ulcer (PU) Prevention Bundle for Critically Ill Patients 
Intervention   The PU prevention bundle Standard care 
Risk assessment Completion and documentation of Braden risk assessment scale 
within 24hours of ICU admission and daily thereafter.  
No PU risk assessment scale used 
Skin assessment Physical assessment of the patient’s skin is undertaken and 
documented within 4 hours of admission and every 8 hours 
thereafter. 
Physical assessment of the patient’s skin completed and 
documented within 24 hours of admission and once daily 
thereafter. No requirement for documentation  
 Loss of skin integrity assessed (and documented) using the PU 
staging tool, noting site, size, depth, and if any exudates are 
present.  
Loss of skin integrity assessed (and documented) using 
local hospital PU documentation tool. No documentation 
required for Stage I PUs. 
Skin care: Patients bed-bathed once per day using a pH balanced cleansing 
agent (pre-package washcloth). Skin treated with a topical 
moisturiser.  
Once a day bed-bath using antiseptic soap containing 2% 
hydrogen peroxide. Moisturiser applied at discretion of 
RN.  
Nutrition Nutritional status assessment is undertaken by the clinical 
nutritionist on admission 
Nutritional status assessment is undertaken by the clinical 
nutritionist on admission 
Repositioning Patients repositioned using a three hourly turning schedule using 
a ‘turn clock’.  
Patients repositioning two hourly as per ICU policy 
 Foot of the bed elevated by 20 degrees if clinically permitted. 
Patient's heels are elevated and supported.  
Foot of the bed elevated by 20 degrees if clinically 
permitted. There was no policy for heel elevation  
 Drawsheets used to transfer and lift patients  There is no policy for use drawsheet or any lifting 
devices.  
 Where clinically possibly patients are mobilised daily to sit out 
of bed on chair.  
There is no policy to mobilize patient out of bed. 
 Position documented including the time of repositioning and 
position adopted  
No documentation required for patient positioning  
Support surface All ICU patients were managed on air mattresses  All ICU patients were managed on air mattresses 
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Intervention   The PU prevention bundle Standard care 
Education and 
training 
RNs educated in the conduct of accurate and reliable Braden 
Scale Score risk assessment.  
Not applicable 
All ICU health practitioners, especially RNs, educated on 
targeted bundle elements of PU prevention (e.g. risk 
assessment, the role of repositioning in PU prevention, correct 
methods for patient repositioning and use of equipment in 
reducing pressure, friction and shear forces). 
Educated RNs during the orientation period of new ICU 
staff regarding PU prevention strategies (e.g. positioning 
policy every 2 hours, PU stages, and PU 
documentation). 
MDRPU Assessment of skin around/underneath medical devices every 
12 hours. Securement and repositioning of Nasogastric tubes 
(NGT) and endotracheal tubes (ETT) as per techniques 
outlined in the study bundle. 
Resecurement of NGT and ETT daily during patient bed 
bath. There is no policy for skin assessment 
around/underneath medical devices, repositioning and 
resecurement of NGT or ETT.  
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8.4.5 Measurements 
Data were gathered using a baseline patient survey including demographic and 
clinical data, and second daily patient data collection, including Braden risk 
assessment scale score, Sequential Organ Failure Assessment (SOFA) score, a skin 
assessment tool, and PU staging. Further, processes of care (i.e., bundle delivery) were 
measured. Data collection tools were revised by a panel of six expert nurses. 
 
Baseline patient survey 
Participant demographic information collected was age, sex, nationality, body 
mass index (BMI), clinical data included diagnosis on admission, comorbidities, 
length of time in operating theatre or emergency department prior to ICU admission if 
applicable, mechanical ventilation (yes or no), ICU length of stay in days, and ICU 
outcome (discharge to ward or death). 
 
Second daily patient data collection 
Skin Assessment Tool  
A tool to record a standardized approach to skin examination and assessment 
was designed by the researchers using a standard physical assessment technique and 
common areas for PU development (Talley & O’Connor, 2014). 
 
PU staging  
PUs were defined and staged according to EPUAP and NPUAP (2009) criteria. 
PUs were identified as skin or mucosal and, if applicable, by cause (i.e., medical-
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device related ulcer [MDRU]). Further, PU site was identified on the data collection 
form by drawing a circle over the relevant area in the body figure. 
 
Braden Risk Assessment Scale  
The Braden Scale score for predicting PUs reflects the conceptualization of the 
physiological sequelae of PU development and formation. Accordingly, it is consists 
of six elements: sensory perception, moisture, activity, mobility, nutrition, and friction 
and shear. While the first five elements are rated from 1 (most impaired) to 4 (least 
impaired), the last item, “friction and shear,” is rated from 1 (problem) to 3 (no 
problem). The total possible score is 23 (Smith et al., 1995). Scores were divided into 
five subcategories: no risk (19–23), at mild risk (15–18), moderate risk (13–14), high 
risk (10–12), and very high risk (9 or below; Smith et al., 1995). 
 
SOFA score 
SOFA is a scoring system to determine the extent of the patient’s organ function 
or rate of failure in the ICU. The score is based on six organ dysfunction or failure 
scores: respiratory, cardiovascular, hepatic, coagulation, renal, and neurological 
systems. Each organ is graded from 0 (normal) to 4 (the most abnormal), providing a 
daily score of 0 to 24 points. The SOFA score is a more sensitive approach to organ 
dysfunction development 24 hr after admission to the ICU (Qiao, Lu, Li, Shen, & Xu, 
2012). 
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Process of care 
RNs’ process of care performance based on the PU prevention bundle and 
standard skin care (see Table 9.1) were measured using a checklist for compliance (yes 
or no). 
 
8.4.6 Randomization 
Randomization at the patient level was not practical as changes to practice to 
deliver the bundle required a whole-unit approach (hospital level). To avoid selection 
and accidental biases, the research sites (hospitals) were randomized to either the 
intervention or control arm of the study by computer-generated randomization, where 
one hospital ICU was the intervention arm and the other the control arm. Recruitment 
and enrollment of the participants is described in a Consolidated Standards of 
Reporting Trials (CONSORT) flow diagram (Figure 9.1). 
 
8.4.7 Blinding 
The bundle was implemented at hospital level. Owing to the nature of the 
bundle, blinding of participants and healthcare providers was not feasible. The 
researcher with a trained bedside nurse assessed each participant’s skin regularly every 
48 hr, to avoid any detection bias and ensure reliability of the PU assessment. 
 
8.4.8 Endpoints 
The primary endpoint of the study was ICU patient stay up to a maximum of 
28 days. A 28-day endpoint was chosen based on the findings of a previous study 
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showing mean time to develop a PU was 10.09 days in this patient population (median 
9 days, SD 4.6195 days, range 5–23 days; Tayyib et al., 2015). Secondary endpoints 
were death or discharge from the ICU prior to 28 days. 
 
8.4.9 Procedure 
Following ethical approval, the researcher attended each ICU every second day 
(alternating ICUs) to screen, recruit, and collect data using the data collection tools 
previously discussed. All patients were followed until discharge, death, or up to a 
maximum of 28 ICU days (study endpoints), whichever occurred first. The 
intervention required a whole-ICU adoption. Therefore, in the intervention group, the 
ICU RNs were informed about the study’s PU prevention bundle through in-service, 
meetings and one-to-one bedside education provided by the researcher. The training 
and education program consisted of (a) brochures that explain the elements of the PU 
prevention bundle, present the evidence that supports the bundle, and provide the 
outcome of the implementation of the bundle in reducing PU incidence in the ICU; (b) 
a PowerPoint presentation with handout used during in-service; (c) consultation and 
clarification with the researcher, which continued throughout the study. RNs’ 
compliance to the intervention was audited monthly and feedback was provided. The 
control group received usual standard skin care and PU prevention practices guided by 
the policies and procedures of the ICU (see Table 8.1). 
 
8.4.10 Ethical Considerations 
Ethical approval to conduct this study was obtained from the Unit of Ethics of 
the relevant Saudi hospitals, as well as the Queensland University of Technology 
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Human Research Ethics Committees (1300000341), Australia. Informed written 
consent was sought from all eligible participants or their family members. 
 
8.4.11 Statistical Methods 
Descriptive statistical and correlation statistical methods were performed using 
SPSS (version 21; SPSS, Chicago, IL, USA). PU cumulative incidence rate was 
measured using the proportion of participants who developed a new PU within a 
specific time divided by the total number of participants who were at risk for PU 
development (Baharestani et al., 2009). Log-rank and Cox proportional hazards 
analyses were used to compare time to new PU events between the two groups and to 
determine a hazard ratio. The Poisson regression model was used to compare the 
incidence rate ratio differences between groups with 95% confidence intervals (CIs). 
A generalized linear model robust variance estimator was used to account for repeated 
measures. PU stage differences between groups were analyzed using the chi-square 
test of independence. 
 
8.5 RESULTS 
8.5.1 Characteristics of the Study Populations 
Of the 140 patients who met study inclusion criteria when admitted to the study 
ICUs during the enrolment period, 70 participants were allocated to the control group 
and had a total of 728 days of observation and 70 participants were allocated to the 
intervention group and had a total of 784 days of observation (see Figure 8.1). There 
were no significant differences between either group in all demographic characteristics 
and all clinical characteristics, with the exception of time in the operation room (Table 
 224   Chapter 8: (Article 5) A Two-Arm Cluster Randomised Control Trial to Determine the Effectiveness of a Pressure Ulcer 
Prevention Bundle for Critically Ill Patients 
8.2). Braden Scale scores showed that the majority of participants in both groups were 
at high risk for PU development.  
 
 
 
 
 
 
 
  
Assessed for eligibility 
(n=167) 
Excluded (n=27) 
Not meeting inclusion criteria (n= 
27) 
Admitted <24 hours (n=2) 
Burns participants (n =4) 
CAPU on admission (n=16) 
Admitted with hip fracture 
(n=5) 
 
 
Analysed (n= 70) 
 
Lost to follow-up (n=0) 
 
Site A Intervention group 
(n= 70) 
Received The PU prevention bundle 
Lost to follow-up (n=0) 
 
Site B Control group (n= 70) 
x Received ICU standard skin 
care practices 
Analysed (n= 70) 
 
Allocation 
Analysis 
Follow-Up 
Randomization (Sites)  
Enrollment 
Figure 8.1 Consolidate Standards of Reporting Trials [CONSORT] Diagram Presenting the Study 
Enrolment in both Groups: Control and Intervention  
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Table 8.2 Demographic and Clinical Characteristics of Patients (N= 140) 
Note. BMI = Body Mass Index; ICU = Intensive care unit; SOFA = Sequential Organ 
Failure Assessment. a Pearson Chi-Square test, b t-test, c Mann-Whitney U test,  
* Significance at p < 0.05 
Variable Control 
(n=70) 
Intervention 
n=70) 
Test Sig. 
(p)* 
Days of observation  728 784   
Male (number, %) 48 (68.6) 50 (71.4) 0.136a 0.712 
Age in years (mean, SD) 52 (19.5) 47.5 (22.5) -1.383b 0.169 
BMI (mean, SD) 32.1 (31.1) 28 (20.7) -1.807b 0.073 
Braden scale score (mean, SD) 10.01 
(1.53 
10.17 (2.23) 2380.5c .763 
Length of time in operating theatre in 
minutes (mean, SD) 
43.33 
(27.24) 
78.12 (45.97) 17.50c 0.018* 
Length of time in emergency 
department in minutes (mean, SD) 
 
95.8 (86.5) 
 
88.66 (58.75) 
 
1336c 
 
0.95 
Comorbidities (number, %)     
Hypertension 38 (54.2) 27 (38.5)   
Insulin dependent diabetes 29 (41.4) 22 (31.4)   
Peripheral vascular disease 15 (21.4) 5 (7.1)   
Other 37 (52.8) 24 (34.2)   
Nil 19 (27.1) 23 (32)   
Diagnosis (number, %)     
Trauma 9 (12.9) 17 (24.3) 4.04 0.256 
Medical related illness 42 (60) 40 (57.1)   
Post-surgery 11 (15.7) 6 (8.6)   
Sepsis/Infectious disease 8 (11.4) 7 (10)   
ICU Length of stay in days (mean, SD) 10.4 (7.69) 11.2 (8.8) 2428.5c 0.928 
SOFA Score (mean, SD) 3.7 (1.95) 3.8 (1.76) 2306c 0.548 
Outcome (number, %) 
ICU-Discharged 
ICU up-to 28days 
Death 
 
39 (55.7) 
7 (10) 
24 (34.3) 
 
41 (58.6) 
11 (15.7) 
18 (25.7) 
 
1.796a 
 
0.407 
Mechanical ventilation (yes) 72.9% 70% .140a 0.708 
Frequent of repositioning in hours 
(mean, SD) 
3.01 (1.30) 
 
4.67 (2.10) 
 
-8.33b 
 
0.001* 
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Table 8.3 outlines the demographic features and clinical characteristics of 
participants who developed a PU whilst in the ICU. Twelve PUs developed in five 
participants in the intervention group, while 37 PUs developed in 23 participants in the 
control group. There were no significant differences between groups, with the 
exception of age, where the mean age of participants in the intervention group (63 
years) was significantly higher than that of the control group (56 years; t = 0.683, p = 
.02). 
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Table 8.3 Demographic and Clinical Characteristics of Patients with Pressure Ulcers (PUs) 
 
Note. BMI = Body Mass Index; ICU = Intensive care unit; MDRU = Medical devices 
related Ulcer; SOFA = Sequential Organ Failure Assessment. a Pearson Chi-Square 
test, b t-test, c Mann-Whitney U test, * Significance at p < 0.05 
 
 
Variable Control 
(n=23)  
Intervention 
(n=5) 
Test Sig.(p)* 
Days of observation 373 95   
Male (number, %) 16 (69.6) 3 (60) 0.172a 0.678 
Age in years (mean, SD)  55.9 (17.7) 63 (33.9) 0.683b 0.021* 
BMI (mean, SD) 27.56 (5.4) 25.53 (3.55) -.796b .488 
Braden scale score 9.5 (.89) 9.2 (.44) -.772b .103 
ICU length of stay in days (mean, 
SD) 
16.21 (7.89) 19 (12.3) 51.50c .71 
SOFA Score (mean, SD) 3.78 (1.2) 3.75 (1.7) -.057a .396 
Total number of PUs  37 12   
Number of PUs per patient     
x One (number) 12  2  7.937a .005* 
x Two (number) 7  1  4.773a .029* 
x Three (number) 1  0    
x Four (number) 2  2    
Stages of skin PUs     
x Suspected deep injury  3 1   
x PU Stage I (number) 19  6 1976c .002* 
x PU Stage II (number) 13  5 2172c .026* 
x PU Stage III & IV (number) 1 0    
x Unstagable (number) 1 0   
MDRUs  7 2   
Skin ulcer location (number)     
x Elbow 1  0    
x Shoulder 1  1    
x Ear 1 0   
x Sacrum 14  5    
x Buttock 2  1    
x Heel  10  3    
x Knee 1 0   
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8.5.2  Cumulative PU Incidence 
PU cumulative incidence was significantly different between the intervention 
group (7.14%, 5/70 patients) and the control group (32.86%, 23/70 patients; X2 = 
14.46, df = 1, p < .001). 
 
8.5.3 PU Prevention Bundle versus Standard Care 
Implementation of the PU prevention bundle was associated with a delayed time 
to adverse event (PU) occurring when comparing the control to the intervention (for 
those who developed a PU, it developed earlier in the control group; Figure 2). There 
were 12 PU events (17.1%) in the intervention group, as compared with 37 PU events 
(52.8%) in the control group (Breslow’s generalized Wilcoxon = 11.130, df = 1, p < 
.001), assuming events were independent. Multivariate survival Cox regression 
confirmed that the relative PU rates were 0.14 times lower amongst the intervention 
group compared to the control group (95% CI 0.05–0.38). This was a statistically 
significant difference of relative PU rate between both groups (p < .001; see Figure 
8.2). 
Figure 8.2 Kaplan-Meier Survival Curves - PU Development Between Intervention and Control 
Group 
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8.5.4 PU Rate over the Study Period 
There was a statistically significant difference in total number of PUs that 
developed between the intervention (12/70) and control (37/70) groups (exp β = 0.30, 
95% CI, 0.158–0.588, p < .001), indicating the likelihood of PU development to be 
70% lower in the intervention group. 
 
8.5.5 PU Severity 
The most common area for PU development was the sacrum, then heels, for both 
groups (see Table 9.3). The intervention group had significantly less Stage I and II PU 
development (U = 1,976, p = .002, and U = 2,172, p = .026, respectively). MDRUs 
were more frequently found in the control group (7/23) than in the intervention group 
(2/5). The most common areas for MDRUs were nare and neck. 
 
8.5.6 Processes of Care 
Processes of care performance was highest (100%) for admission skin 
assessments and documentation within required time frames in both groups (control 
group within 24 hrs; intervention group within 4 hrs), and daily ongoing assessment 
(control group during bed bath, intervention group every 8 hr). There was no difference 
between groups in frequency of bed baths, as patients in both groups were bathed once 
per day. In the intervention group, 85% of participants were repositioned every 3 hr, 
while in the control group 20% of participants were repositionedmore frequently every 
2 hr as per that particular ICU policy. In the control group the mean frequency of 
repositioning was every 4.67 hr. The practice of supporting participants’ heels using 
heel protectors was significantly different between groups (97% in the intervention 
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group; 0% in control group; X2 = 132.22, p < .001). Patient mobilization out of bed 
did not differ between the groups. 
 
8.6 DISCUSSION 
8.6.1 PU Incidence 
The results of this study support the effectiveness of the PU prevention bundle 
in an adult Saudi ICU, showing that a substantial reduction in the cumulative incidence 
of hospital-acquired PUs (HAPUs), total number of PUs per patient, and time to first 
PU development in the intervention group can be achieved. The assumption of the 
effectiveness of the PU prevention bundle in the reduction of PU development for 
critically ill patients is indirectly supported by the shape of the survival curves for time 
to first PU development, which showed a growing gap during the follow-up period 
(see Figure 9.2). The PU prevention bundle, based on the most recent available 
evidence of PU prevention strategies, combined several measures that targeted risk 
factors. Therefore, we could not estimate the effect of individual prevention measures 
(Horner & Bellamy, 2012). The bundle approach (i.e., mandatory implementation of 
all strategies) may be considered successful because a marked reduction in PU 
incidence from 32.86% to 7.14% was recorded. 
Despite a significant reduction in PU development, one wonders why the 
incidence was not lower. Possible explanations include nursing care deviations in the 
PU prevention bundle, patients staying longer in the ICU, or the presence of disease 
burdens with secondary skin failure, making total eradication of PUs extremely 
difficult. It also may be a combination of any or all of the above proposed explanations. 
Another confounder may relate to nurses’ workload as the nurse/patient ratio was one 
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to two or one to three, and nurses delivered all patient care. However, the incidence 
rate of HAPUs now is similar to that reported in other international studies 
(Gunningberg et al., 2012; Stotts et al., 2013) 
 
8.6.2 PU Severity 
Our analyses revealed that the implementation of the PU prevention bundle has 
significantly reduced the severity of PUs. Further, the prevention bundle has been 
shown to be effective in other international studies, which reported that regular 
assessment of the patient’s skin and mucous membranes around and underneath 
devices, with regular repositioning of devices, is essential to reduce MDRU incidence 
(Coyer et al., in press). These findings confirmed that the PU prevention bundle results 
in improvement in patient outcomes in a Saudi setting, as well as other international 
settings. 
 
8.6.3 Process of Care 
The bundle approach is more efficient than a single intervention in changing 
practice (Horner & Bellamy, 2012). However, lack of compliance by RNs can hinder 
the success of any bundle or any process for that matter. Soban, Hempel, Munjas, 
Miles, and Rubenstein (2011) suggest that successful reporting of the intervention (PU 
prevention bundle) should include the intervention’s effect on patient’s outcome (PU 
incidence) and process of care, to understand the extent of conducting each 
intervention and its effect. This study showed increased compliance of most processes 
of care with implementation of the PU prevention bundle; patients were repositioned 
more frequently, had an improvement in ongoing care regarding medical devices (i.e., 
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assessment, repositioning, and resecurement), and the patients’ heels were elevated 
and supported with greater frequency.  
Interestingly, this study found that control group delivery of the PU prevention 
processes of care were dependent on RNs’ clinical decision and provided no 
uniformity of care. Several studies argue that standardization, high reliability, and 
compliance of bundle implementation will improve PU prevention in the ICU 
(Chaboyer et al., 2013; Revello & Fields, 2012). Evidence suggests it is no longer 
sufficient to rely on RNs’ clinical judgment in this area—the risk of variance in 
practice and key elements being omitted (due to a multiplicity of reasons) is too high. 
This study showed a high RN compliance to delivery of the PU prevention bundle 
(processes of care); thus, enabling the PU prevention bundle to be successfully 
translated in the clinical practice (ICU). Further, this study suggests that using a bundle 
approach, with extensive education and training, regular feedback of the performance, 
and increased RN awareness about the extent of the problem, will improve RN 
compliance and the reduction of HAPUs in the ICU. 
 
8.7 LIMITATIONS, FUTURE RESEARCH, AND APPLICATION OF 
FINDINGS 
This study was conducted in two Saudi Arabian ICUs; therefore, the 
generalizability of results is limited to this single setting. Testing a PU prevention 
bundle in a different organizational context may be required for additional resources 
and training. Further research should build on proven PU prevention success strategies 
and evaluate risk factors that could accelerate the PU development in those patients to 
understand any potential trade-off between risk factors and PU development. 
 Chapter 8: (Article 5) A Two-Arm Cluster Randomised Control Trial to Determine the Effectiveness of a Pressure Ulcer 
Prevention Bundle for Critically Ill Patients 233 
Measuring prevalence and incidence of PUs regularly, increasing staff awareness 
about the problem, using PU prevention strategies, and implementing evidence-based 
practice toward PU prevention will positively impact the quality of care and patient 
outcomes. 
 
8.8 IMPLICATIONS FOR PRACTICE 
This bundle had a positive impact on reducing PU development-related 
outcomes, especially incidence and severity of PUs and MDRPUs. Utilizing a bundle 
approach and standardized nursing language through skin assessment and translation 
of the knowledge to practice is essential for PU-related outcomes. Correctly 
identifying risk factors for PU development and high–risk patients and linking with 
relevant nursing interventions will achieve the desired outcome of PU reduction in the 
ICU, consequently improving quality of care and patient safety. 
 
8.9 CONCLUSIONS 
The results of this study showed significant improvements in reducing PUs and 
PU-related events through the implementation of the PU prevention bundle in Saudi 
ICUs. It would appear that the use of the PU bundle can reduce PU incidence, severity, 
and total number of PUs per patient. Since this comprehensive bundle was based on 
international guidelines with evidence based on PU prevention strategies for skin or 
mucosal PUs, it should also be recognized that it is highly likely an increased staff 
awareness about PU prevention, and staff training and education, may also contribute 
to successful results in improving patient care. 
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8.11 CLINICAL RESOURCES:  
x International Guideline Prevention of Pressure Ulcers: Quick Reference Guide: 
http://www.npuap.org/wp-content/uploads/2012/02/Final_ Quick_ 
Prevention_for_web_2010. 
x Prevention and Treatment of Pressure Ulcers: Quick Reference Guide: 
http://www.npuap.org/wp-content/uploads/2014/08/Updated-10-16-14-
Quick-Reference-Guide-DIGITAL-NPUAP-EPUAP-PPPIA-16Oct2014  
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Overlying a Care Bundle 
Approach with a Model for 
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This chapter includes the following article:  
Tayyib, N., & Coyer, F. (2016). Translating pressure ulcer prevention into 
intensive care nursing practice: Overlaying a care bundle approach with a 
model for research implementation. Journal of Nursing Care Quality. 
doi:10.1097/NCQ.0000000000000199  
 
This article presents how all of the findings from the previous chapters informed 
the overall goal, which was the implementation of the PU prevention bundle to 
improve skin integrity in the ICU context, guided by the study’s conceptual 
framework. This article explores whether using a knowledge translation framework 
can assist the advanced practice nurse to implement new evidence (the PU prevention 
bundle) appropriately and successfully into practice. The use of new evidence should 
enable patients to receive the most up to date, evidence based care, improve the quality 
of care the patient receives, and enhance patient safety. The aims of this article were 
to examine how the Ottawa Model of Research Use (OMRU) model was used to guide 
the implementation of a PU prevention bundle integrated into the daily practice context 
of an ICU. Further, this paper provides an in-depth account of this approach as a 
comprehensive vehicle for using high quality evidence to improve skin integrity of 
critically ill patients. 
 This article answers research question 16: 
 240   Chapter 9: (Article 6) Translating Pressure Ulcer Prevention into Intensive Care Nursing Practice: Overlying a Care 
Bundle Approach with a Model for Research Implementation 
Research Question 16: Does the OMRU model, as a framework, facilitate the 
implementation of the PU prevention bundle in the ICU context?  
This publication adds to the existing body of literature by providing evidence that 
use of the OMRU, a translation model, enhanced the integration of evidence-based 
practice into daily clinical practice in a consistent and effective manner. Furthermore, 
confidence in the research outcome, presented in previous chapters, is enhanced 
through addressing the process of care, and the barriers and facilitators that impact 
upon the implementation of an intervention, and using effective strategies for 
implementation. 
Findings from this phase were published in the Journal of Nursing Care Quality, 
as the results from this study were able to contribute to the international audience of 
advanced nursing practice and patient safety. The Journal of Nursing Care Quality has 
an impact factor of 1.389.  
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Translating Pressure Ulcer Prevention into Intensive 
Care Nursing Practice: Overlaying a Care Bundle 
Approach with a Model for Research Implementation 
 
Tayyib, N., and Coyer, F. (2016). Journal of Nursing Care Quality  
  
9.1 ABSTRACT 
This article reports on the development and implementation process used to 
integrate a care bundle approach (a pressure ulcer [PU] prevention bundle to improve 
patients’ skin integrity in intensive care) and the Ottawa Model of Research Use 
(OMRU). The PU prevention care bundle demonstrated significant reduction in PU 
incidence, with the OMRU model providing a successful consolidated framework for 
implementation of bundled evidence in an effective, efficient, and consistent manner 
into daily clinical nursing practice.    
Keywords: care bundle, implementation, Ottawa of Model Research Use, 
pressure ulcer prevention bundle 
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9.2 BACKGROUND 
Hospital Hospital acquired pressure ulcers (HAPUs) are one of the most serious 
problems in healthcare settings. High prevalence and incidence of pressure ulcer (PUs) 
acquired during hospitalization globally (Berlowitz, 2014; Nijs et al., 2009) supports 
a lack of comprehensive processes to guide the implementation of effective PU 
prevention strategies in the clinical setting, particularly in intensive care units (ICU). 
Such a lack of process may lead to PU development, which in turn, increases cost and 
length of stay, as well as morbidity and mortality (Bennett, Dealey, & Posnett, 2004; 
Brown, 2003; Graves, Birrell, & Whitby, 2005).  
Skin breakdown impacts negatively on the patient’s quality of life. All critically ill 
patients managed in ICUs are more susceptible for PU development due to their high 
acuity, physiological responses to critical illness, and subsequent length of stay in ICU 
(Cooper, 2013). Consequently, urgent attention to implement PU prevention strategies 
is required. Evidence suggests that implementing different PU prevention strategies as 
guidelines, or care bundles could reduce HAPU development (Kiernan & Downie, 
2011).  
The terms “evidence-based guideline” and “care bundle approach” refer to a set of 
interventions that are targeted towards a specific procedure, symptom or treatment. 
Robb (2010) argues that the care bundle approach is more effective than simply 
following clinical guidelines (Robb et al., 2010) This may be because of the inherent 
importance of all elements of a care bundle, whilst clinical guidelines are 
recommendations only intended to optimize patient care.  
The bundle approach has been shown to be effective in many areas such as: 
prevention of PUs, and ventilator‐associated pneumonia, as well as increased 
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compliance for hand hygiene.(Gray-Siracusa & Schrier, 2011; Hawe, Ellis, Cairns, & 
Longmate, 2009; Pincock, Bernstein, Warthman, & Holst, 2012) However, this 
approach does not acknowledge the effect of the practice environment (ICU), which is 
never static, on clinical practice performance and outcomes. In addition, the process 
of adoption of the care bundle must be considered (Camporota & Brett, 2011). 
Therefore, introduction of a care bundle approach itself may be insufficient to change 
practice in a complex area. A systematic and dynamic model is required to guide the 
translation of the PU prevention bundle in ICU. One such effective model to promote 
research uptake by health care practitioners is the Ottawa Model for Research Use 
(OMRU) (Rycroft-Malone & Bucknall, 2011).  
This model was chosen as it is dynamic, not a linear process, and it is focuses upon 
the implementation of existing research evidence into practice, taking into account the 
overall context, personal practice, and those responsible for the implementation. 
Whilst OMRU has been used in the implementation of a number of clinical 
interventions, including skin integrity program, there is a limited literature integrating 
the care bundle approach and OMRU principles.  
This article presents how the OMRU model guided a two-arm cluster randomized 
control trial (cRCT) which tested the effectiveness of a PU prevention bundle (Tayyib, 
Coyer, & Lewis, 2015b). The cRCT study was conducted in two Saudi Arabian tertiary 
referral hospital intensive care units from June 2013 to February 2014, where one 
hospital ICU was the intervention arm and the second was the control. All patients 
who admitted during a study period were recruited and followed until discharge, death, 
or up to a maximum of 28 ICU days (study endpoints), whichever occurred first, and 
the 6-PU stages system was used as the outcomes measure. Further, this paper provides 
insight into this approach and argues the OMRU and care bundle approach is a 
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comprehensive vehicle for integrating high quality evidence (PU prevention bundle) 
into the daily practice to improve skin integrity within an ICU practice setting.  
 
9.3 THE OTTAWA MODEL OF RESEARCH USE (OMRU) 
The The OMRU, designed by Logan and Graham, is an interactive model for using 
knowledge in clinical practice. The OMRU is not a sequential stage model of change 
practice (Rycroft-Malone & Bucknall, 2011). The OMRU model has three implicit 
assumptions: patients play a key role in every aspect of model elements; the process 
can be repeated at any stage of the implementation; and the environment that may 
affect all aspects of the translation process (Logan & Graham, 1998). Many studies 
have applied the OMRU model when translating evidence into the clinical practice 
context (Hogan & Logan, 2004; Logan, Harrison, Graham, Dunn, & Bissonnette, 
1999; Stacey, Pomey, O'Connor, & Graham, 2006).  
The OMRU consists of six phases framed by assessment, monitoring and 
evaluation: 1) research-based innovation, 2) the practice environment, 3) potential 
adopters, 4) implementation of the intervention, 5) adoption, and 6) outcomes (see 
Figure 9.1).  
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Figure 9.1 The Ottawa Model of Research Use for Implementing a PU Prevention Bundle in ICU  
(Adapted from Graham & Logan, 2004) 
j 
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The model is classified as a planned action model as it provides direction as to the 
issues that should be addressed and the activities that change agents should undertake 
(Rycroft-Malone & Bucknall, 2011). When knowledge transfer is being planned, the 
model relies on a process of assessing, monitoring, and evaluating each element 
before, during, and after the decision is made, to promote uptake of the innovation 
(Rycroft-Malone & Bucknall, 2011). The OMRU directs change agents through 
assessment of the barriers and facilitators to research use related to the practice 
environment (in this instance the ICU), adopter characteristics (specialist intensive 
care nurses), and the clinical innovation (PU prevention bundle). An implementation 
plan is then tailored to overcome the identified barriers. The strategies to deliver the 
intervention are based on the situational assessment and the transfer of the strategies 
with ongoing evaluation. How the evidence-based research is transferred to clinical 
practice is then monitored. Finally, the intervention is evaluated by assessing the effect 
on patients, practitioners and system to determine the effectiveness of the intervention 
in valid and reliable ways. The following discussion illustrates how the OMRU can be 
used to direct the implementation of a PU prevention bundle innovations in ICU.  
 
9.3.1 Phase 1: Research-Based Innovation (PU Prevention Bundle) 
Innovations in the hospital setting can be defined as changing standard 
practices based on current knowledge and research data. Innovation has been presented 
in different forms, including procedures, policy, practice guidelines, and care bundles 
(Rycroft-Malone & Bucknall, 2011). Whenever an innovative care bundle is planned, 
the following steps should be considered: a review of the relevant literature, a synthesis 
of the best evidence along with the contextual demands and formation of an integrated 
bundle of care. A panel of international experts, constituting the National Pressure 
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Ulcer Advisory Panel (NPUAP) and European Pressure ulcer Advisory Panel 
(EPUAP), as an international consensus committee reviewed evidence on PU 
prevention strategies and found consensus in the following guidelines for the general 
context. These guidelines were contextualized to the Saudi Arabia (SA) ICU context 
and presented as a care bundle (presented in Table 9.1) (Tayyib, Coyer, & Lewis, 
2015a). 
The PU prevention bundle was reviewed by a panel of five local expert nurses 
who had a range of seven to 14 years of clinical experience. The panel included two 
nurse educators (one from each hospital) and two critical care nursing supervisors (one 
from each hospital), and one adult care registered nurse (RN). In addition, the bundle 
was also tailored to the individual practice environment (ICU) and the potential 
adopters (RNs). For example, despite international guideline recommendations for the 
use of any high specification mattress for all at risk patients (European Pressure Ulcer 
Advisory Panel and National Pressure Ulcer Advisory Panel (EPUAP & NPUAP), 
2009), our PU prevention bundle suggested use of an air mattress because this is the 
only mattress available in ICUs in Saudi Arabia. 
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Table 9.1 NPUAP & EPUAP Guideline, Standard, & the PU Prevention Bundle 
NPUAP & EPUAP prevention guideline 
(2009) 
Standard PU prevention care  The PU prevention bundle (our 
intervention) 
Risk assessment: 
- Using a structured risk assessment that 
addresses mobility, activity, friction and 
shear, sensory reception, and body 
temperature. 
- No PU risk assessment scale used  
 
- Completion and documentation of Braden 
risk assessment scale within 24hours of ICU 
admission and daily thereafter. 
Skin assessment/skin care: 
- Physical assessment and documentation for 
any sign of skin changes  
- Pain assessment related to pressure  
- Keep the skin clean, moist, and dry. 
- No skin massages or rubs.  
- Physical assessment of the patient’s skin 
completed and documented within 24 hours 
of admission and once daily thereafter. No 
requirement for documentation  
- Loss of skin integrity assessed (and 
documented) using local hospital PU 
documentation tool. No documentation 
required for Stage I PUs. 
- Once a day bed-bath using antiseptic soap 
containing 2% hydrogen peroxide. 
Moisturiser applied at discretion of RN.  
- Physical assessment of the patient’s skin is 
undertaken and documented within 4 hours 
of admission and every 8 hours thereafter. 
- Loss of skin integrity assessed (and 
documented) using the PU staging tool, 
noting site, size, depth, and if any exudates 
are present.  
- Patients bed-bathed once per day using a pH 
balanced cleansing agent (pre-package 
washcloth). Skin treated with a topical 
moisturiser.  
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NPUAP & EPUAP prevention 
guideline (2009) 
Standard PU prevention care  The PU prevention bundle (our intervention) 
Nutrition: 
- Assess nutritional status regularly. 
Nutritional status assessment is undertaken 
by the clinical nutritionist on admission 
Nutritional status assessment is undertaken by the 
clinical nutritionist on admission 
Repositioning:  
- Frequent patient repositioning is 
recommended according to patient’s 
need, and support surfaces.  
- Using a 30-degree tilted side-lying 
position  
- Seating patients out of the bed (if 
possible) to maintain a full range of 
motion.  
- Patient’s heels should be supported and 
elevated  
- Documentation of repositioning 
regimen and position adopted. 
 
- Patients repositioning two hourly as per 
ICU policy 
- Foot of the bed elevated by 20 degrees if 
clinically permitted. There was no policy for 
heel elevation  
- There is no policy for use drawsheet or any 
lifting devices.  
There is no policy to mobilize patient out of 
bed. 
- No documentation required for patient 
positioning  
- Patients repositioned using a three hourly 
turning schedule using a ‘turn clock’.  
- Foot of the bed elevated by 20 degrees if 
clinically permitted. Patient's heels are elevated 
and supported.  
- Drawsheets used to transfer and lift patients  
- Where clinically possibly patients are mobilised 
daily to sit out of bed on chair.  
- Position documented including the time of 
repositioning and position adopted  
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NPUAP & EPUAP prevention guideline 
(2009) 
Standard PU prevention care  The PU prevention bundle (our intervention) 
Support surface:  
- Use higher-specification foam 
mattresses for all at-risk  
- All ICU patients were managed on air 
mattresses 
- All ICU patients were managed on air 
mattresses 
Education and training include:  
- Conducting of risk assessment scale in 
reliable and accurate ways. 
- Conducting a comprehensive skin 
assessment for any signs of skin 
changes. 
- Considering role and method of 
repositioning and use of equipment for 
repositioning.  
- Educated RNs during the orientation period 
of new ICU staff regarding PU prevention 
strategies (e.g. positioning policy every 2 
hours, PU stages, and PU documentation). 
- RNs educated in the conduct of accurate and 
reliable Braden Scale Score risk assessment.  
- All ICU health practitioners, especially RNs, 
educated on targeted bundle elements of PU 
prevention (e.g. risk assessment, the role of 
repositioning in PU prevention, correct 
methods for patient repositioning and use of 
equipment in reducing pressure, friction and 
shear forces). 
Medical devices:  
- Assessment of the area underneath 
medical devices.  
- Resecurement of NGT and ETT daily during 
patient bed bath. There is no policy for skin 
assessment around/underneath medical 
devices, repositioning and resecurement of 
NGT or ETT. 
- Assessment of skin around/underneath medical 
devices every 12 hours. Securement and 
repositioning of Nasogastric tubes (NGT) and 
endotracheal tubes (ETT) as per 
techniquesoutlined in the study bundle. 
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9.3.2 Phase 2: Practice Environment (ICU) 
The second assessment element is the practice environment. The impact of the 
practice environment on the translation of research into practice has been identified in 
a considerable volume of research (Bradley et al., 2005; Mitchell, Fisher, Hastings, 
Silverman, & Wallen, 2010). The ICU is a complex and dynamic environment, thus it 
has both promoting and constraining influences on the process of translating evidence 
into practice. Our study was conducted in the two ICUs of major metropolitan 
government-funded public hospitals in Saudi Arabia. Both ICUs each have 20 to 24 
beds, each with single rooms, staffed by approximately 60 RNs. The ICU staffing ratio 
is one RN to every two to three mechanically ventilated patients. At the time of the 
study there were no dedicated clinical instructors or nurse educators in the units. The 
ICU patient case mix comprised of cardiovascular and respiratory diseases; cancer; 
renal dysfunction; burns; sepsis; and multi-trauma injuries. Both ICUs are specialist 
areas that deliver complex multi-system support for life-threatening patient or after 
major surgery. 
Ethical approval to conduct this study was granted by the Unit of Ethic of the 
relevant Saudi hospitals as well as the Queensland University of Technology Human 
Research Ethics Committee (130000034), Australia. Our study was unanimously 
approved and supported by the medical and nursing directors of the ICUs, as the 
research aims were congruent with each organisation’s mission and vision for PU 
prevention. Prevention of PUs was considered a routine component of day to day 
nursing care in the study sites, and it was provided based on individual RN clinical 
judgement. 
Prior to our study, ICU PU incidence using the 4 staging classifications (I-IV) 
(European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel 
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(EPUAP & NPUAP), 2009) was measured monthly. The head nurse was responsible 
for calculating and reporting incidence rates, including PU related to medical devices, 
to the hospital administration department. However, this data was not fedback to RNs 
in the ICU. Further, the incidence report relied on retrospective data from RN reports, 
which may not be reliable. This data were used locally to determine if appropriate 
prevention strategies were used.  
No evidence addressing the magnitude of the PU problem in the SA ICU 
settings has previously been reported. Our study undertook prospective observational 
incidence data collection to determine accurate PU data in the ICU. We previously 
found that HAPU incidence was high (39.3%), of which stage I and II were the most 
often noted (Tayyib, Coyer, & Lewis, 2015b), compared to other international 
intensive care settings (1.8%-14.3%) (Gunningberg, Donaldson, Aydin, & Idvall, 
2012; Stotts, Brown, Donaldson, Aydin, & Fridman, 2013). The clinical process at this 
site was that individual RNs are responsible for clinical decision-making and 
implementing the appropriate prevention strategies. If PUs occur, the physician will 
be notified and involved in the treatment plan. Cultural beliefs at the study site 
highlight that RNs play an important decision-making role in preventing and treating 
PUs. However, the RNs, who are caring for the ICU patients, are from different 
cultural and language backgrounds. Such cultural diversity could affect the 
consistency of provided care towards preventing PUs development, especially when 
the provided care is based on individual decision-making and there is an absence of 
opinion leader at the study site.  
The environmental barriers and facilitators relating to PU development were 
assessed through a cross-sectional survey of intensive care RNs to determine the 
characteristics of the setting related to HAPU prevention as a performance 
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improvement initiative (Tayyib, Coyer, & Lewis, 2016a). The modified Pressure Ulcer 
Prevention in the PICU "Barriers and Facilitators" survey included items about the 
potential barriers/ facilitators to optimal skin care. The following findings from this 
survey directly impacted the research translation: workload was identified as a 
significant barrier to providing optimum skin care; three facilitating factors that 
enhanced the ability of RNs to provide optimum skin care were the availability of 
pressure reduction surfaces (p=.007), convenience of appropriate skin care products 
(p=.015), and collaboration with interdisciplinary teams 
(nursing/medicine/pharmacy/dietary) (p=.02) (Tayyib et al., 2016a). 
 
9.3.3 Phase 3: Potential Adopters (Specialist RNs) 
The third assessment element of the OMRU model is potential adopter groups. 
Potential adopter refers to practitioners, intensive care RNs, who implemented the PU 
prevention bundle. Assessment of RNs for their attitudes towards, and willingness to,  
implement a HAPU prevention bundle comprises three concepts: awareness of the 
problem and the HAPU prevention bundle innovation, the intention of RNs to change 
current practice and concern about PU as a problem (Rycroft-Malone & Bucknall, 
2011). 
In the study site, the RNs demonstrated a lack of awareness regarding HAPU 
incidence, as the reporting of internal incidence data were at an administrative level 
only. Additionally, RNs’ attitudes, and perceived barriers and facilitators to PU 
prevention were assessed to understand both potential obstacles and expediters (Tayyib 
et al., 2016a). This was measured via two surveys using the Attitude towards Pressure 
Ulcer Prevention instrument (APuP) (Beeckman, Defloor, Demarré, Van Hecke, & 
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Vanderwee, 2010), and the modified Pressure Ulcer Prevention in the PICU "Barriers 
and Facilitators" instruments.  
The majority of potential adopters were female (80.4%), and 50% held a 
bachelor’s degree in nursing. The original survey was analysed using a 4-point Likert 
scale (1=strongly disagree, 4= strongly agree) and with a mean cut-off point of a 
positive attitude score of >70% (Beeckman et al., 2010). Findings reveal that the 
majority of participants had a positive attitude toward PU prevention strategies 
(73.44%) (Tayyib et al., 2016a). However, the potential adopters had low scores below 
the positive attitude that regards the consequences of PUs on patients and society, and 
priority of PU prevention sub-scales (68%, 69% respectively). A 10-point Likert scale 
(1=lower, 10=highest) was employed to rate perceived personal barriers to 
implementing the PU prevention bundle. Time demands (p=.011), and limitation of 
RNs knowledge (p=.022) were noteworthy adopter-specific limitations to 
implementing the PU prevention bundle.  
Our assessment demonstrated factors that impeded and facilitated the 
implementation of new practices towards PU prevention. These issues were addressed 
during development of the PU prevention bundle, and used to design the strategies that 
enhance, disseminate, diffuse, implement, and sustain the PU prevention bundle. 
Strategies that were used will be discussed in the next phase.  
 
9.3.4 Phase 4: Intervention Implementation (Education and Training of PU 
Prevention Bundle) 
The implementation phase includes addressing barriers and facilitators, 
translating knowledge into practice, and the follow-up activities. Logan and Graham 
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(1998) advise that successful knowledge uptake rests with adapting knowledge 
implementation strategies to salient barriers of the individual and their organisation, 
and identifying evidence-based innovations that are applicable to their clinical setting.  
During our study, intervention implementation strategies were tailored and 
sequenced based on the clinical innovation, practice environment, and adopter profiles. 
Literature suggests that utilising multiple research transfer strategies to ensure 
awareness, understanding, training and skill of each potential adopter facilitates 
change in a routine practice (Bingham & Main, 2010; Doherty, 2006). Roger (2003) 
suggests that five stages of the innovation decision process include knowledge and 
awareness of the potential adopters about the innovation before implementation; the 
persuasion stage, involving the development of positive attitudes towards the 
innovation; the decision stage about the potential adopters’ decisions regarding the use 
of innovation; the implementation and translation stage; and the final stage, which 
includes the continuity of integrating the innovation into routine care (Rogers, 2003).  
An interactive educational in-service was conducted by one of the authors as 
opinion leader and expert PU nurse, to familiarize intensive care RNs members about 
the bundle. The content of the 1-hour workshop included a didactic component 
detailing the magnitude of the PU problem, its implications for the patients, and 
organisational level concerns, prevention strategies, and the core elements of 
prevention guidelines. In addition, availability of the printed brochures, study 
booklets, and the presence of an opinion leader (researcher) on the site every second 
day for eight hours that provided an opportunity to remind RNs of the importance of 
the bundle elements and for further consultation. It has been argued that the presence 
of opinion leaders has a positive educational influence in changing daily practice 
through increased research uptake (van Riet Paap et al., 2015; Yap, Kennerly, 
 256 Chapter 10: Conclusion 
Bergstrom, Hudak, & Horn, 2016). Interactive workshops that combine research 
results with value for the nurses’ experiential knowledge have been shown to be 
effective facilitators of change (Young & Paterson, 2007). Adopters’ feedback from 
the in-service was overwhelmingly positive and upheld the importance of change. 
Moreover, the presence of the opinion leader, the researcher, in the research setting 
facilitated research uptake and use (Borgert, Goossens, & Dongelmans, 2015).  
Biweekly reminders of the study were generated through placing a colorful 
page in the communication notebook and reminders at ICU staff meetings, which 
promoted their practice change towards PU prevention (Tayyib et al., 2015a; Tayyib, 
Coyer, & Lewis, 2016b). Ongoing motivation of the RNs, through repeating the aim 
of implementing the bundle and patient safety, is considered to be a successful 
fundamental translation strategy (Hogan & Logan, 2004). Audit and feedback have 
been proven effective in improving performance (Borgert et al., 2015). Bundle audits 
and monthly personal self-reports were conducted to determine and address perceived 
barriers and facilitators of the bundle implementation.  
 
9.3.5 Phase 5: Adoption 
The next step in monitoring the cycle is the adoption of the innovation, which 
includes intention to use and continued use of the PU prevention bundle.(Rycroft-
Malone & Bucknall, 2011) Monitoring a care bundle implementation is essential to 
determine the degree of diffusing the bundle throughout intensive care RNs, and the 
barriers and facilitators that affected the process of care. This phase would determine 
the impact of the PU prevention bundle on the desired change of reduced PU incidence.  
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Adoption of the PU prevention bundle was monitored through a PU prevention 
bundle compliance checklist completed by the researcher through direct observation, 
patients’ records, and a RNs self-evaluation checklist every two weeks during the 
implementation and evaluation period, which included a four time points (Tayyib et 
al., 2016b). Sharing the results following each data collection point was effective in 
increasing uptake of the bundle and reaching the high implementation (Tayyib et al., 
2016b). High implementation compliance required a score of 75% or greater (Wilson 
et al., 2010). 
In our study, the compliance checklist, which included 30 yes/no questions, 
revealed that intensive care RNs had a high level of compliance overall toward the 
implementation of the bundle, as shown by the mean score of 22.43/30 (78.1%). 
However, the compliance across the four time points revealed that the intensive care 
RNs needed more time to be familiar with the bundle (Tayyib et al., 2016b). 
Furthermore, this study showed that the adoption and sustaining of the bundle was not 
affected by the cultural diversity and characteristics of the intensive care RNs. This 
reflects that the bundle was reliable, easy to implement, compatible with the context, 
and was clear and non-controversial. 
The RN self-evalution survey suggests that, in general, intensive care RNs 
perceived that both the innovation and knowledge acquired during the bundle 
implementation increased their awareness of the effective PU prevention strategies, 
satisfaction and confidence to implement effective PU prevention in ICU. In term of 
barriers to implementation of the bundle, a RNs self-evaluation survey also found that 
severity of illness or high acuity was identified as the main barriers to embedding the 
bundle elements (Tayyib et al., 2016b). 
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9.3.6 Phase 6: Outcome 
The last step of the model includes evaluation of the outcomes of this practice 
change (the implementation of the PU prevention bundle). The outcome should be 
evaluated on patients, practitioners, and healthcare system levels (Rycroft-Malone & 
Bucknall, 2011). The aims of this phase were to determine whether the promotion of 
adoption is of value or not in terms of reduction of incidence or prevalence of PU in 
critically ill patients in ICU. However, this phase will be interpreted according to the 
compliance result of the potential adopters (RNs).  
One of the OMRU’s key assumptions of research adoption is improved patient 
outcome. In our study this was a reduction in the incidence of PUs in ICU. The PU 
incidence rate was measured prospectively using the proportion of participants who 
develop a new PU within a specific time divided by the total number of participants 
who were at risk of PU development (Baharestani et al., 2009). The bundle was 
implemented in the intervention group for all ICU patients until discharge, death, or 
up to a maximum of 28 ICU days (study end points), whichever occurred first. The PU 
incidence outcome was compared between the intervention that received the PU 
prevention bundle and control group, which received the PU prevention standard care. 
Evaluation of the innovation, the PU prevention bundle, also should consider the 
intensive care RNs compliance to the bundle (Horner, Rew, & Torres, 2006). Since 
the intensive care RNs had higher compliance to the bundle in their practice, this 
confirms that the PU prevention bundle could be the main reason for the differences 
of the PU incidence between both groups. The implementation of the PU prevention 
bundle resulted in significantly decreased PU incidence from 32.86% (23/70 patients) 
to 7.14% (5/70 patients) in the intervention group (χ2=14.46, df=1, p < .001) (Tayyib 
et al., 2015a). Moreover, the intervention group had a significant reduction of stage I 
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(U = 1,976, p = .002), stage II (U = 2,172, p = .026) and less medical device-related 
PUs compared to the control group (Tayyib et al., 2015a). This reduction could 
contribute to lower healthcare costs and increased safety and quality of care. In 
addition, this research has a significant practical impact on the ICU by changing the 
repositioning policy to 3 hours and using a pH balanced cleansing agent (pre-package 
washcloth) for patients during their bed baths. 
 
9.4 DISCUSSION 
Implementation of best evidence-based PU prevention strategies is an 
organizational and nursing goal for improving quality of care. However, the processes 
of evidence translation in real clinical practice are complex. Using an effective 
framework, such as the OMRU model, has been important as it provided a complete 
insight of translation processes in the real setting. Mapping out the translation of an 
evidence-based initiative is a deliberate process that aims to counterbalance barriers 
and facilitators to make practice changes. The PU prevention bundle research project 
illustrates an example of a successful performance improvement initiative which 
addressed a specific problem (PU).  
During the implementation period, the OMRU model was found to be highly 
suitable for modifying practice, embedding a new practice in the routine care and 
managing the factors that affect the translation process of the PU prevention bundle. 
Implementation research projects to improve nursing practice require initial and 
ongoing support at the organization level for a clinical change to practice (Graham & 
Logan, 2004; Yap et al., 2016). While potential adopters demonstrated positive 
attitudes towards PU prevention, they perceived a limitation of personal PU prevention 
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knowledge and workload as barriers to providing effective care. This could indicate 
that the RNs recognised the values of additional educational programs that were related 
to up to date effective evidence in PU prevention and implementation. Learning 
theories recommend using a variety of educational strategies, including recurring, 
tailored in-service educational sessions, face-to-face interviews, and printed copies of 
the study (Prior, Guerin, & Grimmer‐Somers, 2008). Engaging a researcher as opinion 
leader during the implementation created a credible effect on increased uptake of the 
bundle. Nursing workload as a barrier to practice change is a significant hurdle to 
overcome. For this study  the frequency of patient repositioning was modified from 
two hourly to every three hours, with the latter supported by evidence (Yap et al., 
2016), to assist intensive care RNs to adopt a practice change of regular patient 
repositioning.   
Ongoing trending of the findings of PU incidence in the study site would serve 
to inform the development of additional value of the PU prevention bundle. Evaluating 
patient outcomes and, PU incidence, are equally vital to ongoing quality improvement 
initiatives that attempt to translate research into practice. Audit and feedback strategies 
were used in a safe and comfortable environment, in the presence of an opinion leader, 
which enhanced the sustainability of the successful implementation of the PU 
prevention bundle (Yap et al., 2016). These strategies have been confirmed with other 
implementation studies in order to promote a high level of sustained performance of 
clinical practice that is directed to improving healthcare outcomes and patient safety 
(Borgert et al., 2015). 
Dissemination and implementation of evidence-based research are essential to 
the delivery of high-quality care that optimizes patients’ outcomes. Addressing the 
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process of care, and the barriers and facilitators that impact upon the implementation 
of an intervention, and using effective strategies for implementation, will promote 
compliance and sustain the intervention in clinical practice. Using the OMRU, a 
translation model, will enhance the integration of evidence-based into daily clinical 
practice in a consistent and effective manner. The confidence of the research outcome 
will increase and similar results will be achieved with replicating the study.  
 
9.5 CONCLUSION 
Using a knowledge translation framework can facilitate the uptake of research into 
practice, which can improve health care outcomes for patients. In this article, use of 
the OMRU model facilitated the successful dissemination of a new PU prevention care 
bundle in the ICU. The transfer of knowledge into practice is a complex process and 
more research is needed regarding the effectiveness of different teaching and learning 
strategies in different practice settings. Moreover, this article demonstrated that use of 
a care bundle approach overlaid with a research translation model, the OMRU, 
promoted change effectively through structured sequences of bundle design, 
adaptation, and implementation. This contributed to evidence-based practice that 
resulted in improvement in patient safety (PU incidence reduction) and enhancement 
the quality of care received by patients and their families. 
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10.1 INTRODUCTION  
This research evaluated the effectiveness of the implementation of the pressure 
ulcer (PU) prevention bundle for critically ill patients to improve skin integrity care. 
This chapter constitutes the conclusion of the study, and addresses a summary of the 
research and key findings, followed by a consideration of the strengths and limitations 
of the research undertaken. The chapter concludes with a discussion of the broader 
implications of, and recommendations that arise from, the study findings as they relate 
to nursing practice, education, policy, and future research.  
 
10.2 SUMMARY OF THE RESEARCH FINDINGS 
The overall goal of this research was to reduce PU incidence in critically ill 
patients in the intensive care (ICU) setting. This was accomplished by applying both 
preventive and corrective action strategies utilising a care bundle approach allied with 
an evidence translation framework into the real practice setting. To ensure that this 
aim was achieved, the research questions are now reviewed. 
At the commencement of the study, 16 research questions were posed (Section 
1.2), all of which were answered, as shown below.  
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Research Question 1: What are the factors that accelerate PU development in 
adult ICUs? 
Research Question 2: What are the common risk assessments that are used and 
the most effective scales for identifying at risk patients for PU development in the 
ICU? 
 
A literature review (see Chapter 2) was conducted to examine research published 
between 2000 and 2012 identifying potential risk factors for the acceleration of PU 
development, and the common risk assessment scales (RASs) utilised in adult ICUs. 
Nineteen articles were included in this review: eight studies addressing PU risk factors, 
eight studies addressing risk assessment scales, and three studies that overlapped both 
areas. The review found that PU development is enhanced by the presence of multiple, 
rather than single, risk factors in the one critically ill individual.  
A list of accelerating factors was identified and conceptualised under two 
labels: intrinsic (inherent factors of critical illness) and extrinsic (related to external 
forces) factors. A total of 28 factors were identified as the main risk factors for PU 
development in ICU settings in two or more studies. The intrinsic factors identified in 
two or more studies were older age, increased length of stay in the ICU, and history of 
cardiovascular disease. The extrinsic factors identified in two or more studies were the 
administration of norepinephrine and patient repositioning (turning). However, there 
have been inconsistencies in how these factors are measured. Thus, a risk factor 
prediction model for critically ill patients has yet to be developed. 
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The review identified RASs that have been examined in many studies in terms of 
predictive performance. No evidence has demonstrated whether some scales are more 
effective than others to determine which patients are more susceptible to PU 
development in the ICU. Possible explanations are: 1) that there is no clear evidence 
regarding which core components, either intrinsic or extrinsic risk factors, accelerated 
the development of PU in the ICU, and, 2) nurses’ competencies in conducting a scale 
may be inconsistent. However, a RAS is considered a fundamental component for any 
prevention and management plan. This review found that the Braden Scale is the most 
appropriate to use in ICUs, which was confirmed by the latest systematic review 
conducted in 2013 (García-Fernández, 2013). 
The findings from this review (Chapter 2) formed the basis for identifying the 
potential risk factors that should be addressed during the design and planning of the 
PU prevention intervention. Moreover, it facilitated the selection of a RAS instrument, 
the Braden Scale, for use in this research. 
 
Research Question 3: What are the effects of prevention strategies on the 
incidence/prevalence of pressure ulcers in adult ICUs? 
A systematic review (see Chapter 3) was undertaken to specifically examine 
prevention strategies aimed at ameliorating known risk factors associated with PU 
development in critically ill patients. Twenty-five studies were included, with 
moderate to strong evidence. The review demonstrated that different prevention 
strategies had a significant impact in reducing the hospital-acquired PUs (HAPUs) in 
ICU. The review showed that a silicon foam dressing had a significant reduction in 
HAPU incidence on the scarum area. However, this result should be considered with 
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caution due to substantial heterogeneity across the included studies. The review 
concluded there was no certainty regarding which prevention strategies were more 
effective than others in the ICU context. The findings from this review formed the 
basis for the selection of the care bundle approach and addressed the translation 
research model, the OMRU (Chapter 4).  
Following the review’s findings, the PU prevention bundle (intervention) was 
designed based on the latest international guideline at the time of the study (2009) and 
interpreted to the KSA ICU setting, taking into consideration that it was time-
consuming; the clinical practitioner workload; and resource allocation including 
personnel, supplies, and equipment. Further, the PU prevention bundle was accepted 
for implementation by the local expert clinical professionals. Consequently, the first 
phase of the OMRU model, developing the clinical innovation, was addressed.  
 
Research Question 4: What are the characteristics of the ICU patients in the 
KSA? 
The results of this study (see Chapter 6) reported that the majority of ICU 
patients were male (66.6%), and that their mean age was 53 years. More of the 
individuals in the study sample were non-Saudi nationals (54.8%). This was attributed 
to the study site, Mekkah, being of religious significance and attracting global 
pilgrimage. Patients were admitted to the ICU with different diagnoses, such as 
cardiovascular illness, respiratory disease, cancer, renal dysfunction, burns, sepsis, and 
multi-trauma injuries. Approximately 85.7% of the participants were at predominantly 
high risk for PU development, with a mean Braden Scale score of 10 (SD 2.12). The 
average SOFA score was 7.8 (SD 3.01), and the length of stay in the ICU was nine 
days. 
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Research Question 5: What is the incidence of PU development in critically ill 
patients in the intensive care units of two tertiary referral hospitals in the KSA? 
The study found that the PU incidence rate in the KAAH ICU hospital was 
40.9% and the KFH ICU was 37.5%. The total PU incidence rate in both ICUs was 
high (39.3%), and ulcers related to medical devices were a significant problem, (24%) 
of the total HAPUs (see Chapter 6). 
 
Research Question 6: What are the factors associated with PU development in 
the ICU in the KSA? 
The study suggests (see Chapter 6) that the predictor factors that accelerated 
the development of PUs in the KSA ICU context included: age (OR: 1.254; 95% CI: 
1.054–1.492; p = 0·011), longer stay in the ICU (OR: 1.831; 95% CI: 1.014–3.309; p 
= 0·045), and infrequent repositioning (OR: 250.04; 95% CI: 5.230-11954.16; p = 
0·005). Length of stay in ICU (OR: 1·23; 95% CI: 1.087–1.392; p = 0·001), and 
infrequent repositioning (OR: 2.96; 95% CI: 1.23–7.153; p = 0·015) were associated 
with the development of stage II-IV PUs. The frequency of repositioning was 
addressed during design of the PU prevention bundle. 
 
Research Question 7: What are the RNs attitudes towards PUs prevention in a 
Saudi Arabian tertiary referral hospital ICU? 
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The study’s results (see Chapter 7) revealed intensive care RNs showed a 
positive attitude towards PU prevention, with a mean score of 38.19 out of a possible 
52 points (73.44%). However, the impact and priority subscale of the APuP instrument 
had the lowest score in comparison to other subscales (68%, 69% respectively). This 
suggests that intensive care RNs did not consider the powerful effect of PU 
development nor consider it urgent issues.  
 
Research Question 8: What are the facilitators and barriers for RNs in the 
adoption of PU prevention strategies in a Saudi Arabian tertiary referral hospital 
ICU? 
The study’s findings demonstrated three perceived factors that facilitated PU 
prevention: the availability of pressure relieving support surfaces (β=-0.388, p=0.007), 
appropriate skin care products (β=0.44, p=0.015), and collaboration between the 
healthcare professional teams (β=0.37, p=0.02). On the other hand, RNs lack of up-to-
date knowledge about PU prevention (β =-0.632, p=0.022) and the demands of a high 
workload (β =0.388, p=0.011) were identified as barriers to implementing effective 
strategies to prevent PU development (see Chapter 7).  
 
Research Question 9: Is there any association between participants’ 
characteristics and RNs’ attitude, or perceived barriers and facilitators to 
implement the PU prevention strategies?  
The study’s findings showed no significant differences between the 
demographic characteristics of the intensive care RNs and the APuP attitude subscale, 
 274 Chapter 10: Conclusion 
or perceived barriers and facilitators for implementation of the PU prevention bundle 
(see Chapter 7).  
According to the OMRU model, the assessment of barriers and facilitators 
related to the practice environment (ICU) and the potential adopters (RNs) is essential 
to facilitate the research intake. In this study, the results of the assessment phase, which 
included the incidence and facilitators and barriers study, informed Phase Two through 
the calculation of the effective sample size for Phase Two (cRCT). Moreover, the 
design of the intervention and selection of effective strategies for the implementation 
and adoption of the research were informed by the assessment of the barriers and 
facilitators in the second study. 
 
Research Question 10: Does a PU prevention bundle reduce the cumulative 
incidence of PU development in critically ill patients in the intensive care unit of 
a Saudi Arabian tertiary referral hospital? 
 H0: There is no difference in PU incidence between ICU who implements the 
PU prevention bundle with ICU continuing to implement standard care. 
Key findings from this phase showed a significant reduction in PU cumulative 
incidence in the intervention group (7.14%) compared to the control group (32.86%) 
(X2 = 14.46, df = 1, p < .001) (see Chapter 8). The null hypothesis was rejected.  
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Research Question 11: Does a PU prevention bundle decrease the cumulative PU 
incidence by 25% or greater when compared to standard hospital care?  
H0: The difference in PU incidence between ICU who implements the PU 
prevention bundle with ICU continuing to implement standard care was less than 
25%. 
The result of this study shows that the likelihood of PU development was 70% 
lower in the intervention group (see Chapter 8). The null hypothesis was rejected. 
 
Research Question 12: Will patients who receive a PU prevention bundle develop 
a PU later in their intensive care unit stay? 
 H0:  There is no significant difference in a delayed time to PU development 
with implement the PU prevention bundle. 
A survival curve revealed that the implementation of the PU prevention bundle 
was associated with a significantly delayed time to PU development (p < .001) (see 
Chapter 8). The null hypothesis was rejected. 
 
Research Question 13: Will patients who receive the PU prevention bundle have 
fewer numbers of PUs per patient during their ICU stay? 
 H0: There is no significant difference in number of PU per patients with 
implement the PU prevention bundle during the ICU stay. 
The implementation of the PU prevention bundle showed a significant 
reduction in the total number of PUs that developed between the intervention (12/70) 
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and control (37/70) groups (exp β = 0.30, 95% CI, 0.158–0.588, p < .001) (see Chapter 
8). The null hypothesis was rejected. 
 
Research Question 14: Will patients who receive the PU prevention bundle have 
fewer full thicknesses PUs (Stage III and IV)? 
 H0: There are no significant differences in full thicknesses PUs (Stage III and 
IV) with implement the PU prevention bundle. 
The results demonstrated that the intervention group had a significant reduction 
in Stage I ((U=1976, p=0.002), Stage II PU development (U=2172, p = .026), and no 
full thicknesses PUs were developed (see Chapter 8). The null hypothesis was rejected. 
 
Research Question 15: Does the PU prevention bundle increase the adherence to 
the process of care compared to standard hospital skin care?  
The RNs had a high level of compliance toward the implementation of each 
key element of the PU prevention bundles compared to the control group. For 
example, in the intervention group, the adoption of the repositioning regimen 
element was high (85%), while in the control group, 20% of participants were 
repositioned as per that particular ICU’s policy. This study also showed that the 
characteristics of the intensive care RNs did not affect the implementation and 
adoption of the bundle (see Chapter 8). This reflects that the bundle was accepted 
and applicable for implementation. Moreover, the effectiveness of the 
implementation strategies that were proposed, such as active learning classes, one-
to one education, reminders, presence of opinion leaders, and audit and feedback, 
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enhanced the research uptake and integrated the implementation of the new bundle 
into daily practice. 
 
Research Question 16: Does the OMRU model, as a framework, facilitate the 
implementation of the PU prevention bundle in the ICU context?  
This study also supports the emphasis on using translation knowledge 
frameworks allied with a care bundle approach to confirm adequate delivery of key 
components and to assist with the interpretation of outcome results (see Chapter 9). 
This study concludes that continued monitoring of PU incidence rate and sustaining 
of PU prevention bundles enables in-depth analysis and timely responses to changes 
in PU rates going forward. 
 
10.3 STRENGTHS AND LIMITATIONS  
This research has had a significant impact on the PU prevention field, 
particularly in the context of KSA PU research. This study has made a significant 
contribution to PU prevention in the KSA, as it the first study to determine the 
incidence of PU events in KSA ICUs and the first to test the effectiveness of a PU 
prevention bundle, comprised of the best available evidence, to improve skin integrity. 
The research has also demonstrated a comprehensive conceptual framework that can 
be used to guide future evaluations of interventions within health care research. This 
study validated the OMRU model as able to demonstrate comparable outcomes and 
promote adoption and sustainability of the changing health care reform. According to 
the conceptual framework, this research systematically identified the barriers and 
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facilitators, either among healthcare providers or at organisational levels, that affected 
the adoption and implementation of PU prevention bundles in ICU, and then addressed 
them. This research can be seen as an example of effective translation of evidence in 
complex environments such as the ICU. Furthermore, the use of a two-arm cluster 
randomised control trial design was a strength of this study. Finally, this study also 
contributed to adding up-to-date knowledge regarding PU prevention and management 
that will enable nurses to provide high quality evidence-based nursing care.  
However, this study does have limitations. Firstly, the study’s findings were 
limited to the study settings due to practical constraints (time, access, and finance). 
Secondly, the PU prevention bundle (the intervention) was not based on a high level 
of evidence; such as meta-analysis, or RCTs; as there is a lack of strong evidence 
regarding the effectiveness of some elements in PU prevention in the ICU (e.g., risk 
assessment scale and frequency of repositioning). Therefore, the intervention may not 
reflect the true nature of the care bundle approach, where, if one intervention element 
is removed the outcome is diminished. Thirdly, the self-evaluation and retrospective 
method may have led to bias in reporting and overestimation of the compliance results 
(Van de Mortel, 2008). Finally, health economic analysis of the intervention 
implementation was not conducted.  
 
10.4 IMPLICATIONS AND RECOMMENDATIONS  
The findings of this study not only contribute to a theoretical understanding of 
the study phenomenon in the KSA, but could also be translated into practice for the 
benefit of patient safety and quality of care received. Finally, implications and 
recommendations for practice, education, and future research are drawn from the 
study.  
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10.4.1  Implications and Recommendations for Practice  
Implementation of the PU prevention bundle decreased the overall incidence in 
a clinically meaningful way. It is unclear which individual intervention may have been 
the most influential. Rather, it is likely that the synergistic effect of the bundle of 
interventions led to a more significant decrease in incidence than any one of the 
interventions might have had on its own. The PU prevention bundle was applied to all 
patients in the ICU, with significant improvement of skin care, which reflects that the 
PU prevention bundle was sensitive to the skin of patients who are most at risk. 
However, standard PU prevention practices in KSA need to reflect contemporary 
guidelines for example it is recommended that the practice of using draw sheet to 
reposition patient be discontinued in favour of slide sheets and the use of hydrogen 
peroxide as a cleansing agent is discontinued in favour of a pH balanced, gentle no 
rinse cleansing agent.  
Standardised nursing language through risk assessment and translation of 
knowledge to practice is essential for PU-related outcomes. Increased compliance to 
the PU prevention bundle by the intensive care clinician reflects the extent to which 
the bundle was accepted. Moreover, there was a positive relationship between 
increased practitioners’ familiarity with, and increased compliance to, the care bundle 
in the ICU context. Monitoring the process of care, the link between intervention 
implementation and research outcomes was systematically explored and evaluated, 
ultimately leading to a greater understanding of the strengths and weakness of the 
intervention, enhancing both the internal and external validity of the research, and 
increasing opportunities for replicating the study in other settings with the same result. 
Since this bundle was introduced, several other initiatives have been introduced for the 
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nursing staff, including educational opportunities. For example, the study 
demonstrated that despite having access to the right skin care products, nurses needed 
more education and training about how and when to use them.  
The presence of the opinion leader (researcher) played an important role in 
educating the staff, ensuring that skin assessments were being completed, and that the 
staff understood and maintained fidelity (process of care) to the pressure ulcer 
prevention bundle. Following the conclusion of the study, there is now a pressure ulcer 
champion in these two KSA ICUs and an additional clinical instructor whose role, in 
part, is to provide education about PU prevention strategies. Regular monitoring of the 
PU rate will provide valuable information about the pressure ulcer itself, and also 
which risk factors appear to contribute to pressure ulcer development.  
 
10.4.2 Implications and Recommendations for Education  
The KSA intensive care RNs had a positive attitude towards PU prevention, 
implying that RNs were eager for knowledge related to PU prevention, wound care, 
and the products available to them. Thus, staff education should be undertaken prior 
to any policy changes to inform staff of new standards for assessing, monitoring, 
preventing, and treating skin breakdown. Ideally, the education for all new policy 
changes and expectations would be given by the opinion leader. Education efforts 
should focus on specific, measurable interventions to be performed consistently across 
the unit in order to enhance the effect of prevention efforts. 
This study suggests that traditional nursing education may not be sufficient to 
create or sustain changes in nursing practice. A need exists for new and innovative 
strategies to bring education to clinical nurses, including interactive technology, 
“hands on” learning opportunities, training at the bedside, and audit and feedback. This 
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study revealed the importance of the connection between change in practice and 
improved outcomes to sustain any change in practice. 
 
10.4.3 Implications and Recommendations for Policy Consideration  
Policy changes should be based on the need to change factors that precede the 
development of a PU. Accurate measurement of the incidence of PUs, both before and 
after the implementation of the guidelines, is important in determining the 
effectiveness of the interventions detailed in the previous chapter. To measure the 
incidence of skin breakdown, the literature suggests the use of a skin care team to 
perform audits and help staff members with comprehensive skin assessments 
(Bernabe, 2012; Pasek et al., 2008). In order to accurately determine the incidence of 
PUs in hospitalised patients, a detailed assessment must be performed on every patient 
upon admission to the ICU, preferably within four to eight hours of arrival (Coyer et 
al, 2015; NPUAP, EPUAP, & PPPIA, 2014). Subsequent skin care assessments should 
take place frequently, and should include the use of a standardised assessment tool in 
order to monitor the development of any skin breakdown over time (Bernabe, 2012; 
Lyder et al., 2012).  
Policies should also include the formation of a skin care team to be responsible 
for compiling and monitoring the data across the unit. To determine if the interventions 
suggested in Chapter 4 are effective, baseline data would be compared to subsequent 
information as it is gathered. Moreover, comprehensive documentation should be 
incorporated into any PU prevention care to increase the understanding of the level of 
effectiveness of the intervention. Documentation should be contextualised to the ICU 
and provide options for consistent and feasible documentation of skin assessments, 
pressure ulcer staging, interventions completed for skin care, and appropriate risk 
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assessment scales. Staff education about the importance of consistent documentation 
will need to be completed prior to the implementation of guidelines.  
10.4.4 Implications and Recommendations for Future Research  
The findings of this study provide guidance for future investigation. First, this 
study should be replicated on a larger scale to validate that this bundle of care, using a 
slide sheet instead of a draw sheet, is actually associated with improved patient 
outcomes in different ICUs. Little is known about the factors associated with nurses’ 
adequate implementation of the PU prevention bundle in mechanically ventilated 
patients. Further identification of these factors will promote a broader understanding, 
thereby facilitating the development of interventions aimed at improving nurses’ 
adherence to evidence-based practices.  
Secondly, future research is needed to develop and test quality improvement 
measures that specifically address other barriers and facilitators to nurses’ adherence 
to the PU prevention bundle. These measures should be based on strategies that have 
been empirically shown to have effectively changed nursing practice. In doing so, 
attention must be given to strategies that might facilitate nurses’ process of 
implementing evidence-based practice. One of the first issues to deal with may be how 
to address nurses’ overconfidence in their implementation of standardised protocols 
and decision making.  
Thirdly, in extending research in this patient population, additional studies are 
needed to evaluate the level of nursing compliance required to demonstrate a 
significant decrease in the development of PUs. In this study, an overall high level of 
compliance to the PU prevention bundle was found, despite  the high workload and a 
shortage of bedside RNs in the ICU, which would imply this bundle is compatible and 
suitable to use in a complex setting (ICU). Moreover, the PU incidence was not 
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influenced by the compliance level. Further research is needed to confirm that a 
minimal level of compliance to this bundle may be beneficial in the PU incidence 
reduction.  
Fourthly, increased length of stay has been associated with an increased risk of 
PU development in the literature and in this study (Tayyib, et al., 2013; Tayyib, et al., 
2015a). This pattern raises questions about whether patients can be identified early as 
potentially having a long ICU stay, as well as whether early targeted interventions 
could help decrease pressure ulcer development in patients who have extended ICU 
stays. Finally, more research is required to determine the efficacy of PU prevention 
interventions based on standardised criteria for reporting interventions. 
 
10.5 IMPACT OF THIS RESEARCH ON PRACTICE TO DATE 
This study on PU prevention bundle effectiveness has had a significant and 
practical impact at the unit and national level. Following the conclusion of this study, 
the PU prevention bundle used in this research was adopted at both the control and 
intervention sites. Furthermore, this adoption has been sustained over time and is 
ongoing at the time of submission of this thesis. Both ICU research sites now have a 
PU champion (RN) position to increase staff awareness and to facilitate the currency 
of clinical knowledge in PU prevention strategies. The intervention site still uses an 
internal benchmarking strategy with feedback of monthly PU incidence rates to all 
staff within the intensive care unit. Moreover, the quality and patient safety department 
from the intervention hospital has requested a copy of the two-arm cRCT paper 
published in the Journal of Nursing Scholarship, to submit to the KSA Ministry of 
Health (MOH). Consequently, if accepted by the KSA MOH, it will then be distributed 
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to all MOH hospitals, with a recommendation from the MOH that the PU prevention 
care bundle be adopted in all MOH hospitals ICUs. The latter particularly shows the 
long lasting significant impact of this research on national clinical practice in the KSA.  
Following a conference presentation in Dubai, UAE, a copy of the two-arm 
cRCT published paper was also requested by one major metropolitan UAE hospital, 
as they wished to use this as evidence to guide a comprehensive local PU prevention 
project. 
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4) PU Staging Tool  
 
PU STAGING TOOL  
 
 Patient Initials:|__|__|__|  Patient Study Number:|__|__|__|__| 
 
1) Pressure injuryStaging 
Stage Definition  
Suspected deep 
tissue injury 
 
 
Is characterised by the discoloration of 
intact skin by purple- or maroon-
coloured or blood-filled blisters as a 
consequence of prolonged pressure, 
shear or friction to underlying tissue 
 
Stage I 
 
Is marked by non-blanchable redness of 
intact skin that is not dissolved by relief 
of pressure. It is localised over a bony 
prominence. It can be painful, firm, 
warmer or cooler as compared to another 
area.  
Stage II 
 
Is defined as partial thickness loss 
including the epidermis and dermis. It 
appears as a shallow pink ulcer or 
superficial blister or abrasion. 
 
Stage III Is involves full-thickness tissue loss. This 
damage may include subcutaneous tissue 
but not the underlying fascia. As a result 
of the anatomical difference of each part 
of the body, assessing the depth of stage 
III PrI varies.  
Stage IV Is involves full-thickness tissue loss with 
exposed bone, tendon or muscle. Slough 
or eschar may be present on some parts 
of the wound bed. In stage IV PrI, 
undermining and tunnelling of the wound 
can be observed. 
 
 
Unstageable Is full-thickness tissue loss in which the 
base of the ulcer is covered by slough 
(yellow, tan, grey, green or brown) and/or 
eschar (tan, brown or black) in the wound 
bed. This may confound the 
identification of the depth of the tissue.  
  
Source: NPUAP & EPUAP (2009). 
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All Nasal and Lip Pressure Ulcer (PU) need to be coded as Muscoal PU (MPU) and 
not staged (ie no number) 
 
2) Pressure Ulcer Prevalence Body Chart Form 
Date: _________________ Time: ______________ 
 
x Circle the location of Pressure Ulcerand indicate the stage 
 
x If more than one Pressure Ulcer found please indicate a number to correspond 
with the additional Pressure Ulcer documentation audit sheet. 
 
 
 
( 
 
INSTRUCTION: 
x Inform RN at bedside   YES   NO 
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5) Braden Risk Assessment Scale  
 
Patient Initials:|__|__|__| Patient Study Number:|__|__|__|__|  Date: ___/___/ 2013 
 
Items 1 2 3 4 Score  
Sensory Perception 
- 
Ability to respond 
meaningfully to 
pressure related 
discomfort 
1. Completely Limited 
Unresponsive (does not moan, 
flinch or grasp) to painful stimuli, 
due to diminished level of 
consciousness or sedation. OR 
limited ability to feel pain over 
most of body surface. 
 
2. Very Limited 
Responds only to painful 
stimuli. Cannot communicate 
discomfort except by 
moaning or restlessness. OR 
has a sensory impairment 
that limits the ability to feel 
pain or discomfort over ½ of 
body. 
3. Slightly Limited 
Responds to verbal commands, but 
cannot always communicate 
discomfort or need to be turned. 
OR has some sensory impairment 
that limits ability to feel pain or 
discomfort in 1 or 2 extremities. 
4. No Impairment 
Responds to verbal 
commands. Has no sensory 
deficit that would limit ability 
to feel or voice pain or 
discomfort 
 
Moisture -Degree to 
which skin is 
exposed to moisture 
1. Constantly Moist 
Skin is kept moist almost 
constantly by perspiration, urine, 
etc. Dampness is detected every 
time patient/ client is moved or 
turned. 
2. Very Moist 
Skin is often, but not always, 
moist. Linen must be 
changed at least once a shift. 
3. Occasionally Moist 
Skin is occasionally moist, 
requiring an extra linen change 
approximately once a day. 
4. Rarely Moist 
Skin is usually dry. Linen only 
requires changing at routine 
intervals. 
 
 
 
Activity -Degree of 
physical activity 
1. Bedfast 
Confined to bed 
2. Chairfast 
Ability to walk severely 
limited or non-existent. 
Cannot bear own weight 
and/or must be assisted into 
chair or wheelchair. 
3. Walks Occasionally 
Walks occasionally during day, but 
for very short distances, with or 
without assistance. Spends majority 
of each shift in bed or chair. 
4.Walks Frequently 
Walks outside the room at 
least twice a day and inside the 
room every 2 hours during 
waking hours. 
 
Mobility - Ability to 
change and control 
body position 
1.Completely Immobile  
Does not make even slight 
changes in body or extremity 
position without assistance. 
2.Very Limited 
Makes occasional slight 
changes in body or extremity 
position but unable to make 
3.Slightly Limited 
Makes frequent though slight 
changes in body or extremity 
position independently. 
4.No Limitations 
Makes major and frequent 
changes in position without 
assistance. 
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Items 1 2 3 4 Score  
Nutrition -Usual food 
intake pattern 
1.Very Poor 
Never eats a complete 
meal. Rarely eats more 
than 1/3 of any food 
offered. Eats 2 servings or 
less of protein (meat or 
dairy products) per day. 
Takes fluids poorly. Does 
not take a liquid dietary 
supplement. OR is NPO 
and/or maintained on 
clear liquids or IV’s for 
more than 5 days 
 
2.Probably Inadequate 
Rarely eats a complete 
meal and generally eats 
only about ½ of any food 
offered. Protein intake 
includes only 3 servings 
of meat or dairy products 
per day. Occasionally will 
take a dietary supplement. 
OR receives less than 
optimum amount of liquid 
diet or tube feeding. 
3.Adequate 
Eats over half of most 
meals. Eats a total of 4 
servings of protein (meat, 
dairy products) each day. 
Occasionally will refuse a 
meal, but will usually take 
a supplement if offered. 
OR is on a tube feeding or 
TPN regimen which 
probably meets most of 
nutritional needs. 
4.Excellent 
Eats most of every meal. 
Never refuses a meal. 
Usually eats a total of 4 or 
more servings of meat and 
dairy products. 
Occasionally eats between 
meals. Does not require 
supplementation 
 
Friction and Shear 1.Problem 
Requires moderate to 
maximum assistance in 
moving. 
2.Potential Problem 
Moves feebly or requires 
minimum assistance. 
During a move, skin 
probably slides to some 
extent against sheets, 
chair restraints, or other 
devices. Maintains 
relatively good position in 
chair or bed most of the 
time, but occasionally 
slides down. 
 
3.No Apparent Problem 
Moves in bed and in chair 
independently and has 
sufficient muscle strength 
to lift up completely 
during move. Maintains 
good position in bed or 
chair at all times. 
  
     Total Braden Score 
 
frequent or significant 
changes independently. 
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6) Barriers and Facilitators Survey  
 
Pressure Ulcer Prevention Bundle in ICU 
Barriers and Facilitators 
 
Pressure Ulcers continue to be a significant problem in ICU. We are interested in hearing from 
you about what (if anything) gets in the way of you being able to provide optimal skin care for 
your patients, as well as what (if anything) helps you to provide optimal skin care for your 
patients. This is part of a research study being conducted in the ICU. Your participation is 
voluntary and implies informed consent. We anticipate that the survey will take 10 to 15 
minutes to complete. Some questions may seem the same, but we would appreciate your 
response to all questions. 
 
 
 
 
1. Sex: MaleF FemaleF  
2. Education: Diploma   FBachelor degree   FMaster degree    FPost registration ICU 
qualification certificateF 
3. Number of years as a RN?____ Years  
4. Number of years working in the ICU? ____ Years 
5. Number of years employed in this hospital?____ Years 
  
 
 
 
 
 
 
1. Competing demands on my time 
0 1 2 3 4 5 6 7 8 9 10 
Not a barrier                                                                                                                 A major barrier 
 
2. Limitations in my ability to assess risk of pressure injury development 
0 1 2 3 4 5 6 7 8 9 10 
Not a barrier                                                                                                                 A major barrier 
 
3. Limitations in my knowledge about pressure injury prevention 
0 1 2 3 4 5 6 7 8 9 10 
Not a barrier                                                                                                                       A major barrier 
 
4. Low priority given to pressure injury prevention by medical staff 
0 1 2 3 4 5 6 7 8 9 10 
Not a barrier                                                                                                                      A major barrier 
Part 1 Demographic information  
Part 2 Potential barriers to optimal skin care  
Below are some potential barriers to optimal skin care. The scale ranges from 0 (Not 
a barrier) to 10 (A major barrier). Please select the number that best rates these 
barriers to your personal ability to provide optimal skin care for your patients. 
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5. Low priority given to pressure ulcer prevention by nursing staff 
0 1 2 3 4 5 6 7 8 9 1
0 
Not a barrier                                                                                                             A major barrier 
 
6. Low priority given to pressure ulcer prevention by me 
0 1 2 3 4 5 6 7 8 9 1
0 
Not a barrier                                                                                                              A major barrier 
 
7. Current documentation format for pressure ulcer risk/ nursing interventions 
0 1 2 3 4 5 6 7 8 9 1
0 
Not a barrier                                                                                                              A major barrier 
 
8. Insufficient resources to provide guidance/expertise in pressure ulcer prevention 
0 1 2 3 4 5 6 7 8 9 1
0 
Not a barrier                                                                                                              A major barrier 
 
9. Insufficient supplies/equipment to provide optimal pressure ulcer prevention care 
0 1 2 3 4 5 6 7 8 9 1
0 
Not a barrier                                                                                                              A major barrier 
 
10. Low priority given to pressure ulcer prevention due to the severity of patient's illness  
0 1 2 3 4 5 6 7 8 9 1
0 
Not a barrier                                                                                                              A major barrier 
 
11. Low cooperation levels from patients or/and their family  
0 1 2 3 4 5 6 7 8 9 1
0 
Not a barrier                                                                                                              A major barrier 
 
12. Lack of authority to change patient care 
0 1 2 3 4 5 6 7 8 9 1
0 
Not a barrier                                                                                                              A major barrier 
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13. What other barriers to pressure ulcer prevention are not included on this tool? 
 
 
 
 
 
 
14. In general, to what degree do you feel you are able to overcome barriers and ultimately 
provide optimal skin care for your patients? 
0 1 2 3 4 5 6 7 8 9 1
0 
Not at all able                                                                                                                     Very able 
 
 
 
 
 
 
 
 
 
1. Education about Braden risk assessment of pressure injury development 
0 1 2 3 4 5 6 7 8 9 1
0 
Not at all helpful                                                                                                            Very helpful 
 
2. Education about pressure ulcer grading 
0 1 2 3 4 5 6 7 8 9 1
0 
Not at all helpful                                                                                                            Very helpful 
 
3. Current documentation format for pressure ulcer risk/ nursing interventions 
0 1 2 3 4 5 6 7 8 9 1
0 
Not at all helpful                                                                                                            Very helpful 
 
4. Ease of obtaining pressure reduction surfaces 
0 1 2 3 4 5 6 7 8 9 1
0 
 Not at all helpful                                                                                                           Very helpful 
 
5. Collaboration with interdisciplinary team (nursing/medicine/pharmacy/dietary) 
Part 3 potential facilitators to optimal skin care  
Below are some potential facilitators to optimal skin care. The scale ranges from 0 
(Not at all helpful) to 10 (very helpful). Please select the number that best rates these 
facilitators to your personal ability to provide optimal skin care for your patients.  
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0 1 2 3 4 5 6 7 8 9 1
0 
Not at all helpful                                                                                                            Very helpful 
 
6. Appropriate skin care products readily available 
0 1 2 3 4 5 6 7 8 9 1
0 
 Not at all helpful                                                                                                         Very helpful 
 
7. What other facilitators to pressure ulcer prevention are not included on this tool?  
 
 
 
 
8. In general, to what degree do you feel you that efforts are being made to facilitate your 
ability to prevent pressure ulcer development in the ICU? 
0 1 2 3 4 5 6 7 8 9 1
0 
Not at all                                                                                                                         A great deal 
 
 
 
 
 
 
 
1. I feel confident in my ability to prevent pressure ulcers. 
1 2 3 4 
Strongly 
disagree 
Disagree Agree Strongly agree 
 
2. I am well trained to prevent pressure ulcers. 
 
1 2 3 4 
Strongly 
disagree 
Disagree Agree Strongly agree 
 
3. Pressure ulcers are too difficult. Others are better than I am.  
1 2 3 4 
Part 4 RNs attitude towards pressure ulcer prevention   
Below are some questions about assessment of RNs’ attitude towards pressure ulcer prevention. The 
scale ranges from 1 (disagree) to 4 (strongly agree). Please select the number that indicates how much 
you agree or disagree with each of the following statements. 
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Strongly 
disagree 
Disagree Agree Strongly agree 
 
4. Too much attention goes to the prevention of pressure ulcers. 
1 2 3 4 
Strongly 
disagree 
Disagree Agree Strongly agree 
 
5. Pressure ulcer prevention is not that important.  
1 2 3 4 
Strongly 
disagree 
Disagree Agree Strongly agree 
 
6. Pressure ulcer prevention should be a priority.  
1 2 3 4 
Strongly 
disagree 
Disagree Agree Strongly agree 
 
7. A pressure ulcer almost never causes discomfort for a patient. 
1 2 3 4 
Strongly 
disagree 
Disagree Agree Strongly agree 
 
8. The impact of pressure ulcers on a patient should not be exaggerated. 
1 2 3 4 
Strongly 
disagree 
Disagree Agree Strongly agree 
 
9. The financial impact of pressure ulcers on society should not be exaggerated.  
1 2 3 4 
Strongly 
disagree 
Disagree Agree Strongly agree 
 
10. I personally do not feel nresponsible if a pressure ulcer develops in my patient. 
1 2 3 4 
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Strongly 
disagree 
Disagree Agree Strongly agree 
 
11. I personally have an important task in pressure ulcer prevention. 
1 2 3 4 
Strongly 
disagree 
Disagree Agree Strongly agree 
 
12. Pressure ulcers are preventable in high risk patients. 
1 2 3 4 
Strongly 
disagree 
Disagree Agree Strongly agree 
 
13. Pressure ulcers are never preventable. 
1 2 3 4 
Strongly 
disagree 
Disagree Agree Strongly agree 
 
 
 
Thanks for your willingness to participate. 
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7) PU Prevention Bundle Adherence Self-Report 
 
“Pressure Ulcer Prevention Bundle Adherence Self-Report” 
 Complete one bundle adherence checklist for the last shift. By completing this survey you are giving 
consent to participate in this research project related to adherence to PU prevention. 
 
 
 
1. Sex: Male  F    Female  F                  
2. Education: Diploma F    Bachelor degree  F    Master degree  F    Post registration ICU 
qualification certificate  F       
3. Number of years as a RN?  ____ Years        
4. Number of years working in the ICU? ____ Years 
5. Number of years employed in this hospital?  ____ Years   
  
 
 
 
We would like to get your best guess about how much you can rate yourself for the PrI prevention 
bundle adherence. Please make a mark on the following scale: 
10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
 
 
 
1. Please identify any barriers and facilitators in following the PU prevention bundle? 
 
 
 
 
Thanks for your willingness to participate. 
 
Part 2 RNs reflection 
Questions Strongly 
disagree 
disagree agree strongly 
agree 
1 Do you feel you have received enough education to 
conduct the Braden Scale score risk assessment? 
    
2 Do you feel you have received enough education to 
undertake comprehensive skin physical assessment? 
    
3 Do you feel you have received sufficient training in 
documenting skin integrity assessment? 
    
4 Do you feel you have received enough education 
and training regarding the role of repositioning in 
PrI prevention, correct methods for repositioning 
and use of equipment in reducing pressure, friction 
and shear forces?   
    
5 The PrI prevention was easy to implement.      
Part 1 Demographic information  
 
Part 2 Pressure ulcer prevention bundle Adherence 
 
Part 3 Potential barriers and facilitators could affect the RNs adherence 
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8) Researcher Audit of the PU Prevention Bundle   
 
 Questions Yes  No  
1 Completed Braden risk assessment scale for the patients 
within the first 24 hours after admission.  
  
2 Completed Braden risk assessment scale with any changes 
in patient’s physical condition noted, and daily risk 
assessment thereafter. 
  
3 Documented the risk assessment scale score?    
4 Completed comprehensive physical examination of the 
patient’s skin within 4 hours of ICU admission. 
  
5 Documented skin assessment within 4 hours of patient's 
admission.   
  
6 Performed physical examination of the patient’s skin 
within last 8 hours.  
  
7 Documented physical examination of the patient’s skin for 
last 8 hours. 
  
8 Performed physical examination of the patient’s skin on 
each turning/repositioning manoeuvre. 
  
9 Documented any loss of skin integrity.   
10 Reported skin integrity loss to RN in charge.   
11 Patients bed-bathed once per day.    
12 Pre-packaged wash clothes used for bed-bath.   
13 Prudent amount of moisturiser applied to dry, flaky or 
scaling skin. 
  
14 Avoided patient massage.   
15 Avoided patient skin contact with plastic surfaces (e.g., 
plastic-lined disposable underpads or plastic surface of 
pillow.  
  
16 Nutritional status assessment was undertaken by the 
specialist as per ICU current practice 
  
17 On my shift, patient was turned every 3 hours.   
18 Patients positioned in a full lateral turn    
19 Support surfaces (such as a pillow) were used for patient 
support during repositioning/ turning.  
 
  
20 Patient’s position change was done according to turn 
clock. 
  
21 Exposed skin was protected using padding, protective 
dressing. 
  
22 If clinically possible, foot of bed is elevated at 20ᵒ.   
23 If clinically possible, head of bed is positioned at 30-45? 
Or if not possible, head of bed was positioned as required. 
  
24 Patient’s heels elevated by pillow   
25 Heel protectors utilized   
26 Patient sat out of bed today   
27 (If applicable) Appropriate technique and devices used to 
assist carers with transferring and lifting patients to reduce 
friction and shear? 
  
28 Other health care teams such as physiotherapist, helped 
you to mobilise patients. 
  
29 Positioning regimes were documented including the time 
of repositioning and position adopted? 
  
30 Securement and repositioning of nasogastric tubes (NGT) 
and endotracheal tubes (ETT) every 12 hours 
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Appendix B 
LETTER AND APPROVAL TO USE THE INSTRUMENTS 
 
1) Permission letter for “Pressure Ulcer Prevention in PICU (Barriers and 
Facilitators) 
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2) The Original Instrument “Pressure Ulcer Prevention in PICU (Barriers and 
facilitators)” 
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3) Permission Letter for the Attitude Towards Pressure Ulcer Prevention 
Instrument (APuP). 
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Appendix C 
ETHICAL APPROVAL 
 
1) Ethical Approval from King Faisal Hospital, Makkah, Kingdom of Saudi 
Arabia 
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2) Ethical Approval Kind Abdul-Aziz Hospital, Makkah, Kingdom of Saudi 
Arabia  
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2) Ethical approval from Queensland university of Technology Human Research 
Ethics Committees  
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Appendix D 
PARTICIPANT INFORMATION SHEET FOR PHASE ONE, PART A 
 
RESEARCH TEAM   
Principal 
Researcher: 
Nahla Tayyib, PhD student, Queensland University of Technology (QUT) 
Associate 
Researchers: 
 
Associate Professor Fiona Coyer and Dr. Peter Lewis, QUT   
 
DESCRIPTION 
This project is being undertaken by Nahla Tayyib, student, as part of a Doctor of Philosophy 
degree in the School of Nursing at Queensland University of Technology – Australia.  
 
Ulcer to your skin, such as pressure ulcers, may cause you considerable harm, be painful and 
cause the development of serious infection which may hinder your recovery and cause you to 
stay longer in hospital. Although pressure ulcers are commonly preventable, worldwide the 
number of pressure ulcers seen in health care facilities are increasing. To date little research 
attention has been given to number of pressure ulcers occuring in critically ill patients in Saudi 
Arabian intensive care units. This study will calculate the number of new cases of pressure 
ulcers occurring in critically ill patients in intensive care unit during a consecutive two-month 
period. During the study period there will be no change to the medical and nursing practice 
you will receive in relation to your illness.   
 
You are invited to participate in this research study because any patients admitted to an 
intensive care unit are at high risk for damage to their skin such as pressure ulcer development.  
 
This participant information sheet contains detailed information about the study. Its purpose 
is to explain to you as openly and clearly as possible all procedures involved in this study. 
Please read this participant information sheet carefully. Feel free to ask questions about any 
information in the document.   
 
 
PARTICIPATION 
During an four (4) week period, we plan to collect initial information about you, and then on 
a second daily basis information about the condition of your skin. This will involve the 
prinicpal researcher assessing your skin for the possibility that you may have developed a 
pressure ulcer. This assessment will take approximately five to ten minutes. The skin 
assessments will not affect or interrupt your care in the intensive care unit care.  
 
 
 
 
EXPECTED BENEFITS 
 
PARTICIPANT INFORMATION FOR QUT RESEARCH PROJECT 
Use of an Interventional Patient Skin Integrity Care Bundle in the Intensive Care Unit to Best Manage 
Skin Integrity in Critically Ill Patients  (Pressure Ulcer Incidence) 
QUT Ethics Approval Number 1300000341 
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It is expected that this project will not directly benefit you. However, results from this study 
will inform a future research study, which will test strategies to prevent pressure ulcers 
occurring in critically ill patients in the intensive care unit.  
 
RISKS 
There are no risks beyond normal day-to-day living associated with your participation in this 
project.  However, should you develop a pressure ulcer during this study, and this has not already 
been identified by the registered nurse caring for you, the researcher will inform the registered 
nurse caring for you. You will then receive the usual care for pressure ulcers following the hospital 
policy and procedures. 
 
PRIVACY AND CONFIDENTIALITY 
All information collected for this study will be treated confidentially. This information will be 
undertaken by the researcher only.  Only the researcher will know your identity, and this will 
be during the data collection period only. All information will be kept in the strictest 
confidence in a locked filing cabinet accessible only to the researcher. It is hoped to publish a 
report of the findings of the research, but no information will be published that would allow 
any individual or organisation to be recognised.  
 
Any data collected as part of this project will be stored securely as per protocol of the Unit of 
Ethics at the hospital  
 
Please note that non-identifiable data collected in this project may be used as comparative data 
in future projects. 
 
CONSENT TO PARTICIPATE 
Measuring the number of pressure ulcers in the intensive care unit will not affect or interrupt 
the care you will receive. This study seeks to calculate the number of new cases of pressure 
ulcer in intensive care units, therefore complete patient numbers are crucial for accurate 
calculation. However, if you, or your family member, wish to opt out of this study by not 
agreeing to participate, please contact the principal researcher or let the registered nurse caring 
for you know. Your information will then be withdrawn from the study without comment or 
penalty. Your decision not to participate will not affect the care you receive in the intensive 
care unit. 
 
QUESTIONS / FURTHER INFORMATION ABOUT THE PROJECT 
If have any questions or require further information, please contact me:  
 
 
 
CONCERNS / COMPLAINTS REGARDING THE CONDUCT OF THE PROJECT 
QUT is committed to research integrity and the ethical conduct of research projects.  However, 
if you do have any concerns or complaints about the ethical conduct of the project you may 
contact the Ethic department of Ministry of Health on tel. +966567123507 or email 
makkah_research_group@hotmail.com and/or the QUT Research Ethics Unit on [+61 7] 3138 
5123 or email ethicscontact@qut.edu.au. The Ethic committee of Ministry of Health and QUT 
Research Ethics Unit are not connected with the research project and can facilitate a resolution 
to your concern in an impartial manner. 
Thank you for helping with this research project.  Please keep this sheet for your 
information.  
Nahla Tayyib – Student                                                Dr. Fiona Coyer – Principal supervisor  Dr. Peter Lewis – Associate supervisor 
School of Nursing    
Faculty  of Health 
School of Nursing  
Faculty of Health 
School of Nursing  
Faculty of Health 
Phone (+966550106868) 
Email: nahla.tayyib@student.qut.edu.au   
Phone (+61731383895) 
Email: f.coyer@qut.edu.au  
Phone (+61731383834) 
Email: p.lewis@qut.edu.au  
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Appendix E 
PARTICIPANT INFORMATION SHEET FOR PHASE ONE PART B 
 
RESEARCH TEAM   
Principal Researcher: Nahla Tayyib, PhD student, Queensland University of Technology  
Associate Researchers: 
 
Associate professor Fiona Coyer and Dr. Peter Lewis, QUT   
DESCRIPTION 
This project is being undertaken by Nahla Tayyib, student, as part of a Doctor of Philosophy 
degree in the School of Nursing at Queensland University of Technology – Australia.  
 
Although pressure ulcers are commonly preventable, worldwide the number of pressure ulcers 
seen in health care facilities are increasing.  This study is part of a future study testing ways to 
reduce pressure ulcers in the intensive care unit of this hospital. We are interested in hearing 
from you about what (if anything) gets in the way of you being able to provide optimal skin 
care for your patients, as well as what (if anything) helps you to provide optimal skin care for 
your patients. In order to effect change in practice, it is important to design a comprehensive, 
supported, and sustained approach to the prevention of pressure ulcers. Your feedback will 
assist us in identifying gaps in support and allow us to make changes as necessary to support 
your efforts in significantly reducing pressure ulcers. You are asked to complete this survey, 
as a registered nurse providing care for critically ill patients in the intensive care unit.  
 
Participation 
Your participation will involve completing an anonymous survey with 42 questions. This will 
take approximately 10 minutes of your time.  
 
Your participation in this project is entirely voluntary. If you agree to participate, we ask that 
you complete the questionnaire and then post the completed questionnaire in the mail box 
placed at the nurses' station in the intensive care unit. Your decision to participate, or not to 
participate, will in no way impact upon your current or future relationship with the hospital. 
No consequence, comment or penalty will arise if you refuse to participate in this study. 
However, as the questionnaire is anonymous, once it has been submitted (posted in the mail 
box) it will not be possible to withdraw. 
 
 
 
Expected benefits 
 
PARTICIPANT INFORMATION FOR QUT 
RESEARCH PROJECT 
– Questionnaire – 
Use of an Interventional Patient Skin Integrity Care Bundle in the Intensive Care Unit to 
Best Manage Skin Integrity in Critically Ill Patients  (Registered Nurse Survey 
"Facilitators and Barriers")  
QUT Ethics Approval Number 1300000341 
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This project is of benefit to you, as the information gained from your responses will assist 
the researchers in assessing and tailoring the training protocol for the intervention toward 
prevention of pressure ulcer in intensive care.  
 
Risks 
There are no risks beyond normal day-to-day living associated with your participation in this 
project. The hospital provides limited free counselling for research participants, who may 
experience some distress as a result of their participation in the research.  Should you wish to 
access this service please contact (the hospital counseling service (place, tel. X,). 
 
PRIVACY AND Confidentiality 
All comments and responses are anonymous and will be treated confidentially.  The names of 
individual persons are not required in any of the responses. 
 
Any data collected as part of this project will be stored securely as per QUT’s Management of 
research data policy. 
 
Please note that non-identifiable data collected in this project may be used as comparative data 
in future projects. 
 
Consent to Participate 
The return of the completed questionnaire is accepted as an indication of your consent to 
participate in this project. 
 
Questions / further information about the project 
If have any questions or require further information, please contact me:  
Nahla Tayyib – Student                                                A/Prof. Fiona Coyer – principal 
supervisor  
Dr. Peter Lewis – Associate supervisor 
School of Nursing    
Faculty  of Health 
School of Nursing  
Faculty of Health 
School of Nursing  
Faculty of Health 
Phone (+966550106868) 
Email: 
nahla.tayyib@student.qut.edu.au   
Phone (+61731383895) 
Email: f.coyer@qut.edu.au  
Phone (+61731383834) 
Email: p.lewis@qut.edu.au  
 
Concerns / complaints regarding the conduct of the project 
QUT is committed to research integrity and the ethical conduct of research projects.  However, 
if you do have any concerns or complaints about the ethical conduct of the project you may 
contact the Ethic department of Ministry of Health tel. +966567123507 or email 
makkah_research_group@hotmail.com and/or the QUT Research Ethics Unit on [+61 7] 3138 
5123 or email ethicscontact@qut.edu.au. The Ethic committee of Ministry of Health and QUT 
Research Ethics Unit are not connected with the research project and can facilitate a resolution 
to your concern in an impartial manner. 
Thank you for helping with this research project.  Please keep this sheet for your 
information. 
Appendix F 
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Participant Information Sheet for Phase Two 
1) Participant Information for Next of Kin  
 
RESEARCH TEAM 
Principal Researcher:  Nahla Tayyib, PhD student 
Principal and Associate Supervisors: Associate Professor Fiona Coyer and Dr Peter Lewis  
 
School of Nursing, Faculty of Health, Queensland University of 
Technology (QUT), Australia 
 
Part 1 What does my participation involve? 
 
1 Introduction 
Ulcer to a patient’s skin, such as a pressure ulcery, may  be painful and cause a serious 
infection, which may mean a longer stay in hospital. Although pressure ulcers are preventable, 
worldwide the number of pressure ulcers seen in health care facilities is increasing. This study 
is looking at ways to reduce pressure ulcers in intensive care units.  
 
The study will test the effectiveness of a new pressure ulcer prevention strategy, based on best 
available current evidence, aimed at reducing the number of pressure ulcers. The strategy 
consists of: risk assessment, skin assessment, skin care, nutrition, repositioning, support 
surfaces, and education and training for health care practitioners.  
 
The patient, your next of kin, is invited to participate in this research study because any patients 
admitted to an intensive care unit are at high risk for impaired skin integrity such as pressure 
ulcer development. This is sometimes due to their illness and resulting management in the 
intensive care unit.  
 
This project is being undertaken by Nahla Tayyib, student, as part of a Doctor of Philosophy 
degree at QUT. 
 
This Participant Information Sheet/Consent Form tells you about the research project. It 
explains the prevention strategies involved. Knowing what is involved will help you decide if 
you want the patient to take part in the research. 
 
Please read this information carefully. Ask questions about anything that you don’t understand 
or want to know more about. Before deciding whether or not the patient, your next of kin, 
might take part, feel free to talk about the study with a relative, friend or doctor. 
 
2 What does participation in this research involve? 
1.  
PARTICIPANT INFORMATION FOR QUT RESEARCH PROJECT 
(Next of Kin) 
Use of an Interventional Patient Skin Integrity Care Bundle in the Intensive Care Unit to 
Best Manage Skin Integrity in Critically Ill Patients   
QUT Ethics Approval Number 1300000341 
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Sometimes we do not know which care is best for improving skin condition of intensive care 
unit patients. To find out, we need to compare different care to our standard practices. We will 
put people into groups and give each group either a different care or our standard care.  
 
The results will be compared to see if one is better in improving skin integrity, or avoiding 
damage to the skin, of critically ill patients.  
 
There are no additional costs associated with participating in this study, nor will you or the 
patient, your next of kin, be paid. All medical care required as part of the research project will 
be provided to the patient, your next of kin, free of charge.  
 
Firstly, we will collect personal health information about your next of kin from their admission 
record. The information we require includes: the patient’s age, gender, nationality, body mass 
index (BMI) and clinical data including their reason for admission to the intensive care unit, 
other health conditions the patient may have, whether their admission was an emergency or 
elective admission, the length of time they may have spent in the operating theatre or 
emergency department prior to ICU admission and how long they have been in the intensive 
care unit. 
 
Secondly, this study will involve approximately 300 patients from two intensive care units in 
Saudi Arabia.  Patients in one intensive care unit will receive routine standard care and patients 
in the other intensive care unit will receive a different form of care for improving skin integrity.  
We will ask all patients admitted to the intensive care units during the study period of 4 to 6 
months to take part.  Registered nurses will deliver the care for improving skin integrity in 
each site. 
 
Thirdly, we will conduct an assessment of your next of kin’s skin on a second daily basis while 
they are in the intensive care unit. This will involve the researcher assessing the patient’s skin 
for the possibility that they may have developed a pressure ulcery. This assessment will take 
approximately five to ten minutes. The skin assessments will not affect or interrupt the 
patient’s care in the intensive care unit.  
3 Do I have to take part in this research project? 
Participation in any research project is voluntary. If you do not wish the patient, your next of 
kin, to take part, you do not have to. If you decide the patient, your next of kin, may take part 
and later change your mind, you are free to withdraw them from the project at any stage. 
 
Your decision on whether the patient, next of kin, may take part or not, or to take part and then 
withdraw, will not affect the care the patient will receive, the patient’s or your relationship 
with those giving care or with the hospital. 
4 What are the possible benefits of taking part? 
It is expected that outcomes from this project will possibly result in decreased pressure ulcer 
occurrences for critically ill patients in intensive care.   
5 What are the possible risks and disadvantages of taking part? 
There are no risks, discomfort or inconvenience beyond usual general care associated with 
patient participation in this project, as no invasive interventions will be used.  However, if the 
patient, your next of kin, experiences or has a pressure ulcer during this study, the researcher will 
inform the registered nurse caring for the patient.  The patient will then receive the usual care for 
pressure ulcers following the hospital policy and procedures. If there is any adverse effect 
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experienced by the patient, your next of kin, related to pressure area care, the intervention will 
be stopped immediately and reviewed. 
 
Part 2 How is the research project being conducted? 
 
6 What will happen to information about me? 
By signing a consent form, you consent to the researcher collecting and using personal 
information about the patient, your next of kin, for the research project. This information will 
be kept confidential by the principal researcher. The patient health information will only be 
used for the purpose of this research project and it will only be disclosed with your permission, 
except as required by law. 
 
In accordance with privacy law requirements, the patient personal data will not be directly or 
indirectly identifiable. De-identified study data in a de-identified format may be published in 
medical or scientific journals. Medical information about the patient, your next of kin, will be 
held and processed on a computer. Records created in relation to this study will be kept in a 
safe and secure archive area for 7 years as per QUT’s Management of Research Data Policy. 
7 Complaints and compensation 
QUT is committed to research integrity and the ethical conduct of research projects.  However, 
if you do have any concerns or complaints about the ethical conduct of the project you may 
contact the Ethics Department of Ministry of Health tel. +966 56 712 3507, or email 
makkah_research_group@hotmail.com and/or the QUT Research Ethics Unit on +61 7 3138 
5123 or email ethicscontact@qut.edu.au. The Ethics Committee of Ministry of Health and 
QUT Research Ethics Unit are not connected with the research project and can facilitate a 
resolution to your concern in an impartial manner.  
8 Further information and who to contact 
If have any questions or require further information please contact me:  
 
 
  
Nahla Tayyib  Dr Fiona Coyer Dr Peter Lewis 
+966 25205906 
nahla.tayyib@student.qut.edu.au  
+61 7 3138 3895 
f.coyer@qut.edu.au  
+61 7 3138 3834 
p.lewis@qut.edu.au  
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2) Participant Information for Patients  
 
 
RESEARCH TEAM  
Principal Researcher: Nahla Tayyib, PhD student 
Principal and Associate 
Supervisors: 
Associate Professor Fiona Coyer and Dr Peter Lewis 
School of Nursing, Faculty of Health, Queensland University of 
Technology (QUT), Australia 
 
Part 1 What does my participation involve? 
 
1 Introduction 
Ulcer to your skin, such as a pressure ulcer, may be painful and cause the development of 
serious infection, which may mean a longer stay in hospital. This study is looking at ways to 
reduce pressure ulcers in the intensive care unit of this hospital. This study will test the 
effectiveness of a new pressure ulcer prevention strategy based on best available current 
evidence and aimed at reducing the number of pressure ulcers in intensive care unit patients.  
 
The strategy consists of: risk assessment, skin assessment, skin care, nutrition, repositioning, 
support surfaces, and education and training for health care practitioners.  
 
You are invited to participate in this research study because any patients admitted to an 
intensive care unit are at high risk for pressure ulcer development. This is sometimes due to 
your illness and resulting care in the intensive care unit.  
 
This project is being undertaken by Nahla Tayyib, student, as part of a Doctor of Philosophy 
degree at QUT.  
 
This Participant Information Sheet/Consent Form tells you about the research project. It 
explains what the study involves. Knowing what is involved will help you decide if you want 
to take part in the research. You may want a relative to read this information to you. If you are 
able please ask questions about anything that you don’t understand or want to know more 
about.  
 
2 What does participation in this research involve? 
Sometimes we do not know which care is best for improving the skin condition of intensive 
care unit patients. To find out we need to compare different care to our standard practices. In 
this study we will put patients into groups and give each group a different care or our standard 
care. The results will be compared to see if one is better in improving skin integrity, or avoiding 
damage to the skin, of critically ill patients.  
 
There are no additional costs associated with participating in this research project. All medical 
care required as part of the research project will be provided to you free of charge.  
 
PARTICIPANT INFORMATION FOR QUT RESEARCH 
PROJECT 
Use of an Interventional Patient Skin Integrity Care Bundle in the 
Intensive Care Unit to Best Manage Skin Integrity in Critically Ill Patients  
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Firstly, we will collect personal health information about you from your admission record.  
The information we require includes: your age, gender, nationality, body mass index (BMI) 
and clinical data including your reason for admission to the intensive care unit, other health 
conditions you may have, whether your admission was an emergency or elective admission, 
the length of time you may have spent in the operating theatre or emergency department prior 
to ICU admission and how long you stayed in the intensive care unit. 
 
Secondly, this study will involve approximately 300 patients from two intensive care units in 
Saudi Arabia.  Patients in one intensive care unit will receive routine standard care and patients 
in the other intensive care unit will receive a different form of care for improving skin integrity.  
We are asking all patients admitted to the intensive care unit during the study period of 4 to 6 
months to take part.  Registered nurses will deliver the care for improving skin integrity in 
each site.   
 
Thirdly, we will conduct an assessment of your skin on a second daily basis while you are in 
the intensive care unit, as is a usual part of practice in ICU.  This will involve the researcher 
assessing your skin for the possibility that you may have developed a pressure ulcer. This 
assessment will take approximately five to ten minutes. The skin assessments will not interrupt 
your care in the intensive care unit.  
 
3 Do I have to take part in this research project? 
Participation in any research project is voluntary. If you do not wish to take part, you do not 
have to. If you decide to take part and later change your mind, you are free to withdraw from 
the project at any stage. 
 
Your decision on whether to take part or not, or to take part and then withdraw, will not affect 
the care you receive in the intensive care unit or your relationship with those providing your 
care or with the hospital. 
 
4 What are the possible benefits of taking part? 
It is expected that this project will possibly decrease and delay pressure ulcer occurrences for 
critically ill patients in intensive care by providing appropriate pressure ulcer prevention 
strategies.   
 
5 What are the possible risks and disadvantages of taking part? 
There are no risks, discomfort or inconvenience beyond usual general care associated with 
participation in this project.  However, if there is any adverse effect from the study intervention, 
the intervention will be stopped immediately, the registered nurse caring for you will be informed 
and you will then receive the usual care for pressure ulcer following hospital policy and procedures.   
 
 
Part 2 How is the research project being conducted? 
 
6 What will happen to information about me? 
By signing the consent form, you consent to the researcher collecting and using personal 
information about you for the research project. This information will be kept confidential by 
the principal researcher. In addition, your health information will only be used for the purpose 
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of this research project and it will only be disclosed with your permission, except as required 
by law. 
 
In accordance with privacy law requirements, your personal data will not be directly or 
indirectly identifiable.  De-identified study data in a de-identified format may be published in 
medical or scientific journals. Your medical information will be held and processed on a 
computer.  Records created in relation to this study will be kept in a safe and secure archive 
area for 7 years as per QUT’s Management of Research Data Policy. 
 
7 Complaints and compensation 
QUT is committed to research integrity and the ethical conduct of research projects.  However, 
if you do have any concerns or complaints about the ethical conduct of the project you may 
contact the Ethics Department of Ministry of Health tel. +966 56 712 3507 or email 
makkah_research_group@hotmail.com and/or the QUT Research Ethics Unit on +61 7 3138 
5123 or email ethicscontact@qut.edu.au. The Ethics Committee of Ministry of Health and 
QUT Research Ethics Unit are not connected with the research project and can facilitate a 
resolution to your concern in an impartial manner.  
 
8 Further information and who to contact 
If have any questions or require further information please contact me:  
 
 
  
Nahla Tayyib  Dr Fiona Coyer Dr Peter Lewis 
+966 25205906 
nahla.tayyib@student.qut.edu.au  
+61 7 3138 3895 
f.coyer@qut.edu.au  
+61 7 3138 3834 
p.lewis@qut.edu.au  
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3) Consent Form for Next of Kin  
 
RESEARCH TEAM CONTACTS 
STATEMENT OF CONSENT 
By signing below, you are indicating that you: 
x Have read and understood the information document regarding this project. 
x Have had any questions answered to your satisfaction. 
x Understand that if you or your relative has any additional questions you can 
contact the research team. 
x Understand that you are free to withdraw from the research at any time, without 
comment or penalty. 
x Understand that you can contact the Ethics Department of Ministry of Health on 
+966 56 712 3507 or email makkah_research_group@hotmail.com and/or the 
QUT Research Ethics Unit on +61 7 3138 5123 or email 
ethicscontact@qut.edu.au if you have concerns about the ethical conduct of the 
project. 
x Understand that non-identifiable data collected in this project may be used as 
comparative data in future projects. 
x Freely agree for your relative to participate in this research project  
x Understand that you will be given a signed copy of this document to keep on 
behalf of the participant [insert name of patient]. 
 
 
Name  
Signature  
Date   
 
Please return this sheet to the investigator 
  
 CONSENT FORM FOR QUT RESEARCH PROJECT 
(Next of Kin) 
Use of an Interventional Patient Skin Integrity Care Bundle in the Intensive Care 
Unit to Best Manage Skin Integrity in Critically Ill Patients   
QUT Ethics Approval Number 1300000341 
Nahla Tayyib  Dr Fiona Coyer Dr Peter Lewis 
+966 25205906 
nahla.tayyib@student.qut.edu.au  
+61 7 3138 3895 
f.coyer@qut.edu.au  
+61 7 3138 3834 
p.lewis@qut.edu.au  
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4) Consent Form for Patient   
 
RESEARCH TEAM CONTACTS 
STATEMENT OF CONSENT 
By signing below, you are indicating that you: 
x Have read and understood the information document regarding this project. 
x Have had any questions answered to your satisfaction. 
x Understand that if you have any additional questions you can contact the research 
team. 
x Understand that you are free to withdraw at any time, without comment or penalty. 
x Understand that you can contact the Ethics Department of Ministry of Health on +966 
56 712 3507 or email makkah_research_group@hotmail.com and/or the QUT 
Research Ethics Unit on +61 7 3138 5123 or email ethicscontact@qut.edu.au if you 
have concerns about the ethical conduct of the project. 
x Understand that non-identifiable data collected in this project may be used as 
comparative data in future projects. 
x Agree to participate in the project. 
 
 
Name  
Signature  
Date   
 
Please return this sheet to the investigator 
  
 CONSENT FORM FOR QUT RESEARCH PROJECT 
(Patients) 
Use of an Interventional Patient Skin Integrity Care Bundle in the Intensive Care 
Unit to Best Manage Skin Integrity in Critically Ill Patients   
QUT Ethics Approval Number 1300000341 
Nahla Tayyib  Dr Fiona Coyer Dr Peter Lewis 
+966 25205906 
nahla.tayyib@student.qut.edu.au  
+61 7 3138 3895 
f.coyer@qut.edu.au  
+61 7 3138 3834 
p.lewis@qut.edu.au  
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5) Consent Form for Registered Nurse   
 
RESEARCH TEAM CONTACTS 
STATEMENT OF CONSENT 
By signing below, you are indicating that you: 
x Have read and understood the information document regarding this project. 
x Have had any questions answered to your satisfaction. 
x Understand that if you have any additional questions you can contact the research 
team. 
x Understand that you are free to withdraw at any time, without comment or penalty. 
x Understand that you can contact the Ethics Department of Ministry of Health on +966 
56 712 3507 or email makkah_research_group@hotmail.com and/or the QUT 
Research Ethics Unit on +61 7 3138 5123 or email ethicscontact@qut.edu.au if you 
have concerns about the ethical conduct of the project. 
x Agree to participate in the project. 
 
 
Name  
Signature  
Date   
 
Please return this sheet to the investigator 
  
 CONSENT FORM FOR QUT RESEARCH PROJECT 
( Registered Nurse ) 
Use of an Interventional Patient Skin Integrity Care Bundle in the Intensive Care 
Unit to Best Manage Skin Integrity in Critically Ill Patients   
QUT Ethics Approval Number 1300000341 
Nahla Tayyib  Dr Fiona Coyer Dr Peter Lewis 
+966 25205906 
nahla.tayyib@student.qut.edu.au  
+61 7 3138 3895 
f.coyer@qut.edu.au  
+61 7 3138 3834 
p.lewis@qut.edu.au  
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6) Withdrawal of Consent for Next of Kin 
 
 
WITHDRAWAL OF CONSENT FOR QUT RESEARCH 
PROJECT 
(Next of Kin) 
Use of an Interventional Patient Skin Integrity Care Bundle in the Intensive Care Unit 
to Best Manage Skin Integrity in Critically Ill Patients   
QUT Ethics Approval Number 1300000341 
 
RESEARCH TEAM CONTACTS 
 
 
I hereby wish to withdraw my family member [insert name of patient] from taking part 
in the research project named above. 
 
I understand that this withdrawal WILL NOT jeopardise the patient relationship with 
the hospital or affect the patient care will receive. 
 
 
Name  
Signature  
Date   
 
  
Nahla Tayyib  Dr Fiona Coyer Dr Peter Lewis 
+966 550 106 868 
nahla.tayyib@student.qut.edu.au  
+61 7 3138 3895 
f.coyer@qut.edu.au  
+61 7 3138 3834 
p.lewis@qut.edu.au  
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7) Withdrawal of Consent for Patient  
 
 
WITHDRAWAL OF CONSENT FOR QUT RESEARCH 
PROJECT 
(Patient) 
Use of an Interventional Patient Skin Integrity Care Bundle in the Intensive Care Unit 
to Best Manage Skin Integrity in Critically Ill Patients   
QUT Ethics Approval Number 1300000341 
 
RESEARCH TEAM CONTACTS 
 
I hereby wish to WITHDRAW my consent to participate in the research project named 
above. 
I understand that this withdrawal WILL NOT jeopardise my relationship with 
the hospital. 
 
Name  
Signature  
Date   
 
  
Nahla Tayyib  Dr Fiona Coyer Dr Peter Lewis 
+966 550 106 868 
nahla.tayyib@student.qut.edu.au  
+61 7 3138 3895 
f.coyer@qut.edu.au  
+61 7 3138 3834 
p.lewis@qut.edu.au  
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8) Withdrawal of Consent for Registered Nurse  
 
 
WITHDRAWAL OF CONSENT FOR QUT RESEARCH 
PROJECT 
(Patient) 
Use of an Interventional Patient Skin Integrity Care Bundle in the Intensive Care Unit 
to Best Manage Skin Integrity in Critically Ill Patients   
QUT Ethics Approval Number 1300000341 
 
RESEARCH TEAM CONTACTS 
 
I hereby wish to WITHDRAW my consent to participate in the research project named 
above. 
I understand that this withdrawal WILL NOT jeopardise my relationship with 
the hospital. 
 
Name  
Signature  
Date   
 
  
Nahla Tayyib  Dr Fiona Coyer Dr Peter Lewis 
+966 550 106 868 
nahla.tayyib@student.qut.edu.au  
+61 7 3138 3895 
f.coyer@qut.edu.au  
+61 7 3138 3834 
p.lewis@qut.edu.au  
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 فريق البحث
 الباحثة:  نهلة طيب، طالبة دكتوراه
 الدكتورة فيونا كوير و الدكتور بيتر لويس 
 من كلية التمريض بجامعة كوينزلاند للتكنولوجيا استراليا
 المشرفين:
 
 
 
 ؟على ماذا تنطوي مشاركة المريض 1لجزء ا
 
 المقدمة
، قد تكون مؤلمة وتتسبب في وضع عدوى خطيرة وهو ما قد يعني بالقرح السريريةصابة الا ، مثلجلد المريضإصابة 
في وحدة العناية المركزة  القرح السريريةالبقاء لفترة أطول في المستشفى. وتبحث هذه الدراسة في سبل للحد من إصابات 
من القرح  جديدةالوقاية من الإصابات ال الجديدة في فعالية استراتيجية رختبتفي هذا المستشفى. هذه الدراسة سوف 
في مرضى وحدة  القرح السرسريةاستنادا إلى أفضل الأدلة المتاحة حاليا والتي تهدف إلى تخفيض عدد إصابات  السريرية
تغير وضعية الجسم : تقييم المخاطر، تقييم الجلد، العناية بالبشرة، والتغذية، من  العناية المركزة. تتكون استراتيجية
 . ، والتعليم والتدريب لممارسي الرعاية الصحيةللتقليل الاصابة من القرح السريرية ، الأسطح الدعمباستمرار
المرضى الذين يتم إدخالهم إلى وحدة العناية المركزة  جميعمدعو للمشاركة في هذه الدراسة البحثية لأن  مريضك، قريبك،
و  وما ينتج من الرعايةايضا  ك في بعض الأحيان بسبب مرضنتيجة هذا و. اكثر تعرضا للإصابة بالقرحالمعرضة 
  .في وحدة العناية المركزة العلاج
في جامعة كوينزلاند  تمريضدكتوراه في الال دراسة  ، كجزء منةويجري تنفيذ هذا المشروع من قبل نهلة الطيب، طالب
  .للتكنولوجيا
الدراسة. ومعرفة ما  يةنطوي علتما تفسر و تشرح  هيخبرك عن المشروع البحثي. وهذتشمل على معلومات  المنشورةهذه 
. يرجى طرح الأسئلة عن أي ث او لافي البح قلايبك المريض تنطوي تساعدك على أن تقرر إذا كنت ترغب مشاركة
  .شيء كنت لا تفهم أو تريد أن تعرف المزيد عنه
 
  نطوي؟ي ث على ماذاالبح االمشاركة في هذ 
ذلك  مرضى وحدة العناية المركزة. لمعرفةلالجلد  لسلامةأفضل  ينعرف أي الرعاية ه قد نحتاج ان  في بعض الأحيان
في هذه  بين استخدام استراتيجية جديدة للعناية بسلامة الجلد وبين الرعاية المستخدمة حاليا.حاجة إلى المقارنة ب فأننا 
و المجموعه الاخر أحد المجموعتين حزمة العناية بسلامة الجلد وإعطاء  في مجموعتين الدراسة سوف نضع المرضى 
. وسيتم مقارنة النتائج لمعرفة ما إذا واحد هو أفضل في تحسين سوف تنال العناية الحالية المقدمة في العناية لسلامة الجلد
 سلامة الجلد، الذي يعني أن البشرة تكون صحية، سليمة وغير التالفة، من مرضى مصابين بأمراض خطيرة
لمشاركة في هذا المشروع البحثي. وسيتم توفير كل الرعاية الطبية اللازمة كجزء من ل لا توجد أية تكاليف إضافية مرتبطة
 .مشروع بحثي لك مجانا
. المعلومات التي تتطلب ةالخاص بة من سجل عن المريض، قريبك،أولا، سوف نقوم بجمع المعلومات الصحية الشخصية 
في وحدة  دخولةبما في ذلك سببا  السريرية مثلا  كالطول و الوزن و  البيانات  ، ونوع الجنس، والجنسية،ةما يلي: عمر
و كم من الوقت ، سبب دخولة هل هي حالة طارئة كانلدبهم، وما العناية المركزة، وظروف صحية أخرى قد تكون 
 . في غرفة العمليات أو قسم الطوارئ قبل قبوله وحدة العناية المركزةاستغرقت 
العناية المركزة في المملكة العربية السعودية.  تىوحد منمريض  003لدراسة ما يقرب من ثانيا، سوف تنطوي هذه ا
تتلقى شكلا مختلفا من الرعاية لتحسين و الاخري والمرضى في وحدة العناية المركزة واحدة تلقي الرعاية  الروتينية 
 6إلى  4اية المركزة خلال فترة الدراسة من سلامة الجلد. نحن نطلب من جميع المرضى الذين يتم إدخالهم إلى وحدة العن
  تقديم الرعاية لتحسين سلامة الجلد في كل موقع.ب تقوم الممرضات الموجودين في العناية المركزة أشهر للمشاركة. سوف 
 
 معلومات عن البحث ( للاقرباء )
 استخدام حزمة من للعناية بسلامة جلد المرضي ذوي الحالات الحرجة  في العناية المركزية 
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في وحدة العناية المركزة، كما هو جزء من  تواجدةأثناء  يوم بعد يوم ة المريض، قريبك،ثالثا، وسنجري تقييما لبشر
. اصبت بالقرح السريريةالممارسة المعتادة في وحدة العناية المركزة. وسيشمل هذا الباحث تقييم بشرتك لاحتمال أن كنت 
 وهذا التقييم يستغرق ما يقرب من خمس إلى عشر دقائق. فإن التقييمات الجلد لا يقطع رعايتك في وحدة العناية المركزة.
 
  بحثي؟لا بد لي للمشاركة في هذا المشروع ال
إذا قررت  أو .فهذا من حقك، للمريض، قريبك، طوعية. إذا كنت لا ترغب في المشاركةتمشروع هذا لمشاركة في 
  من المشروع في أي مرحلة. للقريبك الانسحاب فلك حقتغيير في وقت لاحق ، أالمشاركة و
يتلقاها ، أو للمشاركة، ثم الانسحاب، لن يؤثر على الرعاية التي  المريض سوف يشارك او لا قرارك على ما اذا كان
  مع أولئك الذين يقدمون الرعاية الخاصة بك أو مع المستشفى. ةفي وحدة العناية المركزة أو علاقت المريض
 
  ؟ةشاركالمما هي الفوائد المحتملة من 
حرجة ال ذوي الحالاتللمرضى  بها تأخير الإصابةو القرح السريريةمن  يقللومن المتوقع أن هذا المشروع سوف ربما 
 . بالقرح السريريةلوقاية من الإصابة ل المناسبة في العناية المركزة من خلال توفير استراتيجيات
 
 ما هي المخاطر المحتملة ومساوئ المشاركة؟
المرتبطة بالمشاركة في هذا المشروع. عدم وجود مخاطر، وعدم الراحة أو إزعاج يتجاوز الرعاية العامة المعتادة متوقع ب
، الخاصة بالمريضسيتم إبلاغ ممرضة وفورا،  دراسةومع ذلك، إذا كان هناك أي تأثير سلبي من الدراسة، سيتم إيقاف ال
  القرح السريرية المتبعة في المستشفيى الرعاية المعتادة لإصابات يتلقوسوف 
  
  ؟كيف يتم هذا المشروع البحثي  2الجزء 
 
  ؟لمعلوماتك ا سيحدث ماذ
 عن المريض، قريبك،جمع واستخدام المعلومات الشخصية بلباحث ل منك ةموافق.  على استمارة الموافقة توقيعكن خلال م
لمشروع البحث. وسيتم الإبقاء على سرية هذه المعلومات من قبل الباحث الرئيسي. وبالإضافة إلى ذلك، لن يستخدم 
، باستثناء ما اذا رضيتملغرض هذا المشروع البحثي وسيتم فقط الكشف عنه  مريض الابالالمعلومات الصحية الخاصة 
 .يقتضيه القانون
مباشرة أو غير مباشرة. نشر لن يتمكن احد من معرقة شخصية المريض بطريقة   وفقا لمتطلبات القانون والخصوصية،
في المجلات الطبية أو العلمية. وستعقد المعلومات الطبية  نتائج بدون تحديد المشاركين شخصياشكل  علىبيانات الدراسة 
ومعالجتها على جهاز كمبيوتر. سيتم الاحتفاظ السجلات التي تم إنشاؤها في إطار هذه الدراسة في آمنة  المريضالخاصة ب
 . البيانات البحثية لحفظسنوات وفقا لإدارة جامعة كوينزلاند  7ومأمونة منطقة الأرشيف لمدة 
 
  اوى والتعويضالشك 
وتلتزم جامعة كوينزلاند للتكنولوجيا في السلامة البحوث والسلوك الأخلاقي من المشاريع البحثية. ومع ذلك، إذا كان لديك 
 217 65 669أية مخاوف أو شكاوى حول السلوك الأخلاقي للمشروع قد اتصل بقسم أخلاقيات وزارة الصحة هاتف. +
و / أو وحدة أخلاقيات البحوث جامعة  moc.liamtoh@puorg_hcraeser_hakkam  أو البريد الإلكتروني 7053
البريد الإلكتروني. ولا ترتبط لجنة  ua.ude.tuq@tcatnocscihte  أو 3215 8313 7 16كوينزلاند للتكنولوجيا في +
بحثي ويمكن تسهيل الأخلاقيات من وزارة وحدة أخلاقيات البحوث الصحية وجامعة كوينزلاند للتكنولوجيا مع المشروع ال
 التوصل إلى حل لقلق الخاص بك بطريقة نزيهة
 
 مزيد من المعلومات والذين في الاتصال 
 إذا كان لديك أي أسئلة أو تحتاج إلى مزيد من المعلومات، يرجى الاتصال بي
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 فريق البحث
 الباحثة:  نهلة طيب، طالبة دكتوراه
 الدكتورة فيونا كوير و الدكتور بيتر لويس 
 من كلية التمريض بجامعة كوينزلاند للتكنولوجيا استراليا
 المشرفين:
 
 
 
 ؟على ماذا تنطوي مشاركتي 1الجزء 
 المقدمة 1
، قد تكون مؤلمة وتتسبب في وضع عدوى خطيرة وهو ما قد يعني البقاء بالقرح السريريةصابة الا إصابة لبشرتك، مثل
ة في هذا في وحدة العناية المركز القرح السريريةلفترة أطول في المستشفى. وتبحث هذه الدراسة في سبل للحد من إصابات 
ن القرح م ابات الجديدةالوقاية من الإص الجديدة في فعالية من ضغط استراتيجية رختبتالمستشفى. هذه الدراسة سوف 
رضى وحدة في م القرح السرسريةاستنادا إلى أفضل الأدلة المتاحة حاليا والتي تهدف إلى تخفيض عدد إصابات  السريرية
، عية الجسم باستمرارتغير وض: تقييم المخاطر، تقييم الجلد، العناية بالبشرة، والتغذية، من  العناية المركزة. تتكون استراتيجية
 .، والتعليم والتدريب لممارسي الرعاية الصحيةللتقليل الاصابة من القرح السريرية الدعم الأسطح
كثر االمرضى الذين يتم إدخالهم إلى وحدة العناية المركزة المعرضة  جميعأنت مدعو للمشاركة في هذه الدراسة البحثية لأن 
حدة العناية في و و العلاج وما ينتج من الرعايةايضا  في بعض الأحيان بسبب مرضك نتيجة هذا و. تعرضا للإصابة بالقرح
 .المركزة
 في جامعة كوينزلاند تمريضدكتوراه في الال دراسة  ، كجزء منةويجري تنفيذ هذا المشروع من قبل نهلة الطيب، طالب
 .للتكنولوجيا
ا الدراسة. ومعرفة م يةنطوي علتما تفسر و تشرح  هيخبرك عن المشروع البحثي. وهذتشمل على معلومات  المنشورةهذه 
. ةيمكنك الاستعانة بعائلتك في قراءة المنشور. ث او لاتنطوي تساعدك على أن تقرر إذا كنت ترغب في المشاركة في البح
 .إذا كنت قادرا يرجى طرح الأسئلة عن أي شيء كنت لا تفهم أو تريد أن تعرف المزيد عنه
 ي؟نطوي ث على ماذاالبح االمشاركة في هذ 2
 ك فأننا ذل مرضى وحدة العناية المركزة. لمعرفةلالجلد  لسلامةأفضل  ينعرف أي الرعاية ه قد نحتاج ان  في بعض الأحيان
ذه الدراسة في ه بين استخدام استراتيجية جديدة للعناية بسلامة الجلد وبين الرعاية المستخدمة حاليا.حاجة إلى المقارنة ب
أحد المجموعتين حزمة العناية بسلامة الجلد و المجموعه الاخر سوف تنال وإعطاء  في مجموعتين سوف نضع المرضى 
. وسيتم مقارنة النتائج لمعرفة ما إذا واحد هو أفضل في تحسين سلامة الجلد، العناية الحالية المقدمة في العناية لسلامة الجلد
 بين بأمراض خطيرةالذي يعني أن البشرة تكون صحية، سليمة وغير التالفة، من مرضى مصا
لمشاركة في هذا المشروع البحثي. وسيتم توفير كل الرعاية الطبية اللازمة كجزء من ل لا توجد أية تكاليف إضافية مرتبطة
 .مشروع بحثي لك مجانا
الخاص بك. المعلومات التي تتطلب ما يلي: عمرك، ك أولا، سوف نقوم بجمع المعلومات الصحية الشخصية عنك من سجل
عناية في وحدة ال دخولكبما في ذلك سببا  السريرية مثلا  كالطول و الوزن و  والسريرية البيانات الجنس، والجنسية،ونوع 
 فيو كم من الوقت استغرقت ، سبب دخولك هل هي حالة طارئة كانلدبكم، وما المركزة، وظروف صحية أخرى قد تكون 
 .اية المركزةغرفة العمليات أو قسم الطوارئ قبل قبوله وحدة العن
العناية المركزة في المملكة العربية السعودية.  تىوحد منمريض  003ثانيا، سوف تنطوي هذه الدراسة ما يقرب من 
لامة تتلقى شكلا مختلفا من الرعاية لتحسين سو الاخري والمرضى في وحدة العناية المركزة واحدة تلقي الرعاية  الروتينية 
أشهر  6إلى  4رضى الذين يتم إدخالهم إلى وحدة العناية المركزة خلال فترة الدراسة من الجلد. نحن نطلب من جميع الم
 تقديم الرعاية لتحسين سلامة الجلد في كل موقع.ب تقوم الممرضات الموجودين في العناية المركزة للمشاركة. سوف 
ركزة، كما هو جزء من الممارسة المعتادة في أثناء وجودك في وحدة العناية الم يوم بعد يومثالثا، وسنجري تقييما لبشرتك 
يستغرق ما  . وهذا التقييماصبت بالقرح السريريةوحدة العناية المركزة. وسيشمل هذا الباحث تقييم بشرتك لاحتمال أن كنت 
 يقرب من خمس إلى عشر دقائق. فإن التقييمات الجلد لا يقطع رعايتك في وحدة العناية المركزة.
  
 
  (للمريض)معلومات عن البحث 
 استخدام حزمة من للعناية بسلامة جلد المرضي ذوي الحالات الحرجة  في العناية المركزية 
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 شاركة في هذا المشروع البحثي؟لا بد لي للم 3
 تغيير في وقتأإذا قررت المشاركة و أو .فهذا من حقكطوعية. إذا كنت لا ترغب في المشاركة، تمشروع هذا لمشاركة في 
 الانسحاب من المشروع في أي مرحلة. فلك حقلاحق ، 
الرعاية التي تتلقاها في وحدة العناية  قرارك على ما اذا كانت ستشارك أم لا، أو للمشاركة، ثم الانسحاب، لن يؤثر على
 المركزة أو علاقتك مع أولئك الذين يقدمون الرعاية الخاصة بك أو مع المستشفى.
 
 ؟ةشاركالمما هي الفوائد المحتملة من  4
ي ة فحرجال ذوي الحالاتللمرضى  بها وتأخير الإصابة القرح السريريةمن  يقللومن المتوقع أن هذا المشروع سوف ربما 
 .بالقرح السريريةلوقاية من الإصابة ل المناسبة العناية المركزة من خلال توفير استراتيجيات
 
 ما هي المخاطر المحتملة ومساوئ المشاركة؟ 5
عدم وجود مخاطر، وعدم الراحة أو إزعاج يتجاوز الرعاية العامة المعتادة المرتبطة بالمشاركة في هذا المشروع. متوقع ب
سوف ، والخاصة بكسيتم إبلاغ ممرضة وفورا،  دراسةكان هناك أي تأثير سلبي من الدراسة، سيتم إيقاف الومع ذلك، إذا 
 القرح السريرية المتبعة في المستشفي تتلقى الرعاية المعتادة لإصابات 
 ؟كيف يتم هذا المشروع البحثي  2الجزء 
 
 ؟لمعلوماتك ماذا سيحدث  6
جمع واستخدام المعلومات الشخصية عنك لمشروع البحث. بلباحث ل منك ةموافق.  على استمارة الموافقة توقيعكن خلال م
وسيتم الإبقاء على سرية هذه المعلومات من قبل الباحث الرئيسي. وبالإضافة إلى ذلك، لن يستخدم إلا في المعلومات الصحية 
 .، باستثناء ما يقتضيه القانوناذا رضيتمنه الخاصة بك لغرض هذا المشروع البحثي وسيتم فقط الكشف ع
مباشرة أو غير مباشرة. نشر بيانات  بطريقة  لن يتمكن احد من اعرف شخصيك سواء وفقا لمتطلبات القانون والخصوصية،
في المجلات الطبية أو العلمية. وستعقد المعلومات الطبية الخاصة  نتائج بدون تحديد المشاركين شخصياشكل  علىالدراسة 
بك ومعالجتها على جهاز كمبيوتر. سيتم الاحتفاظ السجلات التي تم إنشاؤها في إطار هذه الدراسة في آمنة ومأمونة منطقة 
 .البيانات البحثية لحفظسنوات وفقا لإدارة جامعة كوينزلاند  7الأرشيف لمدة 
 
 والتعويضالشكاوى  7
وتلتزم جامعة كوينزلاند للتكنولوجيا في السلامة البحوث والسلوك الأخلاقي من المشاريع البحثية. ومع ذلك، إذا كان لديك 
 217 65 669أية مخاوف أو شكاوى حول السلوك الأخلاقي للمشروع قد اتصل بقسم أخلاقيات وزارة الصحة هاتف. +
و / أو وحدة أخلاقيات البحوث جامعة  moc.liamtoh@puorg_hcraeser_hakkam أو البريد الإلكتروني 7053
البريد الإلكتروني. ولا ترتبط لجنة  ua.ude.tuq@tcatnocscihte أو 3215 8313 7 16كوينزلاند للتكنولوجيا في +
سهيل ويمكن ت الأخلاقيات من وزارة وحدة أخلاقيات البحوث الصحية وجامعة كوينزلاند للتكنولوجيا مع المشروع البحثي
 التوصل إلى حل لقلق الخاص بك بطريقة نزيهة
 
 مزيد من المعلومات والذين في الاتصال 8
 .:إذا كان لديك أي أسئلة أو تحتاج إلى مزيد من المعلومات، يرجى الاتصال بي
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 فريق البحث
 
 
 الموافقة بيان
 :تشير إلى أنك، أنت أدناه من خلال التوقيع
 قرأت وفهمت وثيقة المعلومات بخصوص هذا المشروع.• 
 على أية أسئلة لالارتياح الخاص بك. هل كان الرد• 
 أنه إذا كنت أنت أو قريبك لديه أي أسئلة إضافية يمكنك الاتصال فريق البحث. تفهم• 
 أن أنت حر في الانسحاب من البحث في أي وقت، دون تعليق أو جزاء. تفهم• 
أو البريد الإلكتروني  7053 217 65 669أنه يمكنك الاتصال بقسم الأخلاقيات وزارة الصحة على + تفهم• 
و / أو وحدة أخلاقيات البحوث جامعة كوينزلاند  moc.liamtoh@puorg_hcraeser_hakkam
لديك مخاوف  ua.ude.tuq@tcatnocscihteأو البريد الإلكتروني إذا  3215 8313 7 16للتكنولوجيا في +
 حول السلوك الأخلاقي للمشروع.
التي تم جمعها في هذا المشروع يمكن استخدام البيانات المقارنة في  أن البيانات غير قابلة للتعريف تفهم• 
 المشاريع المستقبلية.
 توافق بحرية لقريبك للمشاركة في هذا المشروع البحثي• 
 المشاركين [يدرج اسم المريض].أنك سوف تعطى نسخة موقعة من هذه الوثيقة للحفاظ على نيابة عن  تفهم• 
 
 
  الاسم
  التوقيع
   التاريخ
 
 
 
 الباحث إلى الورقة يرجى إعادة هذه
  
 
   علي المشاركة بالبحثموافقة 
 )لاقرباء(
 ot tinU eraC evisnetnI eht ni eldnuB eraC ytirgetnI nikS tneitaP lanoitnevretnI na fo esU
   stneitaP llI yllacitirC ni ytirgetnI nikS eganaM tseB
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 موافقة علي المشاركة بالبحث
 eraC evisnetnI eht ni eldnuB eraC ytirgetnI nikS tneitaP lanoitnevretnI na fo esU
   stneitaP llI yllacitirC ni ytirgetnI nikS eganaM tseB ot tinU
 1430000031 rebmuN lavorppA scihtE TUQ
 
 فريق البحث
 
 
 الموافقة بيان
 :تشير إلى أنك، أنت أدناه من خلال التوقيع
 .المشروع بخصوص هذا وثيقة المعلومات قرأت وفهمت
 .مناسبا على أية أسئلةالرد  هل كان •
 .فريق البحث يمكنك الاتصال أسئلة إضافية كان لديك أي أنه إذا فهمت •
 .جزاء أو دون تعليق، في أي وقت الانسحاب أنت حر في أن فهمت •
 أو البريد الإلكتروني 7053 217 65 669+ على وزارة الصحة الأخلاقيات الاتصال بقسم أنه يمكنك فهم •
 في جامعة كوينزلاند للتكنولوجيا أخلاقيات البحوث أو وحدة / و moc.liamtoh@puorg_hcraeser_hakkam
السلوك  حول لديك مخاوفكان  اذا ua.ude.tuq@tcatnocscihte  أو البريد الإلكتروني 3215 8313 7 16+
 .للمشروع الأخلاقي
 .ليةالمشاريع المستقب في البيانات المقارنة يمكن استخدامو هذا المشروع في غير قابلة للتعريف أن البيانات فهمت •
 في المشروع الموافقة على المشاركة •
 
 
  الاسم
  التوقيع
   التاريخ
 
 
 
 الباحث إلى الورقة يرجى إعادة هذه
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